Document:

EX-10.1

 Exhibit 10.1 
 Execution Version 
 ABL CREDIT AGREEMENT 

among 
 MOBILE
MINI, INC., 
 THE OTHER BORROWERS AND GUARANTORS PARTY HERETO, 

THE VARIOUS LENDERS PARTY HERETO 
 and 
 DEUTSCHE BANK AG NEW YORK BRANCH, 

as ADMINISTRATIVE AGENT 
  

 
 Dated as of
February 22, 2012 
  
  

 
 DEUTSCHE BANK SECURITIES INC., 

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED and 
 J.P. MORGAN SECURITIES LLC, 
 as JOINT LEAD ARRANGERS and JOINT BOOKRUNNERS

 BANK OF AMERICA, N.A. and 
 JPMORGAN CHASE BANK, N.A., 
 as CO-SYNDICATION AGENTS, 

And 
 BARCLAYS
BANK PLC, SUNTRUST BANK and WELLS FARGO CAPITAL FINANCE, LLC, 
 as SENIOR MANAGING AGENTS and CO-DOCUMENTATION AGENTS 

 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	 SECTION 1.
	 	 Definitions and Accounting Terms
	  	 	1	  
			
	 1.01
	 	 Defined Terms
	  	 	1	  
			
	 SECTION 2.
	 	 Amount and Terms of Credit
	  	 	59	  
			
	 2.01
	 	 The Commitments
	  	 	59	  
	 2.02
	 	 Minimum Amount of Each Borrowing
	  	 	64	  
	 2.03
	 	 Notice of Borrowing
	  	 	64	  
	 2.04
	 	 Disbursement of Funds
	  	 	65	  
	 2.05
	 	 Notes
	  	 	67	  
	 2.06
	 	 Conversions
	  	 	68	  
	 2.07
	 	 Pro Rata Borrowings
	  	 	69	  
	 2.08
	 	 Interest
	  	 	69	  
	 2.09
	 	 Interest Periods
	  	 	70	  
	 2.10
	 	 Increased Costs, Illegality, etc.
	  	 	71	  
	 2.11
	 	 Compensation
	  	 	74	  
	 2.12
	 	 Change of Lending Office
	  	 	74	  
	 2.13
	 	 Replacement of Lenders
	  	 	74	  
	 2.14
	 	 US Company as Agent for US Borrowers, UK Company as Agent for UK Borrower and Canadian Company as Agent for Canadian Borrowers
	  	 	75	  
	 2.15
	 	 Incremental Commitments
	  	 	77	  
	 2.16
	 	 UK Revolving Loans and Canadian Revolving Loans; Intra-Lender Issues
	  	 	79	  
	 2.17
	 	 Equivalent Amount
	  	 	82	  
	 2.18
	 	 Provisions Regarding Bankers’ Acceptances, Drafts, etc.
	  	 	83	  
	 2.19
	 	 Defaulting Lenders
	  	 	83	  
			
	 SECTION 3.
	 	 Letters of Credit
	  	 	84	  
			
	 3.01
	 	 US Letters of Credit
	  	 	84	  
	 3.02
	 	 UK Letters of Credit
	  	 	85	  
	 3.03
	 	 Canadian Letters of Credit
	  	 	86	  
	 3.04
	 	 Maximum US Letter of Credit Outstandings; Final Maturities
	  	 	87	  
	 3.05
	 	 Maximum UK Letter of Credit Outstandings; Final Maturities
	  	 	87	  
	 3.06
	 	 Maximum Canadian Letter of Credit Outstandings; Final Maturities
	  	 	88	  
	 3.07
	 	 US Letter of Credit Requests; Minimum Stated Amount
	  	 	88	  
	 3.08
	 	 UK Letter of Credit Requests; Minimum Stated Amount
	  	 	89	  
	 3.09
	 	 Canadian Letter of Credit Requests; Minimum Stated Amount
	  	 	89	  
	 3.10
	 	 US Letter of Credit Participations
	  	 	90	  
	 3.11
	 	 UK Letter of Credit Participations
	  	 	91	  
	 3.12
	 	 Canadian Letter of Credit Participations
	  	 	93	  
	 3.13
	 	 Agreement to Repay US Letter of Credit Drawings
	  	 	95	  
	 3.14
	 	 Agreement to Repay UK Letter of Credit Drawings
	  	 	96	  

  
 i 

  

							
	 	 	 	  	Page	 
			
	 3.15
	 	 Agreement to Repay Canadian Letter of Credit Drawings
	  	 	97	  
	 3.16
	 	 Increased Costs – US Letters of Credit
	  	 	97	  
	 3.17
	 	 Increased Costs – UK Letters of Credit
	  	 	98	  
	 3.18
	 	 Increased Costs – Canadian Letters of Credit
	  	 	99	  
			
	 SECTION 4.
	 	 Commitment Commission; Fees; Reductions of Commitment
	  	 	99	  
			
	 4.01
	 	 Fees
	  	 	99	  
	 4.02
	 	 Voluntary Termination of Unutilized Commitments
	  	 	101	  
	 4.03
	 	 Mandatory Reduction of Commitments
	  	 	101	  
			
	 SECTION 5.
	 	 Prepayments; Payments; Taxes
	  	 	101	  
			
	 5.01
	 	 Voluntary Prepayments
	  	 	101	  
	 5.02
	 	 Mandatory Repayments; Cash Collateralization
	  	 	102	  
	 5.03
	 	 Method and Place of Payment
	  	 	106	  
	 5.04
	 	 Net Payments – US Borrowers
	  	 	109	  
	 5.05
	 	 Tax Gross Up and Indemnities – UK Subsidiaries
	  	 	111	  
	 5.06
	 	 Net Payments – Canadian Borrowers
	  	 	118	  
			
	 SECTION 6.
	 	 Conditions Precedent to Credit Events on the Effective Date
	  	 	119	  
			
	 6.01
	 	 Effective Date; Notes
	  	 	119	  
	 6.02
	 	 Officer’s Certificate
	  	 	119	  
	 6.03
	 	 Opinions of Counsel
	  	 	119	  
	 6.04
	 	 Company Documents; Proceedings; etc.
	  	 	120	  
	 6.05
	 	 Consummation of the Transactions; etc.
	  	 	121	  
	 6.06
	 	 No Material Adverse Effect on US Company
	  	 	121	  
	 6.07
	 	 US Pledge Agreement
	  	 	121	  
	 6.08
	 	 UK Share Charge
	  	 	121	  
	 6.09
	 	 US Security Agreement
	  	 	122	  
	 6.10
	 	 UK Debentures
	  	 	122	  
	 6.11
	 	 Canadian Security Agreement and Canadian Share Pledge Agreement
	  	 	122	  
	 6.12
	 	 Luxembourg Security Agreement and Luxembourg Share Charge
	  	 	123	  
	 6.13
	 	 Mortgages
	  	 	123	  
	 6.14
	 	 Financial Statements; Pro Forma Balance Sheet; Projections; etc.
	  	 	123	  
	 6.15
	 	 Solvency Certificate; Insurance Certificates
	  	 	124	  
	 6.16
	 	 Fees, etc.
	  	 	124	  
	 6.17
	 	 Initial Borrowing Base Certificate; etc.
	  	 	124	  
	 6.18
	 	 No Defaults under Senior Note Indentures
	  	 	124	  
	 6.19
	 	 Patriot Act
	  	 	124	  
	 6.20
	 	 Absence of Litigation
	  	 	124	  
	 6.21
	 	 Margin Regulations
	  	 	124	  
			
	 SECTION 7.
	 	 Conditions Precedent to All Credit Events
	  	 	125	  
			
	 7.01
	 	 No Default; Representations and Warranties
	  	 	125	  
	 7.02
	 	 Notice of Borrowing; Letter of Credit Request
	  	 	125	  

  
 ii 

  

							
	 	 	 	  	Page	 
			
	 SECTION 8.
	 	 Representations, Warranties and Agreements
	  	 	126	  
			
	 8.01
	 	 Organization and Qualification
	  	 	126	  
	 8.02
	 	 Power and Authority; No Violation
	  	 	126	  
	 8.03
	 	 Legally Enforceable Agreement
	  	 	126	  
	 8.04
	 	 Capital Structure
	  	 	127	  
	 8.05
	 	 Names
	  	 	127	  
	 8.06
	 	 Business Locations; Agent for Process
	  	 	127	  
	 8.07
	 	 Title to Properties; Priority of Liens
	  	 	127	  
	 8.08
	 	 Accounts
	  	 	128	  
	 8.09
	 	 Equipment
	  	 	128	  
	 8.10
	 	 Financial Statements; Financial Condition; Undisclosed Liabilities; Projections
	  	 	128	  
	 8.11
	 	 Full Disclosure
	  	 	129	  
	 8.12
	 	 Surety Obligations
	  	 	129	  
	 8.13
	 	 Tax Returns and Payments
	  	 	129	  
	 8.14
	 	 Dutch Credit Parties and Luxembourg Subsidiary
	  	 	130	  
	 8.15
	 	 Intellectual Property, etc.
	  	 	130	  
	 8.16
	 	 Government Consents
	  	 	130	  
	 8.17
	 	 Compliance with Laws
	  	 	130	  
	 8.18
	 	 Restrictions
	  	 	130	  
	 8.19
	 	 Litigation
	  	 	131	  
	 8.20
	 	 No Defaults
	  	 	131	  
	 8.21
	 	 Leases
	  	 	131	  
	 8.22
	 	 Use of Proceeds; Margin Regulations
	  	 	131	  
	 8.23
	 	 Compliance with ERISA
	  	 	131	  
	 8.24
	 	 Trade Relations
	  	 	133	  
	 8.25
	 	 Security Documents
	  	 	133	  
	 8.26
	 	 Investment Company Act
	  	 	134	  
	 8.27
	 	 Representations and Warranties in Other Credit Documents
	  	 	134	  
	 8.28
	 	 Environmental Matters
	  	 	134	  
	 8.29
	 	 Employment and Labor Relations
	  	 	135	  
	 8.30
	 	 Indebtedness
	  	 	135	  
	 8.31
	 	 Insurance
	  	 	135	  
	 8.32
	 	 Plans; Non-Compete Agreements; Collective Bargaining Agreements; Existing Indebtedness Agreements
	  	 	135	  
	 8.33
	 	 Anti-Terrorism Laws
	  	 	136	  
	 8.34
	 	 UK Pensions
	  	 	136	  
			
	 SECTION 9.
	 	 Affirmative Covenants
	  	 	136	  
			
	 9.01
	 	 Information Covenants
	  	 	136	  
	 9.02
	 	 Books, Records and Inspections; Field Examinations; Appraisals; Records and Reports of Inventory, Machinery and Equipment
	  	 	140	  
	 9.03
	 	 Maintenance of Property; Insurance
	  	 	141	  
	 9.04
	 	 Administration of Equipment; Maintenance of Equipment
	  	 	142	  
	 9.05
	 	 Existence; Franchises
	  	 	142	  

  
 iii

  

							
	 	 	 	  	Page	 
			
	 9.06
	 	 Compliance with Statutes, etc.
	  	 	143	  
	 9.07
	 	 Compliance with Environmental Laws
	  	 	143	  
	 9.08
	 	 ERISA
	  	 	143	  
	 9.09
	 	 End of Fiscal Years; Fiscal Quarters
	  	 	145	  
	 9.10
	 	 Performance of Obligations
	  	 	145	  
	 9.11
	 	 Payment of Taxes
	  	 	145	  
	 9.12
	 	 Use of Proceeds
	  	 	145	  
	 9.13
	 	 Additional Security; Further Assurances; etc.
	  	 	145	  
	 9.14
	 	 Convertible Preferred Stock
	  	 	146	  
	 9.15
	 	 Projections
	  	 	147	  
	 9.16
	 	 Landlord, Processor and Storage Agreements
	  	 	147	  
	 9.17
	 	 Deposit and Brokerage Accounts
	  	 	147	  
	 9.18
	 	 Credit Party Financial Statements
	  	 	147	  
	 9.19
	 	 Qualified Derivative Obligations
	  	 	147	  
	 9.20
	 	 Centre of Main Interest
	  	 	147	  
	 9.21
	 	 Administration of Accounts
	  	 	147	  
			
	 SECTION 10.
	 	 Negative Covenants
	  	 	148	  
			
	 10.01
	 	 [Reserved]
	  	 	148	  
	 10.02
	 	 Liens
	  	 	148	  
	 10.03
	 	 Sale of Assets
	  	 	149	  
	 10.04
	 	 Restricted Payments
	  	 	150	  
	 10.05
	 	 Indebtedness
	  	 	151	  
	 10.06
	 	 Contingent Obligations
	  	 	154	  
	 10.07
	 	 Advances, Investments and Loans
	  	 	154	  
	 10.08
	 	 Transactions with Affiliates
	  	 	155	  
	 10.09
	 	 Registered Pension Plans
	  	 	155	  
	 10.10
	 	 Additional Negative Pledges
	  	 	155	  
	 10.11
	 	 No Subsidiaries
	  	 	155	  
	 10.12
	 	 Operating Leases; Off-Balance Sheet Financing
	  	 	156	  
	 10.13
	 	 Permitted Acquisitions
	  	 	157	  
	 10.14
	 	 Modifications of Certificate of Incorporation, By-Laws and Certain Other Agreements, etc.
	  	 	158	  
	 10.15
	 	 Limitation on Certain Restrictions on Subsidiaries
	  	 	159	  
	 10.16
	 	 Limitation on Issuance of Equity Interests
	  	 	159	  
	 10.17
	 	 Business; etc.
	  	 	159	  
	 10.18
	 	 No Additional Deposit Accounts; etc.
	  	 	159	  
	 10.19
	 	 Tax Consolidation
	  	 	160	  
	 10.20
	 	 Fiscal Year End
	  	 	160	  
	 10.21
	 	 Applicability of Financial Covenants
	  	 	160	  
	 10.22
	 	 Fixed Charge Coverage Ratio
	  	 	160	  
	 10.23
	 	 Debt Ratio
	  	 	160	  
			
	 SECTION 11.
	 	 Events of Default
	  	 	161	  
			
	 11.01
	 	 Payment of Obligations
	  	 	161	  

  
 iv 

  

							
	 	 	 	  	Page	 
			
	 11.02
	 	 Misrepresentations
	  	 	161	  
	 11.03
	 	 Breach of Specific Covenants
	  	 	161	  
	 11.04
	 	 Breach of Other Covenants
	  	 	162	  
	 11.05
	 	 Default Under Other Agreements
	  	 	162	  
	 11.06
	 	 Failure of Enforceability of Credit Documents; Security
	  	 	162	  
	 11.07
	 	 Canadian Insolvency and Related Proceedings
	  	 	162	  
	 11.08
	 	 Insolvency and Related Proceedings
	  	 	162	  
	 11.09
	 	 Business Disruption; Condemnation
	  	 	163	  
	 11.10
	 	 ERISA
	  	 	163	  
	 11.11
	 	 Guarantee
	  	 	164	  
	 11.12
	 	 Criminal Forfeiture
	  	 	164	  
	 11.13
	 	 Judgments
	  	 	164	  
	 11.14
	 	 Change of Control
	  	 	164	  
			
	 SECTION 12.
	 	 The Administrative Agent and the Collateral Agent
	  	 	165	  
			
	 12.01
	 	 Appointment
	  	 	165	  
	 12.02
	 	 Nature of Duties
	  	 	165	  
	 12.03
	 	 Lack of Reliance on the Administrative Agent and the Collateral Agent
	  	 	166	  
	 12.04
	 	 Certain Rights of the Agents
	  	 	166	  
	 12.05
	 	 Reliance
	  	 	166	  
	 12.06
	 	 Indemnification
	  	 	167	  
	 12.07
	 	 The Administrative Agent and the Collateral Agent in their Individual Capacities
	  	 	167	  
	 12.08
	 	 Holders
	  	 	167	  
	 12.09
	 	 Resignation by the Administrative Agent and the Collateral Agent
	  	 	167	  
	 12.10
	 	 Collateral Matters
	  	 	168	  
	 12.11
	 	 Delivery of Information
	  	 	169	  
	 12.12
	 	 Withholding
	  	 	169	  
	 12.13
	 	 Delegation of Duties
	  	 	170	  
	 12.14
	 	 Quebec Security
	  	 	170	  
			
	 SECTION 13.
	 	 Miscellaneous
	  	 	171	  
			
	 13.01
	 	 Payment of Expenses, etc.
	  	 	171	  
	 13.02
	 	 Right of Setoff
	  	 	172	  
	 13.03
	 	 Notices
	  	 	173	  
	 13.04
	 	 Benefit of Agreement; Assignments; Participations
	  	 	174	  
	 13.05
	 	 No Waiver; Remedies Cumulative
	  	 	176	  
	 13.06
	 	 Payments Pro Rata
	  	 	177	  
	 13.07
	 	 Calculations; Computations
	  	 	177	  
	 13.08
	 	 GOVERNING LAW; SUBMISSION TO JURISDICTION; VENUE; WAIVER OF JURY TRIAL
	  	 	178	  
	 13.09
	 	 Counterparts
	  	 	179	  
	 13.10
	 	 Effectiveness
	  	 	179	  
	 13.11
	 	 Headings Descriptive
	  	 	179	  
	 13.12
	 	 Amendment or Waiver; etc.
	  	 	179	  

  
 v 

  

							
	 	 	 	  	Page	 
			
	 13.13
	 	 Survival
	  	 	181	  
	 13.14
	 	 Domicile of Loans
	  	 	181	  
	 13.15
	 	 Register
	  	 	182	  
	 13.16
	 	 Confidentiality
	  	 	182	  
	 13.17
	 	 No Fiduciary Duty
	  	 	183	  
	 13.18
	 	 Patriot Act
	  	 	183	  
	 13.19
	 	 Interest Rate Limitation
	  	 	183	  
	 13.20
	 	 Release of Borrowers
	  	 	184	  
			
	 SECTION 14.
	 	 Nature of Borrower Obligations
	  	 	184	  
			
	 14.01
	 	 Nature of Borrower Obligations
	  	 	184	  
	 14.02
	 	 Independent Obligation
	  	 	184	  
	 14.03
	 	 Authorization
	  	 	185	  
	 14.04
	 	 Reliance
	  	 	185	  
	 14.05
	 	 Contribution; Subrogation
	  	 	185	  
	 14.06
	 	 Waiver
	  	 	185	  
			
	 SECTION 15.
	 	 Guarantee
	  	 	186	  
			
	 15.01
	 	 The Guarantees
	  	 	186	  
	 15.02
	 	 Obligations Unconditional
	  	 	186	  
	 15.03
	 	 Reinstatement
	  	 	189	  
	 15.04
	 	 Subrogation; Subordination
	  	 	189	  
	 15.05
	 	 Remedies
	  	 	189	  
	 15.06
	 	 Instrument for Payment of Money
	  	 	190	  
	 15.07
	 	 Continuing Guarantee
	  	 	190	  
	 15.08
	 	 General Limitation on Guarantee Obligations
	  	 	190	  
	 15.09
	 	 Release of Guarantors
	  	 	191	  
	 15.10
	 	 Right of Contribution
	  	 	191	  

  
 vi 

  

			
	 SCHEDULES
	 	
		
	 Schedule 1.01(a)
	 	 Lenders and Commitments

	 Schedule 1.01(b)
	 	 Locations – United States and Canada (US Borrowing Base Parties)

	 Schedule 1.01(c)
	 	 Locations – United Kingdom (UK Borrowing Base Parties)

	 Schedule 1.01(d)
	 	 Locations – United States and Canada (Canadian Borrowing Base Parties)

	 Schedule 1.01(e)
	 	 Eligible Real Property

	 Schedule 1.01(f)
	 	 Qualified Derivative Obligations

	 Schedule 1.01(g)
	 	 B/A Discount Notes

	 Schedule 3.01(j)
	 	 Existing US Letters of Credit

	 Schedule 6.13
	 	 Effective Date Mortgages

	 Schedule 8.01
	 	 Qualifications to do Business

	 Schedule 8.04
	 	 Capital Structure

	 Schedule 8.05
	 	 Names

	 Schedule 8.06
	 	 Business Locations

	 Schedule 8.12
	 	 Surety Obligations

	 Schedule 8.18
	 	 Restrictions

	 Schedule 8.19
	 	 Litigation

	 Schedule 8.21
	 	 Leases

	 Schedule 8.23
	 	 ERISA Plans

	 Schedule 8.24
	 	 Business Relationships

	 Schedule 8.30
	 	 Continuing Indebtedness

	 Schedule 8.31
	 	 Insurance

	 Schedule 8.32
	 	 Plans; Existing Indebtedness Agreements

	 Schedule 10.02
	 	 Liens

	 Schedule 10.05
	 	 Indebtedness

	 Schedule 10.07
	 	 Deposits with Financial Institutions

	 Schedule 10.08
	 	 Transactions with Affiliates

	 Schedule 10.12
	 	 Operating Leases

	 Schedule 10.18
	 	 Deposit Accounts

	 Schedule 13.03
	 	 Lender Addresses

		
	 EXHIBITS
	 	
		
	 Exhibit A-1
	 	 Notice of Borrowing

	 Exhibit A-2
	 	 Notice of Conversion/Continuation

	 Exhibit B-1
	 	 Form of US Revolving Note

	 Exhibit B-2
	 	 Form of US Swingline Note

	 Exhibit B-3
	 	 Form of UK Revolving Note

	 Exhibit B-4
	 	 Form of UK Swingline Note

	 Exhibit B-5
	 	 Form of Canadian Revolving Note

	 Exhibit C
	 	 Form Assignment and Assumption Agreement

	 Exhibit D
	 	 Form of Incremental Commitment Agreement

	 Exhibit E
	 	 Form of Joinder Agreement

	 Exhibit F
	 	 Form of US Letter of Request

	 Exhibit G
	 	 Form of UK Letter of Request

	 Exhibit H
	 	 Form of Canadian Letter of Credit Request

	 Exhibit I
	 	 Form of Section 5.04(b)(ii) Certificate

	 Exhibit J-1
	 	 Form of DLA Piper (US) Opinion

	 Exhibit J-2
	 	 Form of DLA Piper (UK) Opinion

	 Exhibit J-3
	 	 Form of Luxembourg Opinion

  
 vii

  

			
	 Exhibit J-4
	 	 Form of Canadian Opinion

	 Exhibit J-5
	 	 Form of Special Delaware Counsel Opinion

	 Exhibit J-6
	 	 Form of Real Estate Local Counsel Opinions

	 Exhibit K
	 	 Form of Credit Party Secretary’s Certificate

	 Exhibit L
	 	 Form of US Pledge Agreement

	 Exhibit M
	 	 Form of UK Share Charge

	 Exhibit N
	 	 US Security Agreement

	 Exhibit O
	 	 UK Debenture and UK Partnership Debenture

	 Exhibit P
	 	 Form of Solvency Certificate

	 Exhibit Q
	 	 Form of Compliance Certificate

	 Exhibit R
	 	 Form of Borrowing Base Certificate

	 Exhibit S
	 	 UK Intercreditor Deed

	 Exhibit T
	 	 Form of Canadian Security Agreement

	 Exhibit U
	 	 Form of Canadian Share Pledge Agreement

	 Exhibit V
	 	 Form of Luxembourg Security Agreement

	 Exhibit W
	 	 Form of Luxembourg Share Charge

  
 viii

 ABL CREDIT AGREEMENT, dated as of February 22, 2012, among MOBILE MINI,
INC., a Delaware corporation (the “US Company” and, together with each other entity that executes this Agreement as a US Borrower or that becomes a US Borrower pursuant to Section 9.13(f), Section 9.13(g), or
Section 10.11, collectively, the “US Borrowers”, and each, a “US Borrower”), RAVENSTOCK MSG LIMITED, a limited liability company incorporated in England and Wales (the “UK Company”),
MOBILE MINI UK LIMITED, a corporation incorporated in England and Wales (“Mobile Mini UK” and together with UK Company and each other entity that executes this Agreement as a UK Borrower or that becomes a UK Borrower pursuant to
Section 10.11, collectively, the “UK Borrowers”, and each, a “UK Borrower”), MOBILE MINI CANADA, ULC, an unlimited liability corporation incorporated in British Columbia (“Canadian
Company” and together with each other entity that executes this Agreement as a Canadian Borrower or that becomes a Canadian Borrower pursuant to Section 10.11, collectively, the “Canadian Borrowers”, and each, a
“Canadian Borrower” and, together with each US Borrower and each UK Borrower, collectively, the “Borrowers”, and each, a “Borrower”), the Guarantors party hereto from time to time, the Lenders party
hereto from time to time and Deutsche Bank AG New York Branch, as Administrative Agent. All capitalized terms used herein and defined in Section 1 are used herein as therein defined. 

W I T N E S S E T H: 
 WHEREAS, subject to and upon the terms and conditions set forth herein, the Arrangers have arranged, and the Lenders are willing to make available to the Borrowers, the senior secured revolving credit
facility provided for herein; 
 NOW, THEREFORE, IT IS AGREED: 

SECTION 1. Definitions and Accounting Terms. 

1.01 Defined Terms. As used in this Agreement, the following terms shall have the following meanings (such
meanings to be equally applicable to both the singular and plural forms of the terms defined): 

“Account” shall mean an “account” as such term is defined in Article 9 of the UCC, and any and
all supporting obligations in respect thereof. 
 “Account Debtor” shall mean each Person who
is obligated on an Account. 
 “Acquisition” shall mean (i) the acquisition by US Company
or any of its Subsidiaries of all of the issued and outstanding Equity Interests of a Person, (ii) the acquisition by US Company or any of its Subsidiaries of all or substantially all of the assets of a Person or a line of business of a Person
or (iii) the merger or consolidation of US Company or any of its Subsidiaries with a Person other than a Person that was a Subsidiary of US Company or such Subsidiary immediately prior to such merger. 

“Additional Security Documents” shall have the meaning provided in Section 9.13. 

“Adjustable Applicable Margins” shall have the meaning provided in the definition of Applicable Margin.

 “Administrative Agent” shall mean Deutsche Bank AG New York Branch, in its capacity as
Administrative Agent for the Lenders hereunder and under the other Credit Documents, and shall include any successor to the Administrative Agent appointed pursuant to Section 12.09. 

  
 1 

 “Affiliate” shall mean, with respect to any Person, any
other Person directly or indirectly controlling (including, but not limited to, all directors and officers of such Person), controlled by, or under direct or indirect common control with, such Person. A Person shall be deemed to control another
Person if such Person possesses, directly or indirectly, the power (a) to vote 15% or more of the securities having ordinary voting power for the election of directors (or equivalent governing body) of such Person or (b) to direct or cause
the direction of the management and policies of such other Person, whether through the ownership of voting securities, by contract or otherwise; provided, however, that none of the Administrative Agent, any Lender or any of their
respective Affiliates shall be considered an Affiliate of US Company or any Subsidiary thereof. 

“Agent Advance” shall have the meaning provided in Section 2.01(i). 

“Agent Advance Amount” shall have the meaning provided in Section 2.01(i). 

“Agent Advance Period” shall have the meaning provided in Section 2.01(i). 

“Agents” shall mean and include the Administrative Agent, the Collateral Agent, the Co-Syndication
Agents, the Senior Managing Agents and the Co-Documentation Agents. 
 “Aggregate Borrowing
Base” shall mean as of any date of determination thereof, an amount equal to the lesser of: 
 (i) the
sum of (A) the amount calculated under the definition of US Borrowing Base; plus (B) an amount equal to the lesser of (x) the UK Maximum Amount and (y) the amount calculated under the definition of UK Borrowing Base (excluding
from such calculation, subclause (i) thereof) plus (C) an amount equal to the lesser of (x) the Canadian Maximum Amount and (y) the amount calculated under the definition of Canadian Borrowing Base (excluding from such
calculation, subclause (i) thereof); or 
 (ii) the amount permitted to be outstanding under this Agreement
by each of the Senior Note Indentures. 
 “Aggregate Exposure” shall mean, at any time, the sum
of (a) the Aggregate UK Exposure, (b) the Aggregate US Exposure and (c) the Aggregate Canadian Exposure. 
 “Aggregate Canadian Exposure” shall mean, at any time, the sum of (a) the aggregate principal amount of all Canadian Revolving Loans then outstanding and (b) the aggregate
amount of all Canadian Letter of Credit Outstandings at such time (exclusive of Canadian Letter of Credit Outstandings which are repaid with the proceeds of, and simultaneously with the incurrence of, the respective incurrence of Canadian Revolving
Loans). 
 “Aggregate UK Exposure” shall mean, at any time, the sum of (a) the aggregate
principal amount of all UK Revolving Loans then outstanding, (b) the aggregate amount of all UK Letter of Credit Outstandings at such time (exclusive of UK Letter of Credit Outstandings which are repaid with the proceeds of, and simultaneously
with the incurrence of, the respective incurrence of UK Revolving Loans), and (c) except for purposes of calculating the Applicable Commitment Commission Percentage, the aggregate principal amount of all UK Swingline Loans then outstanding
(exclusive of UK Swingline Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the respective incurrence of UK Revolving Loans). 

  
 2 

 “Aggregate US Exposure” shall mean, at any time, the sum of
(a) the aggregate principal amount of all US Revolving Loans then outstanding, (b) the aggregate amount of all US Letter of Credit Outstandings at such time (exclusive of US Letter of Credit Outstandings which are repaid with the proceeds
of, and simultaneously with the incurrence of, the respective incurrence of US Revolving Loans), and (c) except for purposes of calculating the Applicable Commitment Commission Percentage, the aggregate principal amount of all US Swingline
Loans then outstanding (exclusive of US Swingline Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the respective incurrence of US Revolving Loans). 

“Agreement” shall mean this Credit Agreement, as modified, supplemented, amended, restated (including
any amendment and restatement hereof), extended and/or renewed from time to time. 
 “Anti-Terrorism
Laws” shall have the meaning provided in Section 8.33(a). 
 “Applicable Commitment
Commission Percentage” shall mean (i) for each day on which the Aggregate Exposure is less than or equal to 33.3% of the Total Revolving Loan Commitment, 0.500% and (ii) for each day during which the Aggregate Exposure exceeds
33.3% of the Total Revolving Loan Commitment, 0.375%. 
 “Applicable Law” shall mean all laws,
rules and regulations applicable to the Person, conduct, transaction, covenant, Credit Document or other material contract in question, including all applicable common law and equitable principles; all provisions of all applicable state, provincial,
federal and foreign constitutions, statutes, rules, regulations and legally enforceable orders of governmental bodies; and legally enforceable orders, judgments and decrees of all courts and arbitrators, in each case, in any jurisdiction.

 “Applicable Margin” shall mean, for the period from the Effective Date until the first Start
Date thereafter, a percentage per annum equal to, in the case of 
 (a) US Revolving Loans maintained as
(i) Base Rate Loans, 1.25%, and (ii) US LIBOR Loans, 2.25%; 
 (b) US Swingline Loans, 1.25%;

 (c) UK Revolving Loans, 2.25%; 

(d) UK Swingline Loans, 2.25%; and 

(e) Canadian Revolving Loans maintained as (i) Canadian Prime Rate Loans, 1.25% and (ii) Bankers’
Acceptance Loans, 2.25%. 
 From and after the first day of the fiscal quarter in which a certificate is
delivered in accordance with the first sentence of the following paragraph (or from and after the date an Initial Post-Closing Availability Certificate is delivered in accordance with the following paragraph) indicating an entitlement to a different
margin for any Type of Loan than that described in the immediately preceding sentence (each, a “Start Date”) to and including the applicable End Date described below, the Applicable Margins for such Type of Loan (hereinafter, the
“Adjustable Applicable Margins”) shall be those set forth below opposite the Total Borrowing Availability indicated to have been achieved in any certificate delivered in accordance with the following sentence:

  
 3 

							
	 Level
	  	 Daily Average

Total Borrowing
 Availability
	  	 Revolving Loan

LIBOR/EURIBOR and UK
 Swingline Loan Margin and
 Drawing Fee on Bankers’

Acceptance Loans
	  	 US Revolving Loan and

US Swingline Loan
 Base Rate Margin
 and Canadian Revolving

Loan Canadian Prime Rate
 Margin

				
	 I
	  	Greater than $650,000,000	  	1.75%	  	0.75%
				
	 II
	  	Greater than $250,000,000 but less than or equal to $650,000,000	  	2.00%	  	1.00%
				
	 III
	  	Less than or equal to $250,000,000	  	2.25%	  	1.25%

 The Total Borrowing Availability used in a determination of Adjustable Applicable Margins
shall be determined based on the delivery of a certificate of US Company (each, a “Quarterly Pricing Certificate”) by an Authorized Officer of US Company to the Administrative Agent (with a copy to be sent by the Administrative
Agent to each Lender), within 10 days after the last day of any fiscal quarter of US Company, which certificate shall set forth the calculation of the daily average Total Borrowing Availability for such fiscal quarter ended immediately prior to the
relevant Start Date and the Adjustable Applicable Margins which shall be thereafter applicable (until same are changed or cease to apply in accordance with the following sentences). The Adjustable Applicable Margins so determined shall apply, except
as set forth in the succeeding sentence, from the relevant Start Date to the last day of the fiscal quarter immediately preceding the date on which the next Quarterly Pricing Certificate is delivered to the Administrative Agent (the “End
Date”); provided that if no such subsequent Quarterly Pricing Certificate is delivered on or prior to the date which is 10 days following the last day of the fiscal quarter in which the previous Start Date occurred, a new Start Date
shall be deemed to have commenced and the Adjustable Applicable Margins shall automatically adjust to those that correspond to a Total Borrowing Availability at Level III (such Adjustable Applicable Margins as so determined, the “Highest
Adjustable Applicable Margins”), effective from the first day of such fiscal quarter until the next End Date. Notwithstanding anything to the contrary contained above in this definition, the Applicable Margin and the Adjustable Applicable
Margins shall be the Highest Adjustable Applicable Margins (i) at all times during which there shall exist any Default or Event of Default and (ii) for the period from the Effective Date through (but not including) the earlier of
(x) the first day of the fiscal quarter in which a Quarterly Pricing Certificate is delivered for the fiscal quarter of US Company ending September 30, 2012 and (y) the date, not earlier than 180 days after the Effective Date, of
delivery of a certificate of US Company by an Authorized Officer of US Company to the Administrative Agent (with a copy to be sent by the Administrative Agent to each Lender), which certificate (the “Initial Post-Closing Availability
Certificate”) sets forth the calculation of the daily average Total Borrowing Availability for the 90 days ended immediately prior to the date thereof. 

Notwithstanding anything to the contrary contained above in this definition or elsewhere in this Agreement, if it is
subsequently determined that the Total Borrowing Availability set forth in any Quarterly Pricing Certificate delivered to the Administrative Agent is inaccurate for any reason and the result thereof is that the Lenders received interest or fees for
any period based on an Adjustable Applicable Margin that is less than that which would have been applicable had the Total Borrowing Availability been accurately determined, then, for all purposes of this Agreement, the “Adjustable Applicable
Margin” for any day occurring within the applicable period shall retroactively be deemed to be the relevant percentage as based upon the accurately determined Total Borrowing Availability for such

  
 4 

 
period, and any shortfall in the interest or fees theretofore paid by the Borrowers for the relevant periods pursuant to Sections 2.08 and 4.01(b) as a result of the miscalculation
of the Total Borrowing Availability shall be deemed to be (and shall be) due and payable under the relevant provisions of Section 2.08 or 4.01(b), as applicable, within two Business Days of discovery of such inaccuracy (and shall
remain due and payable until paid in full, together with all amounts owing under Section 2.08(e), in accordance with the terms of this Agreement). 
 “Appraised Fair Market Value” shall mean, with respect to any Real Property, the price at which a willing buyer, not an Affiliate of the seller, and a willing seller who does not have to
sell, would agree to purchase and sell such Real Property, as determined by an Appraiser in an appraisal in form and substance reasonably satisfactory to Administrative Agent. 

“Appraiser” shall mean an appraiser employed by Administrative Agent or an independent third party
appraiser engaged by Administrative Agent, at US Company’s expense. 
 “Approved Credit
Support” shall mean an Account is (a) supported by an irrevocable letter of credit satisfactory to the Administrative Agent, in its Permitted Discretion (as to form, substance, and issuer or domestic confirming bank), that has been
delivered to the Administrative Agent and is directly drawable by the Administrative Agent, or (b) is covered by credit insurance in form, substance, and amount, and by an insurer, satisfactory to the Administrative Agent, in its Permitted
Discretion. 
 “Arrangers” shall mean collectively, Deutsche Bank Securities Inc., Merrill
Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC. 
 “Asset
Sale” shall have the meaning set forth in Section 10.03. 
 “Assignment and
Assumption Agreement” shall mean an Assignment and Assumption Agreement substantially in the form of Exhibit C. 
 “Authorized Officer” shall mean, with respect to (a) delivering Notices of Borrowing, Notices of Conversion/Continuation and similar notices, any person or persons that has or have
been authorized by the board of directors (or equivalent governing body) of the respective Borrower to deliver such notices pursuant to this Agreement and for which an appropriate incumbency certificate in form and substance satisfactory to the
Administrative Agent has been delivered to the Administrative Agent, the Swingline Lender or the respective Issuing Lender, (b) delivering financial information and officer’s certificates pursuant to this Agreement, the chief financial
officer or the chief accounting officer of the US Company or the respective Borrower, and (c) any other matter in connection with this Agreement or any other Credit Document, any officer (or a person or persons so designated by any two
officers) of the US Company or the respective Borrower. 
 “B/A Discount Note” shall have the
meaning provided in Schedule 1.01(g). 
 “B/A Discount Proceeds” shall mean, in respect
of any Bankers’ Acceptance or Draft to be purchased by a Lender on any date pursuant to Section 2.18 and Schedule 1.01(g), the difference between (i) the result (rounded to the nearest whole Canadian cent, and with
one-half of one Canadian cent being rounded up) calculated on such day by dividing the aggregate Face Amount of such Bankers’ Acceptance or Draft by the sum of one plus the product of (x) the B/A Discount Rate (expressed as a decimal)
applicable to such Bankers’ Acceptance or Draft multiplied by (y) a fraction, the numerator of which is the number of days in the term of such Bankers’ Acceptance or Draft and the denominator of which is 365 (with such product being
rounded up or down to the fifth decimal place and .000005 being rounded up), and (ii) the aggregate applicable Drawing Fee. 

  
 5 

 “B/A Discount Rate” shall mean, for any Drawing Date, in
respect of any Banker’s Acceptance or Draft to be purchased hereunder, the discount rate (calculated on an annual basis and rounded to the nearest one-hundredth of 1%, with five-thousandth of 1% being rounded up) quoted by the Canadian
Sub-Agent at approximately 10:00 am (New York time) as the discount rate at which the Canadian Sub-Agent would purchase, on the relevant Drawing Date, its own banker’s acceptances or drafts with the term to maturity equal or comparable to the
Banker’s Acceptance or Draft to be purchased. 
 “B/A Instruments” shall mean,
collectively, Bankers’ Acceptances, Drafts and B/A Discount Notes, and, in the singular, any one of them. 

“B/A Lender” shall mean any Lender that is not a Non-B/A Lender. 

“Bank” shall mean Deutsche Bank AG New York Branch. 

“Bankers’ Acceptance” shall mean a Draft drawn by any Canadian Borrower and accepted by a Lender
pursuant to Section 2.18 and Schedule 1.01(g). 
 “Bankers’ Acceptance
Loans” shall mean (i) the creation of Bankers’ Acceptances or (ii) the creation and purchase of completed Drafts and the exchange of such Drafts for B/A Discount Notes, in each case as contemplated in Section 2.18
and Schedule 1.01(g). 
 “Banking Product Obligations” of the Credit Parties means any
and all obligations of the Credit Parties, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications thereof and substitutions therefor) in connection
with Banking Products of which the Administrative Agent has received written notice. 
 “Banking
Products” means each and any of the following bank services provided to any Credit Party (or the LKE Qualified Intermediary with respect to a LKE Joint Account) by any Banking Products Provider: (a) commercial credit cards,
(b) stored value cards and (c) treasury management services (including, without limitation, controlled disbursement, automated clearinghouse transactions, E-payables or comparable services, return items, overdrafts and interstate
depository network services). 
 “Banking Products Agreement” means any agreement with respect
to Banking Products to which any Credit Party is a party. 
 “Banking Products Provider” means,
with respect to any Banking Products Agreement, (x) any provider who was an Agent or Affiliate of an Agent at the time such Banking Products Agreement was entered into (or in the case of a Banking Products Agreement that was entered into prior
to the Effective Date, was an Agent or an Affiliate of an Agent on the date hereof), or (y) a provider who was a Lender or an Affiliate of a Lender at the time such Banking Products Agreement was entered into (or in the case of a Banking
Products Agreement that was entered into prior to the Effective Date, was a Lender or an Affiliate of a Lender on the date hereof), in each case, that has entered into such Banking Products Agreement with any Credit Party; provided that, a Lender
(and any Affiliate thereof) shall not be a Banking Products Provider with respect to any Banking Products Agreement entered into when such Lender was a Defaulting Lender. 

“Banking Products Reserve” shall mean a reserve established by the Administrative Agent from time to
time in respect of the Borrowing Base Parties’ liabilities or potential liabilities as part of their cash management system (including, without limitation, liabilities related to Banking Products) such as, but not limited to, reserves for
returned items, customary charges for maintaining Deposit Accounts and similar items. 

  
 6 

 “Bankruptcy Code” shall mean Title 11 of the United States
Code entitled “Bankruptcy” as now or hereafter in effect, or any successor thereto. 
 “Base Rate” shall mean, at any time, the highest of (i) the Prime Lending Rate at such time, (ii)  1/2 of 1% per annum in excess of the overnight Federal Funds Rate
at such time and (iii) LIBOR for a LIBOR Loan denominated in Dollars with a one month Interest Period commencing on such day plus 1.00%. For purposes of this definition, LIBOR shall be determined using LIBOR as otherwise determined by the
Administrative Agent in accordance with the definition of LIBOR, except that (x) if a given day is a Business Day, such determination shall be made on such day (rather than two Business Days prior to the commencement of an Interest Period) or
(y) if a given day is not a Business Day, LIBOR for such day shall be the rate determined by the Administrative Agent pursuant to preceding clause (x) for the most recent Business Day preceding such day. Any change in the Base Rate due to
a change in the Prime Lending Rate, the Federal Funds Rate or LIBOR shall be effective as of the opening of business on the day of such change in the Prime Lending Rate, the Federal Funds Rate or LIBOR, respectively 

“Base Rate Loan” shall mean (a) each US Swingline Loan and (b) each US Revolving Loan
designated or deemed designated as such by the relevant Borrower at the time of the incurrence thereof or conversion thereto determined by reference to the Base Rate. 

“Board” shall mean the Board of Governors of the Federal Reserve System of the United States.

 “Borrower” and “Borrowers” shall have the meaning provided in the first
paragraph of this Agreement. 
 “Borrowing” shall mean a UK Borrowing, a US Borrowing or a
Canadian Borrowing. 
 “Borrowing Base Certificate” shall have the meaning provided in
Section 9.01(i). 
 “Borrowing Base Party” shall mean each US Borrowing Base Party,
each UK Borrowing Base Party and each Canadian Borrowing Base Party. 
 “Business Day” shall
mean (a) for all purposes other than as covered by clause (b) below, any day except Saturday, Sunday and any day which shall be in New York, New York, Toronto, Ontario, Brussels, Belgium and/or London, England, a legal holiday or a day on
which banking institutions are authorized or required by law or other government action to close and (b) with respect to all notices and determinations in connection with, and payments of principal and interest on, (i) LIBOR Loans, any day
which is a Business Day described in clause (a) above and which is also a day for trading by and between banks in US Dollar and Pounds Sterling deposits in the interbank eurodollar market and (ii) EURIBOR Loans, any TARGET Day. 

“Cabin Fleet Inventory” shall mean timber accommodation units which are included in UK Borrowers’
lease fleet. 
 “Canadian Borrower” or “Canadian Borrowers” shall have the
meaning provided in the first paragraph of this Agreement. 
 “Canadian Borrowing” shall mean
the borrowing of Canadian Revolving Loans from all the Lenders on a given date having the same Interest Period. 

  
 7 

 “Canadian Borrowing Availability” shall mean, as of any
date of determination, the remainder of (a) the lesser of (i) the Canadian Maximum Amount at such time and (ii) the Canadian Borrowing Base at such time minus (b) the Aggregate Canadian Exposure at such time. 

“Canadian Borrowing Base” shall mean, as of any date of calculation, the amount calculated pursuant to
the Borrowing Base Certificate most recently delivered to the Administrative Agent in accordance with Section 9.01(i) (but as modified as provided below in this definition), equal to, without duplication, the sum of 

(i) (A) the amount calculated under the definition of US Borrowing Base, provided that in no event shall
any asset constituting a portion of the US Borrowing Base concurrently constitute a portion of the Canadian Borrowing Base plus (B) the amount calculated under the definition of UK Borrowing Base, provided that in no event shall any asset
constituting a portion of the UK Borrowing Base concurrently constitute a portion of the Canadian Borrowing Base, plus 
 (ii) eighty-five percent (85%) of Eligible Canadian Accounts, plus 
 (iii) ninety percent (90%) of Eligible Canadian Rental Fleet Inventory, plus 
 (iv) [Reserved] 
 (v) the lesser of
(A) (1) $40,000,000 less (2) the amount included in such Borrowing Base Certificate with respect to clause (iv)(B) of the definition of US Borrowing Base and clause (v)(B) of the definition of UK Borrowing Base and (B) the sum of
(1) ninety percent (90%) of Eligible Canadian Container Inventory Held for Sale; plus (2) ninety percent (90%) of Eligible Canadian Work-In-Process Container Inventory; plus (3) sixty-five percent (65%) of
Eligible Canadian Raw Materials Inventory; plus 
 (vi) the lesser of
(A) (1) $50,000,000 less (2) the amount included in such Borrowing Base Certificate with respect to clause (v)(B) of the definition of US Borrowing Base and clause (vi)(B) of the definition of UK Borrowing Base and
(B) eighty-five percent (85%) of Eligible Canadian Machinery and Equipment; minus  
 (vii) the amount of all Reserves then established by the Administrative Agent against the Canadian Borrowing Base. 
 The Administrative Agent shall have the right (but no obligation) to review such computations and if, in its Permitted Discretion, such computations have not been calculated in accordance with the terms
of this Agreement, the Administrative Agent shall have the right to correct any such errors in such manner it shall determine in its Permitted Discretion. The Canadian Borrowing Base (and the Borrowing Base Certificate then most recently delivered)
may be adjusted by the Administrative Agent to reflect any new or incremental Reserves required by the Administrative Agent in its Permitted Discretion; provided that no change in the amount of any Reserve shall be effective until the date
occurring three Business Days after written notice thereof by the Administrative Agent to the US Company and the Canadian Company following consultation with the US Company. 

“Canadian Borrowing Base Party” shall mean each Wholly-Owned Subsidiary of US Company that is
incorporated, amalgamated, continued or otherwise formed under the laws of Canada or any province thereof and that is a Canadian Borrower or a Non-US Obligation Guarantor and is incorporated, amalgamated, continued or otherwise formed in Canada or
any province thereof. 

  
 8 

 “Canadian Company” shall have the meaning provided in the
first paragraph of this Agreement. 
 “Canadian Corresponding Lender” means, with respect to
any Lender, the Canadian branch or Affiliate of such Lender, if any, set forth on the signature page hereto for such Lender, or the applicable Assignment and Assumption Agreement. 

“Canadian Credit Party” shall mean each subsidiary of the US Company, other than any US Credit Party.

 “Canadian Dollars” and the sign “CA$” shall each mean freely transferable
lawful money of Canada. 
 “Canadian Drawing” shall have the meaning set forth in
Section 3.15(b). 
 “Canadian Funding Capacity” shall mean, for any Lender, the
ability of such Lender or an Affiliate or branch office thereof to fund Canadian Revolving Loans denominated in Canadian Dollars, as set forth in the records of Administrative Agent. 

“Canadian Funding Capacity Lender” shall mean each Lender other than (i) in the case of each Lender
as of the Effective Date, each Lender that shall have confirmed in writing, to the satisfaction of the Administrative Agent, on or prior to the Effective Date, that neither it nor any domestic or foreign branch or Affiliate of such Lender has the
ability to fund Canadian Revolving Loans denominated in Canadian Dollars and (ii) in the case of each Lender after the Effective Date, each Lender that shall have confirmed in writing, to the satisfaction of the Administrative Agent, on or
prior to the date such Lender becomes a Lender hereunder, that neither it nor any domestic or foreign branch or Affiliate of such Lender has the ability to fund Canadian Revolving Loans denominated in Canadian Dollars, in each case until such time
as such Lender shall have confirmed in writing to the Administrative Agent that it or any domestic or foreign branch or Affiliate of such Lender does have the ability to fund Canadian Revolving Loans denominated in Canadian Dollars. 

“Canadian Insolvency Laws” shall mean any of the Bankruptcy and Insolvency Act (Canada), the
Companies’ Creditors Arrangement Act (Canada), and the Winding-Up and Restructuring Act (Canada), each as now and hereafter in effect, and any successors to such statutes and any proceeding under applicable corporate law statutes seeking a
compromise or arrangement of any debts of the corporation, or a stay of proceedings to enforce any of the claims of the corporation’s creditors against it. 

“Canadian Issuing Lender” shall mean each of DB Canada (except as otherwise provided in
Section 12.09) and any other Lender reasonably acceptable to the Administrative Agent and US Company or Canadian Company which agrees to issue Canadian Letters of Credit hereunder. Any Canadian Issuing Lender may, in its discretion,
arrange for one or more Canadian Letters of Credit to be issued by one or more Affiliates of such Canadian Issuing Lender (and such Affiliate shall be deemed to be a “Canadian Issuing Lender” for all purposes of the Credit Documents).

 “Canadian L/C Supportable Obligations” shall mean (a) obligations of a Canadian
Borrower with respect to workers compensation, surety bonds and other similar statutory obligations and (b) such other obligations of a Canadian Borrower as are reasonably acceptable to the respective Canadian Issuing Lender and otherwise
permitted to exist pursuant to the terms of this Agreement (other than obligations in respect of (i) any Indebtedness or other obligations that are subordinated in right of payment to the Canadian Obligations and (ii) any Equity
Interests). 

  
 9 

 “Canadian Letter of Credit” shall have the meaning provided
in Section 3.03(a). 
 “Canadian Letter of Credit Fee” shall have the meaning
provided in Section 4.01(b). 
 “Canadian Letter of Credit Outstandings” shall
mean, at any time, the sum of (a) the Stated Amount of all outstanding Canadian Letters of Credit at such time and (b) the aggregate amount of all Unpaid Canadian Drawings in respect of all Canadian Letters of Credit at such time.

 “Canadian Letter of Credit Request” shall have the meaning provided in
Section 3.09(a). 
 “Canadian Maximum Amount” shall mean, as of any date of
determination, the lesser of (a) Equivalent Amount of $100,000,000 and (b) the Equivalent Amount of the Total Revolving Loan Commitment minus the Equivalent Amount of the Aggregate UK Exposure minus the Equivalent Amount of
the Aggregate US Exposure. 
 “Canadian Obligations” shall mean, with respect to any Canadian
Credit Party, all Loans, all obligations under Letters of Credit and all other advances, debts, liabilities, obligations, covenants and duties, together with all interest, fees and other charges thereon, owing, arising, due or payable from such
Canadian Credit Party to an Agent, any Lender or any Affiliate of any Lender, or from a Canadian Borrower to any Canadian Issuing Lender, of any kind or nature, present or future, whether or not evidenced by any note, guaranty or other instrument,
whether arising under this Agreement or any of the other Credit Documents or cash management services rendered in connection therewith, whether direct or indirect (including those acquired by assignment), absolute or contingent, primary or
secondary, due or to become due, now existing or hereafter arising and however acquired, and any Banking Products Obligations or Qualified Derivative Obligations owing to a Banking Products Provider or a Qualified Derivative Counterparty, as
applicable. 
 “Canadian Participant” shall have the meaning set forth in
Section 3.12(a). 
 “Canadian Prime Rate” shall mean, for any day, the rate of
interest per annum equal to the greater of (i) the per annum rate of interest quoted or established as the “prime rate” of the Canadian Sub-Agent which it quotes or establishes for such day as its reference rate of interest in order
to determine interest rates for commercial loans in Canadian Dollars in Canada to its Canadian borrowers; and (ii) the arithmetic average rate for Canadian Dollar banker’s acceptances having a term of 30 days that appears on Reuters Screen
CDOR Page (or such other page as may be selected by the Canadian Sub-Agent as a replacement page for such banker’s acceptances if such screen is not available) at approximately 10:00 a.m. (Toronto time) on such day plus 100 basis points per
annum, adjusted automatically with each quoted or established change in such rate, all without the necessity of any notice to any Canadian Borrower or any other Person. 

“Canadian Prime Rate Loan” shall mean each Canadian Revolving Loan designated or deemed designated as
such by the relevant Borrower at the time of the incurrence thereof or conversion thereto determined by reference to the Canadian Prime Rate. 
 “Canadian Priority Payables” shall mean, at any time, with respect to any Borrowing Base Party which has employees in Canada or otherwise carries on business in Canada or which leases,
sells or otherwise owns goods in Canada or has Accounts with Account Debtors located in Canada: 

  
 10 

 (i) the amount past due and owing by such Borrowing Base
Party, or the accrued amount for which such Borrowing Base Party has an obligation to remit to a Governmental Authority in Canada or in any province, municipality or other political subdivision thereof (“Canadian Governmental
Authority”) or other Person pursuant to any applicable law, rule or regulation, in respect of (a) pension fund obligations; (b) Canada Pension Plan and Quebec Pension Plan, (c) unemployment insurance; (d) harmonized
sales taxes, goods and services taxes, sales taxes, excise taxes, employee income taxes and other taxes payable or to be remitted or withheld; (e) workers’ compensation; (f) wages, (g) vacation pay; and (h) other like
charges and demands; in each case, in respect of which any Canadian Governmental Authority or other Person may claim a security interest, lien, trust, right or other claim ranking or capable of ranking in priority to or pari passu with one or more
of the Liens granted in the Security Documents; 
 (ii) the aggregate of any other amounts for
which provision for payment is required to be made pursuant to Section 6(3), (4), (5) and (6) of the Companies’ Creditors Arrangement Act (Canada) or Section 60(1.1), (1.2), (1.3), (1.5) and (2) of the Bankruptcy
and Insolvency Act (Canada) (as such provisions may be amended or re-enacted from time to time) in order to obtain the court’s sanction or approval of an arrangement, compromise or proposal; and 

(iii) the aggregate amount of any other liabilities of such Borrowing Base Party (a) in respect of
which a trust has been or may be imposed on any Collateral to provide for payment, (b) which are secured by a security interest, pledge, lien, charge, right or claim on any Collateral or (c) the holder of which enjoys a right; in each
case, pursuant to any applicable law, rule or regulation and which trust, security interest, pledge, lien, charge, right or claim ranks or is capable of ranking in priority to or pari passu with one or more of the Liens granted in the Security
Documents. 
 “Canadian Revolving Loan” shall have the meaning set forth in
Section 2.01(c). 
 “Canadian Revolving Loan Commitment” shall mean, for each
Lender, the amount set forth opposite such Lender’s name in Schedule 1.01(a) directly below the column entitled “Canadian Revolving Loan Commitment,” as same may be (x) reduced from time to time or terminated pursuant to
Sections 4.02, 4.03 and/or 11, as applicable, (y) increased from time to time pursuant to Section 2.15, or (z) adjusted from time to time as a result of assignments to or from such Lender pursuant to
Section 2.13 or 13.04(b). 
 “Canadian Revolving Note” shall have the
meaning set forth in Section 2.05(a). 
 “Canadian Security Agreement” shall mean
the security agreement executed by each Canadian Borrower with respect to the Canadian Obligations in favour of the Collateral Agent for the benefit of the Secured Creditors. 

“Canadian Share Pledge Agreement” shall mean the security agreement executed by the US Company with
respect to the Equity Interests of the Canadian Company in favour of the Collateral Agent for the benefit of the Secured Creditors. 
 “Canadian Sub-Agent” shall mean DB Canada. 

“Canadian Subsidiary” shall mean each Subsidiary of US Company that is incorporated, amalgamated,
continued or otherwise formed in Canada or any province thereof. 
 “Canadian Taxes” shall have
the meaning set forth in Section 5.06(a). 

  
 11 

 “Capital Expenditures” shall mean expenditures made or
liabilities incurred for the acquisition of any fixed assets (including but not limited to containers) or improvements, replacements, substitutions or additions thereto which have a useful life of more than one year, including the total principal
portion of Capitalized Lease Obligations and that portion of Investments allocable to property, plant or equipment. Capital Expenditures shall exclude (i) new and used manufactured or remanufactured portable container Inventory held for sale,
(ii) proceeds of a Casualty Loss applied to the repair or replacement of the property affected by the Casualty Loss and (iii) Inventory or Equipment acquired in a Permitted Acquisition. 

“Capitalized Lease Obligation” shall mean any Indebtedness represented by obligations under a lease that
is required to be capitalized for financial reporting purposes in accordance with GAAP. 
 “Cash
Equivalents” shall mean, as to any Person, (a) securities issued or directly and fully guaranteed or insured by the United States, Canada or the United Kingdom or any agency or instrumentality thereof (provided that the full
faith and credit of such country is pledged in support thereof or it otherwise has a equivalent credit rating) having maturities of not more than one year from the date of acquisition, (b) marketable direct obligations issued by any state of
the United States, Canada or the United Kingdom or any political subdivision of such country or any public instrumentality thereof maturing within one year from the date of acquisition thereof and, at the time of acquisition, having one of the two
highest ratings obtainable from either S&P or Moody’s, (c) Pounds Sterling, Canadian Dollar or Dollar-denominated time deposits, certificates of deposit and bankers acceptances of any Lender or any commercial bank having, or which is
the principal banking subsidiary of a bank holding company having, a long-term unsecured debt rating of at least “A” or the equivalent thereof from S&P or “A2” or the equivalent thereof from Moody’s with maturities of
not more than one year from the date of acquisition by such Person, (d) repurchase obligations with a term of not more than seven days for underlying securities of the types described in clause (a) above entered into with any bank meeting
the qualifications specified in clause (c) above, (e) commercial paper denominated in Pounds Sterling, Canadian Dollars or Dollars and not convertible or exchangeable into any other securities issued by any Person incorporated in the
United States, Canada or the United Kingdom rated at least A-1 or the equivalent thereof by S&P or at least P-1 or the equivalent thereof by Moody’s and in each case maturing not more than one year after the date of acquisition by such
Person, (f) Pounds Sterling bills of exchange eligible for rediscount at the Bank of England and accepted by any bank meeting the qualifications specified in clause (c) above, (g) investments in money market funds substantially all of
whose assets are comprised of securities of the types described in clauses (a) through (f) above and which can be turned into cash on not more than 30 days’ notice, (h) securities with maturities of one year or less from the date
of acquisition backed by a standby letter of credit issued by any Lender or any commercial bank satisfying the requirements of clause (c), (i) shares in money market investment programs or mutual or similar funds with the Administrative Agent
or any other Lender with a corporate rating of at least A by S&P or at least A-2 by Moody’s, or (j) any other debt security approved by the Required Lenders, and in each case described in clauses (a) through (i) above, which
is not subject to any Lien (other than any Lien arising under the Security Documents). 
 “Cash
Management Control Agreement” shall mean a “control agreement” in form and substance reasonably acceptable to the Administrative Agent and Collateral Agent and containing terms regarding the treatment of all cash and other amounts
on deposit in the respective Collection Account, Disbursement Account, Designated Petty Cash Account, Designated Payroll Account or LKE Joint Account governed by such Cash Management Control Agreement consistent with the requirements of
Section 5.03 hereto and Section 3.9 of the US Security Agreement (including, without limitation, any such agreement with respect to any LKE Joint Account pursuant to which the applicable Credit Party and the LKE Qualified
Intermediary instruct the appropriate financial institution(s) to transfer funds from the LKE Joint Accounts to the Administrative Agent in accordance with Section 5.03 hereto). 

  
 12 

 “Casualty Loss” shall mean (i) the loss, damage, or
destruction of any asset owned or used by US Company or any of its Subsidiaries, (ii) the condemnation, confiscation, or other taking, in whole or in part, of any such asset, or (iii) the diminishment of such asset so as to render use for
its intended purpose impracticable or unreasonable. 
 “CERCLA” shall mean the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as the same has been amended and may hereafter be amended from time to time, 42 USC. § 9601 et seq. 

“Certificate of Title” shall mean a certificate of title, certificate of ownership or other registration
certificate issued or required to be issued for any asset under the certificate of title or similar laws of any jurisdiction. 
 “Change in Law” shall have the meaning provided in Section 11.10. 
 “Change of Control” shall mean (i) any “person” (as such term is used in Subsections 13(d) and 14(d) of the Securities and Exchange Act of 1934, as amended) on or after the
Effective Date is or becomes a “beneficial owner” (as defined in Rule 13d-3 under such Act), directly or indirectly, of Equity Interests of US Company representing 35% or more of the combined voting power of US Company’s
then-outstanding Equity Interests; or (ii) the existing directors for any reason cease to constitute a majority of US Company’s Board of Directors or (iii) any Borrower or Guarantor ceases to be a wholly-owned Subsidiary of US
Company, except as expressly permitted by the Credit Documents; or (iv) a “Change of Control” (as defined in any of the Senior Note Indentures or any Permitted Additional Financing Document) occurs. For purposes of this definition,
“existing directors” means (x) individuals constituting US Company’s Board of Directors on the Effective Date, and (y) any subsequent director whose election by the Board of Directors or nomination for election by US
Company’s shareholders was approved by a vote of at least a majority of the directors then in office which directors either were directors on the Effective Date or whose election or nomination for election was previously so approved.

 “Chief Executive Office” shall mean, with respect to any Person, the location from which
such Person manages the main part of its business operations or other affairs. 
 “CITA” shall
have the meaning provided in Section 8.23(b). 
 “Claims” shall have the meaning
provided in the definition of Environmental Claims. 
 “Code” shall mean the Internal Revenue
Code of 1986, as amended from time to time, and the regulations promulgated and rulings issued thereunder. Section references to the Code are to the Code, as in effect at the date of this Agreement and any subsequent provisions of the Code,
amendments thereof, supplements thereto or substitutions therefor. 
 “Co-Documentation Agents”
shall mean Barclays Bank PLC, SunTrust Bank and Wells Fargo Capital Finance, LLC, each in its capacity as a documentation agent. 
 “Co-Syndication Agents” shall mean Bank of America, N.A. and JPMorgan Chase Bank, N.A., each in its capacity as a syndication agent. 

“Collateral” shall mean all property (whether real or personal) with respect to which any Liens have
been granted (or purported to be granted) pursuant to any Security Document, including, without limitation, all Pledge Agreement Collateral, all Security Agreement Collateral, all Mortgaged Properties and all cash and Cash Equivalents delivered as
collateral pursuant to Section 5.02 or Section 11. 

  
 13 

 “Collateral Agent” shall mean the Administrative Agent, in
its capacity as collateral agent for the Lenders hereunder and under the other Credit Documents, and shall include any successor to the Administrative Agent appointed pursuant to Section 12.09. 

“Collection Account” shall mean each account established at a Collection Bank subject to a Cash
Management Control Agreement into which funds shall be transferred as provided in Section 5.03(b). 

“Collection Bank” shall have the meaning provided in Section 5.03(b). 

“Collective Bargaining Agreements” shall mean all collective bargaining agreements applying or relating
to any employee of US Company or any of its Subsidiaries. 
 “Commitment Commission” shall have
the meaning provided in Section 4.01(a). 
 “Compliance Period” shall mean any
period (x) (A) for purposes of Section 10.21 hereof, commencing on the first Business Day on which the Total Borrowing Availability is less than the Minimum Availability Amount and (B) for all other purposes hereunder, commencing
on the third consecutive Business Day on which the Total Borrowing Availability is less than the applicable Minimum Availability Amount and (y) in each case, ending on the first Business Day thereafter on which the Total Borrowing Availability
has been equal to or greater than the applicable Minimum Availability Amount for 30 consecutive days. 

“Computation Date” shall mean the date on which the Equivalent Amount of any currency is determined.

 “Concentration Account” shall have the meaning provided in Section 5.03(c).

 “Consolidated” shall mean the consolidation in accordance with GAAP of the accounts or other
items as to which such term applies. 
 “Consolidated EBITDA” shall mean for a period, the
Consolidated Net Income of US Company and its Subsidiaries (excluding (a) extraordinary gains and (b) non-cash extraordinary or non-recurring losses) and without duplication (i) plus all Interest Expense, income tax expense,
depreciation and amortization (including amortization of any goodwill or other intangibles) for the period, (ii) less gains or plus losses attributable to any fixed asset sales (excluding sales of containers held for lease) in the
period, (iii) plus or minus any other non-cash charges which have been subtracted or added in calculating Consolidated Net Income, (iv) plus reasonable fees and expenses directly incurred in connection with the
Transactions (including, without limitation, reasonable professional, legal and other advisory fess, and other costs incurred in connection with the initial funding under this Agreement), (v) plus non-recurring fees, costs and expenses
incurred in connection with any Permitted Acquisition that are set forth in reasonable detail in form acceptable to the Administrative Agent, and (vi) plus debt issuance expenses, debt extinguishing expenses and deferred financing costs,
provided that such fees, costs and expenses are incurred on or prior to March 31, 2012, in each case to the extent deducted (and not added back) in such period in computing such Consolidated Net Income. For all purposes other than
calculating Consolidated Net Cash Flow, Consolidated EBITDA for any such period shall be calculated by giving pro forma effect to any Permitted Acquisition and any Asset Sale specifically permitted pursuant to clauses (iv) or (v) of
Section 10.03 during such period, as if such Acquisition or Asset Sale, as 

  
 14 

 
the case may be, had been consummated on the first day of such period, as long as US Company shall have delivered to Administrative Agent audited financial statements for such period for the
Person or assets acquired or if consented to by Administrative Agent, other reasonably acceptable financial statements or other supporting documentation. 
 “Consolidated Net Cash Flow” shall mean for a period, Consolidated EBITDA less, without duplication, the sum of (i) Unfinanced Capital Expenditures during such period
plus (ii) income taxes paid in cash during such period plus (iii) Restricted Payments paid in cash during such period (other than Restricted Payments paid by a Subsidiary of US Company to a Credit Party). 

“Consolidated Net Income” shall mean, for any period, the net income (or loss) of US Company and its
Subsidiaries determined on a consolidated basis for such period (taken as a single accounting period) in accordance with GAAP (after any deduction for minority interests); provided that the following items shall be excluded in computing
Consolidated Net Income (without duplication): (a) the net income of any other Person which is not a Subsidiary of US Company or is accounted for by the equity method of accounting except to the extent of the payment of cash dividends or cash
distributions by such other Person to US Company or a Subsidiary thereof during such period, and (b) the net income of any Subsidiary of US Company to the extent that the declaration or payment of cash dividends or similar cash distributions by
such Subsidiary of such net income is not at the time permitted by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule or governmental regulation applicable to such Subsidiary. 

“Container Fleet Inventory” shall mean new and used manufactured or remanufactured portable and ISO
containers and portable mobile offices held by US Company or another Credit Party for intended lease or rental by US Company or another Credit Party to third parties. 

“Contingent Obligation” shall mean, as to any Person, any obligation of such Person as a result of such
Person being a general partner of any other Person, unless the underlying obligation is expressly made non-recourse as to such general partner, and any obligation of such Person guaranteeing or intended to guarantee any Indebtedness, leases,
dividends or other obligations (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, including, without limitation, any obligation of such Person, whether or not
contingent, (a) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (b) to advance or supply funds (i) for the purchase or payment of any such primary obligation or (ii) to
maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (c) to purchase property, securities or services primarily for the purpose of assuring the owner of any
such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (d) otherwise to assure or hold harmless the holder of such primary obligation against loss in respect thereof; provided,
however, that the term Contingent Obligation shall not include endorsements of instruments for deposit or collection in the ordinary course of business or guarantees by a parent entity of real property leases entered into by a UK Subsidiary
in the ordinary course of business. The amount of any Contingent Obligation shall be deemed to be an amount equal to the stated or determinable amount of the primary obligation in respect of which such Contingent Obligation is made or, if not stated
or determinable, the maximum reasonably anticipated liability in respect thereof (assuming such Person is required to perform thereunder) as determined by such Person in good faith. 

“Convertible Preferred Stock” shall mean US Company’s Series A Convertible Redeemable Participating
Preferred Stock. 
 “Converting Canadian Dollar Lender” shall have the meaning set forth in
Section 2.16(c). 

  
 15 

 “Converting Euro Lender” shall have the meaning set forth
in Section 2.16(b). 
 “Converting Pounds Sterling Lender” shall have the meaning
set forth in Section 2.16(a). 
 “Credit Account” shall have the meaning provided
in Section 5.03(f). 
 “Credit Documents” shall mean this Agreement, the US Pledge
Agreement, the US Security Agreement, the UK Security Agreements, the Canadian Security Agreement, the Fee Letter and, after the execution and delivery thereof pursuant to the terms of this Agreement, each Note, each Incremental Commitment
Agreement, each Joinder Agreement, each Mortgage and each other Security Document. 
 “Credit
Event” shall mean the making of any Loan or the issuance of any Letter of Credit under this Agreement. 

“Credit Party” shall mean each of the US Credit Parties, each of the UK Credit Parties and each of the
Canadian Credit Parties. 
 “DB Canada” shall mean Deutsche Bank AG Canada Branch, and its
permitted successors and assigns. 
 “DBNY” shall mean Deutsche Bank AG New York Branch, and
its permitted successors and assigns. 
 “Debt Ratio” shall mean as of any date of
determination, the ratio of (i) Funded Debt as of such date to (ii) Consolidated EBITDA in each case for the four fiscal quarters ending on such date. 

“Default” shall mean any event, act or condition which with notice or lapse of time, or both, would
constitute an Event of Default. 
 “Defaulting Lender” shall mean any Lender with respect to
which a Lender Default is in effect. 
 “Deposit Account” shall mean a demand, time, savings,
passbook or like account with a bank, savings and loan association, credit union or like organization. 

“Derivative Obligations” shall mean every obligation of a Person under any forward contract, futures
contract, swap, option or other financing agreement or arrangement (including, without limitation, caps, floors, collars and similar agreements), the value of which is dependent upon interest rates, currency or exchange rates or valuations.

 “Designated Payroll Accounts” shall mean those accounts set forth on Part E of Schedule
10.18, as well as any new payroll account established pursuant to Section 10.18, in each case which are maintained near a branch for any Credit Party and in which cash is transferred in accordance with the terms of this Agreement to
pay ordinary course payroll expenses of such Credit Party. 
 “Designated Petty Cash Accounts”
shall mean those accounts set forth on Part D of Schedule 10.18, as well as any new petty cash account established pursuant to Section 10.18, in each case which are maintained near a branch for any Credit Party and in which cash
is transferred in accordance with the terms of this Agreement to pay certain ordinary course cash expenses of such Credit Party. 

  
 16 

 “Disbursement Account” shall mean each checking and/or
disbursement account set forth on Part C of Schedule 10.18, maintained for any Credit Party for their respective general corporate purposes, including for the purpose of paying their trade payables and other operating expenses. 

“Dollars” and the sign “$” shall each mean freely transferable lawful money of the
United States. 
 “Domestic Subsidiary” of any Person shall mean any Subsidiary of such Person
incorporated or organized in the United States or any State thereof or the District or Columbia. 

“Draft” shall mean, at any time, either a deposit bill within the meaning of the Depository Bills and
Notes Act (Canada), or a bill of exchange, within the meaning of the Bills of Exchange Act (Canada), drawn by any Canadian Borrower on a Lender and bearing such distinguishing letters and numbers as such Lender may determine, but which at such time
has not been completed or accepted by such Lender. 
 “Drawing Date” shall mean any Business
Day fixed pursuant to Schedule 1.01(g) for the creation of Bankers’ Acceptances or the purchase of completed Drafts and the exchange thereof for B/A Discount Notes, in each case by a Lender pursuant to Schedule 1.01(g).

 “Drawing Fee” shall mean, in respect of a Draft drawn by any Canadian Borrower hereunder and
accepted by a B/A Lender or a Draft purchased by a Non-B/A Lender, a fee calculated on the Face Amount of such Draft at a rate per annum equal to the Applicable Margin that would be payable with respect to a Revolving Loan maintained as a LIBOR Loan
drawn on the Drawing Date of such Draft. Drawing Fees shall be calculated on the basis of the term to maturity of the Draft and a year of 365 days. 
 “Dutch Credit Parties” shall mean Mobile Mini Holding B.V. and Mobile Mini B.V. 
 “Effective Date” shall have the meaning provided in Section 13.10. 
 “Eligible Account” shall mean those Accounts created by a Borrowing Base Party in the ordinary course of its business that arise out of its sale, lease or rental of goods or rendition of
services, that comply in all material respects with each of the representations and warranties respecting Eligible Accounts made in the Credit Documents, and that are not excluded as ineligible by virtue of one or more of the excluding criteria set
forth below. The Administrative Agent shall have the right to establish or modify Reserves against Eligible Accounts from time to time in its Permitted Discretion on three Business Days’ prior written notice to US Company in respect of the US
Borrowing Base or the UK Company in respect of the UK Borrowing Base or the Canadian Company in respect of the Canadian Borrowing Base, in each case after consultation with US Company, UK Company or the Canadian Company, as applicable. In
determining the amount to be included, Eligible Accounts shall be the face amount of such Eligible Accounts and shall be calculated net of unearned revenue, charge-backs, customer deposits, unapplied cash, bonding subrogation rights to the extent
not cash collateralized, any and all returns, rebates, discounts (which may, at the Administrative Agent’s option, be calculated on shortest terms), service charges, customer deposits, credits, allowances or excise taxes of any nature at any
time issued, owing, claimed by Account Debtors, granted, outstanding or payable in connection with such Accounts at such time. Without limiting the generality of the foregoing, unless otherwise approved in writing by Administrative Agent, no Account
shall be an Eligible Account if: 
 (i) it arises out of a sale made or services rendered by a
Borrowing Base Party to US Company, a Subsidiary of US Company or an Affiliate of US Company or to a Person controlled by an Affiliate of US Company; or 

  
 17 

 (ii) it is an Account that has payment terms longer than 60
days from the date of invoice; provided, however, that $2,500,000 or the Equivalent Amount thereof may be considered Eligible Accounts with payment terms longer than 60 days but no longer than 90 days from the date of the invoice;

 (iii) it remains unpaid more than 90 days after the original invoice date; or 

(iv) it is owed by an Account Debtor and the total unpaid Accounts of such Account Debtor exceed 10% of
the net amount of all Eligible Accounts, but only to the extent of such excess; or 
 (v) any
covenant, representation or warranty contained in this Agreement or any Security Document with respect to such Account has been breached; or 
 (vi) (1) the Account Debtor is also a creditor or supplier of the applicable Borrowing Base Party or any other Subsidiary of US Company, or the Account Debtor has disputed liability with respect to such
Account, or the Account Debtor has made any claim with respect to any other Account due from such Account Debtor to the applicable Borrowing Base Party or any other Subsidiary of US Company, or the Account otherwise is or may become subject to right
of setoff by the Account Debtor, provided, that any such Account shall be eligible to the extent such amount thereof exceeds such contract, dispute, claim, setoff or similar right; or (2) it is a portion (and only such portion) of any
Account that constitutes late fees or finance charges or (3) it is less than ninety (90) days past the original invoice date and related to invoices that have been partially paid, if the US Company, the UK Company or the Canadian Company,
as applicable, has reason to believe that such Account will not be fully paid; or 
 (vii) the
Account Debtor has commenced a voluntary case under the federal bankruptcy laws, as now constituted or hereafter amended, (or otherwise voluntarily submitted to insolvency, bankruptcy, arrangement, liquidation or equivalent proceedings in any
jurisdiction (including any Canadian Insolvency Law)) or made an assignment for the benefit of creditors, or a decree or order for relief has been entered by a court having jurisdiction in the premises in respect of the Account Debtor in an
involuntary case under the federal or other similar bankruptcy, receivership, reorganization, arrangement, liquidation or insolvency laws (including Canadian Insolvency Laws), as now constituted or hereafter amended, or any other petition, procedure
or other application for relief under the federal or other similar bankruptcy, receivership, reorganization or insolvency laws of any jurisdiction (including Canadian Insolvency Laws), as now constituted or hereafter amended, has been filed against
the Account Debtor, declared a moratorium on any indebtedness or is the subject of a voluntary scheme of arrangement or if the Account Debtor has failed, suspended business or payments, ceased to be Solvent, or consented to or suffered a receiver,
receiver manager, trustee, administrator, liquidator, compulsory manager, monitor or custodian to be appointed for it or for all or a significant portion of its assets or affairs; or 

(viii) (1) with respect to Account Debtors of any US Borrowing Base Party, it arises from a sale made or
services rendered to an Account Debtor outside the United States, unless the sale is either (a) to an Account Debtor located in Ontario, British Columbia or Alberta or any other province of Canada in which the PPSA has been adopted in
substantially the same form as currently in effect in Ontario or (b) is subject to Approved Credit Support or (2) with respect to Account Debtors of any UK Borrowing Base Party it arises from a sale made or services rendered to an Account
Debtor outside the United Kingdom, unless the sale is subject to Approved Credit Support, or (3) with respect to Account Debtors of any US Borrowing Base 

  
 18 

 
Party, the Account Debtor is the government of any country or sovereign state other than the United States, or of any state, municipality, or other political subdivision thereof, or of any
department, agency, public corporation, or other instrumentality thereof, unless the sale is subject to Approved Credit Support, or (4) with respect to Account Debtors of any UK Borrowing Base Party or Canadian Borrowing Base Party, the Account
Debtor is the government of any country or sovereign state, or of any state, province, municipality, or other political subdivision thereof, or of any department, agency, public corporation, or other instrumentality thereof, unless the sale is
subject to Approved Credit Support, or (5) with respect to Account Debtors of any Canadian Borrowing Base Party, it arises from a sale made or services rendered to an Account Debtor that is not located in Ontario, British Columbia or Alberta or
any other province or territory of Canada in which the PPSA has been adopted in substantially the same form as currently in effect in Ontario, unless the sale is subject to Approved Credit Support. 

(ix) (1) it arises from a sale to the Account Debtor on a bill-and-hold or, consignment basis or in any
other transaction wherein goods are sold pursuant to a guaranteed sale, a sale or return, a sale on approval, or any other terms by reason of which the payment by the Account Debtor may be conditional (other than, for the avoidance of doubt, a
rental or lease basis) or (2) it is subject to a reserve established by US Company or any of its Subsidiaries for potential returns or refunds, to the extent of such reserve; or 

(x) the Account Debtor is the United States of America, any State or any political subdivision or
department, agency or instrumentality thereof, unless the applicable Borrowing Base Party, assigns its right to payment of such Account to the Administrative Agent, in a manner satisfactory to the Administrative Agent, in its Permitted Discretion,
so as to comply with the Assignment of Claims Act of 1940 (31 USC. §203 et seq., as amended) or complies with any similar applicable state or local law as the Administrative Agent may require; or 

(xi) the Account Debtor is the federal government of Canada or the Provinces of Alberta, Manitoba or New
Brunswick or the Territory of Northwest Territories or Nunavut or any other province or territory of Canada which has legislation which restricts the collateral assignment of Crown obligations which are Accounts or, in each case, of any department,
agency or instrumentality thereof, unless the applicable Borrowing Base Party complies with the requirements of the Financial Administration Act (Canada), CITA, or any similar applicable provincial or territorial law, so that such Borrowing Base
Party may assign its right to payment of such Account to the Collateral Agent, in a manner satisfactory to the Administrative Agent, in its Permitted Discretion; or 

(xii) it is not at all times subject to Collateral Agent’s duly perfected, First Priority security
interest and to no other Lien that is not a Permitted Lien; or 
 (xiii) the goods giving rise
to such Account have not been delivered to and accepted by the Account Debtor or the services giving rise to such Account have not been performed by the applicable Borrowing Base Party and accepted by the Account Debtor or the Account otherwise does
not represent a final sale; or 
 (xiv) the Account is evidenced by an instrument of any kind,
or has been reduced to judgment; or 
 (xv) the applicable Borrowing Base Party has made any
agreement with the Account Debtor for any deduction therefrom, except for discounts or allowances which are made in the ordinary course of business for prompt payment and which discounts or allowances are reflected in the calculation of the face
value of each invoice related to such Account; or 

  
 19 

 (xvi) more than 50% of the Accounts owing from the Account
Debtor are not Eligible Accounts hereunder; or 
 (xvii) the Account is subject to any progress
payment or other similar advance made by or for the benefit of the applicable Account Debtor; or 
 (xviii) the Account evidences a lease or sale to an Account Debtor that is an individual to the extent that the aggregate of such Accounts exceeds $750,000; or 

(xix) the Account represents amounts which have not yet been billed to the applicable Account Debtor and
the amount of such Account together with the amount of all other Accounts which represent amounts which have not yet been billed to the applicable Account Debtors to the extent such amount exceeds $2,000,000 or the Equivalent Amount thereof; or

 (xx) except as provided in clause (x) above, with respect to which either the
perfection, enforceability, or validity of the Collateral Agent’s Liens in such Account, or the Collateral Agent’s right or ability to obtain direct payment to the Collateral Agent of the proceeds of such Account, is governed by any
national, federal, state, provincial or local statutory requirements other than those of the UCC or, in the case of the UK Borrowing Base Parties, the UK Companies Act of 1985 (as amended), or, in the case of the Canadian Borrowing Base Parties, a
PPSA in substantially the same form as currently in effect in Ontario; or 
 (xxi) in the case
of Accounts of any US Borrowing Base Party, is not payable in Dollars or Canadian Dollars or, in the case of Accounts of any UK Borrowing Base Party, is not payable in Pounds Sterling or Euros or, in the case of Accounts of any Canadian Borrowing
Base Party, is not payable in Dollars or Canadian Dollars; or 
 (xxii) with respect to the UK
Borrowing Base Parties, Accounts regulated by the UK Consumer Credit Act of 1974 (as amended); or 
 (xxiii) with respect to the UK Borrowing Base Parties, the Accounts are governed by laws other than that of England and Wales; or 

(xxiv) it is a LKE Account. 

“Eligible Cabin Fleet Inventory” shall mean Eligible Goods Inventory of a UK Borrowing Base Party
consisting of Cabin Fleet Inventory, valued at the lower of such Borrowing Base Party’s cost or Net Orderly Liquidation Value. 
 “Eligible Canadian Account” shall mean an Eligible Account of Canadian Company or another Canadian Borrowing Base Party. 

“Eligible Canadian Container Inventory Held For Sale” shall mean Eligible Container Inventory Held For
Sale of Canadian Company or another Canadian Borrowing Base Party. 
 “Eligible Canadian Machinery and
Equipment” shall mean Eligible Machinery and Equipment of Canadian Company or another Canadian Borrowing Base Party. 

  
 20 

 “Eligible Canadian Raw Materials Inventory” shall mean
Eligible Raw Materials Inventory of Canadian Company or another Canadian Borrowing Base Party. 

“Eligible Canadian Rental Fleet Inventory” shall mean Eligible Rental Fleet Inventory of Canadian
Company or another Canadian Borrowing Base Party. 
 “Eligible Canadian Work-In-Process Container
Inventory” shall mean Eligible Work-In-Process Container Inventory of Canadian Company or another Canadian Borrowing Base Party. 
 “Eligible Container Fleet Inventory” shall mean Eligible Goods Inventory of a Borrowing Base Party consisting of Container Fleet Inventory, valued at the lower of such Borrowing Base
Party’s cost or Net Orderly Liquidation Value, except for custom containers that are pre-sold and ISO containers that are pre-sold, which will be valued at the lower of Borrowing Base Party’s cost or sales invoice price. 

“Eligible Container Inventory Held For Sale” shall mean Eligible Goods Inventory of a Borrowing Base
Party consisting of (a) new and used manufactured or remanufactured portable and ISO containers and portable mobile offices held by a Borrowing Base Party for intended sale to third parties, containers temporarily out of service and otherwise
unrefurbished ISO units and (b) up to $10,000,000 (or the Equivalent Amount thereof) of containers used by Borrowing Base Parties in the conduct of their business (and not held for sale or lease), each of which containers in clauses
(a) and (b) shall be valued at the net book value thereof. 
 “Eligible Goods
Inventory” shall mean all of the Inventory owned by one of the Borrowing Base Parties that comply in all material respects with each of the representations and warranties respecting such Inventory made in the Credit Documents, and that are
not excluded as ineligible by one or more of the excluding criteria set forth below, and which the Administrative Agent shall have, in its Permitted Discretion, deemed to be Eligible Goods Inventory. The Administrative Agent shall have the right to
establish or modify Reserves against Eligible Goods Inventory from time to time in its Permitted Discretion on three Business Days’ prior written notice to US Company after consultation with US Company. The amount of Eligible Goods Inventory
shall be determined on a first-in, first-out basis; and Inventory “cost” shall be determined in a manner consistent with the respective Borrowing Base Parties’ current and historical accounting practices unless otherwise specifically
provided in this Agreement. Unless otherwise approved in writing by Administrative Agent, no Inventory shall be deemed Eligible Goods Inventory if: 

(i) it is not owned solely by a Borrowing Base Party or a Borrowing Base Party does not have good, valid
and marketable title thereto; or 
 (ii) it is not (A) with respect to a US Borrowing Base
Party (x) located at one of the locations in the United States or Canada, in either case, set forth on Schedule 1.01(b), or from and after the date hereof, another location maintained by US Company or any of its Subsidiaries in the
United States or Canada (it being understood that, with respect to Inventory with a cost in excess of $1,000,000 located in any Province of Canada other than the Provinces of British Columbia, Alberta or Ontario, such Inventory must be subject to a
valid and perfected First Priority Lien in favor of the Collateral Agent, enforceable on substantially the same basis as the Liens in favor of the Collateral Agent pursuant to the Security Documents over Inventory located in the United States (as
reasonably determined by the Administrative Agent) and supported by such Additional Security Documents and opinions of counsel as the Administrative Agent may reasonably request, and with all actions required pursuant to Section 9.13(a)
with respect to such Additional Security Documents having been completed), or (y) on lease with a customer in the ordinary course of business and located in the United States or Canada (it being understood that,

  
 21 

 
with respect to Inventory located in Canada, such Inventory must be subject to a valid and perfected First Priority Lien in favor of the Collateral Agent, enforceable on substantially the same
basis as the Liens in favor of the Collateral Agent pursuant to the Security Documents over Inventory located in the United States (as reasonably determined by the Administrative Agent) and supported by such Additional Security Documents and
opinions of counsel as the Administrative Agent may reasonably request, and with all actions required pursuant to Section 9.13(a) with respect to such Additional Security Documents having been completed), (B) with respect to a UK
Borrowing Base Party (x) located at one of the locations in the United Kingdom set forth on Schedule 1.01(c), or from and after the date hereof, another location maintained by a UK Borrowing Base Party in the United Kingdom, or
(y) on lease with a customer in the ordinary course of business and located in the United Kingdom or (C) with respect to a Canadian Borrowing Base Party, located at one of the locations in Canada set forth on Schedule 1.01(d), or
from and after the date hereof, another location maintained by a Canadian Borrowing Base Party in the United States or Canada (it being understood that, with respect to Inventory with a cost in excess of $1,000,000 located in any Province of Canada
other than the Provinces of British Columbia, Alberta or Ontario, such Inventory must be subject to a valid and perfected First Priority Lien in favor of the Collateral Agent, enforceable on substantially the same basis as the Liens in favor of the
Collateral Agent pursuant to the Security Documents over Inventory located in the Provinces of British Columbia, Alberta or Ontario (as reasonably determined by the Administrative Agent) and supported by such Additional Security Documents and
opinions of counsel as the Administrative Agent may reasonably request, and with all actions required pursuant to Section 9.13(a) with respect to such Additional Security Documents having been completed); or 

(iii) it is not subject to a valid and perfected First Priority Lien in favor of Collateral Agent except,
with respect to Inventory stored at sites described in clause (ii) above, for Liens for unpaid rent or normal and customary warehousing charges; provided that this clause (iii) will not apply to either (A) Inventory represented
by a Certificate of Title (such Inventory being subject to clause (xi) below) or (B) Inventory with a cost not in excess of $1,000,000 located in any Province of Canada other than the Provinces of British Columbia or Ontario, which such
Inventory described in this clause (B) need not be subject to a First Priority Lien; or 

(iv) it consists of goods returned or rejected by Borrowing Base Party’s or Affiliate’s
customers or goods in transit to third parties; or 
 (v) it is not first-quality finished goods
or work in process, is obsolete, or does not otherwise conform to the representations and warranties contained in the Credit Documents; or 
 (vi) it is subject to a lease which should be classified as a capital lease under GAAP or contains a purchase option for an amount less than the amount equal to the net book value; or 

(vii) it can not be located at the time of Borrowing Base Party’s physical inventory; or 

(viii) it is subject to any third party retention of title or romalpa provision, unless a Reserve has
been established by the Administrative Agent in respect of the UK Priority Claims related thereto in an amount equal to the value of such claims; or 

(ix) it is Eligible Raw Materials Inventory or Eligible Machinery and Equipment; or 

(x) it is damaged or defective and is not repairable; or 

  
 22 

 (xi) it is Inventory represented (or required to be
represented) by a Certificate of Title unless the Credit Parties shall have complied with Article 6 of the US Security Agreement; or 
 (xii) it has not been appraised by the Appraiser with an appraisal in form and substance satisfactory to Administrative Agent and reasonably satisfactory to the Required Lenders and it is not of an
identical kind or type of Inventory that has been appraised. 
 “Eligible Inventory” shall mean
Eligible Goods Inventory and Eligible Raw Materials Inventory. 
 “Eligible Machinery and
Equipment” shall mean all of the Equipment owned by a Borrowing Base Party in the ordinary course of business and which complies in all material respects with the representations and warranties respecting Eligible Machinery and Equipment
made in the Credit Documents and that are not excluded as ineligible by virtue of one or more of the exclusionary criteria set forth below. The Administrative Agent shall have the right to establish or modify Reserves against Eligible Machinery and
Equipment from time to time in its Permitted Discretion on three Business Days’ prior written notice to US Company after consultation with US Company. Eligible Machinery and Equipment shall be valued at its Net Orderly Liquidation Value.
Without limiting the generality of the foregoing, unless otherwise approved in writing by Administrative Agent, no Equipment shall be deemed Eligible Machinery and Equipment if: 

(i) it is not owned solely by a Borrowing Base Party or a Borrowing Base Party does not have good, valid
and marketable title thereto; or 
 (ii) it is not (A) with respect to a US Borrowing Base
Party, located at one of the locations in the United States or Canada set forth on Schedule 1.01(b), or from and after the date hereof, another location maintained by US Company or one of its Subsidiaries in the United States or Canada (it
being understood that, with respect to Equipment located in any Province of Canada other than the Provinces of British Columbia, Alberta or Ontario, such Equipment must be subject to a valid and perfected First Priority Lien in favor of the
Collateral Agent, enforceable on substantially the same basis as the Liens in favor of the Collateral Agent pursuant to the Security Documents over Equipment located in the United States (as reasonably determined by the Administrative Agent) and
supported by such Additional Security Documents and opinions of counsel as the Administrative Agent may reasonably request, and with all actions required pursuant to Section 9.13(a) with respect to such Additional Security Documents
having been completed), (B) with respect to a UK Borrowing Base Party, located at one of the locations in the United Kingdom set forth on Schedule 1.01(c), or from and after the date hereof, another location maintained by a UK Borrowing
Base Party in the United Kingdom or (C) with respect to a Canadian Borrowing Base Party, located at one of the locations in Canada set forth on Schedule 1.01(d), or from and after the date hereof, another location maintained by a
Canadian Borrowing Base Party in the United States or Canada (it being understood that, with respect to Equipment located in the United States or any Province of Canada other than the Provinces of British Columbia, Alberta or Ontario, such Equipment
must be subject to a valid and perfected First Priority Lien in favor of the Collateral Agent, enforceable on substantially the same basis as the Liens in favor of the Collateral Agent pursuant to the Security Documents over Equipment located in the
Provinces of British Columbia, Alberta or Ontario (as reasonably determined by the Administrative Agent) and supported by such Additional Security Documents and opinions of counsel as the Administrative Agent may reasonably request, and with all
actions required pursuant to Section 9.13(a) with respect to such Additional Security Documents having been completed); or 

  
 23 

 (iii) it is not subject to a valid and perfected First
Priority Lien in favor of Collateral Agent except, with respect to Equipment stored at sites described in clause (ii) above, for Liens for unpaid rent or normal and customary warehousing charges; provided that this clause (iii) will
not apply to Equipment represented by a Certificate of Title (such Equipment being subject to clause (v) below); or 
 (iv) it has not been appraised by the Appraiser with an appraisal in form and substance satisfactory to Administrative Agent and reasonably satisfactory to the Required Lenders and it is not of an
identical kind or type of Equipment that has been appraised; or 
 (v) it is Equipment
represented (or required to be represented) by a Certificate of Title or constitutes Serial Numbered Equipment unless the Credit Parties shall have complied with Article 6 of the US Security Agreement; or 

(vi) it is Eligible Goods Inventory. 

“Eligible Raw Materials Inventory” shall mean Inventory of a Borrowing Base Party, purchased from third
parties consisting of steel, lumber, plywood, paint, drywall, plumbing materials and fixtures, electrical components, insulation materials, HVAC materials, doors and windows, and fasteners, valued at the applicable Borrowing Base Party’s cost
(except, in the case of steel, lumber, plywood, paint, where, for purposes of fiscal year end calculations, the value will be the lower of the applicable Borrowing Base Party’s cost or market), which Administrative Agent, in its Permitted
Discretion, deems to be Eligible Raw Materials Inventory. The amount of Raw Materials Inventory shall be determined on a first-in, first-out basis. Without limiting the generality of the foregoing, unless otherwise approved in writing by
Administrative Agent, no Inventory shall be deemed Eligible Raw Materials Inventory if: 
 (i)
it is not owned solely by a Borrowing Base Party or a Borrowing Base Party does not have good, valid and marketable title thereto; or 
 (ii) it is not (A) with respect to a US Borrowing Base Party, located at one of the locations in the United States or Canada set forth on Schedule 1.01(b), or from and after the date hereof,
another location maintained by US Company or one of its Subsidiaries in the United States or Canada (it being understood that, with respect to Inventory located in any Province of Canada other than the Provinces of British Columbia, Alberta or
Ontario, such Inventory must be subject to a valid and perfected First Priority Lien in favor of the Collateral Agent, enforceable on substantially the same basis as the Liens in favor of the Collateral Agent pursuant to the Security Documents over
Inventory located in the United States (as reasonably determined by the Administrative Agent) and supported by such Additional Security Documents and opinions of counsel as the Administrative Agent may reasonably request, and with all actions
required pursuant to Section 9.13(a) with respect to such Additional Security Documents having been completed), (B) with respect to a UK Borrowing Base Party, it is not located at one of the locations in the United Kingdom set forth
on Schedule 1.01(c), or from and after the date hereof, another location maintained by a UK Borrowing Base Party in the United Kingdom or (C) with respect to a Canadian Borrowing Base Party, located at one of the locations in Canada set
forth on Schedule 1.01(d), or from and after the date hereof, another location maintained by a Canadian Borrowing Base Party in the United States or Canada (it being understood that, with respect to Inventory located in the United States or
any Province of Canada other than the Provinces of British Columbia, Alberta or Ontario, such Inventory must be subject to a valid and perfected First Priority Lien in favor of the Collateral Agent, enforceable on substantially the same basis as the
Liens in favor of the Collateral Agent pursuant to the Security Documents over Inventory located in the Provinces of British Columbia or Ontario (as reasonably determined by the 

  
 24 

 
Administrative Agent) and supported by such Additional Security Documents and opinions of counsel as the Administrative Agent may reasonably request, and with all actions required pursuant to
Section 9.13(a) with respect to such Additional Security Documents having been completed); or 
 (iii) it is not subject to a valid and perfected First Priority Lien in favor of Collateral Agent except, with respect to Inventory stored at sites described in clause (ii) above, for Liens for
unpaid rent or normal and customary warehousing charges; or 
 (iv) it is not first-quality raw
materials, is obsolete or slow moving, or does not otherwise conform to the representations and warranties contained in the Credit Documents; or 

(v) it is Eligible Goods Inventory or Eligible Machinery and Equipment; or 

(vi) it is subject to any third party retention of title or romalpa provision, unless a Reserve has been
established by the Administrative Agent in respect of the UK Priority Claims related thereto in an amount equal to the value of such claims. 
 “Eligible Real Property” shall mean all of the Real Property owned by a US Borrowing Base Party in the ordinary course of business and which complies in all material respects with the
representations and warranties respecting Real Property made in the Credit Documents and that are not excluded as ineligible by virtue of one or more of the exclusionary criteria set forth below. The Administrative Agent shall have the right to
establish or modify Reserves against Eligible Real Property from time to time in its Permitted Discretion on three Business Days’ prior written notice to US Company after consultation with US Company. Eligible Real Property shall be valued at
its Appraised Fair Market Value. Without limiting the generality of the foregoing, unless otherwise approved in writing by Administrative Agent, no Real Property shall be deemed Eligible Real Property if: 

(i) it is not owned solely by a US Borrowing Base Party or a US Borrowing Base Party does not have good
record and valid and marketable title in fee simple thereto; or 
 (ii) it is not located in the
United States; or 
 (iii) it is not subject to a valid and perfected First Priority Lien,
subject only to any Permitted Encumbrances, pursuant to a Mortgage in form and substance satisfactory to the Administrative Agent, in favor of the Collateral Agent on behalf of itself and the Secured Creditors; or 

(iv) it has not been appraised by the Appraiser with a FIRREA-compliant appraisal satisfactory to
Administrative Agent; or 
 (v) it is not designated as “Eligible Real Property” on
Schedule 1.01(e), as amended from time to time with the consent of Administrative Agent; or 
 (vi) it is not covered by a Mortgage Policy with respect to the Lien of the Collateral Agent and casualty and property insurance, in each case reasonably acceptable to the Administrative Agent; or

 (vii) environmental due diligence satisfactory to the Administrative Agent has not been
completed with respect to such Real Property; or 

  
 25 

 (viii) an opinion of counsel for the Credit Party which is
the owner of the Real Property has not been delivered to the Administrative Agent, in a form, scope and substance reasonably satisfactory to the Administrative Agent and its counsel, if reasonably requested by the Administrative Agent; or

 (ix) a customary certificate in a form reasonably acceptable to the Administrative Agent has
not been obtained indicating that the property is not in a flood zone, or if the property is in a flood zone, appropriate insurance reasonably acceptable to the Administrative Agent has not been obtained. 

“Eligible Rental Fleet Inventory” shall mean (w) Eligible Cabin Fleet Inventory, (x) Eligible
Container Fleet Inventory, (y) Eligible Trailer Fleet Inventory and (z) any other rental storage fleet Inventory or rental mobile office Inventory acquired and used in compliance with Section 10.17, in each case, valued at the
lower of cost or Net Orderly Liquidation Value, excluding in each case any Inventory that is not manufactured in accordance with and does not meet all standards imposed by all requirements of law or by any governmental authority having regulatory
authority over such goods or their manufacture, use, sale, or lease. 
 “Eligible Trailer Fleet
Inventory” shall mean Eligible Goods Inventory consisting of Trailer Fleet Inventory, excluding any Inventory that is not manufactured in accordance with and does not meet all standards imposed by all requirements of law or by any
governmental authority having regulatory authority over such goods or their manufacture, use, sale, or lease. 

“Eligible Transferee” shall mean and include a commercial bank, an insurance company, a finance company,
a financial institution, any fund that invests in loans or any other “accredited investor” (as defined in Regulation D of the Securities Act) other than a natural Person, but in any event excluding US Company and its Subsidiaries and
Affiliates. 
 “Eligible UK Account” shall mean an Eligible Account of UK Company or another UK
Borrowing Base Party. 
 “Eligible UK Container Inventory Held For Sale” shall mean Eligible
Container Inventory Held For Sale of UK Company or another UK Borrowing Base Party. 
 “Eligible UK
Machinery and Equipment” shall mean Eligible Machinery and Equipment of UK Company or any other UK Borrowing Base Party. 
 “Eligible UK Raw Materials Inventory” shall mean Eligible Raw Materials Inventory of UK Company or another UK Borrowing Base Party. 

“Eligible UK Rental Fleet Inventory” shall mean Eligible Rental Fleet Inventory of UK Company or another
UK Borrowing Base Party. 
 “Eligible UK Work-In-Process Container Inventory” shall mean
Eligible Work-In-Process Container Inventory of UK Company or another UK Borrowing Base Party. 

“Eligible US Account” shall mean an Eligible Account of US Company or another US Borrowing Base Party.

 “Eligible US Container Inventory Held For Sale” shall mean Eligible Container Inventory Held
For Sale of US Company or another US Borrowing Base Party. 

  
 26 

 “Eligible US Machinery and Equipment” shall mean Eligible
Machinery and Equipment of US Company or another US Borrowing Base Party. 
 “Eligible US Raw Materials
Inventory” shall mean Eligible Raw Materials Inventory of US Company or another US Borrowing Base Party. 
 “Eligible US Rental Fleet Inventory” shall mean Eligible Rental Fleet Inventory of US Company or another US Borrowing Base Party. 

“Eligible US Work-In-Process Container Inventory” shall mean Eligible Work-In-Process Container
Inventory of US Company or another US Borrowing Base Party. 
 “Eligible Work-In-Process Container
Inventory” shall mean Eligible Goods Inventory, valued at net book value, consisting of: (a) new and used manufactured or remanufactured portable containers, which is in the work-in-process phase of manufacturing; (b) shaped steel
component parts; or (c) sub-assemblies. 
 “End Date” shall have the meaning provided in
the definition of Applicable Margin. 
 “Environmental Claims” shall mean any and all
administrative, regulatory or judicial actions, suits, demands, demand letters, directives, claims, liens, notices of noncompliance or violation, investigations or proceedings relating in any way to any Environmental Law or any permit issued, or any
approval given, under any such Environmental Law (hereafter, “Claims”), including, without limitation, (a) any and all Claims by Governmental Authorities for enforcement, cleanup, removal, response, remedial or other actions or
damages pursuant to any applicable Environmental Law, and (b) any and all Claims by any third party seeking damages, contribution, indemnification, cost recovery, compensation or injunctive relief in connection with alleged injury or threat of
injury to health, safety or the environment due to the presence of Hazardous Materials. 

“Environmental Law” shall mean any Federal, state, provincial, foreign or local statute, law, rule,
regulation, ordinance, code, guideline, policy and rule of common law now or hereafter in effect and in each case as amended, and any judicial or administrative interpretation thereof, including any judicial or administrative order, agreement,
consent decree or judgment, relating to the environment, employee health and safety or Hazardous Materials, including, without limitation, CERCLA; the Resource Conservation and Recovery Act, 42 USC § 6901 et seq.; the Federal Water Pollution
Control Act, 33 USC. § 1251 et seq.; the Toxic Substances Control Act, 15 USC. § 2601 et seq.; the Clean Air Act, 42 USC. § 7401 et seq.; the Safe Drinking Water Act, 42 USC. § 3803 et seq.; the Oil Pollution Act of 1990, 33 USC.
§ 2701 et seq.; the Emergency Planning and the Community Right-to-Know Act of 1986, 42 USC. § 11001 et seq.; the Hazardous Material Transportation Act, 49 USC. § 1801 et seq.; the Occupational Safety and Health Act, 29 USC. §651
et seq.; and any state, provincial and local or foreign counterparts or equivalents in any jurisdiction, in each case as amended from time to time. 
 “Equipment” shall mean all machinery, apparatus, equipment, motor vehicles and other similar assets (other than Inventory) used in the operations of the US Company or any of its
Subsidiaries or owned by the US Company or any of its Subsidiaries or in which the US Company or any of its Subsidiaries has an interest, whether now owned or hereafter acquired by a Borrower or any of its Subsidiaries or Affiliates and wherever
located, and all parts, accessories and special tools and all increases and accessions thereto and substitutions and replacements therefore. 
 “Equity Interests” of any Person shall mean any and all shares, interests, rights to purchase, warrants, options, participation or other equivalents of or interest in (however designated)
equity of such Person, including any common stock, preferred stock, any limited or general partnership interest and any limited liability company membership interest. 

  
 27 

 “Equivalent Amount” shall mean (i) the equivalent
amount in US Dollars of any amount expressed in Pounds Sterling, Euros or Canadian Dollars, as the case may be, as determined by Administrative Agent on the date of determination on the basis of the Spot Rate for the purchase of US Dollars with
Pounds Sterling, Euros or Canadian Dollars, as the case may be, on the relevant Computation Date provided for hereunder; or (ii) the equivalent amount in Pounds Sterling, Euros or Canadian Dollars, as the case may be, of any amount expressed in
US Dollars as determined by Administrative Agent on the date of determination on the basis of the Spot Rate for the purchase of Pounds Sterling, Euros or Canadian Dollars, as the case may be, with Dollars on the relevant Computation Date provided
for hereunder. 
 “ERISA” shall mean the Employee Retirement Income Security Act of 1974, as
amended from time to time, and the regulations promulgated and rulings issued thereunder. Section references to ERISA are to ERISA, as in effect at the date of this Agreement and any subsequent provisions of ERISA, amendatory thereof, supplemental
thereto or substituted therefor. 
 “ERISA Affiliate” shall mean each person (as defined in
Section 3(9) of ERISA) which together with any Credit Party would be deemed to be a “single employer” within the meaning of Section 414(b) or (c) of the Code, and for the purpose of Section 302 of ERISA and/or
Section 412, 4971, 4977 and/or each “applicable section” under Section 414(t)(2) of the Code, within the meaning of Section 414(b), (c), (m) or (o) of the Code. 

“Euro” and “€” means the single currency of the Participating Member States.

 “EURIBOR” shall mean, for each Interest Period: 

(a) the Euro Inter-Bank Offered Rate displayed on the relevant Reuters Screen LIBOR01 Page (or any other
page or screen that would be substituted therefor) at 11:00 a.m. (Brussels time) under the supervision of the European Banking Federation two Business Days before the first day of such Interest Period, with respect to deposits in Euros on the
European interbank market amongst leading banks for a period equivalent to such Interest Period; and 
 (b) if no rate is available as described above with respect to an Interest Period applicable to UK Revolving Loans, the annual rate determined by the Administrative Agent as being equal to the arithmetic
mean (rounded up if necessary to the nearest four decimal places) of the rates supplied to the Administrative Agent by four (4) reference banks selected by the Administrative Agent in the European interbank market, at approximately 3:00 p.m.
(Brussels time) three Business Days before the first day of such Interest Period as quoted by the respective reference banks to leading banks on the European interbank market for deposits in Euros, for a period equivalent to such Interest Period and
starting on the first day of such Interest Period and for an amount comparable to the amount of such EURIBOR Loan. 
 If the EURIBOR is replaced by a similar or equivalent interest rate, or in the event of a change affecting the entity which publishes the EURIBOR or the terms of its publication, the corresponding
modified or replacement interest rate shall automatically apply in accordance with the foregoing paragraphs and any reference herein to “EURIBOR” shall be deemed to be a reference to such rate. 

“EURIBOR Loan” shall mean each UK Revolving Loan denominated in Euros bearing interest at a rate
determined by reference to EURIBOR. 

  
 28 

 “Euro Denominated Revolving Loan” shall have the meaning
set forth in Section 2.01(b) hereof. 
 “Euro Funding Capacity” shall mean, for any
Lender, the ability of such Lender or an Affiliate or branch office thereof to fund UK Revolving Loans denominated in Euros, as set forth in the records of Administrative Agent. 

“Euro Funding Capacity Lender” shall mean each Lender other than (i) in the case of each Lender as
of the Effective Date, each Lender that shall have confirmed in writing, to the satisfaction of the Administrative Agent, on or prior to the Effective Date, that neither it nor any domestic or foreign branch or Affiliate of such Lender has the
ability to fund UK Revolving Loans denominated in Euros and (ii) in the case of each Lender after the Effective Date, each Lender that shall have confirmed in writing, to the satisfaction of the Administrative Agent, on or prior to the date
such Lender becomes a Lender hereunder, that neither it nor any domestic or foreign branch or Affiliate of such Lender has the ability to fund UK Revolving Loans denominated in Euros, in each case until such time as such Lender shall have confirmed
in writing to the Administrative Agent that it or any domestic or foreign branch or Affiliate of such Lender does have the ability to fund Euro Revolving Loans denominated in Pounds Sterling. 

“Event of Default” shall have the meaning provided in Section 11. 

“Executive Order” shall have the meaning provided in Section 8.33(a). 

“Existing Indebtedness” shall have the meaning provided in Section 8.30. 

“Existing Indebtedness Agreements” shall mean all agreements evidencing or relating to Indebtedness of
US Company or any of its Subsidiaries which is to remain outstanding after giving effect to the Transactions. 

“Existing US Letter of Credit” shall have the meaning provided in Section 3.01(c).

 “Expenses” shall mean all present and future reasonable and invoiced expenses incurred by or
on behalf of the Administrative Agent, the Collateral Agent or any Issuing Lender in connection with this Agreement, any other Credit Document or otherwise in its capacity as the Administrative Agent under this Agreement or the Collateral Agent
under any Security Document or as an Issuing Lender under this Agreement, whether incurred heretofore or hereafter, which expenses shall include, without limitation, the cost of record searches, the reasonable fees and expenses of attorneys and
paralegals, all reasonable and invoiced costs and expenses incurred by the Administrative Agent (and the Collateral Agent) in opening bank accounts, depositing checks, electronically or otherwise receiving and transferring funds, and any other
charges imposed on the Administrative Agent (and the Collateral Agent) due to insufficient funds of deposited checks and the standard fee of the Administrative Agent (and the Collateral Agent) relating thereto, collateral examination fees and
expenses, reasonable fees and expenses of accountants, appraisers or other consultants, experts or advisors employed or retained by the Administrative Agent and the Collateral Agent, fees and taxes related to the filing of financing statements,
costs of preparing and recording any other Credit Documents, all expenses, costs and fees set forth in this Agreement and the other Credit Documents, all other fees and expenses required to be paid pursuant to any other letter agreement and all fees
and expenses incurred in connection with releasing Collateral and the amendment or termination of any of the Credit Documents. 
 “Face Amount” shall mean, in respect of a Draft, Bankers’ Acceptance or B/A Discount Note, as the case may be, the amount payable to the holder thereof on its maturity. The Face
Amount of any Bankers’ Acceptance Loan shall be equal to the aggregate Face Amounts of the underlying Bankers’ Acceptances, B/A Discount Notes or Drafts, as the case may be. 

  
 29 

 “Facing Fee” shall have the meaning provided in
Section 4.01(c). 
 “Fair Market Value” shall mean, with respect to any asset
(including any Equity Interests of any Person), the price at which a willing buyer, not an Affiliate of the seller, and a willing seller who does not have to sell, would agree to purchase and sell such asset, as determined in good faith by the board
of directors or other governing body or, pursuant to a specific delegation of authority by such board of directors or other governing body, a designated senior executive officer, of US Company, or the Subsidiary of US Company selling such asset.

 “FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or
any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof. 

“Federal Funds Rate” shall mean, for any period, a fluctuating interest rate equal for each day during
such period to the weighted average of the rates on overnight Federal Funds transactions with members of the Federal Reserve System arranged by Federal Funds brokers, as published for such day (or, if such day is not a Business Day, for the next
preceding Business Day) by the Federal Reserve Bank of New York, or, if such rate is not so published for any day which is a Business Day, the average of the quotations for such day on such transactions received by the Administrative Agent from
three Federal Funds brokers of recognized standing selected by the Administrative Agent. 
 “Fee
Letter” shall mean, collectively, each Fee Letter dated January 31, 2012, by and among Mobile Mini, Inc. and (i) Deutsche Bank Securities Inc. and Deutsche Bank AG New York Branch, (ii) Merrill Lynch, Pierce,
Fenner & Smith Incorporated and Bank of America, N.A. and (iii) J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. 
 “Fees” shall mean all amounts payable pursuant to or referred to in Section 4.01. 
 “Final Maturity Date” shall mean the earlier of (x) February 22, 2017 and (y) the date that is 90 days prior to the final maturity date (as set forth in the Mobile Mini
2015 Indenture) of the Mobile Mini 2015 Senior Notes if the Mobile Mini 2015 Senior Notes in an aggregate principal amount in excess of $50,000,000 remain outstanding on such date. 

“First Priority” shall mean, with respect to any Lien purported to be created on any Collateral pursuant
to any Security Document, that such Lien is prior in right to any other Lien thereon, other than any Permitted Liens applicable to such Collateral which as a matter of law have priority over the respective Liens on such Collateral created pursuant
to the relevant Security Document. 
 “Fixed Charge Coverage Ratio” shall mean as of any date
of determination, the ratio of (i) Consolidated Net Cash Flow for the four fiscal quarters ending on such date to (ii) Fixed Charges. 
 “Fixed Charges” shall mean as of any date of determination, the sum of Interest Expense for the four fiscal quarters ending on such date plus the principal payments with respect to
Funded Debt (other than payments of Revolving Loans) made during the four fiscal quarters ending on such date. 

“Foreign Account” shall mean each account of any Credit Party established at a bank, other than in the
United States, Canada or the United Kingdom set forth on Part F of Schedule 10.18. 

  
 30 

 “Foreign Pension Plan” shall mean any plan, fund
(including, without limitation, any superannuation fund) or other similar program established or maintained outside the United States by any Credit Party or any of its Subsidiaries primarily for the benefit of employees of any Credit Party or any
such Subsidiaries residing outside the United States, which plan, fund or other similar program provides, or results in, retirement income, a deferral of income in contemplation of retirement or payments to be made upon termination of employment,
and which plan is not subject to ERISA or the Code. 
 “Foreign Subsidiary” shall mean any
Subsidiary of US Company that is not a Domestic Subsidiary. 
 “Funded Debt” shall mean,
without duplication, (i) Indebtedness arising from the lending of money by any Person to US Company or any of its Subsidiaries; (ii) Indebtedness, whether or not in any such case arising from the lending by any Person of money to US
Company or any of its Subsidiaries, (1) which is represented by notes payable or drafts accepted that evidence extensions of credit, (2) which constitutes obligations evidenced by bonds, debentures, notes or similar instruments, or
(3) upon which interest charges are customarily paid (other than accounts payable) or that was issued or assumed as full or partial payment for Property; (iii) Indebtedness that constitutes a Capitalized Lease Obligation;
(iv) reimbursement obligations with respect to letters of credit or guaranties of letters of credit; and (v) Indebtedness of US Company or any of its Subsidiaries under any guaranty of obligations that would constitute Funded Debt under
clauses (i) through (iv) hereof, if owed directly by US Company or any of its Subsidiaries. Funded Debt shall not include trade payables or accrued expenses or Indebtedness (other than Indebtedness under this Agreement) of up to the amount
permitted pursuant to Section 10.05(g) incurred to finance insurance premiums. 

“GAAP” shall mean generally accepted accounting principles in the United States as in effect from time
to time. 
 “General Intangibles” shall mean “general intangibles” as such term is
defined in Article 9 of the UCC. 
 “Governmental Authority” shall mean the government of the
United States, the United Kingdom, Canada, any other nation or any political subdivision thereof, whether state, provincial, territorial or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity
exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government, in each case, in any jurisdiction. 

“Guarantees” shall mean the guarantees issued pursuant to Section 15. 

“Guarantor” shall mean each US Guarantor and each Non-US Obligation Guarantor. 

“Hazardous Materials” shall mean (a) any petroleum or petroleum products, radioactive materials,
asbestos in any form that is or could become friable, urea formaldehyde foam insulation, dielectric fluid containing levels of polychlorinated biphenyls, and radon gas; (b) any chemicals, materials or substances defined as or included in the
definition of “hazardous substances,” “hazardous waste,” “hazardous materials,” “extremely hazardous substances,” “restricted hazardous waste,” “toxic substances,” “toxic
pollutants,” “contaminants,” or “pollutants,” or words of similar import, under any applicable Environmental Law; and (c) any other chemical, material or substance, the exposure to, or Release of which is prohibited,
limited or regulated by any Governmental Authority. 
 “Highest Adjustable Applicable Margins”
shall have the meaning provided in the definition of Applicable Margin. 

  
 31 

 “Immaterial Subsidiary” shall mean, as of any date of
determination, any Foreign Subsidiary that as of such time has (i) consolidated total assets with a book value of $5,000,000 or less and (ii) consolidated revenues of $5,000,000 or less for the most recently ended period of four
consecutive fiscal quarters; provided that all such Foreign Subsidiaries in the aggregate may not have (i) consolidated total assets with a book value in excess of $25,000,000 or (ii) consolidated revenues in excess of $25,000,000
for the most recently ended period of four consecutive fiscal quarters. 
 “Incremental
Commitment” shall mean, for any Lender, any Revolving Loan Commitment provided by such Lender after the Effective Date in an Incremental Commitment Agreement delivered pursuant to Section 2.15; it being understood, however, that
on each date upon which an Incremental Commitment of any Lender becomes effective, such Incremental Commitment of such Lender shall be added to (and thereafter become a part of) the Revolving Loan Commitment of such Lender for all purposes of this
Agreement as contemplated by Section 2.15. 
 “Incremental Commitment Agreement”
shall mean each Incremental Commitment Agreement in substantially the form of Exhibit D (appropriately completed, and with such modifications as may be satisfactory to the Administrative Agent) executed and delivered in accordance with
Section 2.15. 
 “Incremental Commitment Date” shall mean each date upon which an
Incremental Commitment under an Incremental Commitment Agreement becomes effective as provided in Section 2.15(b). 
 “Incremental Commitment Request Requirements” shall mean, with respect to any request for an Incremental Commitment made pursuant to Section 2.15, the satisfaction of each of
the following conditions on the date of such request: (i) no Default or Event of Default then exists or would result therefrom and (ii) all of the representations and warranties contained herein and in the other Credit Documents are true
and correct in all material respects at such time (it being understood and agreed that (x) any representations and warranties stated to relate to a specific earlier date shall have been true and correct in all material respects as of such
earlier date and (y) any representations and warranties qualified as to “materiality” or “Material Adverse Effect” shall be true and correct in all respects at such time). 

“Incremental Commitment Requirements” shall mean, with respect to any provision of an Incremental
Commitment on a given Incremental Commitment Date, the satisfaction of each of the following conditions on or prior to the effective date of the respective Incremental Commitment Agreement: (i) satisfaction of the conditions in the definition
of Incremental Commitment Request Requirements (to the extent applicable) as of the effective date of such Incremental Commitment Agreement as certified by an Authorized Officer of US Company in an officer’s certificate delivered to the
Administrative Agent; (ii) the delivery by US Company to the Administrative Agent of an acknowledgement in form and substance reasonably satisfactory to the Administrative Agent and executed by each other Credit Party, acknowledging that such
Incremental Commitment and all Revolving Loans subsequently incurred, and Letters of Credit issued, pursuant to such Incremental Commitment shall constitute (and be included in the definitions of) Obligations and be secured on a pari passu basis
with the Obligations under the relevant Security Documents; (iii) the delivery by US Company to the Administrative Agent of an opinion or opinions, in form and substance reasonably satisfactory to the Administrative Agent, from counsel to the
Credit Parties reasonably satisfactory to the Administrative Agent and dated such date, covering such matters incident to the transactions contemplated thereby as the Administrative Agent may reasonably request; (iv) the delivery by each Credit
Party to the Administrative Agent of such other officers’ certificates, board of director (or equivalent governing body) resolutions and evidence of good standing (to the extent available under Applicable Law) as the Administrative Agent shall
reasonably request; and (v) the completion by each 

  
 32 

 
Credit Party of such other actions as the Administrative Agent may reasonably request in connection with such Incremental Commitment in order to create, continue or maintain the Liens of the
Collateral Agent in the Collateral and the perfection thereof (including, without limitation, any mortgage amendments, Mortgage Policies and such other documents reasonably requested by the Administrative Agent to be delivered in connection
therewith). 
 “Incremental Lender” shall have the meaning specified in
Section 2.15(b). 
 “Indebtedness” shall mean, as to any Person, without
duplication, (a) all indebtedness of such Person for borrowed money or for the deferred purchase price of property or services, (b) the maximum amount available to be drawn or paid under all letters of credit, bankers’ acceptances,
bank guaranties, surety and appeal bonds and similar obligations issued for the account of such Person and all unpaid drawings and unreimbursed payments in respect of such letters of credit, bankers’ acceptances, bank guaranties, surety and
appeal bonds and similar obligations, (c) all indebtedness of the types described in clause (a), (b), (d), (e), (f), (g) or (h) of this definition secured by any Lien on any property owned by such Person, whether or not such
indebtedness has been assumed by such Person (provided that, if the Person has not assumed or otherwise become liable in respect of such indebtedness, such indebtedness shall be deemed to be in an amount equal to the Fair Market Value of the
property to which such Lien relates), (d) all Capitalized Lease Obligations of such Person, (e) all obligations of such Person to pay a specified purchase price for goods or services, whether or not delivered or accepted, i.e., take-or-pay
and similar obligations, (f) all Contingent Obligations of such Person, (g) all obligations under any Interest Rate Protection Agreement, any Other Hedging Agreement or under any similar type of agreement and (h) all Off-Balance Sheet
Liabilities of such Person. The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is directly liable therefor as a result of
such Person’s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor. Notwithstanding the foregoing, Indebtedness shall not include trade
payables, accrued expenses and deferred tax and other credits incurred by any Person in accordance with customary practices and in the ordinary course of business of such Person. 

“Indemnified Person” shall have the meaning provided in Section 13.01. 

“Indemnified Taxes” shall have the meaning provided in Section 5.04. 

“Individual Exposure” of any Lender shall mean, at any time, the sum of (a) the aggregate principal
amount of all Revolving Loans made by such Lender and then outstanding, (b) such Lender’s RL Percentage of the aggregate principal amount of all Swingline Loans then outstanding and (c) such Lender’s RL Percentage of the
aggregate amount of all Letter of Credit Outstandings at such time. 
 “Initial Post-Closing
Availability Certificate” shall have the meaning provided in the definition of “Applicable Margin.” 
 “Interest Determination Date” shall mean, with respect to any LIBOR Loan or EURIBOR Loan, the second Business Day prior to the commencement of any Interest Period relating to such LIBOR
Loan or EURIBOR Loan. 
 “Interest Expense” shall mean the consolidated expense of US Company
and its Subsidiaries for interest on Indebtedness, including, without limitation, amortization of original issue discount, incurrence fees (to the extent included in interest expense), the interest portion of any deferred payment obligation and the
interest component of any Capitalized Lease Obligation. 

  
 33 

 “Interest Period” shall have the meaning provided in
Section 2.09. 
 “Interest Rate Protection Agreement” shall mean any interest rate
swap agreement, interest rate cap agreement, interest collar agreement, interest rate hedging agreement or other similar agreement or arrangement. 
 “Inventory” shall mean “inventory” as such term is defined in Article 9 of the UCC. 
 “Investments” shall mean all expenditures made and all liabilities incurred (including Contingent Obligations) for or in connection with the acquisition of Equity Interests or
Indebtedness of a Person, loans, advances, capital contributions or transfers of property to a Person, or acquisition of substantially all the assets of a Person. In determining the aggregate amount of Investments outstanding at any particular time,
(i) a guaranty shall be valued at not less than the principal amount guaranteed and outstanding; (ii) returns of capital (but only by repurchase, redemption, retirement, repayment, liquidating dividend or liquidating distribution) shall be
deducted; (iii) earnings, whether as dividends, interest or otherwise, shall not be deducted; and (iv) decreases in the market value shall not be deducted. 

“Issuing Lender” shall mean each US Issuing Lender, each UK Issuing Lender and each Canadian Issuing
Lender. 
 “Joinder Agreement” shall mean a Joinder Agreement substantially in the form of
Exhibit E (appropriately completed). 
 “Joint Bookrunners” shall mean collectively, Deutsche
Bank Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC. 
 “Landlord Personal Property Collateral Access Agreement” shall mean a Landlord Waiver and Consent Agreement in form and substance satisfactory to the Administrative Agent. 

“Leaseholds” of any Person shall mean all the right, title and interest of such Person as lessee or
licensee in, to and under leases or licenses of land, improvements and/or fixtures. 
 “Lender”
shall mean each financial institution listed on Schedule 1.01(a), as well as any Person that becomes a “Lender” hereunder pursuant to Section 2.13, 2.15 or 13.04(b). 

“Lender Default” shall mean, as to any Lender, (i) the refusal (which has not been retracted) of
such Lender or the failure of such Lender (which has not been cured) to make available its portion of any Borrowing (including any Mandatory Borrowing) pursuant to Section 2.04 or to fund its portion of any unreimbursed payment with
respect to a Letter of Credit pursuant to Sections 3.10(c), 3.11(c) or 3.12(c), in each case, within two Business Days of the date of such Borrowing or the date such funding was required to be made, as applicable, unless such
Lender notifies the Administrative Agent and the US Company in writing that such failure is the result of a reasonable determination by such Lender that one or more conditions precedent to funding (which conditions precedent shall be identified to
the Administrative Agent and the US Company in writing) has not been satisfied, (ii) such Lender having been deemed insolvent or having become the subject of a bankruptcy or insolvency proceeding or a takeover by a regulatory authority, in each
case, after the Effective Date; provided that a Lender Default shall not be deemed to have occurred solely by virtue of the ownership or acquisition of any equity interest in a Lender or any direct or indirect parent company thereof by a
Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or
permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm 

  
 34 

 
any contracts or agreements made with such Lender, or (iii) such Lender having notified the Administrative Agent, the Swingline Lender, any Issuing Lender and/or any Credit Party
(x) that it does not intend to comply with its obligations under Sections 2.01(a), (b), (c), (d), (e), (f), (g) or (i), Section 2.04 or Section 3, as the case
may be, in circumstances where such non-compliance would constitute a breach of such Lender’s obligations under the respective Section or (y) of the events described in preceding clause (ii); provided that, for purposes of (and only
for purposes of) Section 2.19 and any documentation entered into pursuant to the Letter of Credit Back-Stop Arrangements (and the term “Defaulting Lender” as used therein), the term “Lender Default” shall also
include, as to any Lender, (i) any Affiliate of such Lender that has “control” (within the meaning provided in the definition of “Affiliate”) of such Lender having been deemed insolvent or having become the subject of a
bankruptcy or insolvency proceeding or a takeover by a regulatory authority, in each case, after the Effective Date; provided that a Lender Default shall not be deemed to have occurred solely by virtue of the ownership or acquisition of any equity
interest in such Affiliate of such Lender or such Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of
courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Affiliate of such Lender or such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any
contracts or agreements made with such Affiliate of such Lender or such Lender, and (ii) the failure of such Lender to make available its portion of any Borrowing (including any Mandatory Borrowing) pursuant to Section 2.04 or to
fund its portion of any unreimbursed payment with respect to a Letter of Credit pursuant to Sections 3.10(c), 3.11(c) or 3.12(c) within one (1) Business Day of the date (x) the Administrative Agent (in its capacity as
a Lender) or (y) Lenders constituting the Required Lenders has or have, as applicable, funded its or their portion thereof. 
 “Letter of Credit” shall mean each US Letter of Credit, each UK Letter of Credit and each Canadian Letter of Credit. 

“Letter of Credit Back-Stop Arrangements” shall have the meaning specified in
Section 2.19(a)(ii). 
 “Letter of Credit Exposure” shall mean, at any time, the
aggregate amount of all Letter of Credit Outstandings at such time in respect of Letters of Credit. The Letter of Credit Exposure of any Lender at any time shall be its RL Percentage of the aggregate Letter of Credit Exposure at such time.

 “Letter of Credit Fee” shall mean each of the US Letter of Credit Fee, the UK Letter of
Credit Fee and the Canadian Letter of Credit Fee. 
 “Letter of Credit Outstandings” shall
mean, at any time, the sum of the US Letter of Credit Outstandings, the UK Letter of Credit Outstandings and the Canadian Letter of Credit Outstandings. 
 “LIBOR” shall mean with respect to any Interest Period, the average of interbank offered rates for deposits in US Dollars or Pounds Sterling, as applicable, having a maturity
approximately equal to such Interest Period in the London eurodollar market as set forth on page 3750 (i.e., the LIBOR page), or any successor page, of the Telerate News Services, titled “British Banker Association Interest Settlement
Rates” at approximately 11:00 a.m. (London time) two London Business Days prior to the first day of such Interest Period (or same day with respect to LIBOR Loans denominated in Pounds Sterling) or if such rate is not then quoted, the arithmetic
average as determined by the Administrative Agent of the rates at which deposits in immediately available US Dollars or Pounds Sterling, as applicable, in an amount equal to the amount of such LIBOR Loan having a maturity approximately equal to such
Interest Period are offered to four (4) reference banks to be selected by the Administrative Agent in the London interbank market, at approximately 11:00 a.m. (London time) two London Business Days prior to the first day of such Interest Period
(or same day with respect to LIBOR Loans denominated in Pounds Sterling). 

  
 35 

 “LIBOR Loan” shall mean each US LIBOR Loan and each UK
LIBOR Loan. 
 “Lien” shall mean any mortgage, pledge, hypothecation, charge, assignment,
deposit arrangement, encumbrance, lien (statutory or other), preference, priority or other security agreement of any kind or nature whatsoever (including, without limitation, any conditional sale or other title retention agreement, any financing or
similar statement or notice filed under the UCC or any other similar recording or notice statute, and any lease having substantially the same effect as any of the foregoing). 

“LKE Account” shall mean any Account arising from the sale or disposal (including by auction) of
Equipment or Inventory of Borrower or any of its Domestic Subsidiaries in the ordinary course of business pursuant to the LKE Master Exchange Agreement. 
 “LKE Joint Account” shall mean any Deposit Account maintained jointly by US Company or any of its Domestic Subsidiaries and the LKE Qualified Intermediary as may be notified by the US
Company to the Administrative Agent from time to time, in which the aggregate amount of funds deposited therein shall not at any time exceed $25,000,000. 
 “LKE Master Exchange Agreement” shall mean any master like-kind exchange agreement, between US Company or any Domestic Subsidiary thereof and the LKE Qualified Intermediary, in a form
reasonably satisfactory to the Administrative Agent, together with all amendments and modifications thereof, and replacements and substitutions therefor, which have been consented to by the Administrative Agent, which consent shall not be
unreasonably withheld, conditioned or delayed. 
 “LKE QI Receivables” shall mean amounts owing
to the US Company or any of its Domestic Subsidiaries from the LKE Qualified Intermediary. 
 “LKE
Proceeds” shall mean the proceeds received by the LKE Qualified Intermediary from an LKE Account or from the sale of Equipment or Inventory in cash or otherwise, in each case in accordance with the LKE Master Exchange Agreement. 

“LKE Qualified Intermediary” shall mean DBNY or such other person as may be consented to by the
Administrative Agent, such consent not to be unreasonable withheld, delayed or conditioned. 
 “LKE
Transaction” shall mean the sale of Equipment and Inventory and the replacement of such Equipment and Inventory with similar property in a manner that qualifies for deferred recognition of taxable gains for US federal income tax purposes
and pursuant to the LKE Master Exchange Agreement. 
 “Loan” shall mean each Revolving Loan and
each Swingline Loan. 
 “London Business Day” shall means a day for trading by and between
banks in US Dollar and Pounds Sterling deposits in the London interbank eurodollar market. 

“Luxembourg Debt” shall mean the intercompany Indebtedness of (i) the UK Company to the Luxembourg
Subsidiary in an aggregate principal amount not to exceed £30,000,000 and (ii) the Luxembourg Subsidiary to UK-LP in an aggregate principal amount not to exceed £30,000,000. 

  
 36 

 “Luxembourg Security Agreement” shall mean the receivables
pledge agreement, dated as of the date hereof, and entered into by the Administrative Agent and UK-LP, as amended, restated, supplemented or otherwise modified from time to time. 

“Luxembourg Security Documents” shall mean the Luxembourg Share Charge, the Luxembourg Security
Agreement and the UK Intercreditor Deed. 
 “Luxembourg Share Charge” shall mean the share
pledge agreement, dated as of the date hereof, and entered into by the Administrative Agent, UK-LP and the Luxembourg Subsidiary, and as amended, restated, supplemented or otherwise modified from time to time. 

“Luxembourg Subsidiary” shall mean LIKO Luxembourg International S.a.r.l, a company organized under the
laws of Luxembourg having its registered office at 74, rue de Merl, L-2146 Luxembourg, Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register under number B.82639, and an indirect Wholly-Owned Subsidiary of the US
Company. 
 “Mandatory Redeemable Obligation” shall mean an obligation of US Company or any of
its Subsidiaries (or guaranteed by any of them) which must be redeemed or repaid (a) at a fixed or determinable date, whether by operation of sinking fund or otherwise, (b) at the option of any Person other than US Company or such
Subsidiary, or (c) upon the occurrence of a condition not solely within the control of US Company or such Subsidiary, such as a redemption required to be made out of future earnings. 

“Mandatory Borrowing” shall mean each of a Mandatory US Borrowing or a Mandatory UK Borrowing.

 “Mandatory Cost” shall mean the rate of interest calculated by the Administrative Agent to
compensate the Lenders for the cost (if any) of compliance with the requirements of the Bank of England, the UK Financial Services Authority and/or the European Central Bank (or, in any case, any other authority which replaces all or any of its
functions). 
 “Mandatory UK Borrowing” shall have the meaning provided in
Section 2.01(g). 
 “Mandatory US Borrowing” shall have the meaning provided in
Section 2.01(f). 
 “Margin Stock” shall have the meaning provided in Regulation U.

 “Material Adverse Effect” shall mean (i) a material adverse effect on the business,
prospects, operations, results of operations, assets, liabilities or condition (financial or otherwise) of US Company and its Subsidiaries, taken as a whole, (ii) the impairment of the ability of US Company or any other Credit Party to perform
its obligations under the Credit Documents to which it is a party or of Administrative Agent or the Lenders to enforce the Obligations or realize upon the Collateral, or (iii) a material adverse effect on the value of a material portion of the
Collateral or the amount which Administrative Agent or the Lenders would receive (after giving consideration to delays in payment and costs of enforcement) in the liquidation of such Collateral. 

“Maximum Incremental Commitment Amount” shall mean $350,000,000. 

“Maximum Canadian Letter of Credit Amount” shall have the meaning provided in Section 3.06.

  
 37 

 “Maximum UK Letter of Credit Amount” shall have the meaning
provided in Section 3.05. 
 “Maximum UK Swingline Amount” shall mean $10,000,000
or the Equivalent Amount thereof. 
 “Maximum US Letter of Credit Amount” shall have the
meaning provided in Section 3.04. 
 “Maximum US Swingline Amount” shall mean
$25,000,000. 
 “Minimum Availability Amount” shall mean, (x) for purposes of
Section 5.03 hereof and 9.17 hereof, at any time, the greater of (i) $110,000,000 and (ii) twelve and a half percent (12.5%) of the then Total Revolving Loan Commitment and (y) for all other purposes hereunder, at any time,
the greater of (i) $90,000,000 and (ii) ten percent (10%) of the then Total Revolving Loan Commitment. 
 “Minimum Borrowing Amount” shall mean for Revolving Loans, $1,000,000, £1,000,000, €1,000,000 or CA$1,000,000, as applicable, and increments of $100,000, £100,000,
€100,000 and CA$100,000 in excess thereof, as applicable; there shall be no Minimum Borrowing Amount with respect to Swingline Loans. 
 “Mobile Mini 2015 Indenture” shall mean the Indenture, dated May 7, 2007 by and among US Company, as issuer, any guarantors party thereto, and the Law Debenture Trust Company of New
York, as trustee, relating to the 6 7/8% Senior Notes due 2015, as modified, supplemented, amended or restated (including any amendment and restatement thereof) in accordance with Section 10.14(a). 

“Mobile Mini 2015 Senior Notes” shall mean US Company’s senior unsecured notes in the aggregate
principal amount of $150,000,000 due 2015 issued pursuant to the Mobile Mini 2015 Indenture, and on terms and conditions satisfactory to the Lenders, as modified, supplemented, amended or restated (including any amendment and restatement thereof) in
accordance with Section 10.14(a). 
 “Mobile Mini 2015 Senior Notes
Reserve” shall mean a reserve established by the Administrative Agent on any date on or after the
90th day prior to the final maturity date (as set forth in
the Mobile Mini 2015 Indenture) of the Mobile Mini 2015 Senior Notes in respect of the Borrowing Base Parties’ obligations or potential obligations under the Mobile Mini 2015 Senior Notes and the Mobile Mini 2015 Indenture. 

“Mobile Mini 2020 Indenture” shall mean the Indenture, dated November 23, 2010 by and among US
Company, as issuer, any guarantors party thereto, and the Law Debenture Trust Company of New York, as trustee, relating to the 7 7/8% Senior Notes due 2020, as modified, supplemented, amended or restated (including any amendment and restatement
thereof) in accordance with Section 10.14(a). 
 “Mobile Mini 2020 Senior Notes”
shall mean US Company’s senior unsecured notes in the aggregate principal amount of $200,000,000 due 2020 issued pursuant to the Mobile Mini 2020 Indenture, and on terms and conditions satisfactory to the Lenders, as modified, supplemented,
amended or restated (including any amendment and restatement thereof) in accordance with Section 10.14(a). 
 “Moody’s” shall mean Moody’s Investors Service, Inc. 

  
 38 

 “Mortgage” shall mean a mortgage, leasehold mortgage, deed
of trust, leasehold deed of trust, deed to secure debt, leasehold deed to secure debt or similar security instrument in form and substance reasonably acceptable to the Administrative Agent. 

“Mortgage Policy” shall mean a lender’s title insurance policy (Form 1992). 

“Mortgaged Property” shall mean any Real Property owned by US Company or any of its Subsidiaries which
is encumbered (or required to be encumbered) by a Mortgage pursuant to the terms of this Agreement or any Security Document. 
 “Motor Vehicles” shall mean Inventory or Equipment that is subject to any motor vehicle registration statute, including, without limitation, any of those statutes described in the Uniform
Commercial Code Section 9-311(a)(2), as adopted in any state in which a Credit Party owns any Collateral. 

“Multiemployer Plan” shall mean any “multiemployer plan” as defined in Section 4001(a)(3)
of ERISA to which contributions are, or within the immediately preceding six-year period, have been made (or have been required to have been made) by any US Borrower or any of its Subsidiaries or an ERISA Affiliate. 

“NAIC” shall mean the National Association of Insurance Commissioners. 

“Net Orderly Liquidation Value” shall mean the Orderly Liquidation Value (net of costs and expenses
reasonably estimated to be incurred in connection with such liquidation) of the Borrowing Base Parties’ Eligible Machinery and Equipment or Eligible Rental Fleet Inventory, as applicable. 

“Non-B/A Lender” shall mean any Lender which is unwilling or unable to create Bankers’ Acceptances
by accepting Drafts and which has identified itself as a “Non-B/A Lender” by written notice to any relevant Canadian Borrower and the Administrative Agent. 

“Non-Compete Agreements” shall mean all non-compete agreements entered into by US Company or any of its
Subsidiaries which materially restrict the activities of US Company or any of its Subsidiaries. 

“Non-Defaulting Lender” shall mean and include each Lender, other than a Defaulting Lender. 

“Non-US Guaranteed Obligation” shall have the meaning provided in Section 15.01(b).

 “Non-US Obligation Guarantors” shall mean US Company and each Subsidiary that guarantees the
Non-US Guaranteed Obligations including each Subsidiary listed under Schedule 8.04, and each other Subsidiary that is or becomes a party to this Agreement pursuant to Section 10.11. For the avoidance of doubt, US Company, each
other US Borrower and each US Guarantor shall be Non-US Obligation Guarantors. 
 “Non-U.S.
Lender” shall have the meaning provided in Section 5.04(b). 
 “Non-Wholly-Owned
Subsidiary” shall mean, as to any Person, each Subsidiary of such Person which is not a Wholly-Owned Subsidiary of such Person. 

  
 39 

 “Note” shall mean each US Revolving Note, US Swingline
Note, UK Revolving Note, UK Swingline Note and Canadian Revolving Note. 
 “Notice of
Borrowing” shall have the meaning provided in Section 2.03(a). 
 “Notice of
Conversion/Continuation” shall have the meaning provided in Section 2.06(a). 

“Notice Office” shall mean (i) for credit notices, the office of the Administrative Agent located
at 60 Wall Street, New York, New York 10005, Attention: Marguerite Sutton, Telephone No.: (212) 250-6150, and Telecopier No.: (212) 797-4655, (ii) for operational notices, the office of the Administrative Agent located at 5022 Gate
Parkway, Building 200, Jacksonville, FL 32256, Attention Tihana Mesic, Telephone (904) 271-2873, and Telecopier (904) 779-3080 and (iii) for the Canadian Sub-Agent, the office of the Canadian Sub-Agent located at 199 Bay Street, Suite
4700, Commerce Court West, Toronto, Ontario, Canada M5L 1E9, Attention: Marcellus Leung, Telephone No.: (416) 682-8252, and Telecopier No.: (416) 682-8484, or (in any case) such other office or person as the Administrative Agent (or the
case of the Canadian Sub-Agent, as the Canadian Sub-Agent) may hereafter designate in writing as such to the other parties hereto. 
 “Obligations” shall mean, collectively, the UK Obligations, the US Obligations and the Canadian Obligations. 

“OFAC” shall have the meaning provided thereto in Section 8.33(a). 

“Off-Balance Sheet Liabilities” of any Person shall mean (a) any repurchase obligation or liability
of such Person with respect to accounts or notes receivable sold by such Person, (b) any liability of such Person under any sale and leaseback transactions that does not create a liability on the balance sheet of such Person, (c) any
obligation under a Synthetic Lease or (d) any obligation arising with respect to any other transaction which is the functional equivalent of or takes the place of borrowing but which does not constitute a liability on the balance sheet of such
Person. 
 “Orderly Liquidation Value” shall mean the orderly liquidation value of the
Borrowing Base Parties’ Eligible Goods Inventory or Eligible Machinery and Equipment that is estimated to be recoverable in an orderly liquidation of such Eligible Goods Inventory or Eligible Machinery and Equipment, as applicable, with such
value determined from time to time by reference to the most recent appraisal completed by a qualified independent third-party appraisal company (approved by the Administrative Agent in its Permitted Discretion in consultation with US Company)
delivered to the Administrative Agent; provided that, unless an appraisal is required pursuant to Section 10.13, such value in respect of any Eligible Goods Inventory or Eligible Machinery and Equipment acquired in accordance with
Section 10.13, may be determined by reference to an identical kind or type of such Eligible Goods Inventory or Eligible Machinery and Equipment, as applicable, that has been so appraised. 

“Other Connection Taxes” means, with respect to any Recipient, taxes imposed as a result of a present or
former connection between such Recipient and the jurisdiction imposing such tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or
perfected a security interest under, engaged in any other transaction pursuant to or enforced any Credit Document, or sold or assigned an interest in any Loan or Credit Document). 

“Other Hedging Agreements” shall mean any foreign exchange contracts, currency swap agreements or other
similar agreements, or arrangements designed to protect against fluctuations in currency values. 

  
 40 

 “Other Taxes” shall have the meaning provided in
Section 13.01. 
 “Participant Register” shall have the meaning provided in
Section 13.04(a). 
 “Participating Member State” means any member state of the
European Community that adopts or has adopted the Euro as its lawful currency in accordance with the legislation of the European Community relating to economic and monetary union. 

“Patriot Act” shall have the meaning provided in Section 13.18. 

“Payment Conditions” means with respect to any Restricted Payment (which such term, for purposes of this
definition, shall include any prepayment, repurchase or redemption of any Indebtedness permitted pursuant to the Senior Note Documents), Restricted Foreign Funding or Acquisition, each of the following conditions shall be satisfied immediately after
giving effect to such Restricted Payment, Restricted Foreign Funding, Acquisition or incurrence of any Permitted Additional Financing Indebtedness: 

(i) no Default or Event of Default exists or would result therefrom and either (a) (x) the
average daily Total Borrowing Availability over the 90 days prior to the making of such Restricted Payment, Restricted Foreign Funding, Acquisition or incurrence of any Permitted Additional Financing Indebtedness is greater than $225,000,000, and
(y) the Total Borrowing Availability calculated on a pro forma basis before and immediately after giving effect to such Restricted Payment, Restricted Foreign Funding, Acquisition or incurrence of any Permitted Additional Financing Indebtedness
shall be greater than $225,000,000 or (b) (x) the average daily Total Borrowing Availability over the 90 days prior to the making of such Restricted Payment, Restricted Foreign Funding, Acquisition or incurrence of any Permitted Additional
Financing Indebtedness is greater than $150,000,000, (y) the Total Borrowing Availability calculated on a pro forma basis before and immediately after giving effect to such Restricted Payment, Restricted Foreign Funding, Acquisition or
incurrence of any Permitted Additional Financing Indebtedness shall be greater than $150,000,000, and (z) before and immediately after giving effect to such Restricted Payment, Restricted Foreign Funding, Acquisition or incurrence of any
Permitted Additional Financing Indebtedness and any Indebtedness incurred in connection therewith, and US Company shall be in compliance with the financial covenants set forth in Section 10.22 (Fixed Charge Coverage Ratio) and
Section 10.23 (Debt Ratio) hereof, each calculated on a pro forma basis (whether or not Section 10.21 hereof would then require compliance with such covenants) for the most recently ended fiscal quarter for which the
financial statements in Section 9.01(b) have been delivered to the Administrative Agent; and 
 (ii) not later than three Business Days prior to the making of such Restricted Payment, Restricted Foreign Funding, Acquisition or incurrence of any Permitted Additional Financing Indebtedness,
Administrative Agent shall receive (a) a certificate of US Company, with supporting detail acceptable to Administrative Agent certifying that on the date on which such Restricted Payment, Restricted Foreign Funding, Acquisition or
incurrence of any Permitted Additional Financing Indebtedness is made, US Company has satisfied the conditions set forth in clause (i) above and (b) financial projections demonstrating that during the six month period following the making
of such Restricted Payment, Restricted Foreign Funding, Acquisition or incurrence of any Permitted Additional Financing Indebtedness, Total Borrowing Availability at all times shall not be less than the amount required to satisfy the condition set
forth in clause (i) above. 

  
 41 

 “Payment Office” shall mean (i) with respect to
payments in US Dollars, the office of the Administrative Agent located at 5022 Gate Parkway, Building 200, Jacksonville, FL 32256 or such other office as the Administrative Agent may hereafter designate in writing as such to the other parties
hereto, (ii) with respect to payments in Pounds Sterling or Euros or other currencies other than US Dollars or Canadian Dollars, such account at such bank or office in London or such other place as Administrative Agent shall designate by notice
to the Person required to make the relevant payment and (iii) with respect to payments in Canadian Dollars, the office of the Canadian Sub-Agent located at 199 Bay Street, Suite 4700, Commerce Court West, Toronto, Ontario, Canada M5L 1E9 or
such other office as the Administrative Agent or the Canadian Sub-Agent may hereafter designate in writing as such to the other parties hereto. 
 “PBGC” shall mean the Pension Benefit Guaranty Corporation established pursuant to Section 4002 of ERISA, or any successor thereto. 

“Permitted Acquisition” shall mean an Acquisition permitted under Section 10.13 of this
Agreement. 
 “Permitted Additional Financing” means additional secured or unsecured
Indebtedness; provided that: 
 (i) no such Indebtedness shall (A) be subject to
scheduled amortization in excess of 1% of its original principal balance per year or (B) have a final maturity, in either case prior to the date occurring six (6) months following the Final Maturity Date; 

(ii) such Permitted Additional Financing shall not be required to be repaid, prepaid, redeemed,
repurchased or defeased, whether on one or more fixed dates, upon the occurrence of one or more events or at the option of any holder thereof (except, in each case, (A) upon the occurrence of an event of default, a sale of assets or a change in
control, (B) as and to the extent such repayment, prepayment, redemption, repurchase or defeasance would have been required pursuant to the terms of any Senior Notes outstanding immediately prior to the incurrence of any such Permitted
Additional Financing, (C) as and to the extent such repayment, prepayment, redemption, repurchase or defeasance provisions are, individually and in the aggregate, no more restrictive than those contained herein (it being understood and agreed
that the repayment, prepayment, redemption, repurchase or defeasance provisions set forth in this Agreement or any Senior Notes as of the Effective Date satisfy such requirement) and such provisions expressly provide that, until such time as the
Revolving Loan Commitments have been terminated, all Obligations have been paid in full and no Letters of Credit are outstanding, any such repayment, prepayment, redemption, repurchase or defeasance shall not be required to be made to the extent not
permitted by this Agreement or (D) upon the incurrence and with the proceeds of other Permitted Additional Financing) prior to the maturity of such Permitted Additional Financing; and 

(iii) such Permitted Additional Financing shall not constitute an obligation (including pursuant to a
guarantee) of any Person unless such Person is also a Credit Party. 

  
 42 

 “Permitted Additional Financing Document” shall mean any
one or more loan agreements or indentures, dated the date any Permitted Additional Financing is incurred, by and among US Company, as issuer, any guarantors party thereto, and the lenders, agents and/or trustee party thereto, relating to the
Permitted Additional Financing, as modified, supplemented, amended or restated (including any amendment and restatement thereof) in accordance with Section 10.14(a). 

“Permitted Additional Financing Indebtedness” shall mean the loans or notes evidencing any Permitted
Additional Financing, as modified, supplemented, amended or restated (including any amendment and restatement thereof) in accordance with Section 10.14(a). 

“Permitted Capped Debt” shall mean Permitted Additional Financing Indebtedness in an aggregate principal
amount not to exceed $300,000,000 or the Equivalent Amount thereof in the aggregate outstanding at any one time, so long as, as of the date of the incurrence thereof, the Payment Conditions shall have been satisfied. 

“Permitted Discretion” shall mean the commercially reasonable judgment of the Administrative Agent
exercised in good faith in accordance with customary business practices for comparable asset-based lending transactions, as to any factor which the Administrative Agent reasonably determines: (a) will or reasonably could be expected to
adversely affect in any material respect the value of any Eligible Accounts, Eligible Inventory, Eligible Machinery and Equipment and Eligible Real Property, the enforceability or priority of the Collateral Agent’s Liens thereon or the amount
which any Secured Creditor would be likely to receive (after giving consideration to delays in payment and costs of enforcement) in the liquidation of such Eligible Accounts, Eligible Inventory, Eligible Machinery and Equipment or Eligible Real
Property or (b) is evidence that any collateral report or financial information delivered to the Administrative Agent by any Person on behalf of US Company is incomplete, inaccurate or misleading in any material respect. In exercising such
judgment, the Administrative Agent may consider, without duplication, such factors already included in or tested by the definition of Eligible Accounts, Eligible Inventory, Eligible Machinery and Equipment or Eligible Real Property, as well as any
of the following: (i) changes after the Effective Date in any material respect in demand for, pricing of, or product mix of Equipment or Inventory; (ii) changes after the Effective Date in any material respect in any concentration of risk
with respect to Accounts; and (iii) any other factors arising after the Effective Date that change in any material respect the credit risk of lending to the Borrowers on the security of the Eligible Accounts, Eligible Inventory, Eligible
Machinery and Equipment or Eligible Real Property. 
 “Permitted Encumbrance” shall mean, with
respect to any Mortgaged Property, such exceptions to title as are set forth in the Mortgage Policy delivered with respect thereto, all of which exceptions must be acceptable to the Administrative Agent in its Permitted Discretion. 

“Permitted Liens” shall have the meaning provided in Section 10.02. 

“Permitted Ratio Debt” shall mean Permitted Additional Financing Indebtedness, so long as, as of the
date of the incurrence thereof, the Credit Parties shall be in compliance with the Debt Ratio then applicable to the most recently completed fiscal quarter as set forth in Section 10.23 (Debt Ratio) calculated on a pro forma basis
(whether or not Section 10.21 hereof would then require compliance with such covenant) before and immediately after giving effect to the incurrence of such Indebtedness. 

“Permitted Senior Notes Refinancing” means, in respect of any one or more series of Senior Notes being
extended, renewed or refinanced, any Indebtedness that extends, renews or refinances such Senior Notes (or any Permitted Senior Notes Refinancing in respect thereof); provided that: 

  
 43 

 (i) the maturity of such Permitted Senior Notes Refinancing
shall not be earlier, and the weighted average life to maturity of such Permitted Senior Notes Refinancing shall not be shorter, than the maturity date or the remaining weighted average life to maturity of such Senior Notes being extended, renewed
or refinanced; 
 (ii) such Permitted Senior Notes Refinancing shall not be required to be
repaid, prepaid, redeemed, repurchased or defeased, whether on one or more fixed dates, upon the occurrence of one or more events or at the option of any holder thereof (except, in each case, upon the occurrence of an event of default, a sale of
assets or a change in control or as and to the extent such repayment, prepayment, redemption, repurchase or defeasance would have been required pursuant to the terms of any Senior Notes outstanding immediately prior to the incurrence of any such
Permitted Senior Notes Refinancing) prior to the maturity of such Senior Notes being extended, renewed or refinanced; 
 (iii) such Permitted Senior Notes Refinancing shall not constitute an obligation (including pursuant to a guarantee) of any Subsidiary that shall not have been (or, in the case of after-acquired
Subsidiaries, shall not have been required to become) an obligor in respect of any Senior Notes outstanding immediately prior to the incurrence of any such Permitted Senior Notes Refinancing, and shall not constitute an obligation of any holding
company of US Company if such Person shall not have been an obligor in respect of any Senior Notes outstanding immediately prior to the incurrence of any such Permitted Senior Notes Refinancing, and, in each case, shall constitute an obligation of
such Subsidiary or of any holding company of US Company only to the extent of their obligations in respect of any Senior Notes outstanding immediately prior to the incurrence of any such Permitted Senior Notes Refinancing; 

(iv) such Permitted Senior Notes Refinancing shall not be secured by any Lien on any asset; 

(v) the covenants and events of default set forth in such Permitted Senior Notes Refinancing shall be,
individually and in the aggregate, no more restrictive than those contained herein (it being understood and agreed that the covenants and events of default set forth in the Senior Notes as of the Effective Date satisfy such requirement); and

 (vi) such Permitted Senior Notes Refinancing shall not include any financial covenants.

 “Permitted Senior Notes Refinancing Indenture” shall mean any one or more indentures, dated
the date any Permitted Senior Notes Refinancing is incurred, by and among US Company, as issuer, any guarantors party thereto, and the trustee party thereto, relating to the Permitted Senior Notes Refinancing incurred thereunder in accordance with
Section 10.05(f) hereof, as modified, supplemented, amended or restated (including any amendment and restatement thereof) in accordance with Section 10.14(a). 

“Person” shall mean any individual, partnership, joint venture, firm, corporation, association, limited
liability company, trust or other enterprise or any Governmental Authority. 

  
 44 

 “Plan” shall mean any pension plan as defined in
Section 3(2) of ERISA subject to Title IV of ERISA, other than a Multiemployer Plan, which is maintained or contributed to by (or to which there is an obligation to contribute of) US Company or a Subsidiary of US Company or an ERISA Affiliate,
and each such plan maintained during the five-year period immediately preceding the date hereof. 

“Pledge Agreements” shall mean each of the US Pledge Agreement and the UK Share Charge. 

“Pounds Sterling” or “£” – lawful money of the United Kingdom. 

“Pounds Sterling Denominated Revolving Loan” shall have the meaning set forth in
Section 2.01(b) hereof. 
 “Pounds Sterling Funding Capacity” shall mean, for any
Lender, the ability of such Lender or an Affiliate or branch office thereof to fund UK Revolving Loans denominated in Pounds Sterling, as set forth in the records of Administrative Agent. 

“Pounds Sterling Funding Capacity Lender” shall mean each Lender other than (i) in the case of each
Lender as of the Effective Date, each Lender that shall have confirmed in writing, to the satisfaction of the Administrative Agent, on or prior to the Effective Date, that neither it nor any domestic or foreign branch or Affiliate of such Lender has
the ability to fund UK Revolving Loans denominated in Pounds Sterling and (ii) in the case of each Lender after the Effective Date, each Lender that shall have confirmed in writing, to the satisfaction of the Administrative Agent, on or prior
to the date such Lender becomes a Lender hereunder, that neither it nor any domestic or foreign branch or Affiliate of such Lender has the ability to fund UK Revolving Loans denominated in Pounds Sterling, in each case until such time as such Lender
shall have confirmed in writing to the Administrative Agent that it or any domestic or foreign branch or Affiliate of such Lender does have the ability to fund UK Revolving Loans denominated in Pounds Sterling. 

“PPSA” shall mean the Personal Property Security Act (Ontario) and other personal property
security legislation of the applicable Canadian province or provinces in respect of the Credit Parties or the Collateral (including the Civil Code of Quebec and the regulation respecting the registration of personal and movable real rights
promulgated thereunder) as all such legislation now exists or may from time to time hereafter be amended, modified, recodified, supplemented or replaced, together with all rules, regulations and interpretations thereunder or related thereto.

 “Preferred Equity”, as applied to the Equity Interests of any Person, means Equity Interests
of such Person (other than common Equity Interests of such Person) of any class or classes (however designed) that ranks prior, as to the payment of dividends or as to the distribution of assets upon any voluntary or involuntary liquidation,
dissolution or winding up of such Person, to shares of Equity Interests of any other class of such Person, and shall include any Qualified Preferred Stock of US Company. 

“Prime Lending Rate” shall mean the rate which the Administrative Agent announces from time to time as
its prime lending rate, the Prime Lending Rate to change when and as such prime lending rate changes. The Prime Lending Rate is a reference rate and does not necessarily represent the lowest or best rate actually charged to any customer by the
Administrative Agent, which may make commercial loans or other loans at rates of interest at, above or below the Prime Lending Rate. 

  
 45 

 “Projections” shall mean the projections that are contained
in the Confidential Information Memorandum dated January 2012 and that were prepared by or on behalf of US Company in connection with this Agreement and delivered to the Administrative Agent and the Lenders prior to the Effective Date. 

“Property” shall mean any interest in any kind of property, asset or undertaking, whether real, personal
or mixed, or tangible or intangible. 
 “Qualified Derivative Agreement” means any agreement
with respect to Qualified Derivative Obligations to which any Credit Party is a party. 
 “Qualified
Derivative Counterparty” means, with respect to any Qualified Derivative Agreement, (x) any counterparty who was an Agent or Affiliate of an Agent at the time such Qualified Derivative Agreement was entered into, or
(y) counterparty who was a Lender or an Affiliate of a Lender at the time such Qualified Derivative Agreement was entered into, in each case, that has entered into such Qualified Derivative Agreement with any Credit Party; provided that,
a Lender (and any Affiliate thereof) shall not be a Qualified Derivative Counterparty with respect to any Qualified Derivative Agreement entered into when such Lender was a Defaulting Lender. 

“Qualified Derivative Obligations” of the Credit Parties shall mean any and all obligations of the
Credit Parties, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications thereof and substitutions therefor) in connection with (i) Derivative
Obligations of which the Administrative Agent has received the notice required pursuant to Section 9.19 or (ii) which is set forth on Schedule 1.01(f). 

“Qualified Preferred Stock” shall mean any Preferred Equity of US Company, so long as the terms of any
such Preferred Equity (a) do not contain any mandatory put, redemption, repayment, sinking fund or other similar provision prior to August 22, 2017, (b) do not require the cash payment of dividends or distributions that would
otherwise be prohibited by the terms of this Agreement or any other agreement or contract of US Company or any of its Subsidiaries, (c) do not contain any covenants (other than periodic reporting requirements), (d) do not grant the holders
thereof any voting rights except for (i) voting rights required to be granted to such holders under Applicable Law and (ii) limited customary voting rights on fundamental matters such as mergers, consolidations, sales of all or
substantially all of the assets of US Company, or liquidations involving US Company, and (e) are otherwise reasonably satisfactory to the Administrative Agent. 

“Qualified Swap Termination Value” means any Swap Termination Value in respect of which (and only to the
extent of the amount which) the US Company has notified the Administrative Agent on any Borrowing Base Certificate delivered in accordance with the terms hereof, and meeting the requirements of Section 9.01(i), that the Borrower intends
such Swap Termination Value to constitute a Qualified Swap Termination Value for purposes of Section 5.03(d) and which amount (and only to the extent of the amount which) is reasonably acceptable to the Administrative Agent;
provided that no Qualified Swap Termination Value may be established or increased at any time that a Default or Event of Default exists, or if a Reserve in such amount would cause a prepayment obligation under Section 5.02(a).

 “Quarterly Payment Date” shall mean the last Business Day of each March, June, September and
December, it being understood that the first Quarterly Payment Date shall be the last Business Day of March 2012. 

  
 46 

 “Quarterly Pricing Certificate” shall have the meaning
provided in the definition of Applicable Margin. 
 “Real Property” of any Person shall mean
all the right, title and interest of such Person in and to land, improvements and fixtures, including Leaseholds. 
 “Receiver” shall have the meaning provided in Section 5.05(f). 
 “Recipient” shall mean (a) the Administrative Agent and (b) any Lender, as applicable. 
 “Refinanced Indebtedness” shall mean Indebtedness outstanding as of the Effective Date under the ABL Credit Agreement, dated as of June 27, 2008 by and among US Company, the
borrowers and guarantors party thereto, the Administrative Agent and the lenders party thereto, as amended. 

“Refinancing” shall mean the refinancing of the Refinanced Indebtedness, as described in
Section 6.05(c). 
 “Refinancing Documents” shall mean all pay-off letters,
guaranty releases, Lien releases (including, without limitation, UCC termination statements) and other documents and agreements entered into in connection with the Refinancing. 

“Refinancing Notes” shall mean the notes evidencing any Permitted Senior Notes Refinancing incurred in
accordance with Section 10.05(f) hereof, as modified, supplemented, amended or restated (including any amendment and restatement thereof) in accordance with Section 10.14(a). 

“Register” shall have the meaning provided in Section 13.15. 

“Regulation” shall have the meaning provided in Section 9.20. 

“Regulation D” shall mean Regulation D of the Board as from time to time in effect and any successor to
all or a portion thereof establishing reserve requirements. 
 “Regulation T” shall mean
Regulation T of the Board as from time to time in effect and any successor to all or a portion thereof. 

“Regulation U” shall mean Regulation U of the Board as from time to time in effect and any successor to
all or a portion thereof. 
 “Regulation X” shall mean Regulation X of the Board as from time
to time in effect and any successor to all or a portion thereof. 
 “Release” shall mean
actively or passively disposing, discharging, injecting, spilling, pumping, leaking, leaching, dumping, emitting, escaping, emptying, pouring, seeping, migrating or the like, into or upon any land or water or air, or otherwise entering into the
environment. 
 “Rent Reserve” shall mean a reserve established by the Administrative Agent in
respect of rent payments (not to exceed three months rent) made by a Borrowing Base Party for each location at which Eligible Inventory or Eligible Machinery and Equipment of a Borrowing Base Party is located that is not subject to a Landlord
Personal Property Collateral Access Agreement (as reported to the Administrative Agent by US Company or UK Company from time to time as requested by the Administrative Agent), as adjusted from time to time by the Administrative Agent in its
Permitted Discretion. 

  
 47 

 “Replaced Lender” shall have the meaning provided in
Section 2.13(a). 
 “Replacement Lender” shall have the meaning provided in
Section 2.13(a). 
 “Reportable Event” shall mean an event described in
Section 4043(c) of ERISA or the regulations issued thereunder with respect to a Plan, other than those events as to which the 30-day notice period is waived. 

“Required Lenders” shall mean, at any time, Non-Defaulting Lenders the sum of whose outstanding
Revolving Loan Commitments at such time (or, after the termination thereof, outstanding Revolving Loans and RL Percentages of (x) outstanding Swingline Loans at such time and (y) Letter of Credit Outstandings at such time) represents at
least a majority of the sum of the Total Revolving Loan Commitment in effect at such time less the Revolving Loan Commitments of all Defaulting Lenders at such time (or, after the termination thereof, the sum of then total outstanding
Revolving Loans of Non-Defaulting Lenders and the aggregate RL Percentages of all Non-Defaulting Lenders of the total outstanding Swingline Loans and Letter of Credit Outstandings at such time). 

“Reserves” shall mean reserves, if any, established by the Administrative Agent from time to time
hereunder in its Permitted Discretion against the Borrowing Base, including without limitation, (i) Rent Reserves, (ii) Banking Products Reserves, (iii) Unpaid Supplier Reserves, (iv) potential dilution related to Accounts,
(v) damaged or defective Equipment, (vi) obsolescence of any Eligible Inventory or Eligible Machinery and Equipment, (vii) sums that the Borrowing Base Parties are or will be required to pay (such as taxes (including, without
limitation, sales taxes and payroll taxes), assessments and insurance premiums) and have not yet paid, (viii) Canadian Priority Payables, (ix) amounts owing by any Borrowing Base Party to any Person to the extent secured by a Lien on, or
trust over, any Collateral, (x) in the case of any UK Borrowing Base Party, reserves to reflect the prior ranking nature or dilutive effect of UK Priority Claims, (xi) reserves in respect of the aggregate amount of any and all Swap
Termination Values constituting Qualified Swap Termination Values for purposes of Section 5.03(d), (xii) Mobile Mini 2015 Senior Notes Reserve and (xiii) such other events, conditions or contingencies as to which the
Administrative Agent, in its Permitted Discretion, determines reserves should be established from time to time hereunder. 
 “Restricted Foreign Funding” shall have the meaning set forth in Section 10.05(e)(v). 
 “Restricted Payment” shall have the meaning set forth in Section 10.04. 
 “Returns” shall have the meaning provided in Section 8.13. 
 “Revolving Loan” shall mean a US Revolving Loan, a UK Revolving Loan or a Canadian Revolving Loan. 

“Revolving Loan Commitment” shall mean, for each Lender, the amount set forth opposite such
Lender’s name in Schedule 1.01(a) directly below the column entitled “Revolving Loan Commitment,” as same may be (x) reduced from time to time or terminated pursuant to Sections 4.02, 4.03 and/or 11,
as applicable, (y) increased from time to time pursuant to Section 2.15, or (z) adjusted from time to time as a result of assignments to or from such Lender pursuant to Section 2.13 or 13.04(b). 

  
 48 

 “Revolving Note” shall mean a US Revolving Note, a UK
Revolving Note or a Canadian Revolving Note. 
 “RL Percentage” of any Lender at any time shall
mean a fraction (expressed as a percentage) the numerator of which is the Revolving Loan Commitment of such Lender at such time and the denominator of which is the Total Revolving Loan Commitment at such time, provided that if the RL
Percentage of any Lender is to be determined after the Total Revolving Loan Commitment has been terminated, then the RL Percentages of such Lender shall be determined immediately prior (and without giving effect) to such termination. 

“S&P” shall mean Standard & Poor’s Ratings Services, a division of McGraw-Hill, Inc.

 “SEC” shall have the meaning provided in Section 9.01(g). 

“Sale Proceeds” shall have the meaning set forth in Section 5.02(c). 

“Section 5.04(b)(ii) Certificate” shall have the meaning provided in Section 5.04(b)(ii).

 “Secured Creditors” means the Agents, Lenders, Issuing Lenders, Banking Products Providers
and Qualified Derivative Counterparties and shall include, without limitation, all former Agents, Lenders, Issuing Lenders, Banking Products Providers and Qualified Derivative Counterparties to the extent that any Obligations owing to such Persons
were incurred while such Persons were Agents, Lenders, Issuing Lenders, Banking Products Providers or Qualified Derivative Counterparties and such Obligations have not been paid or satisfied in full. 

“Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder. 
 “Security Agreement” shall mean the US Security Agreement, the US
Pledge Agreement, the UK Security Agreements, the Canadian Security Agreement, the Canadian Share Pledge Agreement and each other agreement pursuant to which a Credit Party grants a Lien to secure all or part of the Obligations. 

“Security Agreement Collateral” shall mean all “Collateral” as defined in the Security
Agreements. 
 “Security Document” shall mean and include the US Security Agreement, the UK
Debenture, the UK Partnership Debenture, the US Pledge Agreement, the UK Share Charge, the Luxembourg Security Documents, the Canadian Security Agreement, the Canadian Share Pledge Agreement, each Mortgage, after the execution and delivery thereof,
each Additional Security Document and any other related document, agreement or grant pursuant to which US Company or any of its Subsidiaries grants, perfects or continues a Lien in favor of the Collateral Agent for the benefit of the Secured
Creditors. 
 “Senior Managing Agents” shall mean Barclays Bank PLC, SunTrust Bank and Wells
Fargo Capital Finance, LLC, each in its capacity as a senior managing agent. 
 “Senior Note
Documents” shall mean collectively, (a) the Mobile Mini 2015 Indenture, the Mobile Mini 2020 Indenture, the Mobile Mini 2015 Senior Notes, the Mobile Mini 2020 Senior Notes and all other agreements, instruments, and documents delivered
by US Company or any of its Subsidiaries in connection therewith; and (b) if and to the extent any Permitted Senior Notes Refinancing 

  
 49 

 
thereof is incurred in accordance with Section 10.05(f)(ii) hereof after the Effective Date, the Permitted Senior Notes Refinancing Indenture, the Refinancing Notes and all other agreements,
instruments, and documents delivered by US Company or any of its Subsidiaries in connection therewith. 

“Senior Note Indentures” shall mean collectively, the Mobile Mini 2015 Indenture, the Mobile Mini 2020
Indenture and the Permitted Senior Notes Refinancing Indenture. 
 “Senior Notes” means the
Mobile Mini 2015 Senior Notes, the Mobile Mini 2020 Senior Notes and the Refinancing Notes. 
 “Serial
Numbered Equipment” shall mean, collectively, the following types of Equipment located at any time, and from time to time, in Canada: (i) motor vehicles within the meaning of the PPSA of Ontario; (ii) Equipment which is serial
number goods within the meaning of the PPSA of Alberta; (iii) Equipment which is serial numbered goods within the meaning of the PPSA of British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia and Prince Edward Island and
Saskatchewan; and (iv) Equipment which is road vehicles or other movable property for which a descriptive file may be opened at the Quebec provincial registry office within the meaning of the PPSA in Quebec. 

“Settlement Date” shall have the meaning provided in Section 2.04(e)(i). 

“Solvent” and “Solvency” shall mean, with respect to any Person on a particular date,
the condition that, on such date, (a) the fair value of the property of such Person is greater than the total amount of debts and liabilities, including contingent liabilities, of such Person, (b) the present fair salable value of the
assets of such Person is not less than the amount that will be required to pay the probable liability of such Person on its debts and liabilities as they become absolute and matured, (c) such Person will have the ability to pay its debts and
liabilities (including its probable liability in respect of contingent and unliquidated liabilities and its unmatured liabilities) as they become absolute and matured, (d) such Person is not engaged in business or a transaction, and is not
about to engage in business or a transaction, for which such Person’s property would constitute an unreasonably small amount of capital, and (e) in the case of any person incorporated in England and Wales only, a Person that is not
“unable to pay its debts”. In this context, “unable to pay its debts” means that there are no grounds on which such Person would be deemed unable to pay its debts (as defined in Section 123(1) of the Insolvency Act 1986 of
England Wales (as amended by the Enterprise Act 2002 of England and Wales) on the basis that the words “proved to the satisfaction of the court” are deemed omitted from sections 123(1)(e) and 123(2) of that Act) or on which a court would
be satisfied that the value of such Person’s assets is less than the amount of its liabilities, taking into account its contingent and prospective liabilities (as such term would be construed for the purposes of Section 123(2) of the
Insolvency Act 1986 of England and Wales (as amended by the Enterprise Act 2002 of England and Wales)). The amount of contingent liabilities (such as litigation, guaranties and pension plan liabilities) at any time shall be computed as the amount
that, in light of all the facts and circumstances existing at the time, represents the amount that can be reasonably be expected to become an actual or matured liability. 

“Spot Rate” shall mean with respect to any currency, the rate quoted by Administrative Agent as the spot
rate for the purchase by Administrative Agent of such currency with another currency through its foreign exchange office at approximately 11:00 a.m. (New York time) on the date of determination thereof. 

“Start Date” shall have the meaning provided in the definition of Applicable Margin. 

  
 50 

 “Stated Amount” of each Letter of Credit shall mean, at any
time, the maximum amount available to be drawn thereunder (in each case determined without regard to whether any conditions to drawing could then be met). 
 “Subsidiary” shall mean, as to any Person, (a) any corporation more than 50% of whose stock of any class or classes having by the terms thereof ordinary voting power to elect a
majority of the directors of such corporation (irrespective of whether or not at the time stock of any class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time owned by
such Person and/or one or more Subsidiaries of such Person or (b) any partnership, limited liability company, association, joint venture or other entity in which such Person and/or one or more Subsidiaries of such Person has more than a 50%
equity interest at the time. Unless otherwise qualified, all references to a “Subsidiary” or to “Subsidiaries” in this Agreement shall refer to a Subsidiary or Subsidiaries of US Company. 

“Supermajority Lenders” shall mean those Non-Defaulting Lenders which would constitute the Required
Lenders under, and as defined in, this Agreement, if the reference to “a majority” contained in the definition of Required Lenders were changed to “66%.” 

“Swap Termination Value” means, in respect of any one or more Qualified Derivative Obligations, after
taking into account the effect of any legally enforceable netting agreement relating to such Qualified Derivative Obligations, (a) for any date on or after the date on which such Qualified Derivative Obligations have been closed out and
termination value(s) determined in accordance therewith, such termination value(s), and (b) for any date prior to the date referenced in clause (a), the amount(s) determined as the mark-to-market value(s) for such Qualified Derivative
Obligations, as determined based upon one or more mid-market or other readily available quotations provided by any recognized dealer in such Qualified Derivative Obligations (which may include the Administrative Agent, the Bank, a Lender or any
Affiliate of any of the foregoing). 
 “Swingline Expiry Date” shall mean that date which is
five Business Days prior to the Final Maturity Date. 
 “Swingline Lender” shall mean the
Administrative Agent, in its capacity as Swingline Lender hereunder. 
 “Swingline Loan” shall
mean a US Swingline Loan or a UK Swingline Loan. 
 “Swingline Loan Exposure” shall mean, at
any time, the aggregate principal amount of all Swingline Loans outstanding at such time. The Swingline Loan Exposure of any Lender at any time shall be its RL Percentage of the aggregate Swingline Loan Exposure at such time. 

“Swingline Note” shall mean a US Swingline Note or a UK Swingline Note. 

“Synthetic Lease” shall mean a lease transaction under which the parties intend that (a) the lease
will be treated as an “operating lease” by the lessee and (b) the lessee will be entitled to various tax and other benefits ordinarily available to owners (as opposed to lessees) of like property. 

“TARGET2” means the Trans-European Automated Real-time Gross Settlement Express Transfer payment system
which utilises a single shared platform and which was launched on 19 November 2007. 

  
 51 

 “TARGET Day” means any day on which TARGET2 is open for the
settlement of payments in Euros. 
 “Taxes” shall have the meaning provided in
Section 5.04(a). 
 “Total Borrowing Availability” shall mean, as of any date of
determination, the remainder of (i) the lesser of (x) the Total Revolving Loan Commitment at such time and (y) the Aggregate Borrowing Base at such time minus (ii) the Aggregate Exposure at such time. 

“Total Revolving Loan Commitment” shall mean, at any time, the sum of the Revolving Loan Commitments of
each of the Lenders at such time. 
 “Total Unutilized Revolving Loan Commitment” shall mean,
at any time, an amount equal to the remainder of (a) the Total Revolving Loan Commitment in effect at such time less (b) the sum of (i) the aggregate principal amount of all Revolving Loans and Swingline Loans outstanding at
such time plus (ii) the aggregate amount of all Letter of Credit Outstandings at such time. 

“Trailer Fleet Inventory” – new and used manufactured or remanufactured Trailers held by a Borrower
or a Credit Party for intended lease or rental to third parties. 
 “Trailers” shall mean
over-the-road tractor trailers and trailers intended for use as storage facilities not constituting portable and ISO containers owned by US Company or any of its Subsidiaries. 

“Transactions” shall mean, collectively, (a) the consummation of the Refinancing, (b) the
execution, delivery and performance by each Credit Party of the Credit Documents to which it is a party, the incurrence of Loans on the Effective Date and the use of proceeds thereof, and (c) the payment of all fees and expenses in connection
with the foregoing. 
 “Type” shall mean the type of Loan determined with regard to the
interest option applicable thereto, i.e., whether a Base Rate Loan, a Canadian Prime Rate Loan, a Bankers’ Acceptance Loan, a LIBOR Loan or a EURIBOR Loan. 

“UCC” shall mean the Uniform Commercial Code as from time to time in effect in the relevant
jurisdiction. 
 “UK Borrower” and “UK Borrowers” shall have the meaning
provided in the first paragraph of this Agreement. 
 “UK Borrowing” shall mean the borrowing
of UK Revolving Loans from all the Lenders, or from the Swingline Lender in the case of UK Swingline Loans, on a given date having the same Interest Period. 
 “UK Borrowing Availability” shall mean, as of any date of determination, the remainder of (a) the lesser of (i) the UK Maximum Amount at such time and (ii) the UK Borrowing
Base at such time minus (b) the Aggregate UK Exposure at such time. 
 “UK Borrowing Base”
shall mean, as of any date of calculation, the amount calculated pursuant to the Borrowing Base Certificate most recently delivered to the Administrative Agent in accordance with Section 9.01(i) (but as modified as provided below in this
definition), equal to, without duplication, the sum of 

  
 52 

 (i) (A) the amount calculated under the definition of US
Borrowing Base, provided that in no event shall any asset constituting a portion of the US Borrowing Base concurrently constitute a portion of the UK Borrowing Base plus (B) the amount calculated under the definition of Canadian Borrowing Base,
provided that in no event shall any asset constituting a portion of the Canadian Borrowing Base concurrently constitute a portion of the UK Borrowing Base, plus 

(ii) eighty-five percent (85%) of Eligible UK Accounts, plus 

(iii) ninety percent (90%) of Eligible UK Rental Fleet Inventory, plus 

(iv) [Reserved] 

(v) the lesser of (A) (1) $40,000,000 less (2) the amount included in such Borrowing Base
Certificate with respect to clause (iv)(B) of the definition of US Borrowing Base and clause (v)(B) of the definition of Canadian Borrowing Base and (B) the sum of (1) ninety percent (90%) of Eligible UK Container Inventory Held for
Sale; plus (2) ninety percent (90%) of Eligible UK Work-in-Process Container Inventory; plus (3) sixty-five percent (65%) of Eligible UK Raw Materials Inventory; plus 

(vi) the lesser of (A) (1) $50,000,000 less (2) the amount included in such Borrowing Base
Certificate with respect to clause (v)(B) of the definition of US Borrowing Base and clause (vi)(B) of the definition of Canadian Borrowing Base and (B) eighty-five percent (85%) of Eligible UK Machinery and Equipment; minus 

 (vii) the amount of all Reserves then established by the Administrative Agent against the UK
Borrowing Base. 
 The Administrative Agent shall have the right (but no obligation) to review such computations
and if, in its Permitted Discretion, such computations have not been calculated in accordance with the terms of this Agreement, the Administrative Agent shall have the right to correct any such errors in such manner it shall determine in its
Permitted Discretion. The UK Borrowing Base (and the Borrowing Base Certificate then most recently delivered) may be adjusted by the Administrative Agent to reflect any new or incremental Reserves required by the Administrative Agent in its
Permitted Discretion; provided that no change in the amount of any Reserve shall be effective until the date occurring three Business Days after written notice thereof by the Administrative Agent to the US Company and the UK Company following
consultation with the US Company. 
 “UK Borrowing Base Party” shall mean each Wholly-Owned
Subsidiary of US Company that is incorporated under the laws of England and Wales and that is a UK Borrower or a Non-US Obligation Guarantor and is incorporated in England and Wales. 

“UK Company” shall have the meaning provided in the first paragraph of this Agreement. 

“UK Credit Party” shall mean each subsidiary of the US Company, other than any US Credit Party.

 “UK Debenture” shall mean the debenture executed by the UK Company, each UK Subsidiary
(other than UK-LP) and the Luxembourg Subsidiary with respect to the UK Obligations and the Canadian Obligations in favor of the Collateral Agent for the benefit of the Secured Creditors. 

  
 53 

 “UK Debentures” shall mean the UK Debenture and the UK
Partnership Debenture. 
 “UK Drawing” shall have the meaning set forth in
Section 3.14(b). 
 “UK Intercreditor Deed” means the intercreditor deed, dated as
of the date hereof, and entered into by and among the Administrative Agent, the UK Company, the Luxembourg Subsidiary, Mobile Storage (UK) Limited, among others, as amended, restated, supplemented or otherwise modified from time to time. 

“UK Issuing Lender” shall mean (i) each of Deutsche Bank AG, London (except as otherwise provided
in Section 12.09) and any other Lender reasonably acceptable to the Administrative Agent and US Company or UK Company which agrees to issue UK Letters of Credit hereunder and (ii) with respect to the Existing Letters of Credit, the
Lender designated as the issuer thereof on Schedule 3.01(c). Any UK Issuing Lender may, in its discretion, arrange for one or more UK Letters of Credit to be issued by one or more Affiliates of such UK Issuing Lender (and such Affiliate shall
be deemed to be a “UK Issuing Lender” for all purposes of the Credit Documents). 
 “UK L/C
Supportable Obligations” shall mean (a) obligations of a UK Borrower with respect to workers compensation, surety bonds and other similar statutory obligations and (b) such other obligations of a UK Borrower as are reasonably
acceptable to the respective UK Issuing Lender and otherwise permitted to exist pursuant to the terms of this Agreement (other than obligations in respect of (i) any Indebtedness or other obligations that are subordinated in right of payment to
the UK Obligations and (ii) any Equity Interests). 
 “UK Letter of Credit” shall have the
meaning provided in Section 3.02(a). 
 “UK Letter of Credit Fee” shall have the
meaning provided in Section 4.01(b). 
 “UK Letter of Credit Outstandings” shall
mean, at any time, the sum of (a) the Stated Amount of all outstanding UK Letters of Credit at such time and (b) the aggregate amount of all Unpaid UK Drawings in respect of all UK Letters of Credit at such time. 

“UK Letter of Credit Request” shall have the meaning provided in Section 3.08(a).

 “UK LIBOR Loan” shall mean each UK Revolving Loan denominated in Pounds Sterling bearing
interest at a rate determined by reference to LIBOR. 
 “UK-LP” shall mean Mobile Storage UK
Finance LP, a limited partnership formed under the laws of England and Wales. 
 “UK Maximum
Amount” shall mean, as of any date of determination, the lesser of (a) Equivalent Amount of $200,000,000 and (b) the Equivalent Amount of the Total Revolving Loan Commitment minus the Equivalent Amount of the Aggregate US
Exposure minus the Equivalent Amount of the Aggregate Canadian Exposure. 
 “UK
Obligations” shall mean, with respect to any UK Credit Party, all Loans, all obligations under Letters of Credit and all other advances, debts, liabilities, obligations, covenants and duties, together with all interest, fees and other
charges thereon, owing, arising, due or payable from such UK Credit Party to an Agent, any Lender or any Affiliate of any Lender, or from a UK Borrower to any UK Issuing Lender, of any kind or nature, present or future, whether or not evidenced by
any note, guaranty or other instrument, whether arising under this Agreement or any of the other Credit Documents 

  
 54 

 
or cash management services rendered in connection therewith, whether direct or indirect (including those acquired by assignment), absolute or contingent, primary or secondary, due or to become
due, now existing or hereafter arising and however acquired, and any Banking Products Obligations or Qualified Derivative Obligations owing to a Banking Products Provider or a Qualified Derivative Counterparty, as applicable. 

“UK Participant” shall have the meaning set forth in Section 3.11(a). 

“UK Partnership Debenture” shall mean the debenture executed by UK-LP (acting through its general
partner Mobile Storage Group, Inc.), and the limited partners of UK-LP with respect to the UK Obligations and the Canadian Obligations in favor of the Collateral Agent for the benefit of the Secured Creditors. 

“UK Priority Claims” means with respect to any UK Borrowing Base Party only, (a) sums which are due
by way of contributions to occupational pension schemes, including contributions in respect of contracted-out rights; (b) unpaid remuneration of employees in respect of the 4-month period prior to insolvency, together with any amount owed in
respect of accrued holiday; (c) an amount equal to the aggregate of (i) 50% of the first £10,000 in value of assets comprising the UK Borrowing Base of any UK Borrowing Base Party and (ii) 20% of the value of assets comprising
the UK Borrowing Base of any UK Borrowing Base Party above £10,000, subject to a cap for this sub-clause (c) of £600,000 for each UK Borrowing Base Party, (e) the expenses of any administration or winding-up and (f) an
amount equal to the value of suppliers’ valid and subsisting retention of title claims (and including, without limitation, any third party retention of title provision extending to disposal proceeds)) with respect to Eligible Inventory.

 “UK Revolving Loan” shall have the meaning set forth in Section 2.01(b).

 “UK Revolving Loan Commitment” shall mean, for each Lender, the amount set forth opposite
such Lender’s name in Schedule 1.01(a) directly below the column entitled “UK Revolving Loan Commitment,” as same may be (x) reduced from time to time or terminated pursuant to Sections 4.02, 4.03 and/or
11, as applicable, (y) increased from time to time pursuant to Section 2.15, or (z) adjusted from time to time as a result of assignments to or from such Lender pursuant to Section 2.13 or 13.04(b).

 “UK Revolving Note” shall have the meaning set forth in Section 2.05(a).

 “UK Security Agreements” shall mean the UK Debenture, the UK Partnership Debenture and the
UK Share Charge. 
 “UK Share Charge” shall have the meaning set forth in
Section 6.08. 
 “UK Swingline Loans” shall have the meaning set forth in
Section 2.01(e). 
 “UK Swingline Note” shall have the meaning set forth in
Section 2.05(a). 
 “UK Subsidiary” shall mean each Subsidiary of US Company that
is incorporated in England and Wales. 
 “Unfinanced Capital Expenditures” shall mean, for any
period, Capital Expenditures made in cash during such fiscal period, except to the extent financed with the proceeds of Capital Lease Obligations or other Indebtedness (other than Loans incurred hereunder), equity issuances, casualty

  
 55 

 
proceeds, condemnation proceeds or other proceeds that would not be included in Consolidated EBITDA, less cash received from the sale of any fixed assets (including, without limitation,
assets of the type that may constitute Eligible Rental Fleet Inventory hereunder) during such period. 

“Unfunded Current Liability” shall mean the amount, if any, by which the value of the accumulated plan
benefits under any Plan determined on a plan termination basis in accordance with actuarial assumptions at such time consistent with those prescribed by the PBGC for purposes of Section 4044 of ERISA, exceeds the Fair Market Value of all plan
assets allocable to such liabilities under Title IV of ERISA (excluding any accrued but unpaid contributions). 

“United States” and “US” shall each mean the United States of America. 

“Unpaid Supplier Reserve” means, at any time, with respect to any Borrowing Base Party which carries on
business in Canada or which leases or sells goods in Canada or which has Accounts with Account Debtors located in Canada or otherwise has any assets in Canada, the amount equal to the percentage applicable to Eligible Inventory in the calculation of
the US Borrowing Base multiplied by the aggregate value of the Eligible Inventory which the Administrative Agent, in good faith, considers is or may be subject to a right of a supplier to repossess goods pursuant to Section 81.1 of the
Bankruptcy and Insolvency Act (Canada) or any other laws of Canada or any other applicable jurisdiction granting revendication or similar rights to unpaid suppliers, in each case, where such supplier’s right ranks or is capable of ranking in
priority to or pari passu with one or more of the Liens granted in the Security Documents. 
 “Unpaid
Drawing” shall mean an Unpaid Canadian Drawing, an Unpaid UK Drawing or an Unpaid US Drawing. 

“Unpaid Canadian Drawing” shall have the meaning provided in Section 3.15(a). 

“Unpaid UK Drawing” shall have the meaning provided in Section 3.14(a). 

“Unpaid US Drawing” shall have the meaning provided in Section 3.13(a). 

“Unutilized Revolving Loan Commitment” shall mean, with respect to any Lender at any time, such
Lender’s Revolving Loan Commitment at such time less the sum of (a) the aggregate outstanding principal amount of all Revolving Loans made by such Lender at such time and (b) such Lender’s RL Percentage of the Letter of Credit
Outstandings at such time. 
 “US Borrower” and “US Borrowers” shall have the
meaning provided in the first paragraph of this Agreement. 
 “US Borrowing” shall mean the
borrowing of one Type of US Revolving Loan from all the Lenders, or from the Swingline Lender in the case of US Swingline Loans, on a given date (or resulting from a conversion or conversions on such date) having in the case of US LIBOR Loans the
same Interest Period; provided that Base Rate Loans incurred pursuant to Section 2.10(b) shall be considered part of the related US Borrowing of US LIBOR Loans. 

“US Borrowing Availability” shall mean, as of any date of determination, the remainder of (i) the
lesser of (x) the US Maximum Amount at such time and (y) the US Borrowing Base at such time minus (ii) the Aggregate US Exposure at such time. 

  
 56 

 “US Borrowing Base” shall mean, as of any date of
calculation, the amount calculated pursuant to the Borrowing Base Certificate most recently delivered to the Administrative Agent in accordance with Section 9.01(i) (but as modified as provided below in this definition), equal to,
without duplication, an amount equal to the sum of: 
 (i) eighty-five percent (85%) of
Eligible US Accounts, plus  
 (ii) ninety percent (90%) of Eligible US Rental Fleet
Inventory, plus 
 (iii) [Reserved] 

(iv) the lesser of (A) (1) $40,000,000 less (2) the amount included in such Borrowing Base
Certificate with respect to clause (v)(B) of the definition of UK Borrowing Base and clause (v)(B) of the definition of Canadian Borrowing Base and (B) the sum of (1) ninety percent (90%) of Eligible US Container Inventory Held for
Sale; plus (2) ninety percent (90%) of Eligible US Work-in-Process Container Inventory; plus (3) sixty-five percent (65%) of Eligible US Raw Materials Inventory; plus 

(v) the lesser of (A) (1) $50,000,000 less (2) the amount included in such Borrowing Base
Certificate with respect to clause (vi)(B) of the definition of UK Borrowing Base and clause (vi)(B) of the definition of Canadian Borrowing Base and (B) the sum of (1) eighty-five percent (85%) of Eligible US Machinery and Equipment;
plus (2) sixty percent (60%) of Eligible Real Property; minus  
 (vi)
the amount of all Reserves then established by the Administrative Agent against the US Borrowing Base. 
 The
Administrative Agent shall have the right (but no obligation) to review such computations and if, in its Permitted Discretion, such computations have not been calculated in accordance with the terms of this Agreement, the Administrative Agent shall
have the right to correct any such errors in such manner it shall determine in its Permitted Discretion. The US Borrowing Base (and the Borrowing Base Certificate then most recently delivered) may be adjusted by the Administrative Agent to reflect
any new or incremental Reserves required by the Administrative Agent in its Permitted Discretion; provided that no change in the amount of any Reserve shall be effective until the date occurring three Business Days after written notice
thereof by the Administrative Agent to the US Company after consultation with US Company. 
 “US
Borrowing Base Party” shall mean US Company and each Wholly-Owned Domestic Subsidiary of US Company that is a US Borrower and/or a US Guarantor and was formed in a US jurisdiction. 

“US Company” shall have the meaning provided in the first paragraph of this Agreement. 

“US Credit Party” shall mean each of the US Borrowers and each of the US Guarantors. 

“US Drawing” shall have the meaning set forth in Section 3.13(b). 

“US Guaranteed Obligations” shall have the meaning set forth in Section 15.01(a).

 “US Guarantors” shall mean US Company and each Domestic Subsidiary of US Company and each
other Person who now or hereafter guarantees payment or performance of the whole or any part of the US Obligations, including each Domestic Subsidiary listed on Schedule 8.04 and each other Domestic Subsidiary that is or becomes a party to
this Agreement pursuant to Section 10.11. 

  
 57 

 “US Issuing Lender” shall mean (i) each of Deutsche
Bank AG New York Branch (except as otherwise provided in Section 12.09) and any other Lender reasonably acceptable to the Administrative Agent and US Company which agrees to issue US Letters of Credit hereunder and (ii) with respect
to the Existing Letters of Credit, the Lender designated as the issuer thereof on Schedule 3.01(c). Any US Issuing Lender may, in its discretion, arrange for one or more US Letters of Credit to be issued by one or more Affiliates of such US
Issuing Lender (and such Affiliate shall be deemed to be a “US Issuing Lender” for all purposes of the Credit Documents). 
 “US L/C Supportable Obligations” shall mean (a) obligations of a US Borrower with respect to workers compensation, surety bonds and other similar statutory obligations and
(b) such other obligations of a US Borrower as are reasonably acceptable to the respective US Issuing Lender and otherwise permitted to exist pursuant to the terms of this Agreement (other than obligations in respect of (i) any
Indebtedness or other obligations that are subordinated in right of payment to the US Obligations and (ii) any Equity Interests). 
 “US Letter of Credit” shall have the meaning provided in Section 3.01(a). 
 “US Letter of Credit Fee” shall have the meaning provided in Section 4.01(b). 
 “US Letter of Credit Outstandings” shall mean, at any time, the sum of (a) the Stated Amount of all outstanding US Letters of Credit at such time and (b) the aggregate amount of
all Unpaid US Drawings in respect of all US Letters of Credit at such time. 
 “US Letter of Credit
Request” shall have the meaning provided in Section 3.07(a). 
 “US LIBOR
Loan” shall mean each US Revolving Loan designated as such by the relevant Borrower at the time of the incurrence thereof or conversion thereto bearing interest at a rate determined by reference to LIBOR. 

“US Maximum Amount” shall mean, as of any date of determination, the Equivalent Amount of the Total
Revolving Loan Commitment minus the Equivalent Amount of the Aggregate UK Exposure minus the Equivalent Amount of the Aggregate Canadian Exposure. 

“US Obligations” shall mean, with respect to any US Credit Party, all Loans, all obligations arising
under Letters of Credit and all other advances, debts, liabilities, obligations, covenants and duties, together with all interest, fees and other charges thereon, owing, arising, due or payable from such US Credit Party to an Agent, any Lender or
any Affiliate of any Lender, or from a US Borrower to any US Issuing Lender, of any kind or nature, present or future, whether or not evidenced by any note, guaranty or other instrument, whether arising under this Agreement or any of the other
Credit Documents or cash management services rendered in connection therewith, whether direct or indirect (including those acquired by assignment), absolute or contingent, primary or secondary, due or to become due, now existing or hereafter arising
and however acquired, and any Banking Products Obligations and any Qualified Derivative Obligations owing to a Banking Products Provider or a Qualified Derivative Counterparty, as applicable. 

“US Participant” shall have the meaning set forth in Section 3.10(a). 

“US Pledge Agreement” shall have the meaning set forth in Section 6.08. 

  
 58 

 “US Pledge Agreement Collateral” shall mean all
“Collateral” as defined in the US Pledge Agreement. 
 “US Revolving Loans” shall
have the meaning set forth in Section 2.01(a). 
 “US Revolving Note” shall have
the meaning set forth in Section 2.05(a). 
 “US Security Agreement” shall mean the
security agreement executed by US Company and each other US Credit Party with respect to the US Obligations in favor of the Collateral Agent for the benefit of the Secured Creditors. 

“US Swingline Loans” shall have the meaning set forth in Section 2.01(d). 

“US Swingline Note” shall have the meaning set forth in Section 2.05(a). 

“Voting Stock” shall mean Equity Interests of any class or classes of a corporation, limited partnership
or limited liability company or any other entity the holders of which are ordinarily, in the absence of contingencies, entitled to vote with respect to the election of corporate directors (or Persons performing similar functions). 

“Wholly-Owned Domestic Subsidiary” shall mean, as to any Person, any Domestic Subsidiary of such Person
that is a Wholly-Owned Subsidiary. 
 “Wholly-Owned Subsidiary” shall mean, as to any Person,
(a) any corporation 100% of whose capital stock is at the time owned by such Person and/or one or more Wholly-Owned Subsidiaries of such Person and (b) any partnership, limited liability company, association, joint venture or other entity
in which such Person and/or one or more Wholly-Owned Subsidiaries of such Person has a 100% equity interest at such time (other than, in the case of a Foreign Subsidiary of US Company with respect to the preceding clauses (a) and (b),
directors’ qualifying shares and/or other nominal amounts of shares required to be held by Persons other than US Company and its Subsidiaries under Applicable Law). 

SECTION 2. Amount and Terms of Credit. 

2.01 The Commitments. 
 (a) US Revolving Loans. Subject to and upon the terms and conditions set forth herein, each Lender severally agrees to make, at any time and from time to time on or after the Effective Date and
prior to the Final Maturity Date, a revolving loan or revolving loans (each, a “US Revolving Loan” and, collectively, the “US Revolving Loans”) to the US Borrowers (on a joint and several basis), which US Revolving
Loans: (i) shall be denominated in Dollars, (ii) shall, at the option of the respective Borrower, be incurred and maintained as, and/or converted into, Base Rate Loans or LIBOR Loans; provided that, except as otherwise specifically
provided in Section 2.10(c), all US Revolving Loans comprising the same Borrowing shall at all times be of the same Type, (iii) may be repaid and reborrowed in accordance with the provisions hereof, (iv) shall not be made (and
shall not be required to be made) by any Lender in any instance where the incurrence thereof (after giving effect to the use of the proceeds thereof on the date of the incurrence thereof to repay any amounts theretofore outstanding pursuant to this
Agreement) would cause the Individual Exposure of such Lender to exceed the amount of its Revolving Loan Commitment at such time and (v) shall not be made (and shall not be required to be made) by any Lender in any instance where the incurrence
thereof (after giving effect to the use of the proceeds thereof on the date of the incurrence thereof to repay any amounts theretofore outstanding pursuant to this Agreement) would cause (A) the Aggregate Exposure to exceed the Total Revolving
Loan Commitment, 

  
 59 

 
as then in effect, (B) the Aggregate US Exposure to exceed the US Maximum Amount, as then in effect, (C) the Aggregate Exposure to exceed the Aggregate Borrowing Base at such time
(based on the most recently delivered Borrowing Base Certificate) or (D) the Aggregate US Exposure to exceed the US Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate). 

(b) UK Revolving Loans. Subject to and upon the terms and conditions set forth herein, each Lender severally
agrees to make, at any time and from time to time on or after the Effective Date and prior to the Final Maturity Date, a revolving loan or revolving loans (each, a “UK Revolving Loan” and, collectively, the “UK Revolving
Loans”) to the UK Borrowers (on a joint and several basis), which UK Revolving Loans: (i) shall, at the option of the applicable UK Borrower, be denominated in either Pounds Sterling (such Revolving Loans, “Pounds Sterling
Denominated Revolving Loans”) or Euros (such Revolving Loans, “Euro Denominated Revolving Loans”), (ii) shall be incurred and maintained as solely in the case of UK Revolving Loans denominated in Pounds Sterling, LIBOR
Loans, and in the case of UK Revolving Loans denominated in Euros, EURIBOR Loans; provided that, except as otherwise specifically provided in Section 2.01(e), all UK Revolving Loans comprising the same Borrowing shall at all times
be of the same Type, (iii) may be repaid and reborrowed in accordance with the provisions hereof, (iv) shall not be made (and shall not be required to be made) by any Lender in any instance where the incurrence thereof (after giving effect
to the use of the proceeds thereof on the date of the incurrence thereof to repay any amounts theretofore outstanding pursuant to this Agreement) would cause the Individual Exposure of such Lender to exceed the amount of its Revolving Loan
Commitment at such time and (v) shall not be made (and shall not be required to be made) by any Lender in any instance where the incurrence thereof (after giving effect to the use of the proceeds thereof on the date of the incurrence thereof to
repay any amounts theretofore outstanding pursuant to this Agreement) would cause (A) the Aggregate Exposure to exceed the Total Revolving Loan Commitment, as then in effect, (B) the Aggregate UK Exposure to exceed the UK Maximum Amount or
the UK Revolving Loan Commitments, as then in effect, (C) the Aggregate Exposure to exceed the Aggregate Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate) or (D) the Aggregate UK Exposure to
exceed the UK Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate). Upon receipt by the Administrative Agent of any Notice of Borrowing pursuant to which the UK Company or any other UK Borrower proposes to
borrow in Pounds Sterling or Euros, the Administrative Agent shall provide notice of the same to each Lender. 

(c) Canadian Revolving Loans. Subject to and upon the terms and conditions set forth herein, each Lender severally
agrees to make, at any time and from time to time on or after the Effective Date and prior to the Final Maturity Date, a revolving loan or revolving loans (each a “Canadian Revolving Loan” and, collectively, the “Canadian
Revolving Loans”) to the Canadian Borrowers (on a joint and several basis), which Canadian Revolving Loans: (i) shall be made and maintained in Canadian Dollars, (ii) except as hereafter provided, shall, at the option of the
applicable Canadian Borrower, be incurred and maintained as, and/or converted into, one or more Borrowings of (A) Canadian Prime Rate Loans or (B) (x) in the case of a B/A Lender, the creation of Bankers’ Acceptances on the terms
and conditions provided for herein and in Schedule 1.01(g) or (y) in a case of a Non-B/A Lender, the creation and purchase of completed Drafts and the exchange of such Drafts for B/A Discount Notes, in each case on the terms and
conditions provided for herein and in Schedule 1.01(g), (iii) may be repaid and reborrowed in accordance with the provisions hereof, (iv) shall not be made (and shall not be required to be made) by any Lender in any instance where
the incurrence thereof (after giving effect to the use of the proceeds thereof on the date of the incurrence thereof to repay any amounts theretofore outstanding pursuant to this Agreement) would cause the Individual Exposure of such Lender to
exceed the amount of its Revolving Loan Commitment at such time and (v) shall not be made (and shall not be required to be made) by any Lender in any instance where the incurrence thereof (after giving effect to the use of the proceeds thereof
on the date of the incurrence thereof to repay any amounts theretofore outstanding pursuant to this Agreement) would cause (A) the Aggregate Exposure to exceed the Total Revolving 

  
 60 

 
Loan Commitment, as then in effect, (B) the Aggregate Canadian Exposure to exceed the Canadian Maximum Amount or the Canadian Revolving Loan Commitments, as then in effect, (C) the
Aggregate Exposure to exceed the Aggregate Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate) or (D) the Aggregate Canadian Exposure to exceed the Canadian Borrowing Base at such time (based on the
most recently delivered Borrowing Base Certificate). 
 (d) US Swingline Loans. Subject to and upon the
terms and conditions set forth herein, the Swingline Lender agrees to make, at any time and from time to time on or after the Effective Date and prior to the Swingline Expiry Date, a revolving loan or revolving loans (each, a “US Swingline
Loan” and, collectively, the “US Swingline Loans”) to the US Borrowers (on a joint and several basis), which US Swingline Loans: (i) shall be denominated in Dollars, (ii) shall be incurred and maintained as Base
Rate Loans; (iii) may be repaid and reborrowed in accordance with the provisions hereof, (iv) shall not be made (and shall not be required to be made) by the Swingline Lender in any instance where the incurrence thereof (after giving
effect to the use of the proceeds thereof on the date of the incurrence thereof to repay any amounts theretofore outstanding pursuant to this Agreement) would cause (A) the Aggregate Exposure to exceed the Total Revolving Loan Commitment, as
then in effect, (B) the Aggregate US Exposure to exceed the US Maximum Amount, as then in effect, (C) the Aggregate Exposure to exceed the Aggregate Borrowing Base at such time (based on the most recently delivered Borrowing Base
Certificate) or (D) the Aggregate US Exposure to exceed the US Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate), and (v) shall not exceed in aggregate principal amount at any time outstanding
the Maximum US Swingline Amount. Notwithstanding anything to the contrary contained in this Section 2.01(d), (i) the Swingline Lender shall not make any US Swingline Loan after it has received written notice from any Borrower, any
other Credit Party or the Required Lenders stating that a Default or an Event of Default exists and is continuing until such time as the Swingline Lender shall have received written notice (A) of rescission of all such notices from the party or
parties originally delivering such notice or notices or (B) of the waiver of such Default or Event of Default by the Required Lenders, and (ii) no Swingline Lender shall be obligated to make US Swingline Loans to the extent such advance
would cause such Lender’s then outstanding Loans to exceed its Revolving Loan Commitment. 
 (e) UK
Swingline Loans. Subject to and upon the terms and conditions set forth herein, the Swingline Lender agrees to make, at any time and from time to time on or after the Effective Date and prior to the Swingline Expiry Date, a revolving loan or
revolving loans (each, a “UK Swingline Loan” and, collectively, the “UK Swingline Loans”) to the UK Borrowers (on a joint and several basis), which UK Swingline Loans (i) shall be denominated in Pounds Sterling
or Euros, at the option of the applicable Borrower, (ii) shall be incurred and maintained as in the case of UK Revolving Loans denominated in Pounds Sterling, LIBOR Loans, and in the case of UK Revolving Loans denominated in Euros, EURIBOR
Loans, with an Interest Period of one week; (iii) may be repaid and reborrowed in accordance with the provisions hereof, (iv) shall not be made (and shall not be required to be made) by the Swingline Lender in any instance where the
incurrence thereof (after giving effect to the use of the proceeds thereof on the date of the incurrence thereof to repay any amounts theretofore outstanding pursuant to this Agreement) would cause (A) the Aggregate Exposure to exceed the Total
Revolving Loan Commitment, as then in effect, (B) the Aggregate UK Exposure to exceed the UK Maximum Amount, as then in effect, (C) the Aggregate Exposure to exceed the Aggregate Borrowing Base at such time (based on the most recently
delivered Borrowing Base Certificate), or (D) the Aggregate UK Exposure to exceed the UK Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate), and (v) shall not exceed in aggregate principal amount
at any time outstanding the Maximum UK Swingline Amount. Notwithstanding anything to the contrary contained in this Section 2.01(e), (i) the Swingline Lender shall not make any UK Swingline Loan after it has received written notice
from any Borrower, any other Credit Party or the Required Lenders stating that a Default or an Event of Default exists and is continuing until such time as the Swingline Lender shall have received

  
 61 

 
written notice (A) of rescission of all such notices from the party or parties originally delivering such notice or notices or (B) of the waiver of such Default or Event of Default by
the Required Lenders, and (ii) no Swingline Lender shall be obligated to make UK Swingline Loans to the extent such advance would cause such Lender’s then outstanding Loans to exceed its Revolving Loan Commitment. 

(f) Mandatory US Borrowings. On any Business Day, the Swingline Lender may, in its sole discretion, give notice to
the Lenders that the Swingline Lender’s outstanding US Swingline Loans shall be funded with one or more Borrowings of US Revolving Loans (provided that such notice shall be deemed to have been automatically given upon the occurrence of a
Default or an Event of Default under Section 11.08 or upon the exercise of any of the remedies provided in the last paragraph of Section 11), in which case one or more Borrowings of US Revolving Loans constituting Base Rate
Loans (each such Borrowing, a “Mandatory US Borrowing”) shall be made on the immediately succeeding Business Day by all Lenders pro rata based on each such Lender’s RL Percentage (determined before giving effect to any
termination of the Revolving Loan Commitments pursuant to the last paragraph of Section 11) and the proceeds thereof shall be applied directly by the Swingline Lender to repay the Swingline Lender for such outstanding US Swingline Loans.
Each Lender hereby irrevocably agrees to make US Revolving Loans upon one Business Day’s notice pursuant to each Mandatory US Borrowing in the amount and in the manner specified in the preceding sentence and on the date specified in writing by
the Swingline Lender notwithstanding (i) the amount of the Mandatory US Borrowing may not comply with the Minimum Borrowing Amount otherwise required hereunder, (ii) whether any conditions specified in Section 7 are then
satisfied, (iii) whether a Default or an Event of Default then exists, (iv) the date of such Mandatory US Borrowing, (v) the amount of the US Borrowing Base or the US Maximum Amount at such time, and (vi) the amount of the
Aggregate Borrowing Base or the Total Revolving Loan Commitment at such time. In the event that any Mandatory US Borrowing cannot for any reason be made on the date otherwise required above (including, without limitation, as a result of the
commencement of a proceeding under the Bankruptcy Code with respect to any Borrower), then each Lender hereby agrees that it shall forthwith purchase (as of the date the Mandatory US Borrowing would otherwise have occurred, but adjusted for any
payments received from any Borrower on or after such date and prior to such purchase) from the Swingline Lender such participations in the outstanding US Swingline Loans as shall be necessary to cause the Lenders to share in such US Swingline Loans
ratably based upon their respective RL Percentages (determined before giving effect to any termination of the Revolving Loan Commitments pursuant to the last paragraph of Section 11), provided that (x) all interest payable on
the US Swingline Loans shall be for the account of the Swingline Lender until the date as of which the respective participation is required to be purchased and, to the extent attributable to the purchased participation, shall be payable to the
participant from and after such date and (y) at the time any purchase of participations pursuant to this sentence is actually made, the purchasing Lender shall be required to pay the Swingline Lender interest on the principal amount of
participation purchased for each day from and including the day upon which the Mandatory US Borrowing would otherwise have occurred to but excluding the date of payment for such participation, at the overnight Federal Funds Rate for the first three
days and at the interest rate otherwise applicable to US Revolving Loans maintained as Base Rate Loans hereunder for each day thereafter. 
 (g) Mandatory UK Borrowings. On any Business Day, the Swingline Lender may, in its sole discretion, give notice to the Lenders that the Swingline Lender’s outstanding UK Swingline Loans shall
be funded with one or more Borrowings of UK Revolving Loans (provided that such notice shall be deemed to have been automatically given upon the occurrence of a Default or an Event of Default under Section 11.08 or upon the
exercise of any of the remedies provided in the last paragraph of Section 11), in which case one or more Borrowings of UK Revolving Loans constituting LIBOR Loans or, in the case of UK Swingline Loans in Euros, EURIBOR Loans with an Interest
Period of one week (each such Borrowing, a “Mandatory UK Borrowing”) shall be made on the immediately succeeding Business Day by all Lenders pro rata based on each such Lender’s RL Percentage (determined before giving
effect to 

  
 62 

 
any termination of the Revolving Loan Commitments pursuant to the last paragraph of Section 11) and the proceeds thereof shall be applied directly by the Swingline Lender to repay the
Swingline Lender for such outstanding UK Swingline Loans. Each Lender hereby irrevocably agrees to make UK Revolving Loans upon one Business Day’s notice pursuant to each Mandatory UK Borrowing in the amount and in the manner specified in the
preceding sentence and on the date specified in writing by the Swingline Lender notwithstanding (i) the amount of the Mandatory UK Borrowing may not comply with the Minimum Borrowing Amount otherwise required hereunder, (ii) whether any
conditions specified in Section 7 are then satisfied, (iii) whether a Default or an Event of Default then exists, (iv) the date of such Mandatory UK Borrowing, (v) the amount of the UK Borrowing Base or the UK Maximum
Amount at such time, and (vi) the amount of the Aggregate Borrowing Base or the Total Revolving Loan Commitment at such time. In the event that any Mandatory UK Borrowing cannot for any reason be made on the date otherwise required above
(including, without limitation, as a result of the occurrence of any of the circumstances listed in Section 11.08 with respect to any UK Borrower), then each Lender hereby agrees that it shall forthwith purchase (as of the date the
Mandatory UK Borrowing would otherwise have occurred, but adjusted for any payments received from any Borrower on or after such date and prior to such purchase) from the Swingline Lender such participations in the outstanding UK Swingline Loans as
shall be necessary to cause the Lenders to share in such UK Swingline Loans ratably based upon their respective RL Percentages (determined before giving effect to any termination of the Revolving Loan Commitments pursuant to the last paragraph of
Section 11), provided that (x) all interest payable on the UK Swingline Loans shall be for the account of the Swingline Lender until the date as of which the respective participation is required to be purchased and, to the
extent attributable to the purchased participation, shall be payable to the participant from and after such date and (y) at the time any purchase of participations pursuant to this sentence is actually made, the purchasing Lender shall be
required to pay the Swingline Lender interest on the principal amount of participation purchased for each day from and including the day upon which the Mandatory UK Borrowing would otherwise have occurred to but excluding the date of payment for
such participation, at the rate for one-week LIBOR or EURIBOR (as applicable) Interest Period with respect to such UK Swingline Loan. 
 (h) Notwithstanding anything to the contrary in Section 2.01(a), Section 2.01(b) or elsewhere in this Agreement, the Administrative Agent shall have the right, following reasonable
consultation with US Company, to establish Reserves in such amounts, and with respect to such matters, as the Administrative Agent in its Permitted Discretion shall deem necessary or appropriate, against the US Borrowing Base, the UK Borrowing Base
and the Canadian Borrowing Base (which reserves shall reduce the then existing US Borrowing Base, UK Borrowing Base and Canadian Borrowing Base in an amount equal to such reserves). 

(i) (i) In the event that the Borrowers are unable to comply with the US Borrowing Base limitations set forth in
Section 2.01(a), or (ii) the Borrowers are unable to comply with the conditions precedent to the making of Revolving Loans set forth in Section 7, in either case, the Lenders, subject to the immediately succeeding proviso,
hereby authorize the Administrative Agent, for the account of the Lenders, to make US Revolving Loans to the US Borrowers (on a joint and several basis), solely in the event that the Administrative Agent in its Permitted Discretion deems necessary
or desirable (A) to preserve or protect the Collateral, or any portion thereof, (B) to enhance the likelihood of repayment of the Obligations, or (C) to pay any other amount chargeable to the Borrowers pursuant to the terms of this
Agreement or any other Credit Document, including, without limitation, Expenses and Fees, which Revolving Loans may only be made as Base Rate Loans (an “Agent Advance”), for a period commencing on the date the Administrative Agent
first receives a Notice of Borrowing requesting an Agent Advance until the earliest of (x) the twentieth Business Day after such date, (y) the date the respective Borrowers are again able to comply with the US Borrowing Base limitations
and the conditions precedent to the making of US Revolving Loans, or obtains an amendment or waiver with respect thereto and (z) the date the Required Lenders instruct the Administrative Agent to cease making Agent Advances

  
 63 

 
(the “Agent Advance Period”); provided that the Administrative Agent shall not make any Agent Advance to the extent that at the time of the making of such Agent Advance,
the amount of such Agent Advance (I) when added to the aggregate outstanding amount of all other Agent Advances made to the US Borrowers at such time, would exceed 5.0% of the US Borrowing Base at such time (based on the Borrowing Base
Certificate last delivered) (the “Agent Advance Amount”) or (II) when added to the Aggregate US Exposure as then in effect (immediately prior to the incurrence of such Agent Advance), would exceed the US Maximum Amount at such time.
Agent Advances may be made by the Administrative Agent in its sole discretion and the Borrowers shall have no right whatsoever to require that any Agent Advances be made. Agent Advances will be subject to periodic settlement with the Lenders
pursuant to Section 2.04(e). 
 2.02 Minimum Amount of Each Borrowing. The aggregate
principal amount of each Borrowing of Loans shall not be less than the Minimum Borrowing Amount applicable thereto. More than one Borrowing may occur on the same date, but at no time shall there be outstanding more than ten Borrowings of US LIBOR
Loans (or such greater number of Borrowings of US LIBOR Loans as may be agreed to from time to time by the Administrative Agent), more than five Borrowings of UK Revolving Loans (or such greater number of Borrowings of UK Revolving Loans as may be
agreed to from time to time by the Administrative Agent) or more than five Borrowings of Bankers’ Acceptance Loans (or such greater number of Borrowings of Bankers’ Acceptance Loans as may be agreed to from time to time by the
Administrative Agent). 
 2.03 Notice of Borrowing. (a) Whenever a Borrower desires to incur
(i) LIBOR Loans or EURIBOR Loans hereunder (excluding UK Swingline Loans and UK Revolving Loans made pursuant to a Mandatory UK Borrowing) or Bankers’ Acceptance Loans, such Borrower shall give the Administrative Agent at the Notice Office
at least three Business Days’ prior notice of each LIBOR Loan, EURIBOR Loan or Bankers’ Acceptance to be incurred hereunder and (ii) Base Rate Loans or Canadian Prime Rate Loans hereunder (including Agent Advances, but excluding US
Swingline Loans and US Revolving Loans made pursuant to a Mandatory US Borrowing and excluding Canadian Prime Rate Loans to the extent resulting from automatic conversions of Bankers’ Acceptance Loans as provided in Schedule 1.01(g)),
such Borrower shall give the Administrative Agent at the Notice Office at least one Business Day’s prior notice of each Base Rate Loan or Canadian Prime Rate Loan to be incurred hereunder; provided that any such notice shall be deemed to
have been given on a certain day only if given before 2:00 P.M. (New York City time) on such day (or, in the case of any UK Revolving Loans, 10:00 A.M. (New York City time) on such day, or, in the case of any Canadian Revolving Loans, 10:00 A.M.
(Toronto time). Each such notice (each, a “Notice of Borrowing”), except as otherwise expressly provided in Section 2.10, shall be irrevocable and shall be in writing, or by telephone promptly confirmed in writing, in
the form of Exhibit A-1, appropriately completed to specify: (A) the aggregate principal amount (or Face Amount, as the case may be) of the Revolving Loans to be incurred pursuant to such Borrowing, (B) the date of such Borrowing (which
shall be a Business Day), (C) whether the Revolving Loans made pursuant to such Borrowing constitute US Revolving Loans, UK Revolving Loans or Canadian Revolving Loans, (D) whether the Revolving Loans made pursuant to such Borrowing
constitute Agent Advances (it being understood that the Administrative Agent shall be under no obligation to make such Agent Advance), (E) in the case of US Revolving Loans, whether the Revolving Loans being incurred pursuant to such Borrowing
are to be initially maintained as Base Rate Loans or, to the extent permitted hereunder, LIBOR Loans and, if US LIBOR Loans, the initial Interest Period to be applicable thereto, (F) in the case of UK Revolving Loans whether EURIBOR Loans or UK
LIBOR Loans, the initial Interest Period to be applicable thereto and whether denominated in Pounds Sterling or Euros, (G) in the case of Canadian Revolving Loans, whether the respective Borrowing shall consist of Canadian Prime Rate Loans or,
to the extent permitted hereunder, Bankers’ Acceptance Loans and, if Bankers’ Acceptance Loans, the term thereof (which shall comply with the requirements of Schedule 1.01(g)) and (H) the US Borrowing Base, the UK Borrowing
Base and the Canadian Borrowing Base at 

  
 64 

 
such time (based on the Borrowing Base Certificate last delivered). Except as provided in Section 2.04(e), the Administrative Agent shall promptly give each Lender notice of such proposed
Borrowing, of such Lender’s proportionate share thereof and of the other matters required by the immediately preceding sentence to be specified in the Notice of Borrowing. 

(b) (i) Whenever a US Borrower desires to incur US Swingline Loans hereunder, such Borrower shall give the Swingline
Lender no later than 2:00 P.M. (New York City time) on the date that a US Swingline Loan is to be incurred, written notice or telephonic notice promptly confirmed in writing of each US Swingline Loan to be incurred hereunder. Each such notice shall
be irrevocable and specify in each case (A) the date of Borrowing (which shall be a Business Day), and (B) the aggregate principal amount of the US Swingline Loans to be incurred pursuant to such Borrowing. 

(ii) Whenever a UK Borrower desires to incur UK Swingline Loans hereunder, such Borrower shall give the Swingline Lender
one Business Days’ prior notice of each UK Swingline Loan to be incurred hereunder; provided that (in each case) any such notice shall be deemed to have been given on a certain day only if given before 10:00 A.M. (New York City time) on
such day or such later time as shall be acceptable to the Administrative Agent (which such notice shall be written notice or telephonic notice promptly confirmed in writing). Each such notice shall be irrevocable and specify in each case
(A) the date of Borrowing (which shall be a Business Day), and (B) the aggregate principal amount of the UK Swingline Loans to be incurred pursuant to such Borrowing. 

(iii) Mandatory Borrowings shall be made upon the notice specified in Sections 2.01(f) or 2.01(g), as
applicable, with the respective Borrower irrevocably agreeing, by its incurrence of any Swingline Loan, to the making of the Mandatory Borrowings as set forth in Section 2.01(f) or 2.01(g), as applicable. 

(c) Without in any way limiting the obligation of any Borrower to confirm in writing any telephonic notice of any
Borrowing or prepayment of Loans, the Administrative Agent or the Swingline Lender, as the case may be, may act without liability upon the basis of telephonic notice of such Borrowing or prepayment, as the case may be, believed by the Administrative
Agent or the Swingline Lender, as the case may be, in good faith to be from an Authorized Officer of such Borrower, prior to receipt of written confirmation. In each such case, such Borrower hereby waives the right to dispute the Administrative
Agent’s or the Swingline Lender’s record of the terms of such telephonic notice of such Borrowing or prepayment of Loans, as the case may be, absent manifest error. 

2.04 Disbursement of Funds. (a) Disbursement of US Revolving Loans. No later than 2:00 P.M. (New York
City time) on the date specified in each Notice of Borrowing with respect to any US Revolving Loans (or (x) in the case of US Swingline Loans, no later than 4:00 P.M. (New York City time) on the date specified pursuant to
Section 2.03(c) or (y) in the case of Mandatory US Borrowings, no later than 1:00 P.M. (New York City time) on the date specified in Section 2.01(f)), each Lender will make available its pro rata portion (determined in
accordance with Section 2.07) of each such Borrowing requested to be made on such date. All such amounts will be made available in Dollars and in immediately available funds at the Payment Office, and the Administrative Agent will make
available to the relevant US Borrower at the Payment Office the aggregate of the amounts so made available by the Lenders (or in the case of US Swingline Loans, the Swingline Lender will make available the full amount thereof). 

(b) Disbursement of UK Revolving Loans. No later than 2:00 P.M. (London time) on the date specified in each Notice
of Borrowing with respect to any UK Revolving Loans (or (x) in the case of UK Swingline Loans, no later than 2:00 P.M. (London time) on the date specified pursuant to Section 2.03(d) or (y) in the case of Mandatory UK
Borrowings, no later than 1:00 P.M. (London time) 

  
 65 

 
on the date specified in Section 2.01(g)), each Lender will make available its pro rata portion (determined in accordance with Section 2.07) of each such Borrowing
requested to be made on such date. Subject to Section 2.16, all such amounts will be made available in either Pounds Sterling or Euro (as requested by the applicable UK Borrower) and in immediately available funds at the Payment Office,
and the Administrative Agent will make available to the relevant UK Borrower at the Payment Office the aggregate of the amounts so made available by the Lenders (or in the case of UK Swingline Loans, the Swingline Lender will make available the full
amount thereof). 
 (c) Disbursement of Canadian Revolving Loans. No later than 2:00 P.M. (Toronto time)
on the date specified in each Notice of Borrowing with respect to any Canadian Revolving Loans on the date specified in Section 2.01(g), each Lender will make available its pro rata portion (determined in accordance with
Section 2.07) of each such Borrowing requested to be made on such date. Subject to Section 2.16, all such amounts will be made available in Canadian Dollars and in immediately available funds at the Payment Office, and the
Administrative Agent will make available to the relevant Canadian Borrower at the Payment Office the aggregate of the amounts so made available by the Lenders. 
 (d) Unless the Administrative Agent shall have been notified by any Lender prior to the date of Borrowing that such Lender does not intend to make available to the Administrative Agent such Lender’s
portion of any Borrowing to be made on such date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on such date of Borrowing and the Administrative Agent may (but shall not be obligated
to), in reliance upon such assumption, make available to the relevant Borrower a corresponding amount. If such corresponding amount is not in fact made available to the Administrative Agent by such Lender, the Administrative Agent shall be entitled
to recover such corresponding amount on demand from such Lender. If such Lender does not pay such corresponding amount forthwith upon the Administrative Agent’s demand therefor, the Administrative Agent shall promptly notify the relevant
Borrower, and the relevant Borrower shall immediately pay such corresponding amount to the Administrative Agent. The Administrative Agent also shall be entitled to recover on demand from such Lender or the relevant Borrower, as the case may be,
interest on such corresponding amount in respect of each day from the date such corresponding amount was made available by the Administrative Agent to the relevant Borrower until the date such corresponding amount is recovered by the Administrative
Agent, at a rate per annum equal to (i) if recovered from such Lender, in the case of US Revolving Loans, the overnight Federal Funds Rate for the first three days and at the interest rate otherwise applicable to such Loans for each day
thereafter and, the case of all other Loans, the interest rate applicable to such Loans and (ii) if recovered from the relevant Borrower or Borrowers, the rate of interest applicable to the respective Borrowing, as determined pursuant to
Section 2.08. Nothing in this Section 2.04 shall be deemed to relieve any Lender from its obligation to make Loans hereunder or to prejudice any rights which any Borrower may have against any Lender as a result of any failure
by such Lender to make Loans hereunder. 
 (e) Unless the Required Lenders have instructed the Administrative
Agent to the contrary, the Administrative Agent on behalf of the Lenders may, but shall not be obligated to, make US Revolving Loans to the Borrower that are maintained as Base Rate Loans under Section 2.01(a) without prior notice of the
proposed Borrowing to the Lenders as follows: 
 (i) The amount of each Lender’s RL
Percentage of US Revolving Loans shall be computed weekly (or more frequently in the Administrative Agent’s sole discretion) and shall be adjusted upward or downward on the basis of the amount of outstanding US Revolving Loans as of 5:00 P.M.
(New York City time) on the last Business Day of each week, or such other period specified by the Administrative Agent (each such date, a “Settlement Date”). The Lenders shall transfer to the Administrative Agent, or the
Administrative Agent shall transfer to the Lenders, such amounts as are necessary so that (after giving effect to all such transfers) the amount of US 

  
 66 

 
Revolving Loans made by each Lender shall be equal to such Lender’s RL Percentage of the aggregate amount of US Revolving Loans outstanding as of such Settlement Date. If a notice from the
Administrative Agent of any such necessary transfer is received by a Lender on or prior to 12:00 Noon (New York City time) on any Business Day, then such Lender shall make transfers described above in immediately available funds no later than 3:00
P.M. (New York City time) on the day such notice was received; and if such notice is received by a Lender after 12:00 Noon (New York City time) on any Business Day, such Lender shall make such transfers no later than 1:00 P.M. (New York City time)
on the next succeeding Business Day. The obligation of each of the Lenders to transfer such funds shall be irrevocable and unconditional and without recourse to, or without representation or warranty by, the Administrative Agent. Each of the
Administrative Agent and each Lender agrees and the Lenders agree to mark their respective books and records on each Settlement Date to show at all times the dollar amount of their respective RL Percentage of the outstanding US Revolving Loans on
such date. 
 (ii) To the extent that the settlement described in preceding clause
(i) shall not yet have occurred with respect to any particular Settlement Date, upon any repayment of US Revolving Loans by any Borrower prior to such settlement, the Administrative Agent may apply such amounts repaid directly to the amounts
that would otherwise be made available by the Administrative Agent pursuant to this Section 2.04(e). 
 (iii) Because the Administrative Agent on behalf of the Lenders may be advancing and/or may be repaid US Revolving Loans prior to the time when the Lenders will actually advance and/or be repaid US
Revolving Loans, interest with respect to Revolving Loans shall be allocated by the Administrative Agent to each Lender and the Administrative Agent in accordance with the amount of US Revolving Loans actually advanced by and repaid to each Lender
and the Administrative Agent and shall accrue from and including the date such US Revolving Loans are so advanced to but excluding the date such US Revolving Loans are either repaid by the Borrower in accordance with the terms of this Agreement or
actually settled by the Administrative Agent or the applicable Lender as described in this Section 2.04(e). 
 2.05 Notes. (a) Each Borrower’s obligation to pay the principal of, and interest on, the Loans made by each Lender shall be evidenced in the Register maintained by the Administrative
Agent pursuant to Section 13.15 and shall, if requested by such Lender, also be evidenced (i) in the case of US Revolving Loans, by a promissory note duly executed and delivered by each US Borrower substantially in the form of
Exhibit B-1, with blanks appropriately completed in conformity herewith (each, a “US Revolving Note” and, collectively, the “US Revolving Notes”), (ii) in the case of US Swingline Loans, by a promissory
note duly executed and delivered by each US Borrower substantially in the form of Exhibit B-2, with blanks appropriately completed in conformity herewith (each, a “US Swingline Note” and, collectively, the “US
Swingline Notes”), (iii) in the case of UK Revolving Loans, by a promissory note duly executed and delivered by each UK Borrower substantially in the form of Exhibit B-3, with blanks appropriately completed in conformity
herewith (each, a “UK Revolving Note” and, collectively, the “UK Revolving Notes”), (iv) in the case of UK Swingline Loans, by a promissory note duly executed and delivered by each UK Borrower substantially in
the form of Exhibit B-4, with blanks appropriately completed in conformity herewith (each, a “UK Swingline Note” and collectively, the “UK Swingline Notes”) and (v) in the case of Canadian Revolving Loans, by a
promissory note duly executed and delivered by each Canadian Borrower substantially in the form of Exhibit B-5, with blanks appropriately completed in conformity herewith (each, a “Canadian Revolving Note” and, collectively, the
“Canadian Revolving Notes”). 
 (b) Each Lender will note on its internal records the amount of
each Loan made by it and each payment in respect thereof and prior to any transfer of any of its Notes will endorse on the reverse side thereof the outstanding principal amount of Loans evidenced thereby. Failure to make any such notation or any
error in such notation shall not affect any Borrower’s obligations in respect of such Loans. 

  
 67 

 (c) Notwithstanding anything to the contrary contained above in this
Section 2.05 or elsewhere in this Agreement, Notes shall only be delivered to Lenders which at any time specifically request the delivery of such Notes. No failure of any Lender to request, obtain, maintain or produce a Note evidencing
its Loans to any Borrower shall affect, or in any manner impair, the obligations of any Borrower to pay the Loans (and all related Obligations) incurred by such Borrower which would otherwise be evidenced thereby in accordance with the requirements
of this Agreement, and shall not in any way affect the security or guaranties therefor provided pursuant to any Credit Document. Any Lender which does not have a Note evidencing its outstanding Loans shall in no event be required to make the
notations otherwise described in preceding clause (b). At any time when any Lender requests the delivery of a Note to evidence any of its Loans, the respective Borrower shall promptly execute and deliver to the respective Lender the requested Note
in the appropriate amount or amounts to evidence such Loans. 
 2.06 Conversions. (a) Each US
Borrower shall have the option to convert, on any Business Day, all or a portion equal to at least the Minimum Borrowing Amount of the outstanding principal amount of US Revolving Loans made pursuant to one or more Borrowings of one or more Types of
US Revolving Loans into a Borrowing of another Type of US Revolving Loan; provided that, (i) except as otherwise provided in Section 2.10(b), US LIBOR Loans may be converted into Base Rate Loans only on the last day of an
Interest Period applicable to the US Revolving Loans being converted and no such partial conversion of LIBOR Loans shall reduce the outstanding principal amount of such US LIBOR Loans made pursuant to a single Borrowing to less than the Minimum
Borrowing Amount applicable thereto, (ii) unless the Required Lenders otherwise agree, Base Rate Loans may only be converted into US LIBOR Loans if no Default or Event of Default is in existence on the date of the conversion, (iii) no
conversion pursuant to this Section 2.06(a) shall result in a greater number of Borrowings of US LIBOR Loans than are permitted under Section 2.02 and (iv) for the avoidance of doubt, in no event shall any US Revolving
Loan be converted into any UK Revolving Loan or Canadian Revolving Loan and in no event shall any UK Revolving Loan be converted into any US Revolving Loan or Canadian Revolving Loan and in no event shall any Canadian Revolving Loan be converted
into any UK Revolving Loan or US Revolving Loan. Each such conversion shall be effected by the respective US Borrower by giving the Administrative Agent at the Notice Office prior to 11:00 A.M. (New York City time) at least (A) in the case of
conversions of Base Rate Loans into US LIBOR Loans, three Business Days’ prior notice and (B) in the case of conversions of US LIBOR Loans into Base Rate Loans, one Business Day’s prior notice (each, a “Notice of
Conversion/Continuation”), in each case in the form of Exhibit A-2, appropriately completed to specify the Revolving Loans to be so converted, the Borrowing or Borrowings pursuant to which such Revolving Loans were incurred and, if to be
converted into US LIBOR Loans, the Interest Period to be initially applicable thereto. The Administrative Agent shall give each Lender prompt notice of any such proposed conversion affecting any of its Revolving Loans. 

(b) Each Canadian Borrower shall have the option to convert, on any Business Day, all or a portion equal to at least the
Minimum Borrowing Amount of the outstanding principal amount of Canadian Revolving Loans constituting Canadian Prime Rate Loans into a Borrowing of Bankers’ Acceptance Loans; provided, that (i) unless the Required Lenders otherwise
agree, Canadian Prime Rate Loans may only be converted into Bankers’ Acceptance Loans if no Default or Event of Default is in existence on the date of the conversion, and (ii) no conversion pursuant to this Section 2.06(b)
shall result in a greater number of Bankers’ Acceptance Loans than is permitted under Section 2.02. Each such conversion pursuant to this Section 2.06(b) shall be effected by the relevant Canadian Borrower by giving the
Administrative Agent at the applicable Notice Office prior to 11:00 am (Toronto Time) at least two 

  
 68 

 
Business Days’ prior notice in the form of Exhibit A-2, appropriately completed to specify the Canadian Prime Rate Loans to be so converted into Bankers’ Acceptance Loans and the term
of the proposed Borrowing of Bankers’ Acceptance Loans (which, in each case, shall comply with the requirements of Schedule 1.01(g)). The Administrative Agent shall give each Lender prompt notice of any such proposed conversion affecting
any of its Canadian Prime Rate Loans. Upon any such conversion, the proceeds thereof will be applied directly on the day of such conversion to prepay the outstanding principal amount of the Canadian Revolving Loans being converted. 

(c) Mandatory and voluntary conversion of Bankers’ Acceptance Loans into Canadian Prime Rate Loans shall be made in
the circumstances, and to the extent, provided in Schedule 1.01(g). Except as otherwise provided under Section 11 thereof, Bankers’ Acceptance Loans shall not be permitted to be converted into any other Type of Loan prior to the
maturity date of the relevant underlying B/A Instrument, as the case may be. 
 2.07 Pro Rata Borrowings.
All Borrowings of Revolving Loans under this Agreement shall be incurred from the Lenders pro rata on the basis of their Revolving Loan Commitments, provided that all Mandatory Borrowings shall be incurred from the Lenders pro rata on
the basis of their RL Percentages. It is understood that no Lender shall be responsible for any default by any other Lender of its obligation to make Loans hereunder and that each Lender shall be obligated to make the Loans provided to be made by it
hereunder, regardless of the failure of any other Lender to make its Loans hereunder. 
 2.08 Interest.
(a) Each US Borrower jointly and severally agrees to pay interest in respect of the unpaid principal amount of each Base Rate Loan from the date of Borrowing thereof until the earlier of (i) such Loan being paid by the US Borrower and
(ii) the conversion of such Base Rate Loan to a LIBOR Loan pursuant to Section 2.06 or 2.09, as applicable, at a rate per annum which shall be equal to the sum of the relevant Applicable Margin plus the Base Rate, each as in
effect from time to time. 
 (b) Each US Borrower jointly and severally agrees to pay interest in respect of the
unpaid principal amount of each US LIBOR Loan from the date of Borrowing thereof until the earlier of (i) such Loan being paid by the US Borrower and (ii) the conversion of such LIBOR Loan to a Base Rate Loan pursuant to
Section 2.06, 2.09 or 2.10, as applicable, at a rate per annum which shall, during each Interest Period applicable thereto, be equal to the sum of the relevant Applicable Margin as in effect from time to time during such
Interest Period plus LIBOR for such Interest Period. 
 (c) Each UK Borrower jointly and severally agrees to pay
interest in respect of the unpaid principal amount of each UK Revolving Loan from the date of Borrowing thereof until such Loan being paid by the UK Borrower , at a rate per annum which shall, during each Interest Period applicable thereto, be equal
to the sum of the relevant Applicable Margin as in effect from time to time during such Interest Period plus LIBOR and/or EURIBOR as applicable for such Interest Period, plus the Mandatory Cost. 

(d) Each Canadian Borrower agrees to pay interest in respect of the unpaid principal amount of each Canadian Prime Rate
Loan (including with respect to any Bankers’ Acceptance Loan converted into a Canadian Prime Rate Loan pursuant to Section 2.06(c) and Schedule 1.01(g)) made to such Borrower hereunder from the date of the Borrowing thereof (or in
the circumstances described in the immediately preceding parenthetical from the date of the conversion of the Bankers’ Acceptance Loan into a Canadian Prime Rate Loan) until the earlier of (i) such Loan being paid by the Canadian Borrower
and (ii) the conversion of such Canadian Prime Rate Loan to a Bankers’ Acceptance Loan pursuant to Section 2.06(b) and Schedule 1.01(g), at a rate per annum which shall be equal to the sum of the relevant Applicable
Margin plus the Canadian Prime Rate as in effect from time to time. 

  
 69 

 (e) (i) Overdue principal and, to the extent permitted by law, overdue
interest in respect of each Loan shall, in each case, bear interest at a rate per annum equal to the greater of (x) the rate which is 2% in excess of the rate then borne by such Loans and (y) in the case of any US Revolving Loans, US
Swingline Loans and Agent Advances, the rate which is 2% in excess of the rate otherwise applicable to Base Rate Loans from time to time and (ii) all other overdue amounts payable hereunder and under any other Credit Document shall bear
interest at a rate per annum equal to the rate which is 2% in excess of the rate applicable to Base Rate Loans from time to time. Interest that accrues under this Section 2.08(e) shall be payable on demand. 

(f) Accrued (and theretofore unpaid) interest shall be payable (i) in respect of each Base Rate Loan and Canadian
Prime Rate Loan, (A) quarterly in arrears on each Quarterly Payment Date, (B) on the date of any repayment or prepayment in full of all outstanding Base Rate Loans or Canadian Prime Rate Loans, as applicable, and (C) at maturity
(whether by acceleration or otherwise) and, after such maturity, on demand, and (ii) in respect of each LIBOR Loan and EURIBOR Loan, (A) on the last day of each Interest Period applicable thereto and, in the case of an Interest Period in
excess of three months, on each date occurring at three month intervals after the first day of such Interest Period, and (B) on the date of any repayment or prepayment (on the amount repaid or prepaid), at maturity (whether by acceleration or
otherwise) and, after such maturity, on demand. 
 (g) Upon each Interest Determination Date, the Administrative
Agent shall determine LIBOR and EURIBOR for each Interest Period applicable to the respective LIBOR Loans and EURIBOR Loans and shall promptly notify US Company and the Lenders thereof. Each such determination shall, absent manifest error, be final
and conclusive and binding on all parties hereto. 
 (h) The Drawing Fees payable in respect of the Face Amount
of each Bankers’ Acceptance Loan shall be paid by each Canadian Borrower to the Administrative Agent for distribution to each Lender which accepts and/or purchases such Bankers’ Acceptance Loan at the time of the incurrence by such
Canadian Borrower of each Bankers’ Acceptance Loan. 
 2.09 Interest Periods. At the time any
Borrower gives any Notice of Borrowing or Notice of Conversion/Continuation in respect of the making of, or, in the case of any US Revolving Loan, conversion into, any LIBOR Loan or EURIBOR Loan (in the case of the initial Interest Period applicable
thereto) or prior to 11:00 A.M. (New York City time) on the third Business Day prior to the expiration of an Interest Period applicable to such LIBOR Loan or EURIBOR Loan (in the case of any subsequent Interest Period), such Borrower shall have the
right to elect the interest period (each, an “Interest Period”) applicable to such LIBOR Loan or EURIBOR Loan, which Interest Period shall, at the option of the Borrower (but otherwise subject to the provisions of clause (B) of
the proviso in Section 2.01(a)(ii)), be a one (or less than one month if permitted by the Administrative Agent), two, three or six or, to the extent approved by each Lender, nine or twelve month period; provided that (in each
case): 
 (a) all LIBOR Loans or EURIBOR Loans comprising a Borrowing shall at all times have
the same Interest Period; 
 (b) the initial Interest Period for any LIBOR Loan or EURIBOR Loan
shall commence on the date of Borrowing of such LIBOR Loan or EURIBOR Loan (including, in the case of any LIBOR Loan, the date of any conversion thereto from a Base Rate Loan) and each Interest Period occurring thereafter in respect of such LIBOR
Loan or EURIBOR shall commence on the day on which the next preceding Interest Period applicable thereto expires; 

  
 70 

 (c) if any Interest Period for a LIBOR Loan begins on a day
for which there is no numerically corresponding day in the calendar month at the end of such Interest Period, such Interest Period shall end on the last Business Day of such calendar month; 

(d) if any Interest Period for a LIBOR Loan or EURIBOR Loan would otherwise expire on a day which is not
a Business Day, such Interest Period shall expire on the next succeeding Business Day; provided, however, that if any Interest Period for a LIBOR Loan or EURIBOR Loan would otherwise expire on a day which is not a Business Day but is a
day of the month after which no further Business Day occurs in such month, such Interest Period shall expire on the next preceding Business Day; 

(e) unless the Required Lenders otherwise agree, no Interest Period may be selected at any time when a
Default or an Event of Default is then in existence; and 
 (f) no Interest Period in respect of
any Borrowing shall be selected which extends beyond the Final Maturity Date. 
 If by 11:00 A.M. (New York City time) on the
third Business Day prior to the expiration of any Interest Period applicable to a Borrowing of LIBOR Loans or EURIBOR Loans, any Borrower has failed to elect, or is not permitted to elect, a new Interest Period to be applicable to such LIBOR Loans
or EURIBOR Loans as provided above, such Borrower, (i) in the case of any US Revolving Loan, shall be deemed to have elected to convert such LIBOR Loans into Base Rate Loans effective as of the expiration date of such current Interest Period
and (ii) in the case of any UK Revolving Loan, shall be deemed to have elected to continue such LIBOR Loans or EURIBOR Loans as LIBOR Loans or EURIBOR Loans with an Interest Period of one-month, effective as of the expiration date of such
current Interest Period. 
 2.10 Increased Costs, Illegality, etc. (a) In the event that any Lender shall
have determined (which determination shall, absent manifest error, be final and conclusive and binding upon all parties hereto but, with respect to clauses (i) and (iv) below, may be made only by the Administrative Agent): 

(i) on any Interest Determination Date that, by reason of any changes arising after the date of this
Agreement affecting the interbank eurodollar market, adequate and fair means do not exist for ascertaining the applicable interest rate as to Loans constituting LIBOR Loans or EURIBOR Loans on the basis provided for in the definition of LIBOR or
EURIBOR, as applicable; or 
 (ii) at any time, that such Lender shall incur increased costs or
reductions in the amounts received or receivable hereunder or a reduction in the rate of return or on a Lender’s (or its Affiliate’s) overall capital, in each case, with respect to any LIBOR Loan or EURIBOR Loan because of (A) any
change since the Effective Date in any Applicable Law or governmental rule, regulation, order, guideline or request (whether or not having the force of law) or in the interpretation or administration thereof and including the introduction of any new
law or governmental rule, regulation, order, guideline or request, such as to, without limitation, (1) impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of,
deposits with or for the account of, or credit extended or participated in by, any Lender (except any reserves required under Regulation D to the extent included in the computation of LIBOR or EURIBOR); (2) subject any Recipient to any Taxes
(other than (x) Indemnified Taxes or (y) Other Connection Taxes that are imposed on or measured by net income or that are franchise Taxes or branches profits Taxes) on its loans, loan principal, letters of credit, commitments, or other
obligations, or its deposits, reserves, other 

  
 71 

 
liabilities or capital attributable thereto; or (3) impose on any Lender or the London interbank market any other condition, cost or expense (other than Taxes) affecting this Agreement or
Loans made by such Lender or any Letter of Credit or participation therein and/or (B) other circumstances arising since the Effective Date affecting such Lender, the interbank eurodollar market or the position of such Lender in such market; or

 (iii) at any time, that the making or continuance of any LIBOR Loan or EURIBOR Loan has been
made (A) unlawful by any law or governmental rule, regulation or order, (B) impossible by compliance by any Lender in good faith with any governmental request (whether or not having force of law) or (C) impracticable as a result of a
contingency occurring after the Effective Date which materially and adversely affects the interbank eurodollar market; or 
 (iv) that for any reason a market for bankers’ acceptances does not exist at any time or the Lenders cannot for other reasons, after reasonable efforts, readily sell bankers’ acceptances or
perform their other obligations under this Agreement with respect to the Bankers’ Acceptance Loans, in each case, as determined in good faith by the Administrative Agent; 
 then, and in any such event, such Lender (or the Administrative Agent, in the case of clause (i) or (iv) above) shall promptly give notice (by telephone promptly confirmed in writing) to US
Company and, except in the case of clause (i) or (iv) above, to the Administrative Agent of such determination (which notice the Administrative Agent shall promptly transmit to each of the other Lenders). Thereafter (w) in the case of
clause (i) above, US Revolving Loans constituting US LIBOR Loans shall no longer be available until such time as the Administrative Agent notifies US Company and the Lenders that the circumstances giving rise to such notice by the
Administrative Agent no longer exist, and any Notice of Borrowing or Notice of Conversion/Continuation given by any Borrower with respect to US LIBOR Loans which have not yet been incurred (including by way of conversion) shall be deemed rescinded
by such Borrower, (x) in the case of clause (ii) above, the US Borrowers, the UK Borrowers and the Canadian Borrowers, jointly and severally, agree to pay to such Lender, as applicable, upon such Lender’s written request therefor,
such additional amounts (in the form of an increased rate of, or a different method of calculating, interest or otherwise as such Lender in its sole discretion shall determine) as shall be required to compensate such Lender for such increased costs
or reductions in amounts received or receivable hereunder (a written notice as to the additional amounts owed to such Lender, showing in reasonable detail the basis for the calculation thereof, submitted to US Company by such Lender shall, absent
manifest error, be final and conclusive and binding on all the parties hereto), (y) in the case of clause (iii) above, the respective Borrower or Borrowers shall take one of the actions specified in Section 2.10(b) as promptly
as possible and, in any event, within the time period required by law and (z) in the case of clause (iv) above, Bankers’ Acceptance Loans (exclusive of Bankers’ Acceptance Loans which have theretofore been funded) shall no longer
be available until such time as the Administrative Agent notifies the Canadian Borrowers and the Lenders that the circumstances giving rise to such notice by the Administrative Agent no longer exist, and any Notice of Borrowing given by any Canadian
Borrower with respect to such Bankers’ Acceptance Loans which have not been incurred shall be deemed rescinded by such Canadian Borrower. 
 (b) (i) In the case of US Revolving Loans, at any time that any US Revolving Loan constituting a US LIBOR Loan is affected by the circumstances described in Section 2.10(a)(ii), the affected
Borrower may, and in the case of a US LIBOR Loan affected by the circumstances described in Section 2.10(a)(iii), the affected Borrower shall, either (1) if the affected US LIBOR Loan is then being made initially or pursuant to a
conversion, cancel such Borrowing by giving the Administrative Agent telephonic notice (confirmed in writing) on the same date that such Borrower was notified by the affected Lender or the Administrative Agent pursuant to
Section 2.10(a)(ii) or (iii) or (2) if the affected US LIBOR Loan is then outstanding, upon at least three Business Days’ written notice to the Administrative

  
 72 

 
Agent, require the affected Lender to convert such US Revolving Loan constituting a US LIBOR Loan into a Base Rate Loan; provided that, if more than one Lender is affected at any time,
then all affected Lenders must be treated the same pursuant to this Section 2.10(b); and (ii) in the case of UK Revolving Loans, at any time that any of the UK Revolving Loans is affected by the circumstances described in
Section 2.10(a)(iii) then the relevant Borrower shall repay the applicable Lender’s participation in that UK Revolving Loan on the last day of the Interest Period for such UK Revolving Loan or, if earlier, the date specified by the Lender
in the notice delivered to the Administrative Agent (being no earlier than the last day of any applicable grace period permitted by law). Further, at any time that any of the UK Revolving Loans is affected by the circumstances described in
Section 2.10(a)(i) then the applicable LIBOR or EURIBOR, as applicable, shall be calculated in respect of each Lender as the percentage rate of interest per annum reflecting such Lender’s cost of funding its participation in the UK
Revolving Loans from whatever source it may reasonably select. 
 (c) If any Lender determines that after the
Effective Date the introduction of or any change in any Applicable Law or governmental rule, regulation, order, guideline, directive or request (whether or not having the force of law) concerning capital adequacy, or any change in interpretation or
administration thereof by the NAIC or any Governmental Authority, central bank or comparable agency, will have the effect of increasing the amount of capital required or expected to be maintained by such Lender or any corporation controlling such
Lender based on the existence of such Lender’s Revolving Loan Commitment hereunder or its obligations hereunder, then the US Borrowers, the UK Borrowers and the Canadian Borrowers, jointly and severally, agree to pay to such Lender, as
applicable, upon its written demand therefor, such additional amounts as shall be required to compensate such Lender or such other corporation for the increased cost to such Lender or such other corporation or the reduction in the rate of return to
such Lender or such other corporation as a result of such increase of capital. In determining such additional amounts, each Lender will act reasonably and in good faith and will use averaging and attribution methods which are reasonable;
provided that such Lender’s determination of compensation owing under this Section 2.10(c) shall, absent manifest error, be final and conclusive and binding on all the parties hereto. Each Lender, upon determining that any
additional amounts will be payable pursuant to this Section 2.10(c), will give prompt written notice thereof to US Company, which notice shall show in reasonable detail the basis for calculation of such additional amounts. 

(d) Failure or delay on the part of any Lender to demand compensation pursuant to this Section shall not constitute a
waiver of such Lender’s right to demand such compensation; provided that (x) the affected Borrower or Borrowers shall not be required to compensate a Lender pursuant to this Section 2.10 for any increased costs or reductions incurred
more than 180 days prior to the date on which such Lender notifies the Borrowers of the change in law or other circumstance described in Section 2.10(a)(ii) or 2.10(c) giving rise to such increased costs or reductions and of such Lender’s
intention to claim compensation therefor and (y) if such change in law giving rise to such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect
thereof (to the extent that such period of retroactive effect is not already included in such 180-day period). 

(e) Notwithstanding anything in this Agreement to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer
Protection Act and all requests, rules, guidelines, requirements and directives thereunder, issued in connection therewith or in implementation thereof, and (y) all requests, rules, guidelines or directives promulgated by the Bank for
International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States, Canadian, United Kingdom or foreign regulatory authorities, in each case pursuant to Basel III, in each case shall be
deemed to be a change after the Effective Date in a requirement of law or government rule, regulation or order, regardless of the date enacted, adopted, issued or implemented (including for purposes of this Section 2.10 and Sections 3.16, 3.17
and 3.18). 

  
 73 

 2.11 Compensation. Each US Borrower, jointly and severally, and each
UK Borrower, jointly and severally, and each Canadian Borrower, jointly and severally, agrees to compensate the Administrative Agent and each Lender, upon its written request (which request shall set forth in reasonable detail the basis for
requesting such compensation), for all losses, expenses and liabilities (including, without limitation, any loss, expense or liability incurred by reason of the liquidation or reemployment of deposits or other funds required by such Lender to fund
its LIBOR Loans or EURIBOR Loans and including any termination or withdrawal costs incurred by the Administrative Agent in connection with the conversions contemplated by Section 2.16 hereof, but excluding loss of anticipated profits) which
such Lender may sustain: (a) if for any reason (other than a default by such Lender or the Administrative Agent) a Borrowing of, or conversion from or into, LIBOR Loans or EURIBOR Loans does not occur on a date specified therefor in a Notice of
Borrowing or Notice of Conversion/Continuation (whether or not withdrawn by the respective Borrower or Borrowers or deemed withdrawn pursuant to Section 2.10(a)); (b) if any prepayment or repayment (including any prepayment or
repayment made pursuant to Section 5.01, Section 5.02 or as a result of an acceleration of the Loans pursuant to Section 11) or conversion of any of its LIBOR Loans or EURIBOR Loans occurs on a date which is not
the last day of an Interest Period with respect thereto; (c) if any prepayment of any of its LIBOR Loans or EURIBOR Loans is not made on any date specified in a notice of prepayment given by any Borrower; or (d) as a consequence of
(i) any other default by any Borrower to repay LIBOR Loans or EURIBOR Loans when required by the terms of this Agreement or any Note held by such Lender or (ii) any election made pursuant to Section 2.10(b). 

2.12 Change of Lending Office. Each Lender agrees that on the occurrence of any event giving rise to the operation
of Section 2.10(a)(ii) or (iii), Section 2.10(c), Section 3.16, Section 3.17, Section 3.18, Section 5.04, Section 5.05 or Section 5.06 with
respect to such Lender, it will, if requested by US Company, UK Company or Canadian Company, use reasonable efforts (subject to overall policy considerations of such Lender) to designate another lending office for any Loans or Letters of Credit
affected by such event if, in the judgment of such Lender, such designation would eliminate or reduce amounts payable pursuant to Section 2.10(a)(ii) or (iii), Section 2.10(c), Section 3.06,
Section 5.04, Section 5.05 or Section 5.06, as the case may be, in the future; provided that such designation is made on such terms that such Lender and its lending office suffer no economic, legal,
regulatory or other disadvantage, with the object of avoiding the consequence of the event giving rise to the operation of such Section. Nothing in this Section 2.12 shall affect or postpone any of the obligations of any Borrower or the
right of any Lender provided in Sections 2.10, 3.16, 3.17, 3.18, 5.04, 5.05 or 5.06. The applicable Borrowers hereby agree to pay all reasonable costs and expenses incurred by any Lender in connection
with any such designation. 
 2.13 Replacement of Lenders. (a) If any Lender becomes a Defaulting
Lender, (b) upon the occurrence of any event giving rise to the operation of Section 2.10(a)(ii) or (iii), Section 2.10(c), Section 3.16, Section 3.17, Section 3.18,
Section 5.04, Section 5.05 or Section 5.06 with respect to any Lender which results in such Lender charging to any Borrower increased costs in excess of those being generally charged by the other Lenders or
(c) in the case of a refusal by a Lender to consent to a proposed change, waiver, discharge or termination with respect to this Agreement which has been approved by the Required Lenders as (and to the extent) provided in
Section 13.12(b), the US Company, the UK Company or the Canadian Company, as applicable, shall have the right, in accordance with Section 13.04(b), if no Default or Event of Default then exists or would exist after giving
effect to such replacement, to replace such Lender (the “Replaced Lender”) with one or more other Eligible Transferees, none of whom shall constitute a Defaulting Lender at the time of such replacement (collectively, the
“Replacement Lender”) and each of which shall be reasonably acceptable to the Administrative Agent; provided that: 

  
 74 

 (i) at the time of any replacement pursuant to this
Section 2.13, the Replacement Lender shall enter into one or more Assignment and Assumption Agreements pursuant to Section 13.04(b) (and with all fees payable pursuant to said Section 13.04(b) to be paid by the
Borrowers) pursuant to which the Replacement Lender shall acquire all of the Revolving Loan Commitment and outstanding Revolving Loans of, and all participations in Letters of Credit by, the Replaced Lender and, in connection therewith, shall pay to
(i) the Replaced Lender in respect thereof an amount equal to the sum of (A) an amount equal to the principal of, and all accrued interest on, all outstanding Revolving Loans of the respective Replaced Lender, (B) an amount equal to
all Unpaid US Drawings and Unpaid UK Drawings of such Replaced Lender, together with all then unpaid interest with respect thereto at such time and (C) an amount equal to all accrued, but theretofore unpaid, Fees owing to the Replaced Lender
pursuant to Section 4.01, (ii) each US Issuing Lender and UK Issuing Lender an amount equal to such Replaced Lender’s RL Percentage of any Unpaid US Drawing, Unpaid UK Drawing or Unpaid Canadian Drawing relating to Letters of
Credit issued by such US Issuing Lender, UK Issuing Lender or Canadian Issuing Lender (which at such time remains an Unpaid US Drawing, Unpaid UK Drawing or Unpaid Canadian Drawing, as applicable) to the extent such amount was not theretofore funded
by such Replaced Lender and (iii) the Swingline Lender an amount equal to such Replaced Lender’s RL Percentage of any Mandatory Borrowing to the extent such amount was not theretofore funded by such Replaced Lender to the Swingline Lender;
and 
 (ii) all obligations of the Borrowers then owing to the Replaced Lender (other than those
specifically described in clause (i) above in respect of which the assignment purchase price has been, or is concurrently being, paid, but including all amounts, if any, owing under Section 2.11) shall be paid in full to such
Replaced Lender concurrently with such replacement. 
 Upon receipt by the Replaced Lender of all amounts required to be paid to
it pursuant to this Section 2.13, the Administrative Agent shall be entitled (but not obligated) and authorized to execute an Assignment and Assumption Agreement on behalf of such Replaced Lender, and any such Assignment and Assumption
Agreement so executed by the Administrative Agent and the Replacement Lender shall be effective for purposes of this Section 2.13 and Section 13.04. Upon the execution of the respective Assignment and Assumption Agreement,
the payment of amounts referred to in clauses (i) and (ii) above, recordation of the assignment on the Register by the Administrative Agent pursuant to Section 13.15 and, if so requested by the Replacement Lender, delivery to
the Replacement Lender of the appropriate Note or Notes executed by the relevant Borrowers, (x) the Replacement Lender shall become a Lender hereunder and the Replaced Lender shall cease to constitute a Lender hereunder, except with respect to
indemnification provisions under this Agreement (including, without limitation, Sections 2.10, 2.11, 3.16, 3.17, 3.18, 5.04, 5.05, 12.06, 13.01 and 13.06), which shall survive as
to such Replaced Lender and (y) the RL Percentages of the Lenders shall be automatically adjusted at such time to give effect to such replacement. 
 2.14 US Company as Agent for US Borrowers, UK Company as Agent for UK Borrower and Canadian Company as Agent for Canadian Borrowers. (a) Each US Borrower hereby irrevocably appoints the US
Company as its agent and attorney-in-fact for all purposes under this Agreement and each other Credit Document, which appointment shall remain in full force and effect unless and until the Administrative Agent shall have received prior written
notice signed by the respective appointing Borrower that such appointment has been revoked. Each US Borrower hereby irrevocably appoints and authorizes the US Company (i) to provide the Administrative Agent with all notices with respect to
Loans and Letters of Credit obtained for the benefit of any US Borrower and all other notices and instructions under this Agreement or any other Credit Document and (ii) to take such action as the US Company deems appropriate on its behalf to
obtain Loans and Letters of Credit and to exercise such other powers as are reasonably incidental thereto to carry out the purposes of this 

  
 75 

 
Agreement and the other Credit Documents. It is understood that the handling of the Credit Account and the Collateral of the US Borrowers in a combined fashion, as more fully set forth herein, is
done solely as an accommodation to the US Borrowers in order to utilize the collective borrowing powers of the US Borrowers in the most efficient and economical manner and at their request, and that the Lenders shall not incur liability to any US
Borrower as a result hereof. Each US Borrower expects to derive benefit, directly or indirectly, from the handling of the Credit Account and the Collateral in a combined fashion since the successful operation of each US Borrower is dependent on the
continued successful performance of the consolidated group. To induce the Lenders to do so, and in consideration thereof, each US Borrower hereby jointly and severally agrees to indemnify each Lender and hold each Lender harmless against any and all
liability, expense, loss or claim of damage or injury, made against any Lender by any US Borrower or by any third party whosoever, arising from or incurred by reason of (a) the handling of the Credit Account and Collateral of the US Borrowers
as herein provided, (b) the Lenders’ relying on any instructions of US Company, or (c) any other action taken by the Lenders hereunder or under the other Credit Documents, except that the US Borrowers will have no liability to any
Lender, Administrative Agent or the Collateral Agent with respect to any liability that has been determined by a court of competent jurisdiction in a final and non-appealable decision to have resulted solely from the gross negligence or willful
misconduct of such Lender, the Administrative Agent or the Collateral Agent, as the case may be. 
 (b) Each UK
Borrower hereby irrevocably appoints the UK Company as its agent and attorney-in-fact for all purposes under this Agreement and each other Credit Document, which appointment shall remain in full force and effect unless and until the Administrative
Agent shall have received prior written notice signed by the respective appointing Borrower that such appointment has been revoked. Each UK Borrower hereby irrevocably appoints and authorizes the UK Company (i) to provide the Administrative
Agent with all notices with respect to Loans and Letters of Credit obtained for the benefit of any UK Borrower and all other notices and instructions under this Agreement or any other Credit Document and (ii) to take such action as the UK
Company deems appropriate on its behalf to obtain Loans and Letters of Credit and to exercise such other powers as are reasonably incidental thereto to carry out the purposes of this Agreement and the other Credit Documents. It is understood that
the handling of the Credit Account and the Collateral of the UK Borrowers in a combined fashion, as more fully set forth herein, is done solely as an accommodation to the UK Borrowers in order to utilize the collective borrowing powers of the UK
Borrowers in the most efficient and economical manner and at their request, and that the Lenders shall not incur liability to any UK Borrower as a result hereof. Each UK Borrower expects to derive benefit, directly or indirectly, from the handling
of the Credit Account and the Collateral in a combined fashion since the successful operation of each UK Borrower is dependent on the continued successful performance of the consolidated group. To induce the Lenders to do so, and in consideration
thereof, each UK Borrower hereby jointly and severally agrees to indemnify each Lender and hold each Lender harmless against any and all liability, expense, loss or claim of damage or injury, made against any Lender by any UK Borrower or by any
third party whosoever, arising from or incurred by reason of (a) the handling of the Credit Account and Collateral of the UK Borrowers as herein provided, (b) the Lenders’ relying on any instructions of UK Company, or (c) any
other action taken by the Lenders hereunder or under the other Credit Documents, except that the UK Borrowers will have no liability to any Lender, Administrative Agent or the Collateral Agent with respect to any liability that has been determined
by a court of competent jurisdiction in a final and non-appealable decision to have resulted solely from the gross negligence or willful misconduct of such Lender, the Administrative Agent or the Collateral Agent, as the case may be. 

(c) Each Canadian Borrower hereby irrevocably appoints the Canadian Company as its agent and attorney-in-fact for all
purposes under this Agreement and each other Credit Document, which appointment shall remain in full force and effect unless and until the Administrative Agent shall have received prior written notice signed by the respective appointing Borrower
that such appointment 

  
 76 

 
has been revoked. Each Canadian Borrower hereby irrevocably appoints and authorizes the Canadian Company (i) to provide the Administrative Agent with all notices with respect to Loans and
Letters of Credit obtained for the benefit of any Canadian Borrower and all other notices and instructions under this Agreement or any other Credit Document and (ii) to take such action as the Canadian Company deems appropriate on its behalf to
obtain Loans and Letters of Credit and to exercise such other powers as are reasonably incidental thereto to carry out the purposes of this Agreement and the other Credit Documents. It is understood that the handling of the Credit Account and the
Collateral of the Canadian Borrowers in a combined fashion, as more fully set forth herein, is done solely as an accommodation to the Canadian Borrowers in order to utilize the collective borrowing powers of the Canadian Borrowers in the most
efficient and economical manner and at their request, and that the Lenders shall not incur liability to any Canadian Borrower as a result hereof. Each Canadian Borrower expects to derive benefit, directly or indirectly, from the handling of the
Credit Account and the Collateral in a combined fashion since the successful operation of each Canadian Borrower is dependent on the continued successful performance of the consolidated group. To induce the Lenders to do so, and in consideration
thereof, each Canadian Borrower hereby jointly and severally agrees to indemnify each Lender and hold each Lender harmless against any and all liability, expense, loss or claim of damage or injury, made against any Lender by any Canadian Borrower or
by any third party whosoever, arising from or incurred by reason of (a) the handling of the Credit Account and Collateral of the Canadian Borrowers as herein provided, (b) the Lenders’ relying on any instructions of Canadian Company,
or (c) any other action taken by the Lenders hereunder or under the other Credit Documents, except that the Canadian Borrowers will have no liability to any Lender, Administrative Agent or the Collateral Agent with respect to any liability that
has been determined by a court of competent jurisdiction in a final and non-appealable decision to have resulted solely from the gross negligence or willful misconduct of such Lender, the Administrative Agent or the Collateral Agent, as the case may
be. 
 2.15 Incremental Commitments. (a) So long as the Incremental Commitment Request Requirements
are satisfied at the time of the delivery of the request referred to below, the Borrowers shall have the right, in coordination with the Administrative Agent as to all of the matters set forth below in this Section 2.15, but without
requiring the consent of any of the Lenders, to request at any time and from time to time after the Effective Date, and prior to the Final Maturity Date, that one or more Lenders (and/or one or more other Persons which are Eligible Transferees and
which will become Lenders as provided below) provide Incremental Commitments and, subject to the applicable terms and conditions contained in this Agreement, make Revolving Loans pursuant thereto, it being understood and agreed, however, that
(i) no Lender shall be obligated to provide an Incremental Commitment as a result of any such request by the Borrowers, and until such time, if any, as such Lender has agreed in its sole discretion to provide an Incremental Commitment and
executed and delivered to the Administrative Agent an Incremental Commitment Agreement in respect thereof as provided in clause (b) of this Section 2.15, such Lender shall not be obligated to fund any Revolving Loans in excess of
its Revolving Loan Commitment as in effect prior to giving effect to such Incremental Commitment provided pursuant to this Section 2.15, (ii) any Lender (including any Eligible Transferee who will become a Lender) may so provide an
Incremental Commitment without the consent of any other Lender, (iii) each Eligible Transferee who will become a Lender shall be required to be reasonably satisfactory to the Administrative Agent, (iv) each provision of Incremental
Commitments on a given date pursuant to this Section 2.15 shall be in a minimum aggregate amount (for all Lenders (including any Eligible Transferee who will become a Lender)) of at least $5,000,000 and in integral multiples of
$1,000,000 in excess thereof, (v) the aggregate amount of all Incremental Commitments provided pursuant to this Section 2.15, shall not exceed the Maximum Incremental Commitment Amount and (vi) all Revolving Loans (and all
interest, fees and other amounts payable thereon), made pursuant to an Incremental Commitment shall be entitled to the benefits of the guarantees and security provided under the Credit Documents to the other Obligations on a pari passu basis.

  
 77 

 (b) At the time of the provision of Incremental Commitments pursuant to this
Section 2.15, US Company, each US Borrower, UK Company, each UK Borrower, Canadian Company, each Canadian Borrower, the Administrative Agent and each such Lender or other Eligible Transferee which agrees to provide an Incremental
Commitment (each, an “Incremental Lender”) shall execute and deliver to the Administrative Agent an Incremental Commitment Agreement, with the effectiveness of such Incremental Lender’s Incremental Commitment to occur on the
date set forth in such Incremental Commitment Agreement, which date in any event shall be no earlier than the date on which (w) all fees required to be paid in connection therewith at the time of such effectiveness shall have been paid
(including, without limitation, any agreed upon up-front or arrangement fees owing to the Administrative Agent (or any affiliate thereof)), (x) all Incremental Commitment Requirements are satisfied, (y) all other conditions set forth in
this Section 2.15 shall have been satisfied, and (z) all other conditions precedent that may be set forth in such Incremental Commitment Agreement shall have been satisfied. The Administrative Agent shall promptly notify each Lender
as to the effectiveness of each Incremental Commitment Agreement, and at such time, (i) the Total Revolving Loan Commitment under, and for all purposes of, this Agreement shall be increased by the aggregate amount of such Incremental
Commitments, (ii) Schedule 1.01(a) shall be deemed modified to reflect the revised Revolving Loan Commitments of the affected Lenders and (iii) to the extent requested by any Incremental Lender, Revolving Notes will be issued, at
the expense of the Borrowers, to such Incremental Lender in conformity with the requirements of Section 2.05. 
 (c) At the time of any provision of Incremental Commitments pursuant to this Section 2.15, the Borrowers shall, in coordination with the Administrative Agent, repay outstanding Revolving Loans
of certain of the Lenders, and incur additional Revolving Loans from certain other Lenders (including the Incremental Lenders) (even though as a result thereof such new Loans (to the extent required to be maintained as LIBOR Loans or EURIBOR Loans)
may have a shorter Interest Period than the then outstanding Borrowings of the respective such Revolving Loans), in each case to the extent necessary so that all of the Lenders participate in each outstanding Borrowing of Revolving Loans pro
rata on the basis of their respective Revolving Loan Commitments (after giving effect to any increase in the Total Revolving Loan Commitment pursuant to this Section 2.15) and with the Borrowers being jointly and severally obligated
to pay to the respective Lenders any costs of the type referred to in Section 2.11 and such amounts, as reasonably determined by the respective Lenders, to compensate them for funding the various Revolving Loans during an existing
Interest Period (rather than at the beginning of the respective Interest Period, based upon rates then applicable thereto) in connection with any such repayment and/or incurrence. All determinations by any Lender pursuant to the preceding sentence
shall, absent manifest error, be final and conclusive and binding on all parties hereto. 
 (d) The terms and
provisions of the Revolving Loans made pursuant to the Incremental Commitments shall be identical to the Revolving Loans; provided that the yield applicable to the Revolving Loans made pursuant to the Incremental Commitments (after giving effect to
all upfront or similar fees or original issue discount payable with respect to such Revolving Loans) shall not be greater than the applicable yield payable pursuant to the terms of this Agreement as amended through the date of such calculation with
respect to Revolving Loans (including any upfront fees or original issue discount payable to the initial Lenders hereunder) unless the Applicable Margin with respect to the Revolving Loans is increased so as to cause the then applicable yield under
this Agreement on the Revolving Loans to equal the yield then applicable to the Revolving Loans made pursuant to the Incremental Commitment (after giving effect to all upfront or similar fees or original issue discount payable with respect to the
Revolving Loans) made pursuant to the Incremental Commitment. 
 (e) In the event the Borrowers from time to
time obtain any Incremental Commitments under this Section 2.15, all availability levels hereunder denominated in Dollars, Canadian Dollars, Euros or Pounds Sterling hereunder (including, without limitation, in the definitions of

  
 78 

 
“Applicable Margin”, “Minimum Availability Amount” and “Payment Conditions” and in Section 10.04(a)) shall be increased in proportion to the ratio of such
Incremental Commitments to the Total Revolving Loan Commitment as in effect immediately prior to the Borrowers obtaining such Incremental Commitments and, for the avoidance of doubt, all such levels denominated in percentages shall be calculated
based on the Total Revolving Loan Commitment after giving effect to such Incremental Commitments. 
 2.16 UK
Revolving Loans and Canadian Revolving Loans; Intra-Lender Issues. (a) Pounds Sterling Fundings and Conversions. Notwithstanding anything to the contrary contained herein, all Pounds Sterling Denominated Revolving Loans shall be made
available by the Lenders to the UK Borrowers in Pounds Sterling (it being understood and agreed that each Lender at its option may make any Pounds Sterling Denominated Revolving Loan under this Agreement by causing any domestic or foreign
branch or Affiliate of such Lender to make such Loan; provided that any exercise of such option shall not affect the obligation of the Borrowers to repay any such Loan in accordance with the terms of this Agreement). In furtherance of the
foregoing, each Lender that is not a Pounds Sterling Funding Capacity Lender (a “Converting Pounds Sterling Lender”) shall honor its pro rata funding obligations with respect to any Pounds Sterling Denominated Revolving Loans by,
initially, transferring funds denominated in Dollars to the Administrative Agent, which such funds shall be converted into Pounds Sterling in accordance with the settlement procedure set forth in Section 2.16(d) below, and, thereafter,
made available to the UK Borrowers along with all funds denominated in Pounds Sterling otherwise advanced by each Pounds Sterling Funding Capacity Lender. Notwithstanding that a Converting Pounds Sterling Lender may have honored its funding
obligations with respect to any Pounds Sterling Denominated Revolving Loans by delivering funds denominated in Dollars to the Administrative Agent for purposes of conversion in accordance with Section 2.16(d), all Pounds Sterling
Denominated Revolving Loans shall remain denominated in Pounds Sterling and all payments by any UK Borrower or any other Loan Party with respect to any Pounds Sterling Denominated Revolving Loans shall be made to the Administrative Agent for the
account of the Lender or Lenders entitled thereto in Pounds Sterling, subject to further conversion into U.S. Dollars in accordance with the settlement procedure set forth in Section 2.16(d)(3). 

(b) Euro Fundings and Conversions. Notwithstanding anything to the contrary contained herein, all Euro Denominated
Revolving Loans shall be made available by the Lenders to the UK Borrowers in Euro (it being understood and agreed that each Lender at its option may make any Euro Denominated Revolving Loan under this Agreement by causing any domestic or
foreign branch or Affiliate of such Lender to make such Loan; provided that any exercise of such option shall not affect the obligation of the Borrowers to repay any such Loan in accordance with the terms of this Agreement). In furtherance of
the foregoing, each Lender that is not a Euro Funding Capacity Lender (a “Converting Euro Lender”) shall honor its pro rata funding obligations with respect to any Euro Denominated Revolving Loans by, initially, transferring funds
denominated in Dollars to the Administrative Agent, which such funds shall be converted into Euros in accordance with the settlement procedure set forth in Section 2.16(e) below, and, thereafter, made available to the UK Borrowers along
with all funds denominated in Euro otherwise advanced by each Euro Funding Capacity Lender. Notwithstanding that a Converting Euro Lender may have honored its funding obligations with respect to any Euro Denominated Revolving Loans by delivering
funds denominated in Dollars to the Administrative Agent for purposes of conversion in accordance with Section 2.16(e), all Euro Denominated Revolving Loans shall remain denominated in Euro and all payments by any UK Borrower or any
other Loan Party with respect to any Euro Denominated Revolving Loans shall be made to the Administrative Agent for the account of the Lender or Lenders entitled thereto in Euros, subject to further conversion into U.S. Dollars in accordance with
the settlement procedure set forth in Section 2.16(e)(3). 

  
 79 

 (c) Canadian Dollar Fundings and Conversions. Notwithstanding
anything to the contrary contained herein, all Canadian Revolving Loans shall be made available by the Lenders to the Canadian Borrowers in Canadian Dollars (it being understood and agreed that each Lender at its option may make
any Canadian Revolving Loan under this Agreement by causing any domestic or foreign branch or Affiliate of such Lender, including without limitation such Lender’s Canadian Corresponding Lender, to make such Loan; provided that any
exercise of such option shall not affect the obligation of the Borrowers to repay any such Loan in accordance with the terms of this Agreement). In furtherance of the foregoing, each Lender that is not a Canadian Funding Capacity Lender (a
“Converting Canadian Dollar Lender”) shall honor its pro rata funding obligations with respect to any Canadian Dollar Denominated Revolving Loans by, initially, transferring funds denominated in Dollars to the Administrative Agent,
which such funds shall be converted into Canadian Dollars in accordance with the settlement procedure set forth in Section 2.16(f) below, and, thereafter, made available to the Canadian Borrowers along with all funds denominated in
Canadian Dollars otherwise advanced by each Canadian Dollar Funding Capacity Lender. Notwithstanding that a Converting Canadian Dollar Lender may have honored its funding obligations with respect to any Canadian Dollar Denominated Revolving Loans by
delivering funds denominated in Dollars to the Administrative Agent for purposes of conversion in accordance with Section 2.16(f), all Canadian Dollar Denominated Revolving Loans shall remain denominated in Canadian Dollar and all
payments by any Canadian Borrower or any other Loan Party with respect to any Canadian Dollar Denominated Revolving Loans shall be made to the Administrative Agent for the account of the Lender or Lenders entitled thereto in Canadian Dollars,
subject to further conversion into U.S. Dollars in accordance with the settlement procedure set forth in Section 2.16(f)(3). 
 (d) Conversion Procedures for Pounds Sterling Denominated Loan Conversions. In order to facilitate the making of Pounds Sterling Denominated Loans made by Converting Pounds Sterling Lenders,
conversion and settlement among the Administrative Agent and the Converting Pounds Sterling Lenders shall take place in accordance with the following: 

(i) Following receipt of a Notice of Borrowing from a UK Borrower, the Administrative Agent shall, on or
prior to 4:00 P.M. (New York City time) on the Interest Determination Date applicable to such Borrowing, notify each Converting Pounds Sterling Lender a calculation of the amount of US Dollars that such Converting Pounds Sterling Lender shall be
required to provide to the Administrative Agent within the time periods set forth in Section 2.04(b) in order that the Administrative Agent may make available to the relevant UK Borrower at the Payment Office the pro rata amount of such
Borrowing of a Pounds Sterling Denominated Revolving Loan required to be made by such Converting Pounds Sterling Lender; provided that (A) such calculation shall be effected by the Administrative Agent on the date of the Borrowing set
forth in such Borrowing Notice and (B) such calculation shall be made with reference to the Spot Rate on the Interest Determination Date applicable to such Borrowing. 

(ii) If any Converting Pounds Sterling Lender fails to pay to the Administrative Agent the full amount
required to be paid by such Converting Pounds Sterling Lender in accordance with the foregoing clause (i), such Converting Pounds Sterling Lender shall have failed to make available its portion of such Borrowing and shall (unless such failure is
cured) constitute a Defaulting Lender hereunder. 
 (iii) Following receipt from a UK Borrower
of any payment or prepayment with respect to any Pounds Sterling Denominated Loans (all of which are required to be paid by the UK Borrower in Pounds Sterling), the Administrative Agent shall convert any such payment into Dollars prior to making an
distribution to such Converting Pounds Sterling Lender; provided that (A) the calculation with respect to such conversion shall be effected by the Administrative Agent on the date of the payment from the UK Borrower and (B) such
calculation shall be made with reference to the Spot Rate on such date. 

  
 80 

 (e) Conversion Procedures for Euro Denominated Revolving Loan
Conversions. In order to facilitate the making of Euro Denominated Loans made by Converting Euro Lenders, conversion and settlement among the Administrative Agent and the Converting Euro Lenders shall take place in accordance with the following:

 (i) Following receipt of a Notice of Borrowing from a UK Borrower, the Administrative Agent
shall, on or prior to 4:00 P.M. (New York City time) on the Interest Determination Date applicable to such Borrowing, notify each Converting Euro Lender a calculation of the amount of US Dollars that such Converting Euro Lender shall be required to
provide to the Administrative Agent within the time periods set forth in Section 2.04(b) in order that the Administrative Agent may make available to the relevant UK Borrower at the Payment Office the pro rata amount of such Borrowing of a Euro
Denominated Revolving Loan required to be made by such Converting Euro Lender; provided that (A) such calculation shall be effected by the Administrative Agent on the date of the Borrowing set forth in such Borrowing Notice and
(B) such calculation shall be made with reference to the Spot Rate on the Interest Determination Date applicable to such Borrowing. 
 (ii) If any Converting Euro Lender fails to pay to the Administrative Agent the full amount required to be paid by such Converting Euro Lender in accordance with the foregoing clause (i), such Converting
Euro Lender shall have failed to make available its portion of such Borrowing and shall (unless such failure is cured) constitute a Defaulting Lender hereunder. 

(iii) Following receipt from a UK Borrower of any payment or prepayment with respect to any Euro
Denominated Loans (all of which are required to be paid by the UK Borrower in Euro), the Administrative Agent shall convert any such payment into Dollars prior to making an distribution to such Converting Euro Lender; provided that
(A) the calculation with respect to such conversion shall be effected by the Administrative Agent on the date of the payment from the UK Borrower and (B) such calculation shall be made with reference to the Spot Rate on such date.

 (f) Conversion Procedures for Canadian Revolving Loan Conversions. In order to facilitate the making
of Canadian Dollar Denominated Loans made by Converting Canadian Dollar Lenders, conversion and settlement among the Administrative Agent and the Converting Canadian Dollar Lenders shall take place in accordance with the following: 

(i) Following receipt of a Notice of Borrowing from a Canadian Borrower, the Administrative Agent shall,
on or prior to 4:00 P.M. (New York City time) on the Business Day immediately prior to such Borrowing, notify each Converting Canadian Dollar Lender a calculation of the amount of US Dollars that such Converting Canadian Dollar Lender shall be
required to provide to the Administrative Agent within the time periods set forth in Section 2.04(b) in order that the Administrative Agent may make available to the relevant Canadian Borrower at the Payment Office the pro rata amount of such
Borrowing of a Canadian Dollar Denominated Revolving Loan required to be made by such Converting Canadian Dollar Lender; provided that (A) such calculation shall be effected by the Administrative Agent on the date of the Borrowing set
forth in such Borrowing Notice and (B) such calculation shall be made with reference to the Spot Rate on the Business Day immediately prior to such Borrowing. 

  
 81 

 (ii) If any Converting Canadian Dollar Lender fails to pay
to the Administrative Agent the full amount required to be paid by such Converting Canadian Dollar Lender in accordance with the foregoing clause (i), such Converting Canadian Dollar Lender shall have failed to make available its portion of such
Borrowing and shall (unless such failure is cured) constitute a Defaulting Lender hereunder. 

(iii) Following receipt from a Canadian Borrower of any payment or prepayment with respect to any
Canadian Dollar Denominated Loans (all of which are required to be paid by the Canadian Borrowers in Canadian Dollar), the Administrative Agent shall convert any such payment into Dollars prior to making an distribution to such Converting Canadian
Dollar Lender; provided that (A) the calculation with respect to such conversion shall be effected by the Administrative Agent on the date of the payment from the Canadian Borrowers and (B) such calculation shall be made with
reference to the Spot Rate on such date. 
 (g) Indemnification. Each Converting Pounds Sterling Lender,
Converting Euro Lender and Converting Canadian Dollar Lender agrees to indemnify the Administrative Agent (to the extent not reimbursed by any Credit Party and without limiting the obligations of UK Company and UK Borrowers hereunder or under any
other Credit Document) ratably for any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses (including attorneys’ fees) or disbursements of any kind and nature whatsoever that may be imposed
on, incurred by or asserted against the Administrative Agent in any way relating to or arising out of any Pounds Sterling Denominated Revolving Loans, Euro Sterling Denominated Revolving Loans or Canadian Dollar Denominated Revolving Loans,
provided that no Converting Pounds Sterling Lender, Converting Euro Lender or Converting Canadian Dollar Lender shall be liable for any of the foregoing to the extent it arises from the gross negligence or willful misconduct of the
Administrative Agent. Without limiting the foregoing, each Converting Pounds Sterling Lender agrees to reimburse the Administrative Agent promptly upon demand for such Converting Pounds Sterling Lender’s ratable share of any costs or expenses
payable by the Borrowers to the Administrative Agent in respect of the Pounds Sterling Denominated Revolving Loans to the extent that the Administrative Agent is not promptly reimbursed for such costs and expenses by the Borrowers. Without limiting
the foregoing, each Converting Euro Lender agrees to reimburse the Administrative Agent promptly upon demand for such Converting Euro Lender’s ratable share of any costs or expenses payable by the Borrowers to the Administrative Agent in
respect of the Euro Denominated Revolving Loans to the extent that the Administrative Agent is not promptly reimbursed for such costs and expenses by the Borrowers. Without limiting the foregoing, each Converting Canadian Dollar Lender agrees to
reimburse the Administrative Agent promptly upon demand for such Converting Canadian Dollar Lender’s ratable share of any costs or expenses payable by the Borrowers to the Administrative Agent in respect of the Canadian Dollar Denominated
Revolving Loans to the extent that the Administrative Agent is not promptly reimbursed for such costs and expenses by the Borrowers. The agreement contained in this Section 2.16(g) shall survive payment in full of all Loans. 

2.17 Equivalent Amount. For purposes of this Agreement, the Equivalent Amount of each Loan not denominated in
Dollars shall be calculated on the date when any such Loan is made, such Letter of Credit is issued, and at such other times as designated by the Administrative Agent. Such Equivalent Amount shall remain in effect until the same is recalculated by
the Administrative Agent as provided above and notice of such recalculation is delivered to the US Company, it being understood that until such notice of such recalculation is delivered, the Dollar Equivalent shall be that Dollar Equivalent as last
reported to US Company by the Administrative Agent. The Administrative Agent shall promptly notify US Company and the Lenders of each such determination of the Equivalent Amount of each such Loan. 

  
 82 

 2.18 Provisions Regarding Bankers’ Acceptances, Drafts, etc. The
parties hereto agree that the provisions of Schedule 1.01(g) shall apply to all Bankers’ Acceptances, Bankers’ Acceptance Loans, Drafts and B/A Discount Notes created pursuant to this Agreement, and that the provisions of
Schedule 1.01(g) shall be deemed incorporated by reference into this Agreement as if such provisions of Schedule 1.01(g) were set forth in this Agreement in their entirety. 

2.19 Defaulting Lenders. Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a
Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender: 

(a) if any Swingline Loan Exposure or Letter of Credit Exposure exists at the time a Lender becomes a Defaulting Lender
then; 
 (i) all or any part of such Swingline Loan Exposure and Letter of Credit Exposure shall
be reallocated among the Lenders that are Non-Defaulting Lenders in accordance with their respective RL Percentages (calculated without regard to any Defaulting Lender’s Revolving Loan Commitment) but only to the extent (x) the conditions
set forth in Section 7 are satisfied at the time of such reallocation (and, unless the US Company shall have otherwise notified the Administrative Agent at such time, the US Company shall be deemed to have represented and warranted that
such conditions are satisfied at such time), (y) the sum of the Individual Exposures of all Lenders that are Non-Defaulting Lenders plus such Defaulting Lender’s Swingline Loan Exposure and Letter of Credit Exposure does not exceed the
aggregate amount of all Non- Defaulting Lenders’ Revolving Loan Commitments and (z) immediately following the reallocation to a Lender that is a Non-Defaulting Lender, the Individual Exposure of such Lender does not exceed its Revolving
Loan Commitment at such time; 
 (ii) if the reallocation described in clause (i) above
cannot, or can only partially, be effected, the Borrowers shall within five Business Days following notice by the Administrative Agent (x) first, prepay such Swingline Loan Exposure and (y) second, cash collateralize in a manner reasonably
satisfactory to the Administrative Agent and the applicable Issuing Lender such Defaulting Lender’s Letter of Credit Exposure (after giving effect to any partial reallocation pursuant to clause (i) above) in an aggregate amount equal to
100% of such Defaulting Lender’s Letter of Credit Exposure for so long as such Letter of Credit Exposure is outstanding (the “Letter of Credit Back-Stop Arrangements”); 

(iii) the Borrowers shall not be required to pay any Fees to such Defaulting Lender pursuant to
Section 4.01(a) with respect to such Defaulting Lender’s Total Revolving Loan Commitment and Section 4.01(b) with respect to such Defaulting Lender’s Letter of Credit Exposure; 

(iv) if the Letter of Credit Exposure of the Non-Defaulting Lenders is reallocated pursuant to this
Section 2.16(a), then the Letter of Credit Fees payable to the Lenders pursuant to Section 4.01(b) shall be adjusted in accordance with such Non-Defaulting Lenders’ RL Percentages (calculated without regard to any
Defaulting Lender’s Revolving Loan Commitment); and; 
 (v) if any Defaulting Lender’s
Letter of Credit Exposure is neither cash collateralized nor reallocated pursuant to this Section 2.16(a), then, without prejudice to any rights or remedies of any Issuing Lender or any Lender hereunder, all Letter of Credit Fees payable
under Section 4.01(b) with respect to such Defaulting Lender’s Letter of Credit Exposure shall be payable to each Issuing Lender until such Letter of Credit Exposure is cash collateralized and/or reallocated; and 

  
 83 

 (b) notwithstanding anything to the contrary contained in
Section 2.01(d) or (e) or Section 3, so long as any Lender is a Defaulting Lender (i) the Swingline Lender shall not fund any Swingline Loan and no Issuing Lender shall issue, amend or increase any Letter of Credit,
unless it is satisfied that the related exposure will be 100% covered by the Revolving Loan Commitments of the Non-Defaulting Lenders and/or cash collateral has been provided by the Borrowers in accordance with Section 2.19(a), and
(ii) participating interests in any such newly issued or increased Letter of Credit or newly made Swingline Loan shall be allocated among Lenders that are Non-Defaulting Lenders in a manner consistent with Section 2.19(a)(i) (and
Defaulting Lenders shall not participate therein). 
 Notwithstanding the provisions of Sections 5.03(d)
and 13.06, the Administrative Agent and the Collateral Agent shall not be obligated to transfer to a Defaulting Lender any payments made by any Borrower to such Agent for the Defaulting Lender’s benefit or any proceeds of Collateral that
would otherwise be remitted hereunder to the Defaulting Lender, and, in the absence of such transfer to the Defaulting Lender, such Agent shall transfer any such payments (A) first, to the Swingline Lender to the extent of any Swingline Loans
that were made by the Swingline Lender and that were required to be, but were not, paid by the Defaulting Lender, (B) second, to Issuing Lender, to the extent of the portion of an Unpaid Drawing that was required to be, but was not, paid by the
Defaulting Lender, (C) third, to each Non-Defaulting Lender ratably in accordance with their Revolving Loan Commitments (but, in each case, only to the extent that such Defaulting Lender’s portion of a Revolving Loan (or other funding
obligation) was funded by such other Non-Defaulting Lender), (D) to a suspense account maintained by the Administrative Agent, the proceeds of which shall be retained by the Administrative Agent and may be made available to be re-advanced to or
for the benefit of the Borrowers (upon the request of the Borrowers and subject to the conditions set forth in Section 7) as if such Defaulting Lender had made its portion of Revolving Loans (or other funding obligations) hereunder, and
(E) from and after the date on which all other Obligations have been paid in full, to such Defaulting Lender. 
 In the event that the Administrative Agent, the US Company, each Issuing Lender and the Swingline Lender each agrees that a Defaulting Lender has adequately remedied all matters that caused such Lender to
be a Defaulting Lender, then (i) the Swingline Loan Exposure and Letter of Credit Exposure of the Lenders shall be readjusted to reflect the inclusion of such Lender’s Revolving Loan Commitments and on such date such Lender shall purchase
at par such of the Revolving Loans of the other Lenders (other than Swingline Loans) as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Revolving Loans in accordance with its RL Percentage and
(ii) so long as no Default or Event of Default then exists, all funds held as cash collateral pursuant to the Letter of Credit Back-Stop Arrangements shall thereafter be promptly returned to the Company. If the Revolving Loan Commitments have
been terminated, all Obligations have been paid in full and no Letters of Credit are outstanding, then all funds held as cash collateral pursuant to the Letter of Credit Back-Stop Arrangements shall thereafter be promptly returned to the Company.

 SECTION 3. Letters of Credit. 

3.01 US Letters of Credit. (a) Subject to and upon the terms and conditions set forth herein, any US Borrower
may request that a US Issuing Lender issue, at any time and from time to time on and after the Effective Date and prior to the 30th day prior to the Final Maturity Date, for the joint and several account of the US Borrowers and for the benefit of
(x) any holder (or any trustee, agent or other similar representative for any such holders) of US L/C Supportable Obligations, an irrevocable standby 

  
 84 

 
letter of credit, in a form customarily used by such US Issuing Lender or in such other form as is reasonably acceptable to such US Issuing Lender, and (y) sellers of goods to the US Company
or any of its Subsidiaries, an irrevocable trade letter of credit, in a form customarily used by such US Issuing Lender or in such other form as has been approved by such US Issuing Lender (each such letter of credit, a “US Letter of
Credit”) (although without limiting the joint and several nature of the US Borrowers’ obligations in respect of the US Letters of Credit, any particular US Letter of Credit may name only one or more US Borrowers as the account party
therein). All US Letters of Credit shall be issued on a sight basis only. 
 (b) Subject to and upon the terms
and conditions set forth herein, each US Issuing Lender agrees that it will, at any time and from time to time on and after the Effective Date and prior to the 30th day prior to the Final Maturity Date, following its receipt of the respective US
Letter of Credit Request, issue for the joint and several account of the US Borrowers, one or more US Letters of Credit as are permitted to remain outstanding hereunder without giving rise to a Default or an Event of Default; provided that no
US Issuing Lender shall be under any obligation to issue any US Letter of Credit of the types described above if at the time of such issuance: 
 (i) any order, judgment or decree of any Governmental Authority or arbitrator shall purport by its terms to enjoin or restrain such US Issuing Lender from issuing such US Letter of Credit or any
requirement of law applicable to such US Issuing Lender or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over such US Issuing Lender shall prohibit, or request that such US
Issuing Lender refrain from, the issuance of letters of credit generally or such US Letter of Credit in particular or shall impose upon such Issuing Lender with respect to such US Letter of Credit any restriction or reserve or capital requirement
(for which such US Issuing Lender is not otherwise compensated hereunder) not in effect with respect to such US Issuing Lender on the date hereof, or any unreimbursed loss, cost or expense which was not applicable or in effect with respect to such
US Issuing Lender as of the date hereof and which such US Issuing Lender reasonably and in good faith deems material to it; or 
 (ii) such US Issuing Lender shall have received from such US Borrower, any other Credit Party or the Required Lenders prior to the issuance of such US Letter of Credit, notice of the type described in the
second sentence of Section 3.07(b). 
 (c) Schedule 3.01(c) contains a description of letters
of credit that were issued by a Lender for the account of US Company prior to the Effective Date and which remain outstanding on the Effective Date (and setting forth, with respect to each such letter of credit, (i) the name of the issuing
lender, (ii) the letter of credit number, (iii) the name of the account party, (iv) the stated amount (which shall be in Dollars), (v) the name of the beneficiary, (vi) the expiry date and (vii) whether such letter of
credit constitutes a standby letter of credit or a trade letter of credit). The US Company hereby acknowledges and agrees that each such letter of credit, including any extension or renewal thereof in accordance with the terms thereof and hereof
(each, as amended from time to time in accordance with the terms thereof and hereof, an “Existing US Letter of Credit”) shall constitute a “US Letter of Credit” for all purposes of this Agreement and, notwithstanding
anything to the contrary stated in any such Existing US Letter of Credit (including, without limitation, the account party named therein), shall be deemed issued on the Effective Date for the account of the US Company. 

3.02 UK Letters of Credit. (a) Subject to and upon the terms and conditions set forth herein, any UK Borrower
may request that a UK Issuing Lender issue, at any time and from time to time on and after the Effective Date and prior to the 30th day prior to the Final Maturity Date, for the joint and several account of the UK Borrowers and for the benefit of
(x) any person (or any trustee, agent or other 

  
 85 

 
similar representative for any such person) to whom a UK L/C Supportable Obligation is owed, an irrevocable standby letter of credit, in a form customarily used by such UK Issuing Lender or in
such other form as is reasonably acceptable to such UK Issuing Lender, and (y) sellers of goods to the UK Company or any of its Subsidiaries, an irrevocable trade letter of credit, in a form customarily used by such UK Issuing Lender or in such
other form as has been approved by such UK Issuing Lender (each such letter of credit, a “UK Letter of Credit”) (although without limiting the joint and several nature of the UK Borrowers’ obligations in respect of the UK
Letters of Credit, any particular UK Letter of Credit may name only one or more UK Borrowers as the account party therein). All UK Letters of Credit shall be issued on a sight basis only. 

(b) Subject to and upon the terms and conditions set forth herein, each UK Issuing Lender agrees that it will, at any
time and from time to time on and after the Effective Date and prior to the 30th day prior to the Final Maturity Date, following its receipt of the respective UK Letter of Credit Request, issue for the joint and several account of the UK Borrowers,
one or more UK Letters of Credit as are permitted to remain outstanding hereunder without giving rise to a Default or an Event of Default; provided that no UK Issuing Lender shall be under any obligation to issue any UK Letter of Credit of
the types described above if at the time of such issuance: 
 (i) any order, judgment or decree
of any Governmental Authority or arbitrator shall purport by its terms to enjoin or restrain such UK Issuing Lender from issuing such UK Letter of Credit or any requirement of law applicable to such UK Issuing Lender or any request or directive
(whether or not having the force of law) from any Governmental Authority with jurisdiction over such UK Issuing Lender shall prohibit, or request that such UK Issuing Lender refrain from, the issuance of letters of credit generally or such UK Letter
of Credit in particular or shall impose upon such UK Issuing Lender with respect to such UK Letter of Credit any restriction or reserve or capital requirement (for which such UK Issuing Lender is not otherwise compensated hereunder) not in effect
with respect to such UK Issuing Lender on the date hereof, or any unreimbursed loss, cost or expense which was not applicable or in effect with respect to such UK Issuing Lender as of the date hereof and which such UK Issuing Lender reasonably and
in good faith deems material to it; or 
 (ii) such UK Issuing Lender shall have received from
such UK Borrower, any other Credit Party or the Required Lenders prior to the issuance of such UK Letter of Credit, notice of the type described in the second sentence of Section 3.08(b). 

3.03 Canadian Letters of Credit. (a) Subject to and upon the terms and conditions set forth herein, any
Canadian Borrower may request that a Canadian Issuing Lender issue, at any time and from time to time on and after the Effective Date and prior to the 30th day prior to the Final Maturity Date, for the joint and several account of the Canadian
Borrowers and for the benefit of (x) any holder (or any trustee, agent or other similar representative for any such holders) of Canadian L/C Supportable Obligations, an irrevocable standby letter of credit, in a form customarily used by such
Canadian Issuing Lender or in such other form as is reasonably acceptable to such Canadian Issuing Lender, and (y) sellers of goods to the Canadian Company or any of its Subsidiaries, an irrevocable trade letter of credit, in a form customarily
used by such Canadian Issuing Lender or in such other form as has been approved by such Canadian Issuing Lender (each such letter of credit, a “Canadian Letter of Credit”) (although without limiting the joint and several nature of
the Canadian Borrowers’ obligations in respect of the Canadian Letters of Credit, any particular Canadian Letter of Credit may name only one or more Canadian Borrowers as the account party therein). All Canadian Letters of Credit shall be
issued on a sight basis only. 

  
 86 

 (b) Subject to and upon the terms and conditions set forth herein, each
Canadian Issuing Lender agrees that it will, at any time and from time to time on and after the Effective Date and prior to the 30th day prior to the Final Maturity Date, following its receipt of the respective Canadian Letter of Credit Request,
issue for the joint and several account of the Canadian Borrowers, one or more Canadian Letters of Credit as are permitted to remain outstanding hereunder without giving rise to a Default or an Event of Default; provided that no Canadian
Issuing Lender shall be under any obligation to issue any Canadian Letter of Credit of the types described above if at the time of such issuance: 

(i) any order, judgment or decree of any Governmental Authority or arbitrator shall purport by its terms
to enjoin or restrain such Canadian Issuing Lender from issuing such Canadian Letter of Credit or any requirement of law applicable to such Canadian Issuing Lender or any request or directive (whether or not having the force of law) from any
Governmental Authority with jurisdiction over such Canadian Issuing Lender shall prohibit, or request that such Canadian Issuing Lender refrain from, the issuance of letters of credit generally or such Canadian Letter of Credit in particular or
shall impose upon such Canadian Issuing Lender with respect to such Canadian Letter of Credit any restriction or reserve or capital requirement (for which such Canadian Issuing Lender is not otherwise compensated hereunder) not in effect with
respect to such Canadian Issuing Lender on the date hereof, or any unreimbursed loss, cost or expense which was not applicable or in effect with respect to such Canadian Issuing Lender as of the date hereof and which such Canadian Issuing Lender
reasonably and in good faith deems material to it; or 
 (ii) such Canadian Issuing Lender shall
have received from such Canadian Borrower, any other Credit Party or the Required Lenders prior to the issuance of such Canadian Letter of Credit, notice of the type described in the second sentence of Section 3.09(b). 

3.04 Maximum US Letter of Credit Outstandings; Final Maturities. Notwithstanding anything to the contrary
contained in this Agreement, (a) no US Letter of Credit shall be issued (or required to be issued) if the Stated Amount of such US Letter of Credit, when added to the US Letter of Credit Outstandings (exclusive of Unpaid US Drawings which are
repaid on the date of, and prior to the issuance of, the respective US Letter of Credit) at such time would exceed $50,000,000 (the “Maximum US Letter of Credit Amount”), (b) no US Letter of Credit shall be issued (or required
to be issued) at any time when the Aggregate US Exposure exceeds (or would after giving effect to such issuance exceed) either (i) the US Maximum Amount at such time or (ii) the US Borrowing Base at such time (based on the Borrowing Base
Certificate last delivered), or when the Aggregate Exposure exceeds (or would after giving effect to such issuance exceed) either (x) the Total Revolving Loan Commitment or (y) the Aggregate Borrowing Base at such time (based on the
Borrowing Base Certificate last delivered), (c) each US Letter of Credit shall be denominated in Dollars, (d) each standby US Letter of Credit shall by its terms terminate on or before the earlier of (i) the date which occurs 12
months after the date of the issuance thereof (although any such standby US Letter of Credit shall be extendible for successive periods of up to 12 months, but, in each case, not beyond the 5th Business Day prior to the Final Maturity Date) and
(ii) 5 Business Days prior to the Final Maturity Date and (e) each trade US Letter of Credit shall by its terms terminate on or before the earlier of (i) the date which occurs 180 days after the date of issuance thereof and
(ii) 5 Business Days prior to the Final Maturity Date. 
 3.05 Maximum UK Letter of Credit Outstandings;
Final Maturities. Notwithstanding anything to the contrary contained in this Agreement, (a) no UK Letter of Credit shall be issued (or required to be issued) if the Stated Amount of such UK Letter of Credit, when added to the UK Letter of
Credit Outstandings (exclusive of Unpaid UK Drawings which are repaid on the date of, and prior to the issuance of, the respective UK Letter of Credit) at such time would exceed $20,000,000 or the Equivalent Amount thereof (the “Maximum UK
Letter of Credit Amount”), (b) no UK Letter of Credit shall be 

  
 87 

 
issued (or required to be issued) at any time when the Aggregate UK Exposure exceeds (or would after giving effect to such issuance exceed) either (i) the UK Maximum Amount at such time or
(ii) the UK Borrowing Base at such time (based on the Borrowing Base Certificate last delivered), (c) each UK Letter of Credit shall be denominated in Pounds Sterling or Euros, (d) each standby UK Letter of Credit shall by its terms
terminate on or before the earlier of (i) the date which occurs 12 months after the date of the issuance thereof (although any such standby UK Letter of Credit shall be extendible for successive periods of up to 12 months, but, in each case,
not beyond the 5th Business Day prior to the Final Maturity Date) and (ii) 5 Business Days prior to the Final Maturity Date and (e) each trade UK Letter of Credit shall by its terms terminate on or before the earlier of (i) the date
which occurs 180 days after the date of issuance thereof and (ii) 5 Business Days prior to the Final Maturity Date. 
 3.06 Maximum Canadian Letter of Credit Outstandings; Final Maturities. Notwithstanding anything to the contrary contained in this Agreement, (a) no Canadian Letter of Credit shall be issued
(or required to be issued) if the Stated Amount of such Canadian Letter of Credit, when added to the Canadian Letter of Credit Outstandings (exclusive of Unpaid Canadian Drawings which are repaid on the date of, and prior to the issuance of, the
respective Canadian Letter of Credit) at such time would exceed $10,000,000 or the Equivalent Amount thereof (the “Maximum Canadian Letter of Credit Amount”), (b) no Canadian Letter of Credit shall be issued (or required to be
issued) at any time when the Aggregate Canadian Exposure exceeds (or would after giving effect to such issuance exceed) either (i) the Canadian Maximum Amount at such time or (ii) the Canadian Borrowing Base at such time (based on the
Borrowing Base Certificate last delivered), (c) each Canadian Letter of Credit shall be denominated in Canadian Dollars, (d) each standby Canadian Letter of Credit shall by its terms terminate on or before the earlier of (i) the date
which occurs 12 months after the date of the issuance thereof (although any such standby Canadian Letter of Credit shall be extendible for successive periods of up to 12 months, but, in each case, not beyond the 5th Business Day prior to the Final
Maturity Date) and (ii) 5 Business Days prior to the Final Maturity Date and (e) each trade Canadian Letter of Credit shall by its terms terminate on or before the earlier of (i) the date which occurs 180 days after the date of
issuance thereof and (ii) 5 Business Days prior to the Final Maturity Date. 
 3.07 US Letter of Credit
Requests; Minimum Stated Amount. (a) Whenever any US Borrower desires that a US Letter of Credit be issued for its account, such US Borrower shall give the Administrative Agent and the respective US Issuing Lender at least five Business
Days’ (or such shorter period as is acceptable to such US Issuing Lender) written notice thereof (including by way of facsimile). Each notice shall be in the form of Exhibit F, appropriately completed (each, a “US Letter of Credit
Request”). 
 (b) The making of each US Letter of Credit Request shall be deemed to be a representation
and warranty by the respective US Borrower to the Lenders that such US Letter of Credit may be issued in accordance with, and will not violate the requirements of, Section 3.04. Unless the respective US Issuing Lender has received notice
from any US Borrower, any other US Credit Party or the Required Lenders before it issues a US Letter of Credit that one or more of the conditions specified in Section 6 or 7 are not then satisfied, or that the issuance of such US
Letter of Credit would violate Section 3.04, then such US Issuing Lender shall, subject to the terms and conditions of this Agreement, issue the requested US Letter of Credit for the account of the respective US Borrower in accordance
with such US Issuing Lender’s usual and customary practices. Upon the issuance of or modification or amendment to any standby US Letter of Credit, each US Issuing Lender shall promptly notify the respective US Borrower and the Administrative
Agent, in writing of such issuance, modification or amendment and such notice shall be accompanied by a copy of such US Letter of Credit or the respective modification or amendment thereto, as the case may be. Promptly after receipt of such notice
the Administrative Agent shall notify the US Participants, in writing, of such issuance, modification or amendment. On the first Business Day of each week, each US Issuing Lender shall furnish the Administrative Agent with a written (including via
facsimile) report of the daily aggregate outstandings of US Letters of Credit issued by such US Issuing Lender for the immediately preceding week. 

  
 88 

 (c) The initial Stated Amount of each US Letter of Credit shall not be less
than $25,000 or such lesser amount as is acceptable to the respective US Issuing Lender. 
 3.08 UK Letter of
Credit Requests; Minimum Stated Amount. (a) Whenever any UK Borrower desires that a UK Letter of Credit be issued for its account, such UK Borrower shall give the Administrative Agent and the respective UK Issuing Lender at least five
Business Days’ (or such shorter period as is acceptable to such UK Issuing Lender) written notice thereof (including by way of facsimile). Each notice shall be in the form of Exhibit G, appropriately completed (each, a “UK Letter of
Credit Request”). 
 (b) The making of each UK Letter of Credit Request shall be deemed to be a
representation and warranty by the respective UK Borrower to the Lenders that such UK Letter of Credit may be issued in accordance with, and will not violate the requirements of, Section 3.05. Unless the respective UK Issuing Lender has
received notice from any UK Borrower, any other UK Credit Party or the Required Lenders before it issues a UK Letter of Credit that one or more of the conditions specified in Section 6 or 7 are not then satisfied, or that the
issuance of such UK Letter of Credit would violate Section 3.05, then such UK Issuing Lender shall, subject to the terms and conditions of this Agreement, issue the requested UK Letter of Credit for the account of the respective UK
Borrower in accordance with such UK Issuing Lender’s usual and customary practices. Upon the issuance of or modification or amendment to any standby UK Letter of Credit, each UK Issuing Lender shall promptly notify the respective UK Borrower
and the Administrative Agent, in writing of such issuance, modification or amendment and such notice shall be accompanied by a copy of such UK Letter of Credit or the respective modification or amendment thereto, as the case may be. Promptly after
receipt of such notice the Administrative Agent shall notify the UK Participants, in writing, of such issuance, modification or amendment. On the first Business Day of each week, each UK Issuing Lender shall furnish the Administrative Agent with a
written (including via facsimile) report of the daily aggregate outstandings of UK Letters of Credit issued by such UK Issuing Lender for the immediately preceding week. 

(c) The initial Stated Amount of each UK Letter of Credit shall not be less than £25,000 or €25,000, as
applicable, or such lesser amount as is acceptable to the respective UK Issuing Lender. 
 3.09 Canadian
Letter of Credit Requests; Minimum Stated Amount. (a) Whenever any Canadian Borrower desires that a Canadian Letter of Credit be issued for its account, such Canadian Borrower shall give the Administrative Agent and the respective Canadian
Issuing Lender at least five Business Days’ (or such shorter period as is acceptable to such Canadian Issuing Lender) written notice thereof (including by way of facsimile). Each notice shall be in the form of Exhibit H, appropriately completed
(each, a “Canadian Letter of Credit Request”). 
 (b) The making of each Canadian Letter of
Credit Request shall be deemed to be a representation and warranty by the respective Canadian Borrower to the Lenders that such Canadian Letter of Credit may be issued in accordance with, and will not violate the requirements of,
Section 3.06. Unless the respective Canadian Issuing Lender has received notice from any Canadian Borrower, any other Canadian Credit Party or the Required Lenders before it issues a Canadian Letter of Credit that one or more of the
conditions specified in Section 6 or 7 are not then satisfied, or that the issuance of such Canadian Letter of Credit would violate Section 3.06, then such Canadian Issuing Lender shall, subject to the terms and
conditions of this Agreement, issue the requested Canadian Letter of Credit for the account of the respective Canadian Borrower in accordance with such Canadian Issuing Lender’s usual and

  
 89 

 
customary practices. Upon the issuance of or modification or amendment to any standby Canadian Letter of Credit, each Canadian Issuing Lender shall promptly notify the respective Canadian
Borrower and the Administrative Agent, in writing of such issuance, modification or amendment and such notice shall be accompanied by a copy of such Canadian Letter of Credit or the respective modification or amendment thereto, as the case may be.
Promptly after receipt of such notice the Administrative Agent shall notify the Canadian Participants, in writing, of such issuance, modification or amendment. On the first Business Day of each week, each Canadian Issuing Lender shall furnish the
Administrative Agent with a written (including via facsimile) report of the daily aggregate outstandings of Canadian Letters of Credit issued by such Canadian Issuing Lender for the immediately preceding week. 

(c) The initial Stated Amount of each Canadian Letter of Credit shall not be less than CA$25,000 or such lesser amount as
is acceptable to the respective Canadian Issuing Lender. 
 3.10 US Letter of Credit Participations.
(a) Immediately upon the issuance by a US Issuing Lender of any US Letter of Credit, such US Issuing Lender shall be deemed to have sold and transferred to each Lender, and each such Lender (in its capacity under this Section 3.10,
a “US Participant”) shall be deemed irrevocably and unconditionally to have purchased and received from such US Issuing Lender, without recourse or warranty, an undivided interest and participation, to the extent of such US
Participant’s RL Percentage, in such US Letter of Credit, each drawing or payment made thereunder and the obligations of the US Borrowers under this Agreement with respect thereto, and any security therefor or guaranty pertaining thereto. Upon
any change in the Revolving Loan Commitments or RL Percentages of the Lenders pursuant to Section 2.13, 2.15 or 13.04(b), it is hereby agreed that, with respect to all outstanding US Letters of Credit and Unpaid US Drawings
relating thereto, there shall be an automatic adjustment to the participations pursuant to this Section 3.10 to reflect the new RL Percentages of the assignor and assignee Lender, as the case may be. 

(b) In determining whether to pay under any US Letter of Credit, no US Issuing Lender shall have any obligation relative
to the other Lenders other than to confirm that any documents required to be delivered under such US Letter of Credit appear to have been delivered and that they appear to substantially comply on their face with the requirements of such US Letter of
Credit. Any action taken or omitted to be taken by a US Issuing Lender under or in connection with any US Letter of Credit issued by it shall not create for such US Issuing Lender any resulting liability to any US Borrower, any other US Credit
Party, any Lender or any other Person unless such action is taken or omitted to be taken with gross negligence or willful misconduct on the part of such US Issuing Lender (as determined by a court of competent jurisdiction in a final and
non-appealable decision). 
 (c) In the event that a US Issuing Lender makes any payment under any US Letter of
Credit issued by it and the US Borrowers shall not have reimbursed such amount in full to such US Issuing Lender pursuant to Section 3.13(a), such US Issuing Lender shall promptly notify the Administrative Agent, which shall promptly
notify each US Participant of such failure, and each US Participant shall promptly and unconditionally pay to such US Issuing Lender the amount of such US Participant’s RL Percentage of such unreimbursed payment in Dollars in immediately
available funds. If the Administrative Agent so notifies, prior to 12:00 Noon (New York City time) on any Business Day, any US Participant required to fund a payment under a US Letter of Credit, such US Participant shall make available to the
respective US Issuing Lender in Dollars such US Participant’s Percentage of the amount of such payment on such Business Day in immediately available funds. If and to the extent such US Participant shall not have so made its RL Percentage of the
amount of such payment available to the respective US Issuing Lender, such US Participant agrees to pay to such US Issuing Lender, forthwith on demand such amount, together with interest thereon, for each day from such date until the date such
amount is paid to such US Issuing Lender at the overnight Federal Funds Rate for the first three days and at the interest rate applicable to Loans that are maintained as Base Rate Loans for each day thereafter.

  
 90 

 
The failure of any US Participant to make available to a US Issuing Lender its RL Percentage of any payment under any US Letter of Credit issued by such US Issuing Lender shall not relieve any
other US Participant of its obligation hereunder to make available to such US Issuing Lender its RL Percentage of any payment under any US Letter of Credit on the date required, as specified above, but no US Participant shall be responsible for the
failure of any other US Participant to make available to such US Issuing Lender such other US Participant’s RL Percentage of any such payment. 
 (d) Whenever a US Issuing Lender receives a payment of a reimbursement obligation as to which it has received any payments from the US Participants pursuant to clause (c) above, such US Issuing
Lender shall pay to each such US Participant which has paid its RL Percentage thereof, in Dollars and in same day funds, an amount equal to such US Participant’s share (based upon the proportionate aggregate amount originally funded by such US
Participant to the aggregate amount funded by all US Participants) of the principal amount of such reimbursement obligation and interest thereon accruing after the purchase of the respective participations. 

(e) Upon the request of any US Participant, each US Issuing Lender shall furnish to such US Participant copies of any
standby US Letter of Credit issued by it and such other documentation as may reasonably be requested by such US Participant. 
 (f) The obligations of the US Participants to make payments to each US Issuing Lender with respect to US Letters of Credit shall be irrevocable and not subject to any qualification or exception whatsoever
and shall be made in accordance with the terms and conditions of this Agreement under all circumstances, including, without limitation, any of the following circumstances: 

(i) any lack of validity or enforceability of this Agreement or any of the other Credit Documents;

 (ii) the existence of any claim, setoff, defense or other right which US Company or any of
its Subsidiaries may have at any time against a beneficiary named in a US Letter of Credit, any transferee of any US Letter of Credit (or any Person for whom any such transferee may be acting), the Administrative Agent, any US Participant, or any
other Person, whether in connection with this Agreement, any US Letter of Credit, the transactions contemplated herein or any unrelated transactions (including any underlying transaction between US Company or any Subsidiary of US Company and the
beneficiary named in any such US Letter of Credit); 
 (iii) any draft, certificate or any other
document presented under any US Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect; 

(iv) the surrender or impairment of any security for the performance or observance of any of the terms of
any of the Credit Documents; or 
 (v) the occurrence of any Default or Event of Default.

 3.11 UK Letter of Credit Participations. (a) Immediately upon the issuance by a UK Issuing Lender
of any UK Letter of Credit, such UK Issuing Lender shall be deemed to have sold and transferred to each Lender, and each such Lender (in its capacity under this Section 3.11, a “UK Participant”) shall be deemed
irrevocably and unconditionally to have purchased and received from such UK Issuing Lender, without recourse or warranty, an undivided interest and participation, to the extent of such UK Participant’s RL Percentage, in such UK Letter of
Credit, each drawing or payment made thereunder and the obligations of the UK Borrowers under this Agreement with respect thereto, and any 

  
 91 

 
security therefor or guaranty pertaining thereto. Upon any change in the Revolving Loan Commitments or RL Percentages of the Lenders pursuant to Section 2.13, 2.15 or
13.04(b), it is hereby agreed that, with respect to all outstanding UK Letters of Credit and Unpaid UK Drawings relating thereto, there shall be an automatic adjustment to the participations pursuant to this Section 3.11 to
reflect the new RL Percentages of the assignor and assignee Lender, as the case may be. 
 (b) In determining
whether to pay under any UK Letter of Credit, no UK Issuing Lender shall have any obligation relative to the other Lenders other than to confirm that any documents required to be delivered under such UK Letter of Credit appear to have been delivered
and that they appear to substantially comply on their face with the requirements of such UK Letter of Credit. Any action taken or omitted to be taken by a UK Issuing Lender under or in connection with any UK Letter of Credit issued by it shall not
create for such UK Issuing Lender any resulting liability to any UK Borrower, any other UK Credit Party, any Lender or any other Person unless such action is taken or omitted to be taken with gross negligence or willful misconduct on the part of
such UK Issuing Lender (as determined by a court of competent jurisdiction in a final and non-appealable decision). 
 (c) In the event that a UK Issuing Lender makes any payment under any UK Letter of Credit issued by it and the UK Borrowers shall not have reimbursed such amount in full to such UK Issuing Lender pursuant
to Section 3.14(a), such UK Issuing Lender shall promptly notify the Administrative Agent, which shall promptly notify each UK Participant of such failure, and each UK Participant shall promptly and unconditionally pay to such UK Issuing
Lender the amount of such UK Participant’s RL Percentage of such unreimbursed payment in Pounds Sterling or Euros, as applicable, in immediately available funds. The Administrative Agent shall also promptly provide each Converting Euro Lender
and Converting Pounds Sterling Lender a calculation of the amount of US Dollars that such Converting Pounds Sterling Lender or Converting Euro Lender, as applicable, shall be required to provide to the Administrative Agent consistent with
Section 2.16. If the Administrative Agent so notifies, prior to 12:00 Noon (London time) on any Business Day, any UK Participant required to fund a payment under a UK Letter of Credit, such UK Participant shall make available to the
respective UK Issuing Lender in Pounds Sterling or Euros, as applicable, such UK Participant’s Percentage of the amount of such payment on such Business Day in immediately available funds. If and to the extent such UK Participant shall not have
so made its RL Percentage of the amount of such payment available to the respective UK Issuing Lender, such UK Participant agrees to pay to such UK Issuing Lender, forthwith on demand such amount, together with interest thereon, for each day from
such date until the date such amount is paid to such UK Issuing Lender interest at the rate applicable to Loans that are maintained as UK LIBOR Loans or EURIBOR Loans, as applicable with an Interest Period of one-week for each day thereafter. The
failure of any UK Participant to make available to a UK Issuing Lender its RL Percentage of any payment under any UK Letter of Credit issued by such UK Issuing Lender shall not relieve any other UK Participant of its obligation hereunder to make
available to such UK Issuing Lender its RL Percentage of any payment under any UK Letter of Credit on the date required, as specified above, but no UK Participant shall be responsible for the failure of any other UK Participant to make available to
such UK Issuing Lender such other UK Participant’s RL Percentage of any such payment. 
 (d) Whenever a UK
Issuing Lender receives a payment of a reimbursement obligation as to which it has received any payments from the UK Participants pursuant to clause (c) above, such UK Issuing Lender shall pay to each such UK Participant which has paid its RL
Percentage thereof, in Pounds Sterling or Euros, as applicable and in same day funds, an amount equal to such UK Participant’s share (based upon the proportionate aggregate amount originally funded by such UK Participant to the aggregate amount
funded by all UK Participants) of the principal amount of such reimbursement obligation and interest thereon accruing after the purchase of the respective participations. 

  
 92 

 (e) Upon the request of any UK Participant, each UK Issuing Lender shall
furnish to such UK Participant copies of any standby UK Letter of Credit issued by it and such other documentation as may reasonably be requested by such UK Participant. 

(f) The obligations of the UK Participants to make payments to each UK Issuing Lender with respect to UK Letters of
Credit shall be irrevocable and not subject to any qualification or exception whatsoever and shall be made in accordance with the terms and conditions of this Agreement under all circumstances, including, without limitation, any of the following
circumstances: 
 (i) any lack of validity or enforceability of this Agreement or any of the
other Credit Documents; 
 (ii) the existence of any claim, setoff, defense or other right which
US Company or any of its Subsidiaries may have at any time against a beneficiary named in a UK Letter of Credit, any transferee of any UK Letter of Credit (or any Person for whom any such transferee may be acting), the Administrative Agent, any UK
Participant, or any other Person, whether in connection with this Agreement, any UK Letter of Credit, the transactions contemplated herein or any unrelated transactions (including any underlying transaction between US Company or any Subsidiary of US
Company and the beneficiary named in any such UK Letter of Credit); 
 (iii) any draft,
certificate or any other document presented under any UK Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect; 

(iv) the surrender or impairment of any security for the performance or observance of any of the terms of
any of the Credit Documents; or 
 (v) the occurrence of any Default or Event of Default.

 3.12 Canadian Letter of Credit Participations. (a) Immediately upon the issuance by a Canadian
Issuing Lender of any Canadian Letter of Credit, such Canadian Issuing Lender shall be deemed to have sold and transferred to each Lender, and each such Lender (in its capacity under this Section 3.12, a “Canadian
Participant”) shall be deemed irrevocably and unconditionally to have purchased and received from such Canadian Issuing Lender, without recourse or warranty, an undivided interest and participation, to the extent of such Canadian
Participant’s RL Percentage, in such Canadian Letter of Credit, each drawing or payment made thereunder and the obligations of the Canadian Borrowers under this Agreement with respect thereto, and any security therefor or guaranty pertaining
thereto. Upon any change in the Revolving Loan Commitments or RL Percentages of the Lenders pursuant to Section 2.13, 2.15 or 13.04(b), it is hereby agreed that, with respect to all outstanding Canadian Letters of Credit
and Unpaid Canadian Drawings relating thereto, there shall be an automatic adjustment to the participations pursuant to this Section 3.12 to reflect the new RL Percentages of the assignor and assignee Lender, as the case may be.

 (b) In determining whether to pay under any Canadian Letter of Credit, no Canadian Issuing Lender shall have
any obligation relative to the other Lenders other than to confirm that any documents required to be delivered under such Canadian Letter of Credit appear to have been delivered and that they appear to substantially comply on their face with the
requirements of such Canadian Letter of Credit. Any action taken or omitted to be taken by a Canadian Issuing Lender under or in connection with any Canadian Letter of Credit issued by it shall not create for such Canadian Issuing Lender any
resulting liability to any Canadian Borrower, any other Canadian Credit Party, any Lender or any other Person unless such action is taken or omitted to be taken with gross negligence or willful misconduct on the part of such Canadian Issuing Lender
(as determined by a court of competent jurisdiction in a final and non-appealable decision). 

  
 93 

 (c) In the event that a Canadian Issuing Lender makes any payment under any
Canadian Letter of Credit issued by it and the Canadian Borrowers shall not have reimbursed such amount in full to such Canadian Issuing Lender pursuant to Section 3.15(a), such Canadian Issuing Lender shall promptly notify the
Administrative Agent, which shall promptly notify each Canadian Participant of such failure, and each Canadian Participant shall promptly and unconditionally pay to such Canadian Issuing Lender the amount of such Canadian Participant’s RL
Percentage of such unreimbursed payment in Canadian Dollars in immediately available funds. The Administrative Agent shall also promptly provide each Converting Canadian Dollar Lender a calculation of the amount of US Dollars that such Converting
Canadian Dollar Lender shall be required to provide to the Administrative Agent consistent with Section 2.16. If the Administrative Agent so notifies, prior to 12:00 Noon (Toronto time) on any Business Day, any Canadian Participant
required to fund a payment under a Canadian Letter of Credit, such Canadian Participant shall make available to the respective Canadian Issuing Lender in Canadian Dollars such Canadian Participant’s Percentage of the amount of such payment on
such Business Day in immediately available funds. If and to the extent such Canadian Participant shall not have so made its RL Percentage of the amount of such payment available to the respective Canadian Issuing Lender, such Canadian Participant
agrees to pay to such Canadian Issuing Lender, forthwith on demand such amount, together with interest thereon, for each day from such date until the date such amount is paid to such Canadian Issuing Lender interest at the rate applicable to
Canadian Prime Rate Loans. The failure of any Canadian Participant to make available to a Canadian Issuing Lender its RL Percentage of any payment under any Canadian Letter of Credit issued by such Canadian Issuing Lender shall not relieve any other
Canadian Participant of its obligation hereunder to make available to such Canadian Issuing Lender its RL Percentage of any payment under any Canadian Letter of Credit on the date required, as specified above, but no Canadian Participant shall be
responsible for the failure of any other Canadian Participant to make available to such Canadian Issuing Lender such other Canadian Participant’s RL Percentage of any such payment. 

(d) Whenever a Canadian Issuing Lender receives a payment of a reimbursement obligation as to which it has received any
payments from the Canadian Participants pursuant to clause (c) above, such Canadian Issuing Lender shall pay to each such Canadian Participant which has paid its RL Percentage thereof, in Canadian Dollars and in same day funds, an amount equal
to such Canadian Participant’s share (based upon the proportionate aggregate amount originally funded by such Canadian Participant to the aggregate amount funded by all Canadian Participants) of the principal amount of such reimbursement
obligation and interest thereon accruing after the purchase of the respective participations. 
 (e) Upon the
request of any Canadian Participant, each Canadian Issuing Lender shall furnish to such Canadian Participant copies of any standby Canadian Letter of Credit issued by it and such other documentation as may reasonably be requested by such Canadian
Participant. 
 (f) The obligations of the Canadian Participants to make payments to each Canadian Issuing
Lender with respect to Canadian Letters of Credit shall be irrevocable and not subject to any qualification or exception whatsoever and shall be made in accordance with the terms and conditions of this Agreement under all circumstances, including,
without limitation, any of the following circumstances: 
 (i) any lack of validity or
enforceability of this Agreement or any of the other Credit Documents; 

  
 94 

 (ii) the existence of any claim, setoff, defense or other
right which US Company or any of its Subsidiaries may have at any time against a beneficiary named in a Canadian Letter of Credit, any transferee of any Canadian Letter of Credit (or any Person for whom any such transferee may be acting), the
Administrative Agent, any Canadian Participant, or any other Person, whether in connection with this Agreement, any Canadian Letter of Credit, the transactions contemplated herein or any unrelated transactions (including any underlying transaction
between US Company or any Subsidiary of US Company and the beneficiary named in any such Canadian Letter of Credit); 
 (iii) any draft, certificate or any other document presented under any Canadian Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being
untrue or inaccurate in any respect; 
 (iv) the surrender or impairment of any security for the
performance or observance of any of the terms of any of the Credit Documents; or 
 (v) the
occurrence of any Default or Event of Default. 
 3.13 Agreement to Repay US Letter of Credit Drawings.
(a) Each US Borrower hereby jointly and severally agrees to reimburse each US Issuing Lender, by making payment to the Administrative Agent in Dollars in immediately available funds at the Payment Office, for any payment or disbursement made by
such US Issuing Lender under any US Letter of Credit issued by it (each such amount, so paid until reimbursed by the respective US Borrower, an “Unpaid US Drawing”), not later than one Business Day following receipt by the
respective US Borrower of notice of such payment or disbursement (provided that no such notice shall be required to be given if a Default or an Event of Default under Section 11.08 shall have occurred and be continuing, in which
case the Unpaid US Drawing shall be due and payable immediately without presentment, demand, protest or notice of any kind (all of which are hereby waived by the US Borrowers)), with interest on the amount so paid or disbursed by such US Issuing
Lender, to the extent not reimbursed prior to 12:00 Noon (New York City time) on the date of such payment or disbursement (or to the extent such Unpaid US Drawing is repaid with a US Borrowing of US Revolving Loans constituting Base Rate Loans
pursuant to (and to the extent permitted by) clause (ii) of the proviso below), from and including the date paid or disbursed to but excluding the date such US Issuing Lender was reimbursed by the respective US Borrower therefor at a rate per
annum equal to the Base Rate as in effect from time to time plus the Applicable Margin as in effect from time to time for Loans that are maintained as Base Rate Loans; provided, however, to the extent such amounts are not reimbursed
prior to 12:00 Noon (New York City time) on the third Business Day following the receipt by the respective US Borrower of notice of such payment or disbursement or following the occurrence of a Default or an Event of Default under
Section 11.08, interest shall thereafter accrue on the amounts so paid or disbursed by such US Issuing Lender (and until reimbursed by the US Borrowers) at a rate per annum equal to the Base Rate as in effect from time to time plus the
Applicable Margin for Loans that are maintained as Base Rate Loans as in effect from time to time plus 2%, with such interest to be payable on demand. Each US Issuing Lender shall give the respective US Borrower prompt written notice of each US
Drawing under any US Letter of Credit issued by it; provided that the failure to give any such notice shall in no way affect, impair or diminish the US Borrowers’ obligations hereunder. 

(b) The joint and several obligations of the US Borrowers under this Section 3.13 to reimburse each US
Issuing Lender with respect to drafts, demands and other presentations for payment under US Letters of Credit issued by it (each, a “US Drawing”) (including, in each case, interest thereon) shall be absolute and unconditional under
any and all circumstances and irrespective of any setoff, counterclaim or defense to payment which US Company, any US Borrower or any Subsidiary of any US Borrower may have or have had against any Lender (including in its capacity as a US Issuing
Lender or as a US Participant), including, without limitation, any defense based upon the failure of any drawing under a US Letter of Credit to conform to the terms of the US Letter of Credit or any nonapplication or misapplication by the
beneficiary of the proceeds of such US Drawing; provided, however, that no US 

  
 95 

 
Borrower shall be obligated to reimburse any US Issuing Lender for any wrongful payment made by such US Issuing Lender under a US Letter of Credit issued by it as a result of acts or omissions
constituting willful misconduct or gross negligence on the part of such US Issuing Lender (as determined by a court of competent jurisdiction in a final and non-appealable decision). 

3.14 Agreement to Repay UK Letter of Credit Drawings. (a) Each UK Borrower hereby jointly and severally
agrees to reimburse each UK Issuing Lender, by making payment to the Administrative Agent in Pounds Sterling or Euros, as applicable in immediately available funds at the Payment Office, for any payment or disbursement made by such UK Issuing Lender
under any UK Letter of Credit issued by it (each such amount, so paid until reimbursed by the respective UK Borrower, an “Unpaid UK Drawing”), not later than one Business Day following receipt by the respective UK Borrower of notice
of such payment or disbursement (provided that no such notice shall be required to be given if a Default or an Event of Default under Section 11.08 shall have occurred and be continuing, in which case the Unpaid UK Drawing shall
be due and payable immediately without presentment, demand, protest or notice of any kind (all of which are hereby waived by the UK Borrowers)), with interest on the amount so paid or disbursed by such UK Issuing Lender, to the extent not reimbursed
prior to 12:00 Noon (London time) on the date of such payment or disbursement (or to the extent such Unpaid UK Drawing is repaid with a UK Borrowing of UK Revolving Loans pursuant to (and to the extent permitted by) clause (ii) of the proviso
below), from and including the date paid or disbursed to but excluding the date such UK Issuing Lender was reimbursed by the respective UK Borrower therefor at a rate per annum equal to LIBOR or EURIBOR, as applicable, for Loans with a one-week
Interest Period as in effect from time to time plus the Applicable Margin as in effect from time to time for UK Revolving Loans; provided, however, to the extent such amounts are not reimbursed prior to 12:00 Noon (London time) on the
third Business Day following the receipt by the respective UK Borrower of notice of such payment or disbursement or following the occurrence of a Default or an Event of Default under Section 11.08, interest shall thereafter accrue on the
amounts so paid or disbursed by such UK Issuing Lender (and until reimbursed by the UK Borrowers) at a rate per annum equal to LIBOR or EURIBOR, as applicable, for Loans with a one-week Interest Period as in effect from time to time plus the
Applicable Margin for Loans that are maintained as UK Revolving Loans as in effect from time to time plus 2%, with such interest to be payable on demand. Each UK Issuing Lender shall give the respective UK Borrower prompt written notice of each UK
Drawing under any UK Letter of Credit issued by it; provided that the failure to give any such notice shall in no way affect, impair or diminish the UK Borrowers’ obligations hereunder. 

(b) The joint and several obligations of the UK Borrowers under this Section 3.14 to reimburse each UK
Issuing Lender with respect to drafts, demands and other presentations for payment under UK Letters of Credit issued by it (each, a “UK Drawing”) (including, in each case, interest thereon) shall be absolute and unconditional under
any and all circumstances and irrespective of any setoff, counterclaim or defense to payment which US Company, any UK Borrower or any Subsidiary of US Company may have or have had against any Lender (including in its capacity as a UK Issuing Lender
or as a UK Participant), including, without limitation, any defense based upon the failure of any drawing under a UK Letter of Credit to conform to the terms of the UK Letter of Credit or any nonapplication or misapplication by the beneficiary of
the proceeds of such UK Drawing; provided, however, that no UK Borrower shall be obligated to reimburse any UK Issuing Lender for any wrongful payment made by such UK Issuing Lender under a UK Letter of Credit issued by it as a result
of acts or omissions constituting willful misconduct or gross negligence on the part of such UK Issuing Lender (as determined by a court of competent jurisdiction in a final and non-appealable decision). 

  
 96 

 3.15 Agreement to Repay Canadian Letter of Credit Drawings.
(a) Each Canadian Borrower hereby jointly and severally agrees to reimburse each Canadian Issuing Lender, by making payment to the Administrative Agent in Canadian Dollars in immediately available funds at the Payment Office, for any payment or
disbursement made by such Canadian Issuing Lender under any Canadian Letter of Credit issued by it (each such amount, so paid until reimbursed by the respective Canadian Borrower, an “Unpaid Canadian Drawing”), not later than one
Business Day following receipt by the respective Canadian Borrower of notice of such payment or disbursement (provided that no such notice shall be required to be given if a Default or an Event of Default under Section 11.08 shall
have occurred and be continuing, in which case the Unpaid Canadian Drawing shall be due and payable immediately without presentment, demand, protest or notice of any kind (all of which are hereby waived by the Canadian Borrowers)), with interest on
the amount so paid or disbursed by such Canadian Issuing Lender, to the extent not reimbursed prior to 12:00 Noon (Toronto time) on the date of such payment or disbursement (or to the extent such Unpaid Canadian Drawing is repaid with a Canadian
Borrowing of Canadian Revolving Loans pursuant to (and to the extent permitted by) clause (ii) of the proviso below), from and including the date paid or disbursed to but excluding the date such Canadian Issuing Lender was reimbursed by the
respective Canadian Borrower therefor at a rate per annum equal to the Canadian Prime Rate plus the Applicable Margin as in effect from time to time; provided, however, to the extent such amounts are not reimbursed prior to 12:00 Noon
(Toronto time) on the third Business Day following the receipt by the respective Canadian Borrower of notice of such payment or disbursement or following the occurrence of a Default or an Event of Default under Section 11.08, interest
shall thereafter accrue on the amounts so paid or disbursed by such Canadian Issuing Lender (and until reimbursed by the Canadian Borrowers) at a rate per annum equal to the Canadian Prime Rate plus the Applicable Margin for Loans that are
maintained as Canadian Prime Rate Loans as in effect from time to time plus 2%, with such interest to be payable on demand. Each Canadian Issuing Lender shall give the respective Canadian Borrower prompt written notice of each Canadian Drawing under
any Canadian Letter of Credit issued by it; provided that the failure to give any such notice shall in no way affect, impair or diminish the Canadian Borrowers’ obligations hereunder. 

(b) The joint and several obligations of the Canadian Borrowers under this Section 3.15 to reimburse each
Canadian Issuing Lender with respect to drafts, demands and other presentations for payment under Canadian Letters of Credit issued by it (each, a “Canadian Drawing”) (including, in each case, interest thereon) shall be absolute and
unconditional under any and all circumstances and irrespective of any setoff, counterclaim or defense to payment which US Company, any Canadian Borrower or any Subsidiary of US Company may have or have had against any Lender (including in its
capacity as a Canadian Issuing Lender or as a Canadian Participant), including, without limitation, any defense based upon the failure of any drawing under a Canadian Letter of Credit to conform to the terms of the Canadian Letter of Credit or any
nonapplication or misapplication by the beneficiary of the proceeds of such Canadian Drawing; provided, however, that no Canadian Borrower shall be obligated to reimburse any Canadian Issuing Lender for any wrongful payment made by
such Canadian Issuing Lender under a Canadian Letter of Credit issued by it as a result of acts or omissions constituting willful misconduct or gross negligence on the part of such Canadian Issuing Lender (as determined by a court of competent
jurisdiction in a final and non-appealable decision). 
 3.16 Increased Costs – US Letters of
Credit. If at any time after the Effective Date, the introduction of or any change in any Applicable Law, rule, regulation, order, guideline or request or in the interpretation or administration thereof by the NAIC or any Governmental Authority
charged with the interpretation or administration thereof, or compliance by any US Issuing Lender or any US Participant with any request or directive by the NAIC or by any such Governmental Authority (whether or not having the force of law), shall
either (a) impose, modify or make applicable any reserve, deposit, capital adequacy or similar requirement against letters of credit issued by any US Issuing Lender or participated in by any US Participant, or (b) impose on any US Issuing
Lender or any US Participant any other 

  
 97 

 
conditions relating, directly or indirectly, to this Agreement or any US Letter of Credit; and the result of any of the foregoing is to increase the cost to any US Issuing Lender or any US
Participant of issuing, maintaining or participating in any US Letter of Credit, or reduce the amount of any sum received or receivable by any US Issuing Lender or any US Participant hereunder or reduce the rate of return on its capital with respect
to US Letters of Credit (except for changes in the rate of tax on, or determined by reference to, the net income or net profits of such US Issuing Lender or such US Participant pursuant to the laws of the jurisdiction in which it is 

organized or in which its principal office or applicable lending office is located or any subdivision thereof or therein), then, upon the
delivery of the certificate referred to below to the US Company by any US Issuing Lender or any US Participant (a copy of which certificate shall be sent by such US Issuing Lender or such US Participant to the Administrative Agent), the US Borrowers
jointly and severally agree to pay to such US Issuing Lender or such US Participant such additional amount or amounts as will compensate such US Issuing Lender or such US Participant for such increased cost or reduction in the amount receivable or
reduction on the rate of return on its capital. Any US Issuing Lender or any US Participant, upon determining that any additional amounts will be payable to it pursuant to this Section 3.16, will give prompt written notice thereof to the
US Company, which notice shall include a certificate submitted to the US Company by such US Issuing Lender or such US Participant (a copy of which certificate shall be sent by such US Issuing Lender or such US Participant to the Administrative
Agent), setting forth in reasonable detail the basis for the calculation of such additional amount or amounts necessary to compensate such US Issuing Lender or such US Participant. The certificate required to be delivered pursuant to this
Section 3.16 shall, absent manifest error, be final and conclusive and binding on the US Borrowers. 

3.17 Increased Costs – UK Letters of Credit. If at any time after the Effective Date, the introduction of or
any change in any Applicable Law, rule, regulation, order, guideline or request or in the interpretation or administration thereof by the NAIC or any Governmental Authority charged with the interpretation or administration thereof, or compliance by
any UK Issuing Lender or any UK Participant with any request or directive by the NAIC or by any such Governmental Authority (whether or not having the force of law), shall either (a) impose, modify or make applicable any reserve, deposit,
capital adequacy or similar requirement against letters of credit issued by any UK Issuing Lender or participated in by any UK Participant, or (b) impose on any UK Issuing Lender or any UK Participant any other conditions relating, directly or
indirectly, to this Agreement or any UK Letter of Credit; and the result of any of the foregoing is to increase the cost to any UK Issuing Lender or any UK Participant of issuing, maintaining or participating in any UK Letter of Credit, or reduce
the amount of any sum received or receivable by any UK Issuing Lender or any UK Participant hereunder or reduce the rate of return on its capital with respect to UK Letters of Credit (except for changes in the rate of tax on, or determined by
reference to, the net income or net profits of such UK Issuing Lender or such UK Participant pursuant to the laws of the jurisdiction in which it is organized or in which its principal office or applicable lending office is located or any
subdivision thereof or therein), then, upon the delivery of the certificate referred to below to the US Company or UK Company by any UK Issuing Lender or any UK Participant (a copy of which certificate shall be sent by such UK Issuing Lender or such
UK Participant to the Administrative Agent), the UK Borrowers jointly and severally agree to pay to such UK Issuing Lender or such UK Participant such additional amount or amounts as will compensate such UK Issuing Lender or such UK Participant for
such increased cost or reduction in the amount receivable or reduction on the rate of return on its capital. Any UK Issuing Lender or any UK Participant, upon determining that any additional amounts will be payable to it pursuant to this
Section 3.17, will give prompt written notice thereof to the US Company, which notice shall include a certificate submitted to the US Company by such UK Issuing Lender or such UK Participant (a copy of which certificate shall be sent by
such UK Issuing Lender or such UK Participant to the Administrative Agent), setting forth in reasonable detail the basis for the calculation of such additional amount or amounts necessary to compensate such UK Issuing Lender or such UK Participant.
The certificate required to be delivered pursuant to this Section 3.17 shall, absent manifest error, be final and conclusive and binding on the UK Borrowers. 

  
 98 

 3.18 Increased Costs – Canadian Letters of Credit. If at any
time after the Effective Date, the introduction of or any change in any Applicable Law, rule, regulation, order, guideline or request or in the interpretation or administration thereof by the NAIC or any Governmental Authority charged with the
interpretation or administration thereof, or compliance by any Canadian Issuing Lender or any Canadian Participant with any request or directive by the NAIC or by any such Governmental Authority (whether or not having the force of law), shall either
(a) impose, modify or make applicable any reserve, deposit, capital adequacy or similar requirement against letters of credit issued by any Canadian Issuing Lender or participated in by any Canadian Participant, or (b) impose on any
Canadian Issuing Lender or any Canadian Participant any other conditions relating, directly or indirectly, to this Agreement or any Canadian Letter of Credit; and the result of any of the foregoing is to increase the cost to any Canadian Issuing
Lender or any Canadian Participant of issuing, maintaining or participating in any Canadian Letter of Credit, or reduce the amount of any sum received or receivable by any Canadian Issuing Lender or any Canadian Participant hereunder or reduce the
rate of return on its capital with respect to Canadian Letters of Credit (except for changes in the rate of tax on, or determined by reference to, the net income or net profits of such Canadian Issuing Lender or such Canadian Participant pursuant to
the laws of the jurisdiction in which it is organized or in which its principal office or applicable lending office is located or any subdivision thereof or therein), then, upon the delivery of the certificate referred to below to the US Company or
Canadian Company by any Canadian Issuing Lender or any Canadian Participant (a copy of which certificate shall be sent by such Canadian Issuing Lender or such Canadian Participant to the Administrative Agent), the Canadian Borrowers jointly and
severally agree to pay to such Canadian Issuing Lender or such Canadian Participant such additional amount or amounts as will compensate such Canadian Issuing Lender or such Canadian Participant for such increased cost or reduction in the amount
receivable or reduction on the rate of return on its capital. Any Canadian Issuing Lender or any Canadian Participant, upon determining that any additional amounts will be payable to it pursuant to this Section 3.18, will give prompt
written notice thereof to the US Company, which notice shall include a certificate submitted to the US Company by such Canadian Issuing Lender or such Canadian Participant (a copy of which certificate shall be sent by such Canadian Issuing Lender or
such Canadian Participant to the Administrative Agent), setting forth in reasonable detail the basis for the calculation of such additional amount or amounts necessary to compensate such Canadian Issuing Lender or such Canadian Participant. The
certificate required to be delivered pursuant to this Section 3.18 shall, absent manifest error, be final and conclusive and binding on the Canadian Borrowers. 

SECTION 4. Commitment Commission; Fees; Reductions of Commitment. 

4.01 Fees. (a) The US Borrowers jointly and severally agree to pay to the Administrative Agent for
distribution to each Non-Defaulting Lender a commitment commission (the “Commitment Commission”) for the period from and including the Effective Date to and including the Final Maturity Date (or such earlier date on which the Total
Revolving Loan Commitment has been terminated) computed at a rate per annum equal to the Applicable Commitment Commission Percentage of the Unutilized Revolving Loan Commitment of such Non-Defaulting Lender as in effect from time to time. Accrued
Commitment Commission shall be due and payable quarterly in arrears on each Quarterly Payment Date and on the date upon which the Total Revolving Loan Commitment is terminated. 

(b) The US Borrowers jointly and severally agree to pay to the Administrative Agent for distribution to each Lender
(based on each such Lender’s respective RL Percentage) a fee in respect of each US Letter of Credit (the “US Letter of Credit Fee”) for the period from and including the date of issuance of such US Letter of Credit to and
including the date of termination or expiration of such US Letter of Credit, computed at a rate per annum equal to the Applicable Margin as in effect from time to time during such period with respect to US Revolving Loans that are maintained as
LIBOR Loans on the daily Stated Amount of each such US Letter of Credit. The Borrowers jointly and severally agree to pay to the Administrative Agent for distribution to each Lender (based on each such Lender’s respective RL

  
 99 

 
Percentage) a fee in respect of each UK Letter of Credit (the “UK Letter of Credit Fee”) for the period from and including the date of issuance of such UK Letter of Credit to and
including the date of termination or expiration of such UK Letter of Credit, computed at a rate per annum equal to the Applicable Margin as in effect from time to time during such period with respect to LIBOR Loans or EURIBOR Loans on the daily
Stated Amount of each such UK Letter of Credit. The UK Letter of Credit Fee shall be payable in Pounds Sterling or Euros, as applicable, or at the request of the Administrative Agent, Dollars, with the applicable exchange rate calculated in a manner
acceptable to the Administrative Agent. The Borrowers jointly and severally agree to pay to the Administrative Agent for distribution to each Lender (based on each such Lender’s respective RL Percentage) a fee in respect of each Canadian Letter
of Credit (the “Canadian Letter of Credit Fee”) for the period from and including the date of issuance of such Canadian Letter of Credit to and including the date of termination or expiration of such Canadian Letter of Credit,
computed at a rate per annum equal to the Applicable Margin as in effect from time to time during such period with respect to Bankers’ Acceptance Loans on the daily Stated Amount of each such Canadian Letter of Credit. The Canadian Letter of
Credit Fee shall be payable in Canadian Dollars or at the request of the Administrative Agent, Dollars, with the applicable exchange rate calculated in a manner acceptable to the Administrative Agent. Accrued Letter of Credit Fees shall be due and
payable quarterly in arrears on the first day of each fiscal quarter hereafter and on the first day on or after the termination of the Total Revolving Loan Commitment upon which no Letters of Credit remain outstanding. 

(c) The US Borrowers jointly and severally agree to pay to each US Issuing Lender, for its own account, a facing fee in
respect of each US Letter of Credit issued by such Issuing Lender and the Borrowers jointly and severally agree to pay to each UK Issuing Lender and each Canadian Issuing Lender, for its own account, a facing fee in respect of each UK Letter of
Credit and each Canadian Letter of Credit, as applicable, issued by such Issuing Lender (in each case, the “Facing Fee”) for the period from and including the date of issuance of such Letter of Credit to and including the date of
termination or expiration of such Letter of Credit, equal to the greater of (i) $500.00 or the Equivalent Amount thereof and (ii) 0.125% per annum on the daily Stated Amount of such Letter of Credit. Accrued Facing Fees shall be due
and payable monthly in arrears on the first day of each month hereafter and upon the first day on or after the termination of the Total Revolving Loan Commitment, upon which no Letters of Credit remain outstanding. 

(d) The US Borrowers jointly and severally agree to pay to each US Issuing Lender, for its own account, upon each payment
under, issuance of, or amendment to, any US Letter of Credit issued by it, such amount as shall at the time of such event be the administrative charge and the reasonable expenses which such US Issuing Lender is generally imposing in connection with
such occurrence with respect to letters of credit. The Borrowers jointly and severally agree to pay to each UK Issuing Lender and each Canadian Issuing Lender, for its own account, upon each payment under, issuance of, or amendment to, any UK Letter
of Credit issued by it and any Canadian Letter of Credit issued by it, such amount as shall at the time of such event be the administrative charge and the reasonable expenses which such UK Issuing Lender or Canadian Issuing Lender, as applicable, is
generally imposing in connection with such occurrence with respect to letters of credit. 
 (e) The US Borrowers
jointly and severally agree to pay to the Administrative Agent such fees as may have been, or are hereafter, agreed to in writing from time to time by US Company or any of its Domestic Subsidiaries and the Administrative Agent. The Borrowers jointly
and severally agree to pay to the Administrative Agent such fees as may have been, or are hereafter, agreed to in writing from time to time by UK Company, Canadian Company or any of the Foreign Subsidiaries and the Administrative Agent. 

  
 100

 4.02 Voluntary Termination of Unutilized Commitments. (a) Upon
at least three Business Days’ prior written notice to the Administrative Agent at the Notice Office (which notice the Administrative Agent shall promptly transmit to each of the Lenders), the US Company shall have the right, at any time or from
time to time, without premium or penalty to terminate the Total Unutilized Revolving Loan Commitment in whole, or reduce it in part, pursuant to this Section 4.02(a), in an integral multiple of $1,000,000 in the case of partial
reductions to the Total Unutilized Revolving Loan Commitment; provided that each such reduction shall apply proportionately to permanently reduce the Revolving Loan Commitment of each Lender. 

(b) In the event of certain refusals by a Lender to consent to certain proposed changes, waivers, discharges or
terminations with respect to this Agreement which have been approved by the Required Lenders as (and to the extent) provided in Section 13.12(b), the US Company shall have the right, subject to obtaining the consents required by
Section 13.12(b), upon five Business Days’ prior written notice to the Administrative Agent at the Notice Office (which notice the Administrative Agent shall promptly transmit to each of the Lenders), to terminate the entire
Revolving Loan Commitment of such Lender, so long as all Loans, together with accrued and unpaid interest, Fees and all other amounts, owing to such Lender (including all amounts, if any, owing pursuant to Section 2.11) are repaid
concurrently with the effectiveness of such termination (at which time Schedule 1.01(a) shall be deemed modified to reflect such changed amounts) and such Lender’s RL Percentage of all outstanding Letters of Credit is cash collateralized
in a manner satisfactory to the Administrative Agent and the respective Issuing Lenders, and at such time such Lender shall no longer constitute a “Lender” for purposes of this Agreement, except with respect to indemnifications under this
Agreement (including, without limitation, Sections 2.10, 2.11, 3.16, 3.17, 3.18, 5.04, 5.05, 12.06, 13.01 and 13.06), which shall survive as to such repaid Lender. 

(c) If the Borrowers at any time permanently reduce the Total Revolving Loan Commitment hereunder, all availability
levels denominated in Dollars, Canadian Dollars, Euros or Pounds Sterling hereunder (including, without limitation, in the definitions of “Applicable Margin”, “Minimum Availability Amount” and “Payment Conditions” and
in Section 10.04(a)) shall be decreased in proportion to the ratio of the amount of such reduction in the Total Revolving Loan Commitment to the Total Revolving Loan Commitment immediately prior to such reduction and, for the avoidance of
doubt, all such levels denominated in percentages shall be calculated based on the Total Revolving Loan Commitment after giving effect to such reduction. 
 4.03 Mandatory Reduction of Commitments. (a) The Total Revolving Loan Commitment (and the Revolving Loan Commitment of each Lender) shall terminate in its entirety on February 22, 2012,
unless the Effective Date has occurred on or prior to such date. 
 (b) In addition to any other mandatory
commitment reductions pursuant to this Section 4.03, the Total Revolving Loan Commitment (and the Revolving Loan Commitment of each Lender) shall terminate in its entirety on the Final Maturity Date. 

SECTION 5. Prepayments; Payments; Taxes. 

5.01 Voluntary Prepayments. (a) Each Borrower shall have the right to prepay the Loans (other than
Bankers’ Acceptance Loans), without premium or penalty, in whole or in part at any time and from time to time on the following terms and conditions: (i) such Borrower shall give the Administrative Agent prior to 11:00 A.M. (New York City
time) at the Notice Office (A) at least one Business Day’s prior written notice (or telephonic notice promptly confirmed in writing) of its intent to prepay Base Rate Loans or Canadian Prime Rate Loans (or same day notice in the case of a
prepayment of Swingline Loans) and (B) at least three Business Days’ prior written notice (or telephonic notice 

  
 101

 
promptly confirmed in writing) of its intent to prepay LIBOR Loans or EURIBOR Loans, which notice (in each case) shall specify whether Revolving Loans or Swingline Loans shall be prepaid, the
amount of such prepayment and the Types of Loans to be prepaid and, in the case of LIBOR Loans or EURIBOR Loans, the specific Borrowing or Borrowings pursuant to which such LIBOR Loans or EURIBOR Loans were made, and which notice the Administrative
Agent shall, promptly transmit to each of the Lenders; (ii) (x) each partial prepayment of Revolving Loans pursuant to this Section 5.01(a) shall be in an aggregate principal amount of at least $500,000, £500,000, €500,000
or CA$500,000, as applicable (or such lesser amount as is acceptable to the Administrative Agent) and (y) each partial prepayment of Swingline Loans pursuant to this Section 5.01(a) shall be in an aggregate principal amount of at least
$100,000, £100,000 or €100,000, as applicable (or such lesser amount as is acceptable to the Administrative Agent in any given case); provided that if any partial prepayment of US LIBOR Loans made pursuant to any Borrowing shall reduce
the outstanding principal amount of US LIBOR Loans made pursuant to such Borrowing to an amount less than the Minimum Borrowing Amount applicable thereto, then such Borrowing may not be continued as a Borrowing of US LIBOR Loans (and same shall
automatically be converted into a Borrowing of Base Rate Loans) and any election of an Interest Period with respect thereto given by such Borrower shall have no force or effect, and if any partial prepayment of UK Revolving Loans made pursuant to
any Borrowing shall reduce the outstanding principal amount of UK Revolving Loans made pursuant to such Borrowing to an amount less than the Minimum Borrowing Amount applicable thereto, then such Borrowing shall automatically be converted into a
Borrowing of UK Revolving Loans with an Interest Period of one week; (iii) each prepayment pursuant to this Section 5.01(a) in respect of any Loans made pursuant to a Borrowing shall be applied pro rata among such Loans; provided that at
such Borrower’s election in connection with any prepayment of Revolving Loans pursuant to this Section 5.01(a), such prepayment shall not, so long as no Default or Event of Default then exists, be applied to any Revolving Loan of a
Defaulting Lender; and (iv) the respective Borrower shall pay all compensation due with respect to such prepayment specified in Section 2.11 concurrently with such prepayment. Prepayments of Bankers’ Acceptance Loans may not be made
prior the maturity date of the applicable underlying Bankers’ Acceptance. 
 (b) In the event of certain
refusals by a Lender to consent to certain proposed changes, waivers, discharges or terminations with respect to this Agreement which have been approved by the Required Lenders as (and to the extent) provided in Section 13.12(b), the
Borrowers may, upon five Business Days’ prior written notice to the Administrative Agent at the Notice Office (which notice the Administrative Agent shall promptly transmit to each of the Lenders), repay all Loans of such Lender, together with
accrued and unpaid interest, Fees and all other amounts then owing to such Lender (including all amounts, if any, owing pursuant to Section 2.11) in accordance with, and subject to the requirements of Section 13.12(b), so
long as (i) in the case of the repayment of Revolving Loans of any Lender pursuant to this clause (b), (A) the Revolving Loan Commitment of such Lender is terminated concurrently with such repayment pursuant to Section 4.02(b)
(at which time Schedule 1.01(a) shall be deemed modified to reflect the changed Revolving Loan Commitments) and (B) such Lender’s RL Percentage of all outstanding Letters of Credit is cash collateralized in a manner satisfactory to
the Administrative Agent and the respective Issuing Lenders and (ii) the consents, if any, required by Section 13.12(b) in connection with the repayment pursuant to this clause (b) shall have been obtained. 

5.02 Mandatory Repayments; Cash Collateralization. (a) (i) On any day on which the Aggregate US Exposure
exceeds (A) the US Borrowing Base at such time (based on the Borrowing Base Certificate last delivered) (other than during an Agent Advance Period) and/or (B) the US Maximum Amount at such time, then in each case, the US Borrowers jointly
and severally shall repay on such day the principal of US Swingline Loans and, after all US Swingline Loans have been repaid in full or if no US Swingline Loans are outstanding, US Revolving Loans in an amount equal to such excess. If, after giving
effect to the repayment of all outstanding US Swingline Loans and US Revolving Loans, the aggregate amount of the US Letter of Credit Outstandings exceeds (A) the US Borrowing Base at such

  
 102

 
time (based on the Borrowing Base Certificate last delivered) and/or (B) the US Maximum Amount at the time, then in each case, the US Borrowers jointly and severally shall pay to the
Administrative Agent at the Payment Office on such day an amount of cash and/or Cash Equivalents equal to the amount of such excess, such cash and/or Cash Equivalents to be held as security for all US Obligations of the US Borrowers to each
applicable US Issuing Lender and the Lenders hereunder in a cash collateral account to be established by, and under the sole dominion and control of, the Administrative Agent. Any such prepayment under this Section 5.02(a)(i) shall be
applied to reduce the outstanding principal balance of the US Revolving Loans, but shall not permanently reduce the Revolving Loan Commitments; 
 (ii) On any day on which the aggregate amount of the US Letter of Credit Outstandings exceeds the Maximum US Letter of Credit Amount, the US Borrowers jointly and severally shall pay to the Administrative
Agent at the Payment Office on such day an amount of cash and/or Cash Equivalents equal to the amount of such excess, such cash and/or Cash Equivalents to be held as security for all US Obligations of the US Borrowers to each applicable US Issuing
Lender and the Lenders hereunder in a cash collateral account to be established by, and under the sole dominion and control of, the Administrative Agent; 
 (iii) On any day (including on any date on which Equivalent Amounts are determined pursuant to Section 2.17) on which the Aggregate UK Exposure exceeds (A) the UK Borrowing Base at such
time (based on the Borrowing Base Certificate last delivered) (other than during an Agent Advance Period) and/or (B) the UK Maximum Amount at such time, then in each case, the UK Borrowers, jointly and severally, shall repay on such day the
principal of UK Swingline Loans and, after all UK Swingline Loans have been repaid in full or if no UK Swingline Loans are outstanding, UK Revolving Loans in an amount equal to such excess. If, after giving effect to the repayment of all outstanding
UK Swingline Loans and UK Revolving Loans, the aggregate amount of the UK Letter of Credit Outstandings exceeds (A) the UK Borrowing Base at such time (based on the Borrowing Base Certificate last delivered) and/or (B) the UK Maximum
Amount at the time, then in each case, the UK Borrowers, jointly and severally, shall pay to the Administrative Agent at the Payment Office on such day an amount of cash and/or Cash Equivalents equal to the amount of such excess, such cash and/or
Cash Equivalents to be held as security for all UK Obligations of the UK Borrowers to each applicable UK Issuing Lender and the Lenders hereunder in a cash collateral account to be established by, and under the sole dominion and control of, the
Administrative Agent. Any such prepayment under this Section 5.02(a)(iii) shall be applied to reduce the outstanding principal balance of the UK Revolving Loans, but shall not permanently reduce the Revolving Loan Commitments;

 (iv) On any day (including on any date on which Equivalent Amounts are determined pursuant to
Section 2.17) on which the aggregate amount of the UK Letter of Credit Outstandings exceeds the Maximum UK Letter of Credit Amount, the UK Borrowers jointly and severally shall pay to the Administrative Agent at the Payment Office on
such day an amount of cash and/or Cash Equivalents equal to the amount of such excess, such cash and/or Cash Equivalents to be held as security for all UK Obligations of the UK Borrowers to each applicable UK Issuing Lender and the Lenders hereunder
in a cash collateral account to be established by, and under the sole dominion and control of, the Administrative Agent; 
 (v) On any day (including on any date on which Equivalent Amounts are determined pursuant to Section 2.17) on which the Aggregate Canadian Exposure exceeds (A) the Canadian Borrowing Base
at such time (based on the Borrowing Base Certificate last delivered) and/or (B) the Canadian Maximum Amount at such time, then in each case, the Canadian Borrowers, jointly and severally, shall repay on such day the principal of outstanding
Canadian Revolving Loans (other than Bankers’ Acceptance Loans where the underlying B/A Instruments have not matured) in an amount equal to such excess. If, after giving effect to the repayment of all outstanding Canadian Revolving Loans to

  
 103

 
the extent required by the immediately preceding sentence, the aggregate amount of all outstanding Bankers’ Acceptance Loans and/or Canadian Letter of Credit Outstandings exceeds
(A) the Canadian Borrowing Base at such time (based on the Borrowing Base Certificate last delivered) and/or (B) the Canadian Maximum Amount at the time, then in each case, the Canadian Borrowers, jointly and severally, shall pay to the
Administrative Agent at the Payment Office on such day an amount of cash and/or Cash Equivalents equal to the amount of such excess, such cash and/or Cash Equivalents to be held as security for all Canadian Obligations of the Canadian Borrowers to
each applicable Canadian Issuing Lender and the Lenders hereunder in a cash collateral account to be established by, and under the sole dominion and control of, the Administrative Agent. Any such prepayment under this Section 5.02(a)(iv)
shall be applied to reduce the outstanding principal balance of the Canadian Revolving Loans, but shall not permanently reduce the Revolving Loan Commitments; and 

(vi) On any day (including on any date on which Equivalent Amounts are determined pursuant to Section 2.17)
on which the aggregate amount of the Canadian Letter of Credit Outstandings exceeds the Maximum Canadian Letter of Credit Amount, the Canadian Borrowers jointly and severally shall pay to the Administrative Agent at the Payment Office on such day an
amount of cash and/or Cash Equivalents equal to the amount of such excess, such cash and/or Cash Equivalents to be held as security for all Canadian Obligations of the Canadian Borrowers to each applicable Canadian Issuing Lender and the Lenders
hereunder in a cash collateral account to be established by, and under the sole dominion and control of, the Administrative Agent. 
 (b) (i) If US Company or any Domestic Subsidiary issues any additional Indebtedness not permitted by this Agreement (other than intercompany Indebtedness) or obtains proceeds from any capital
contributions or the issuance of any Equity Interests, US Company shall pay to Administrative Agent for the ratable benefit of Lenders, when and as received by any US Borrower or Domestic Subsidiary thereof and as a mandatory prepayment of the US
Obligations, or if none are outstanding, the UK Obligations and the Canadian Obligations, pro rata, a sum equal to 100% of the net cash proceeds to US Company or such Domestic Subsidiary of the issuance of such Indebtedness or Equity Interest or
capital contribution. Any such prepayment shall be applied to reduce the outstanding principal balance of the US Revolving Loans, or if none are outstanding, the UK Revolving Loans and the Canadian Revolving Loans, pro rata, but shall not
permanently reduce the Revolving Loan Commitments, the UK Revolving Loan Commitments or the Canadian Revolving Loan Commitments; and (ii) if UK Company, Canadian Company or any other UK Subsidiary or Canadian Subsidiary (or, in each case, any
Subsidiary thereof) issues any additional Indebtedness (other than intercompany Indebtedness) or obtains proceeds from any capital contributions or the issuance any Equity Interests, UK Company or Canadian Company, as applicable, shall pay to
Administrative Agent for the ratable benefit of Lenders, when and as received by any UK Borrower, Canadian Borrower or other UK Subsidiary or Canadian Subsidiary thereof and as a mandatory prepayment of the UK Obligations and the Canadian
Obligations, pro rata, a sum equal to 100% of the net cash proceeds to UK Company or such other UK Subsidiary of the issuance of such Indebtedness or Equity Interest or capital contribution. Any such prepayment shall be applied to reduce the
outstanding principal balance of the UK Revolving Loans and the Canadian Revolving Loans, but shall not permanently reduce the UK Revolving Loan Commitments or the Canadian Revolving Loan Commitments. If the proceeds of the issuance of Equity
Interests are to be used to redeem or repurchase Senior Notes or Permitted Additional Financing Indebtedness in accordance with Section 10.04 hereof, such proceeds shall be paid to Administrative Agent for application to the Revolving
Loans but, subject to the terms of this Agreement, may be reborrowed for such redemption or repurchase. 
 (c)
(i) Except as provided in Section 10.03(i) or (iv), if US Company or any of its Domestic Subsidiaries sells or otherwise disposes of any of its Equipment or Real Property or other Collateral or assets, or if a Casualty Loss occurs with
respect to any of the Collateral, US Company shall, unless otherwise agreed by the Required Lenders, pay to Administrative Agent for the ratable benefit of 

  
 104

 
Lenders as and when received by US Company or such Domestic Subsidiary and as a mandatory prepayment of the Loans, as herein provided, a sum equal to the proceeds (including insurance payments
and condemnation awards but net of costs and taxes incurred in connection with such sale or event) (“Sale Proceeds”) received by US Company or such Domestic Subsidiary from such sale or Casualty Loss. The applicable prepayment shall
be applied to reduce the outstanding principal balance of the US Revolving Loans, or if none are outstanding, the UK Revolving Loans and the Canadian Revolving Loans, pro rata, but, except as provided below, shall not permanently reduce the
Revolving Loan Commitments, the UK Revolving Loan Commitments or the Canadian Revolving Loan Commitments; provided that any sale or Casualty Loss of Inventory, Equipment or Eligible Real Property by a US Credit Party shall reduce the US
Borrowing Base to the extent of such applicable Property’s contribution to the US Borrowing Base. Such reduction shall be effective on the date of consummation of the sale or receipt of proceeds of a Casualty Loss. If US Company and its
Domestic Subsidiaries do not reinvest the proceeds of any sales or other dispositions of assets within 364 days after receipt of such proceeds in assets used in their business and would be required to make a “Net Proceeds Offer” (as
defined in any Senior Note Indenture or Permitted Additional Financing Document), then the Revolving Loan Commitments shall be automatically permanently reduced by an amount equal to the uninvested portion of such proceeds on the 364th day after receipt of such proceeds. 

(ii) If US Company or any of its Domestic Subsidiaries sells or otherwise disposes of any of its
Equipment or Real Property or other Collateral or assets pursuant to Section 10.03 (ix) or US Company or any of its Domestic Subsidiaries or the LKE Qualified Intermediary otherwise receives any LKE Proceeds, US Company shall,
unless otherwise agreed by the Required Lenders, pay to Administrative Agent for the ratable benefit of Lenders as and when received by US Company or such Domestic Subsidiary or the LKE Qualified Intermediary and as a mandatory prepayment of the
Loans, as herein provided, the Sale Proceeds received by US Company or such Domestic Subsidiary or the LKE Qualified Intermediary from such sale; provided that solely in the event that the LKE Qualified Intermediary shall have received and
retained (pending any permitted reinvestment described below) in the LKE Joint Account any LKE Proceeds (in an aggregate amount not to exceed at any time $25,000,000) in accordance with any LKE Master Exchange Agreement, no such prepayment shall be
required (A) for the period commencing on the date of the applicable sale and ending on the earliest of (I) 180 days thereafter, (II) an Event of Default and (III) the commencement of a Compliance Period (such period, the “LKE
Period”) and (B) with respect to all or a portion of such LKE Proceeds if and only to the extent that such LKE Proceeds are used within the applicable LKE Period to acquire assets in accordance with a LKE Transaction; provided
further that it is expressly understood and agreed that such prepayment shall be required with respect to any such LKE Proceeds that cause (or, if so deposited in the LKE Joint Account, would cause) the aggregate amount of funds deposited in the
LKE Joint Account to exceed at any time $25,000,000. The applicable prepayment shall be applied to reduce the outstanding principal balance of the US Revolving Loans, or if none are outstanding, the UK Revolving Loans and the Canadian Revolving
Loans, pro rata, but, except as provided below, shall not permanently reduce the Revolving Loan Commitments, the UK Revolving Loan Commitments or the Canadian Revolving Loan Commitments; provided that any sale of Inventory, Equipment or
Eligible Real Property by a US Credit Party shall reduce the US Borrowing Base to the extent of such applicable Property’s contribution to the US Borrowing Base. Such reduction shall be effective on the date of consummation of the sale or
receipt of proceeds of a Casualty Loss. If US Company and its Domestic Subsidiaries do not reinvest the proceeds of any sales or other dispositions of such assets within 364 days after receipt of such proceeds in assets used in their business and
would be required to make a “Net Proceeds Offer” (as defined in any Senior Note Indenture or Permitted Additional Financing Document), then the Revolving Loan Commitments shall be automatically permanently reduced by an amount equal to the
uninvested portion of such proceeds on the 364th day after
receipt of such proceeds. 
 (iii) Except as provided in Section 10.03(i) or (iv), if UK Company,
Canadian 

  
 105

 
Company or any other UK Subsidiary or Canadian Subsidiary sells or otherwise disposes of any of its Equipment or Real Property or other Collateral or assets, or if a Casualty Loss occurs with
respect to any of the Collateral, UK Company or Canadian Company, as applicable, shall, unless otherwise agreed by the Required Lenders, pay to Administrative Agent for the ratable benefit of Lenders as and when received by UK Company, Canadian
Company or such other UK Subsidiary or Canadian Subsidiary and as a mandatory prepayment of the UK Revolving Loans and the Canadian Revolving Loans, pro rata, as herein provided, a sum equal to the Sale Proceeds received by UK Company, Canadian
Company or such UK Subsidiary or Canadian Subsidiary from such sale or Casualty Loss. The applicable prepayment shall be applied to reduce the outstanding principal balance of the UK Revolving Loans and Canadian Revolving Loans, pro rata, but,
except as provided below, shall not permanently reduce the Revolving Loan Commitments, the UK Revolving Loan Commitments or the Canadian Revolving Loan Commitments; provided that any sale or Casualty Loss of Inventory or Equipment by a UK
Borrowing Base Party or Canadian Borrowing Base Party shall reduce the UK Borrowing Base or Canadian Borrowing Base, as applicable, to the extent of such applicable Property’s contribution to the UK Borrowing Base or Canadian Borrowing Base, as
applicable. Such reduction shall be effective on the date of consummation of the sale or receipt of proceeds of a Casualty Loss. If UK Company, Canadian Company and/or the other UK Subsidiaries or Canadian Subsidiaries do not reinvest the proceeds
of any sales or other dispositions of assets within 364 days after receipt of such proceeds in assets used in their business and would be required to make a “Net Proceeds Offer” (as defined in any Senior Note Indenture or Permitted
Additional Financing Document), then the UK Revolving Loan Commitments shall be automatically permanently reduced by an amount equal to the uninvested portion of such proceeds on the 364th day after receipt of such proceeds. 

(d) With respect to each repayment of Loans required by this Section 5.02, the Borrowers may designate the
Types of Loans which are to be repaid and, in the case of LIBOR Loans or EURIBOR Loans, the specific Borrowing or Borrowings pursuant to which such LIBOR Loans or EURIBOR Loans were made; provided that: (i) repayments of LIBOR Loans or
EURIBOR Loans pursuant to this Section 5.02 made on a day other than the last day of an Interest Period applicable thereto shall be subject to Section 2.11; (ii) if any repayment of LIBOR Loans or EURIBOR Loans made
pursuant to a single US Borrowing shall reduce the outstanding LIBOR Loans or EURIBOR Loans made pursuant to such US Borrowing to an amount less than the Minimum Borrowing Amount applicable thereto, such US Borrowing shall be automatically converted
into a Borrowing of Base Rate Loans; and (iii) each repayment of any Loans made pursuant to a Borrowing shall be applied pro rata among the Lenders holding such Loans. In the absence of a designation by a Borrower as described in the preceding
sentence, the Administrative Agent shall, subject to the above, make such designation in its sole discretion. 

(e) In addition to any other mandatory repayments pursuant to this Section 5.02, (i) all then
outstanding Swingline Loans shall be repaid in full on the Swingline Expiry Date and (ii) all then outstanding Revolving Loans shall be repaid in full on the Final Maturity Date. 

(f) In addition to any other mandatory repayments pursuant to this Section 5.02, each Swingline Loan will be
repaid (for the avoidance of doubt, such repayment may be made with proceeds from Revolving Loans) no later than the seventh day following the incurrence thereof; provided that, if the seventh day is not a Business Day, such repayment shall
be made on the next succeeding Business Day. 
 5.03 Method and Place of Payment. (a) Except as
otherwise specifically provided herein, all payments under this Agreement and under any Note shall be made to the Administrative Agent for the account of the Lender or Lenders entitled thereto not later than 12:00 Noon (New York City time) on the
date when due and shall be made, with respect to 

  
 106

 
US Obligations, in US Dollars, with respect to UK Obligations, in Pounds Sterling or Euros, as applicable, and with respect to Canadian Obligations, in Canadian Dollars, in immediately available
funds at the Payment Office. Whenever any payment to be made hereunder or under any Note shall be stated to be due on a day which is not a Business Day, the due date thereof shall be extended to the next succeeding Business Day and, with respect to
payments of principal, interest shall be payable at the applicable rate during such extension. 
 (b) Each US
Credit Party shall, along with the Collateral Agent and certain financial institutions selected by US Company and approved by the Administrative Agent (the “Collection Banks”), enter into on or prior to the Effective Date (as such
date may be extended from time to time by the Administrative Agent in its sole discretion) and thereafter maintain separate Cash Management Control Agreements. Each US Credit Party shall instruct all Account Debtors of such US Credit Party, as the
case may be, to remit all payments to the applicable “P.O. Boxes”, “Lockbox Addresses” or a sub-account of the Collection Account of the applicable Collection Bank with respect to all Accounts of such Account Debtor, which
remittances shall be collected by the applicable Collection Bank and deposited in the applicable Collection Account. All amounts received by any US Credit Party and any Collection Bank in respect of any Account, in addition to all other cash
received from any other source, shall upon receipt be deposited into a Collection Account or directly into the Concentration Account. 
 (c) All amounts held in all of the Collection Accounts, Disbursement Accounts, Designated Petty Cash Accounts, Designated Payroll Accounts and LKE Joint Accounts with respect to each US Credit Party shall
be wired by the close of business on each Business Day into one or more concentration accounts with the Collateral Agent and/or one or more other institutions reasonably acceptable to the Administrative Agent (each, a “Concentration
Account”) unless such amounts are otherwise required or permitted to be applied pursuant to Section 5.02; provided, however, (x) so long as no Default and no Event of Default then exists, a balance of up to
$10,000,000 in the aggregate may be maintained in all Disbursement Accounts, Designated Petty Cash Accounts and Designated Payroll Accounts and (y) so long as no Default and no Event of Default and no Compliance Period then exists, the LKE
Qualified Intermediary may retain during any applicable LKE Period in any LKE Joint Account any LKE Proceeds not required by Section 5.02(c)(ii) to be used to prepay the US Revolving Loans. Except as, and to the extent, provided in the proviso
to the immediately preceding sentence, all of the Collection Accounts, Disbursement Accounts, Designated Petty Cash Accounts and Designated Payroll Accounts shall be “zero” balance accounts. So long as no Event of Default or Compliance
Period then exists, the US Credit Parties shall be permitted to transfer cash from the Concentration Accounts to the Disbursement Accounts, the Designated Petty Cash Accounts and the Designated Payroll Accounts to be used for working capital and
general corporate purposes, all subject to the requirements of this Section 5.03(c) and pursuant to procedures and arrangements to be determined by the Administrative Agent. So long as no Default or Event of Default or Compliance Period
then exists, the US Credit Parties and the LKE Qualified Intermediary shall be permitted to transfer cash from the LKE Joint Accounts to be used to acquire assets in accordance with a LKE Transaction, subject to the requirements of this
Section 5.03(c) and pursuant to procedures and arrangements to be determined by the Administrative Agent. If an Event of Default or Compliance Period exists, all collected amounts held in the Concentration Accounts shall be applied as
provided in Section 5.03(d). 
 (d) (d) During the continuance of (i) a Compliance Period or an
Event of Default, all collected amounts held in the Concentration Accounts and (ii) an Event of Default, all amounts or proceeds of Collateral otherwise directed to be applied in accordance with this Section 5.03(d) by the terms of any
Security Document, shall, in each case, be distributed and applied on a daily basis in the following order (in each case, to the extent the Administrative Agent has actual knowledge of the amounts owing or outstanding as described below and after
giving effect to the application of any such amounts otherwise required to be applied pursuant to Section 5.02(b), (c) or (d) constituting proceeds 

  
 107

 
from any Collateral otherwise required to be applied pursuant to the terms of the respective Security Document): 

(i) first, to the payment (on a ratable basis) of any outstanding Expenses actually due and
payable to the Administrative Agent and/or the Collateral Agent under any of the Credit Documents and to repay or prepay outstanding Loans advanced by the Administrative Agent on behalf of the Lenders pursuant to Sections 2.01(i) and
2.04(d); 
 (ii) second, to the extent all amounts referred to in preceding clause
(i) have been paid in full, to pay (on a ratable basis) all outstanding Expenses actually due and payable to each Issuing Lender under any of the Credit Documents and to repay all outstanding Unpaid US Drawings, Unpaid UK Drawings and Unpaid
Canadian Drawings and all interest thereon; 
 (iii) third, to the extent all amounts
referred to in preceding clauses (i) and (ii) have been paid in full, to pay (on a ratable basis) all accrued and unpaid interest actually due and payable on the Loans and all accrued and unpaid Fees actually due and payable to the
Administrative Agent, the Issuing Lenders and the Lenders under any of the Credit Documents; 

(iv) fourth, to the extent all amounts referred to in preceding clauses (i) through (iii),
inclusive, have been paid in full, to repay the outstanding principal of Revolving Loans (whether or not then due and payable) and the Qualified Swap Termination Value under Qualified Derivative Obligations (provided that the aggregate amount of
Qualified Swap Termination Values paid pursuant to this clause (iv) shall not exceed the amount of the Reserves established for Qualified Swap Termination Values under clause (xi) of the definition of “Reserves”), ratably among
(A) the Lenders holding such Revolving Loans and (B) the Qualified Derivative Counterparties holding any such Qualified Derivative Obligations, in proportion to the respective amounts described in this clause (iv) held by them; and

 (v) fifth, to the extent all amounts referred to in preceding clauses (i) through
(iv), inclusive, have been paid in full, to pay (on a ratable basis) all other outstanding Obligations then due and payable to the Administrative Agent, the Collateral Agent, the Lenders and the other Secured Creditors, under any of the Credit
Documents or otherwise (including, without limitation, the Swap Termination Value of any Qualified Derivative Obligations (to the extent not paid pursuant to clause (iv) above) and any Banking Products Obligations); 

provided that, notwithstanding the foregoing, any such money, amounts and proceeds received, recovered or applied by the
Administrative Agent, the Collateral Agent or the Canadian Sub-Agent from any US Credit Party or otherwise pursuant to the US Security Agreement, the US Pledge Agreement, the UK Share Charge or the Canadian Share Charge or any other Security
Document securing all of the Obligations shall, within each of the foregoing sub-clauses (i) through (v), first be applied to the US Obligations of the Administrative Agent, the Collateral Agent, the Issuing Lenders and the Lenders entitled to
such payment within such sub-clause, and, thereafter, ratably, to the UK Obligations and Canadian Obligations of such Secured Creditors; and provided that further that all such moneys, amounts and proceeds received, recovered or applied by the
Collateral Agent, Administrative Agent or Canadian Sub-Agent from any UK Credit Party or Canadian Credit Party or otherwise pursuant to the UK Debenture, the UK Partnership Debenture, the Canadian Security Agreement, the Luxembourg Security
Documents or any other Security Document securing only the UK Obligations and the Canadian Obligations shall be applied in accordance with the above sub-clauses (i) through (v), but solely to the extent such foregoing Obligations constitute UK
Obligations or Canadian Obligations. 

  
 108

 (e) Each UK Subsidiary and each Canadian Subsidiary shall have entered into
a cash management system in form and substance satisfactory to the Administrative Agent, including as required under clauses 4.1 and 10 of the UK Debenture and UK Partnership Debenture and Section 3.11 of the Canadian Security Agreement.

 (f) Without limiting the provisions set forth in Section 13.15, the Administrative Agent shall
maintain accounts on its books in the name of each Borrower (collectively, the “Credit Account”) in which each Borrower will be charged with all loans and advances made by the Lenders to the respective Borrower for the respective
Borrower’s account, including the Loans, the Letter of Credit Outstandings, and the Fees, Expenses and any other Obligations relating thereto. Each Borrower will be credited, in accordance with this Section 5.03, with all amounts
received by the Lenders from such Borrower or from others for its account, including, as set forth above, all amounts received by the Administrative Agent and applied to the Obligations. In no event shall prior recourse to any Accounts or other
Collateral be a prerequisite to the Administrative Agent’s right to demand payment of any Obligation upon its maturity. Further, the Administrative Agent shall have no obligation whatsoever to perform in any respect any of the Borrowers’
or Guarantors’ contracts or obligations relating to the Accounts. 
 5.04 Net Payments – US
Borrowers. (a) To the extent permitted under Applicable Law, all payments made by or on behalf of the US Borrowers hereunder and under any Note will be made without setoff, counterclaim or other defense. All such payments will be made free
and clear of, and without deduction or withholding for, any present or future taxes, levies, imposts, duties, fees, assessments or other charges of whatever nature now or hereafter imposed by any jurisdiction or by any political subdivision or
taxing authority thereof or therein with respect to such payments, including any interest, additions or tax or penalties applicable thereto (“Taxes”) (but excluding, except as provided in the second succeeding sentence, (i) any tax
imposed on or measured by the net income, branch profits taxes, and franchise taxes imposed in lieu of income taxes of a Lender that holds US Obligations pursuant to the laws of the jurisdiction in which it is organized or the jurisdiction in which
the principal office or applicable lending office of such Lender is located or any subdivision thereof or therein, or Other Connection Taxes (ii) in the case of a Non-U.S. Lender that holds US Obligations (other than an assignee pursuant to a
request by a Borrower under Section 2.13), any withholding tax that is imposed on amounts payable to such Non-U.S. Lender at the time such Non-U.S. Lender becomes a party hereto (except to the extent that such Lender’s assignor (if any)
would have been entitled, at the time of assignment, to receive additional amounts from the Borrower with respect to such withholding tax pursuant by this Section 5.04(a) but for such assignment) or is attributable to such Non-U.S.
Lender’s failure (other than as a result of a Change in Law) to comply with Section 5.04(b), and (iii) any US Federal withholding taxes imposed under FATCA) (all such non-excluded taxes, levies, imposts, duties, fees, assessments or
other charges or withholding of a similar nature (including any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same) being referred to collectively as “Indemnified Taxes”). If any Taxes
are so levied or imposed, the US Borrowers jointly and severally agree to pay the full amount of such Taxes, and such additional amounts as may be necessary so that every payment of all amounts due under this Agreement or under any Note, after
withholding or deduction for or on account of any Indemnified Taxes, will not be less than the amount provided for herein or in such Note. If any amounts are payable in respect of Indemnified Taxes pursuant to the preceding sentence, the US
Borrowers jointly and severally agree to reimburse each Lender that holds US Obligations, upon the written request of such Lender, for taxes imposed on or measured by the net income or profits (including branch profits taxes) and franchise or
similar taxes imposed in lieu of income taxes of such Lender pursuant to the laws of the jurisdiction in which such Lender is organized or in which the principal office or applicable lending office of such Lender is located or under the laws of any
political subdivision or taxing authority of any such jurisdiction in which such Lender is organized or in which the principal office or applicable lending office of such Lender is located and for any withholding of taxes as such Lender shall
determine are payable by, 

  
 109

 
or withheld from, such Lender, in respect of such amounts so paid to or on behalf of such Lender pursuant to the preceding sentence and in respect of any amounts paid to or on behalf of such
Lender pursuant to this sentence. The US Borrowers will furnish to the Administrative Agent within 45 days after the date the payment of any Indemnified Taxes is due pursuant to Applicable Law certified copies of tax receipts evidencing such payment
by such US Borrowers. The US Borrowers jointly and severally agree to indemnify and hold harmless each Lender that holds US Obligations, and reimburse such Lender upon its written request, for the amount of any Indemnified Taxes so levied or imposed
and paid by such Lender and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. 

(b) Status of Lenders. 

(i) Each Lender that is a United States person (as such term is defined in Section 7701(a)(30) of
the Code) for US Federal income tax purposes, which holds US Obligations, agrees to deliver to US Company and the Administrative Agent, to the extent reasonably requested by either US Company or the Administrative Agent, two accurate and complete
original signed copies of Internal Revenue Services Form W-9 (or successor forms), or other documentation reasonably satisfactory to US Company, certifying to such Lender’s exemption from back-up withholding. 

(ii) Each Lender that is not a United States person (as such term is defined in Section 7701(a)(30)
of the Code) for US Federal income tax purposes (each, a “Non-U.S. Lender”), which holds US Obligations, agrees to deliver to US Company and the Administrative Agent on or prior to the Effective Date or, in the case of a Non-U.S.
Lender, which holds US Obligations, and that is an assignee or transferee of an interest under this Agreement pursuant to Section 2.13 or 13.04(b) (unless the respective Lender was already a Lender hereunder immediately prior to
such assignment or transfer), on the date of such assignment or transfer to such Lender, in each case, only if such Lender is legally entitled to do so, whichever of the following is applicable: 

 

	 	(A)	 two accurate and complete original signed copies of Internal Revenue Service Form W-8ECI or Form W-8BEN (with respect to an exemption under an
income tax treaty) (or successor forms) certifying to such Lender’s entitlement as of such date to an exemption from United States withholding tax with respect to payments to be made under this Agreement and under any Note;

  

	 	(B)	 if such Lender is not a “bank” within the meaning of Section 881(c)(3)(A) of the Code and cannot deliver either Internal Revenue
Service Form W-8ECI or Form W-8BEN (or any successor forms) pursuant to clause (A) above, (x) a certificate substantially in the form of Exhibit I (any such certificate, a “Section 5.04(b)(ii) Certificate”) and
(y) two accurate and complete original signed copies of Internal Revenue Service Form W-8BEN (with respect to the portfolio interest exemption) (or successor form) certifying to such Lender’s entitlement as of such date to an exemption
from United States withholding tax with respect to payments of interest to be made under this Agreement and under any Note; or 

  

	 	(C)	 Internal Revenue Service Form W-8IMY (together with any applicable forms listed in (i) and (ii) of this Section) certifying to such
Lender’s entitlement as of such date to an exemption from United States withholding tax with respect to payments to be made under this Agreement and under any Note. 

  
 110

 (iii) If a payment made to a Lender under this Agreement
would be subject to U.S. federal withholding tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable),
such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law
(including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply
with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause (iii),
“FATCA” shall include any amendments made to FATCA after the date of this Agreement. 

(iv) In addition, each Lender that holds US Obligations agrees that from time to time after the Effective
Date, when a lapse in time or change in circumstances renders the previous certification obsolete or inaccurate in any material respect, such Lender will deliver (only if such Non-U.S. Lender is legally entitled to do so) to US Company and the
Administrative Agent two new accurate and complete original signed copies of the applicable Forms or other Certificates described above as may be required in order to confirm or establish the entitlement of such Lender to a continued exemption from
or reduction in United States withholding tax with respect to payments under this Agreement and any Note, or such Lender shall immediately notify US Company and the Administrative Agent of its inability to deliver any such Form or Certificate, in
which case such Lender shall not be required to deliver any such Form or Certificate pursuant to this Section 5.04(b). 
 5.05 Tax Gross Up and Indemnities – UK Subsidiaries. 

(a) Definitions.  
 In this Section: 
 “Borrower DTTP Filing” means an HM
Revenue & Customs’ Form DTTP2 duly completed and filed by the relevant Borrower, which: 
 (i) where it relates to a Treaty Lender that is an Lender set forth on Part II of Schedule 1.01(a) hereof as of the Effective Date (each an “Original Treaty Lender”), contains the
scheme reference number and jurisdiction of tax residence stated opposite that Original Treaty Lender’s name in Part II of Schedule 1.01(a), and 

(A) where the Borrower is a Borrower as of the Effective Date (each an “Original
Borrower”), is filed with HM Revenue & Customs within 30 days of the date of this Agreement; or 
 (B) where the Borrower is a Borrower that becomes a Borrower under this Agreement after the date hereof (each an “Additional Borrower”), is filed with HM Revenue & Customs within
30 days of the date on which that Borrower becomes an Additional Borrower; or 

  
 111

 (ii) where it relates to a Treaty Lender that becomes a
Lender after the date of this Agreement (each an “Additional Treaty Lender”), contains the scheme reference number and jurisdiction of tax residence stated in respect of that Lender in the relevant Assignment and Assumption
Agreement, and 
 (A) where the Borrower is a Borrower as at the effective date of the relevant
Assignment and Assumption Agreement (the “Assignment Date”), is filed with HM Revenue & Customs within 30 days of that Assignment Date; or 

(B) where the Borrower is not a Borrower as at the relevant Assignment Date, is filed with HM
Revenue & Customs within 30 days of the date on which that Borrower becomes an Additional Borrower. 

“CTA” means the Corporation Tax Act 2009. 

“ITA” means the United Kingdom Income Tax Act 2007. 

“Party” means a party to this Agreement. 

“Protected Party” means a Lender which is or will be subject to any liability, or required to make any
payment, for or on account of Tax in relation to a sum received or receivable (or any sum deemed for the purposes of Tax to be received or receivable) under a Credit Document. 

“Qualifying Lender” means: 

(i) a Lender (other than a Lender within sub-paragraph (ii) below) which is beneficially entitled to
interest payable to that Lender in respect of an advance under a Credit Document and is: 
  

	 	(A)	 a Lender: 

  

	 	(1)	 which is a bank (as defined for the purpose of section 879 of the ITA) making an advance under a Credit Document; or 

 

	 	(2)	 in respect of an advance made under a Credit Document by a person that was a bank (as defined for the purpose of section 879 of the ITA) at the time
that that advance was made, 

 and which is within the charge to United Kingdom corporation
tax as respects any payments of interest made in respect of that advance; or 
  

	 	(B)	 a Lender which is: 

  

	 	(1)	 a company resident in the United Kingdom for United Kingdom tax purposes; 

 

	 	(2)	 a partnership each member of which is: 

  

	 	(a)	 a company so resident in the United Kingdom; or 

  
 112

	 	(b)	 a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings
into account in computing its chargeable profits (within the meaning of section 19 of the CTA) the whole of any share of interest payable in respect of that advance that falls to it by reason of part 17 of the CTA; 

 

	 	(3)	 a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings
into account interest payable in respect of that advance in computing the chargeable profits (within the meaning of section 19 of the CTA) of that company; or 

 

	 	(C)	 a Treaty Lender; or 

 (ii) a Lender which is a building society (as defined for the purpose of section 880 of the ITA) making an advance under a Credit Document). 

“Tax” means any present or future taxes, levies, imposts, duties, withholdings, fees, assessments or
other charges of whatever nature now or hereafter imposed by any jurisdiction or by any political subdivision or taxing authority thereof or therein with respect to such payments, including any interest, additions or tax or penalties applicable
thereto. 
 “Tax Confirmation” means a confirmation by a Lender that the person beneficially
entitled to interest payable to that Lender in respect of an advance under a Credit Document is either: 
  

	 	(i)	 a company resident in the United Kingdom for United Kingdom tax purposes; 

 

	 	(ii)	 a partnership each member of which is: 

  

	 	(A)	 a company so resident in the United Kingdom; or 

  

	 	(B)	 a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings
into account in computing its chargeable profits (within the meaning of section 19 of the CTA) the whole of any share of interest payable in respect of that advance that falls to it by reason of part 17 of the CTA; or 

 

	 	(C)	 a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings
into account interest payable in respect of that advance in computing the chargeable profits (within the meaning of section 19 of the CTA) of that company. 

“Tax Credit” means a credit against, relief or remission for, or repayment of any Tax. 

“Tax Deduction” means a deduction or withholding for or on account of Tax from a payment under a Credit
Document. 

  
 113

 “Tax Payment” means either the increase in a payment made
by a UK Subsidiary to a Lender under Section 5.05(b) (Tax gross-up) or a payment under Section 5.05(c) (Tax indemnity). 
 “Treaty Lender” means a Lender which: 
 (i) is treated as a resident of a Treaty State for the purposes of the Treaty; and 
 (ii) does not carry on a business in the United Kingdom through a permanent establishment with which that Lender’s participation in the Loan is effectively connected. 

“Treaty State” means a jurisdiction having a double taxation agreement (a “Treaty”)
with the United Kingdom which makes provision for full exemption from tax imposed by the United Kingdom on interest. 
 “UK Non-Bank Lender” means: 
 (i)
where a Lender becomes a Party on the day on which this Agreement is entered into, a Lender listed on Schedule 1.01(a); and 
 (ii) where a Lender becomes a Party after the day on which this Agreement is entered into, a Lender which gives a Tax Confirmation in the Assignment and Assumption Agreement which it executes on becoming
a Party. 
 “VAT” means value added tax as provided for in the United Kingdom Value Added Tax
Act 1994 and any other tax of a similar nature, wherever imposed. 
 (b) Tax Gross-Up.

 (i) Each UK Subsidiary shall make all payments to be made by it without any Tax Deduction,
unless a Tax Deduction is required by law. 
 (ii) The UK Company shall promptly upon becoming
aware that a UK Subsidiary must make a Tax Deduction (or that there is any change in the rate or the basis of a Tax Deduction) notify the Administrative Agent accordingly. Similarly, a Lender shall notify the Administrative Agent on becoming so
aware in respect of a payment payable to that Lender; provided that any failure to deliver any such notification shall not constitute a failure to comply with such Lender’s express obligations under, where applicable, subparagraph (vii) or
(x) below. If the Administrative Agent receives such notification from a Lender it shall notify the UK Company and that UK Subsidiary. 
 (iii) If a Tax Deduction is required by law to be made by a UK Subsidiary, the amount of the payment due from that UK Subsidiary shall be increased to an amount which (after making any Tax Deduction)
leaves an amount equal to the payment which would have been due if no Tax Deduction had been required. 
 (iv) A UK Subsidiary is not required to make an increased payment to a Lender under paragraph (b)(iii) above for a Tax Deduction in respect of tax imposed by the United Kingdom from a payment of interest
on a Loan, if on the date on which the payment falls due: 
  

	 	(A)	 the payment could have been made to the relevant Lender without a Tax Deduction if it was a Qualifying Lender, but on that date that Lender is

  
 114

	 	 
not or has ceased to be a Qualifying Lender other than as a result of any change after the date it became a Lender under this Agreement in (or in the interpretation, administration, or
application of) any law or Treaty, or any published practice or concession of any relevant taxing authority; or 

  

	 	(B)   (1)	 the relevant Lender is a Qualifying Lender solely under sub-paragraph (i)(B) of the definition of Qualifying Lender; 

 

	 	(2)	 an officer of H.M. Revenue & Customs has given (and not revoked) a direction (a “Direction”) under section 931 of the ITA
(as that provision has effect on the date on which the relevant Lender became a Party) which relates to that payment and that Lender has received from that UK Subsidiary or the UK Company a certified copy of that Direction; and

  

	 	(3)	 the payment could have been made to the Lender without any Tax Deduction in the absence of that Direction; or 

 

	 	(C)	 the relevant Lender is a Qualifying Lender solely under sub-paragraph (i)(B) of the definition of Qualifying Lender and it has not given a Tax
Confirmation to the UK Company; or 

  

	 	(D)	 the relevant Lender is a Treaty Lender and the UK Subsidiary making the payment is able to demonstrate to the satisfaction of the Administrative
Agent (in its sole discretion) that the payment could have been made to the Lender without the Tax Deduction had that Lender not failed to satisfy its express obligations under, where applicable, subparagraph (vii) or (x) below, after the
express written request from a Borrower to do so. 

 (v) If a UK Subsidiary is
required to make a Tax Deduction, that UK Subsidiary shall make that Tax Deduction and any payment required in connection with that Tax Deduction within the time allowed and in the minimum amount required by law. 

(vi) Within thirty days of making either a Tax Deduction or any payment required in connection with that
Tax Deduction, the UK Subsidiary making that Tax Deduction shall deliver to the Administrative Agent for the Lender entitled to the payment a statement under Section 975 of the ITA or other evidence reasonably satisfactory to that Lender that
the Tax Deduction has been made or (as applicable) any appropriate payment paid to the relevant taxing authority. 
 (vii) Subject to subparagraph (ix) below, each Treaty Lender shall, upon the express written request of the applicable UK Subsidiary which makes, or may make, a payment to which such Treaty Lender is
entitled, use reasonable efforts to co-operate with such UK Subsidiary or such other Person in completing any procedural formalities reasonably requested by such UK Subsidiary and necessary for that UK Subsidiary to obtain authorisation to make that
payment without a Tax Deduction. 
 (viii) Each Original Treaty Lender set forth on Part II of
Schedule 1.01(a) hereof hereby (A) confirms that it holds a passport under the HMRC DT Treaty Passport scheme, (B) elects that scheme to apply to such Lender’s Commitment and its participation in any Loan hereunder and
(C) confirms its scheme reference number and its jurisdiction of tax residence, in each case set forth opposite its name in Part II of Schedule 1.01(a); and having done so, that Lender shall be under no further obligation pursuant to
subparagraph (vii) above. 

  
 115

 (ix) Each Additional Treaty Lender that becomes a Lender
after the date of this Agreement that elects to (A) confirm that it holds a passport under the HMRC DT Treaty Passport scheme, (B) elect that scheme to apply to such Lender’s participation in this Agreement and (C) confirms its
scheme reference number and its jurisdiction of tax residence, shall, in each case, do so in the Assignment and Assumption Agreement to which it is a party; and having done so, that Lender shall be under no further obligation pursuant to
subparagraph (vii) above. 
 (x) If a Lender has confirmed its scheme reference number and
its jurisdiction of tax residence in accordance with paragraph (viii) or (ix) above and: 
  

	 	(A)	 a Borrower making a payment to that Lender has not made a Borrower DTTP Filing in respect of that Lender; or 

 

	 	(B)	 a Borrower making a payment to that Lender has made a Borrower DTTP Filing in respect of that Lender but (1) that Borrower DTTP Filing has been
rejected by HM Revenue & Customs; or (2) HM Revenue & Customs has not given the Borrower authority to make payments to that Lender without a Tax Deduction within 60 days of the date of the Borrower DTTP Filing

 and in each case, the Borrower has notified that Lender in writing requesting such
cooperation, the applicable Lender shall use its reasonable efforts to co-operate with the applicable Borrower in completing any additional procedural formalities necessary for that Borrower to obtain authorisation to make that payment without a Tax
Deduction. 
 (xi) If a Treaty Lender has not made the HMRC DT Treaty Passport scheme elections
and confirmations in accordance with paragraph (viii) or (ix) above, as applicable, no Borrower shall make a Borrower DTTP Filing or file any other form relating to the HMRC DT Treaty Passport scheme in respect of a Commitment by such
Lender or its participation in any Loan unless the Lender otherwise agrees. 
 (xii) Each
Borrower shall, promptly on making any Borrower DTTP Filing, deliver a copy of that Borrower DTTP Filing to the Administrative Agent for delivery to the relevant Lender. 

(xiii) A UK Non-Bank Lender which becomes a Party on the day on which this Agreement is entered into
gives a Tax Confirmation to the UK Company by entering into this Agreement. 
 (xiv) A UK
Non-Bank Lender shall promptly notify the UK Company and the Administrative Agent if there is any change in the position from that set out in the Tax Confirmation. 

(c) Tax Indemnity. 

(i) The UK Company shall (within three Business Days of demand by the Administrative Agent) pay to a
Protected Party an amount equal to the loss, liability or cost which that Protected Party determines will be or has been (directly or indirectly) suffered for or on account of Tax by that Protected Party in respect of a Credit Document 

  
 116

	 	(ii)	 Paragraph (a) above shall not apply: 

  

	 	(A)	 with respect to any Tax assessed on a Lender: 

  

	 	(1)	 under the law of the jurisdiction in which that Lender is incorporated or, if different, the jurisdiction (or jurisdictions) in which that Lender is
treated as resident for tax purposes; or 

  

	 	(2)	 under the law of the jurisdiction in which that Lender’s lending office is located in respect of amounts received or receivable in that
jurisdiction, 

 if that Tax is imposed on or calculated by reference to the net income
received or receivable (but not any sum deemed to be received or receivable) by that Lender; 
  

	 	(B)	 to the extent a loss, liability or cost: 

  

	 	(1)	 (A) is compensated for by an increased payment under Section 5.05(b) (Tax gross-up); or 

 

	 	(2)	 would have been compensated for by an increased payment under Section 5.05(b) (Tax gross-up) but was not so compensated solely because
one of the exclusions in paragraph (d) of Section 5.05(b) (Tax gross-up) applied. 

 (iii) A Protected Party making, or intending to make a claim under paragraph (a) above shall promptly notify the Administrative Agent of the event which will give, or has given, rise to the claim,
following which the Administrative Agent shall notify the UK Company. 
 (iv) A Protected Party
shall, on receiving a payment from a UK Subsidiary under this Section 5.05(c), notify the Administrative Agent. 
 (d) Tax Credit. 
 If a UK Subsidiary makes
a Tax Payment and the relevant Lender determines in its sole discretion that: 
  

	 	(a)	 a Tax Credit is attributable either to an increased payment of which that Tax Payment forms part, or to that Tax Payment or to a Tax Deduction in
consequence of which that Tax Payment was repaired; and 

  

	 	(b)	 that Lender has obtained, utilised and retained that Tax Credit, 

the Lender shall pay an amount to the UK Subsidiary which that Lender determines in its sole discretion will leave it
(after that payment) in the same after-Tax position as it would have been in had the Tax Payment not been required to be made by the UK Subsidiary. 
 (e) Stamp Taxes. 

  
 117

 The UK Company shall pay and, within three Business Days of demand,
indemnify each Lender against any cost, loss or liability that Lender incurs in relation to all stamp duty, registration and other similar Taxes payable in respect of any Credit Document. 

(f) Value Added Tax. 

(i) All amounts set out, or expressed to be payable under a Credit Document by any Party to a Lender
which (in whole or in part) constitute the consideration for any supply for VAT purposes shall be deemed to be exclusive of any VAT which is chargeable on such supply, and accordingly, subject to paragraph (c) below, if VAT is chargeable on any
supply made by any Lender to any Party under a Credit Document, that Party shall pay to the Lender (in addition to and at the same time as paying the consideration) an amount equal to the amount of the VAT (and such Lender shall promptly provide an
appropriate VAT invoice to such Party). 
 (ii) If VAT is chargeable on any supply made by any
Lender (the “Supplier”) to any other Lender (the “Receiver”) under a Credit Document, and any Party (the “Relevant Party”) is required by the terms of any Credit Document to pay an amount equal to
the consideration for such supply to the Supplier (rather than being required to reimburse the Receiver in respect of that consideration), such Party shall also pay to the Supplier (in addition to and at the same time as paying such amount) an
amount equal to the amount of such VAT. The Receiver will promptly pay to the Relevant Party an amount equal to any credit or repayment from the relevant tax authority which it reasonably determines relates to the VAT chargeable on that supply.

 (iii) Where a Credit Document requires any Party to reimburse a Lender for any costs or
expenses, that Party shall also at the same time pay and indemnify the Lender against all VAT incurred by the Lender in respect of the costs or expenses to the extent that the Lender reasonably determines that neither it nor any other member of any
group of which it is a member for VAT purposes is entitled to credit or repayment from the relevant tax authority in respect of the VAT 
 5.06 Net Payments – Canadian Borrowers. (a) All payments made by or on behalf of the Canadian Borrowers hereunder and under any Note will be made without setoff, counterclaim or other
defense. All such payments will be made free and clear of, and without deduction or withholding for, any present or future taxes, levies, imposts, duties, fees, assessments or other charges of whatever nature now or hereafter imposed by any
jurisdiction or by any political subdivision or taxing authority thereof or therein with respect to such payments (but excluding any tax imposed on or measured by the net income or profits (including branch profits taxes) and franchise or similar
taxes imposed in lieu of income taxes of a Lender that holds Canadian Obligations pursuant to the laws of the jurisdiction in which it is organized or the jurisdiction in which the principal office or applicable lending office of such Lender is
located or any subdivision thereof or therein, or Other Connection Taxes), and all interest, penalties or similar liabilities with respect to such non-excluded taxes, levies, imposts, duties, fees, assessments or other charges or withholding of a
similar nature (including any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same) (all such non-excluded taxes, levies, imposts, duties, fees, assessments or other charges or withholding of a
similar nature (including any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same) being referred to collectively as “Canadian Taxes”). 

(b) If any Canadian Taxes are so levied or imposed, the Canadian Borrowers shall be entitled to withhold such amounts
that it is required to withhold in respect thereof and the Canadian Borrowers jointly and severally agree to remit the full amount of such Canadian Taxes to the relevant Government Authority, and shall pay such additional amounts as may be necessary
so that every payment of all amounts due under this Agreement or under any Note, after withholding or deduction for or on 

  
 118

 
account of any Canadian Taxes, will not be less than the amount that would have been paid and is provided for herein or in such Note had such Canadian Taxes not been levied or imposed. The
Canadian Borrowers jointly and severally agree to indemnify and hold harmless each Lender that holds Canadian Obligations, and reimburse such Lender upon its written request, for the amount of any Canadian Taxes so levied or imposed and paid by such
Lender (including, for greater certainty, any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Canadian Taxes were correctly or legally imposed or asserted by the relevant Governmental
Authority). 
 (c) If any amounts are payable in respect of Canadian Taxes pursuant to
Section 5.06(b) hereof, the Canadian Borrowers jointly and severally agree to reimburse each Lender that holds Canadian Obligations, upon the written request of such Lender, for taxes imposed on or measured by the net income or profits
(including branch profits taxes) and franchise or similar taxes imposed in lieu of income taxes of such Lender pursuant to the laws of the jurisdiction in which such Lender is organized or in which the principal office or applicable lending office
of such Lender is located or under the laws of any political subdivision or taxing authority of any such jurisdiction in which such Lender is organized or in which the principal office or applicable lending office of such Lender is located and for
any withholding of taxes as such Lender shall determine are payable by, or withheld from, such Lender, in respect of such amounts so paid to or on behalf of such Lender pursuant to Section 5.06(b) and in respect of any amounts paid to or
on behalf of such Lender pursuant to this Section 5.06(c). 
 (d) The Canadian Borrowers will
furnish to the Administrative Agent within 45 days after the date the payment of any Canadian Taxes is due pursuant to Applicable Law the original or a certified copy of a receipt issued by the relevant Governmental Authority evidencing such
payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent. 
 (e) The Canadian Borrowers’ obligations under this Section 5.06 shall survive indefinitely following the termination, cancellation, settlement or extinguishment of this Agreement or any
Note. 
 SECTION 6. Conditions Precedent to Credit Events on the Effective Date. The obligation of each
Lender to make Loans, and the obligation of each Issuing Lender to issue Letters of Credit, on the Effective Date, are subject at the time of the making of such Loans or the issuance of such Letters of Credit to the satisfaction of the following
conditions: 
 6.01 Effective Date; Notes. On or prior to the Effective Date, (a) the Effective Date
shall have occurred as provided in Section 13.10 and (b) there shall have been delivered to the Administrative Agent for the account of each of the Lenders that has requested same the appropriate Revolving Notes executed by
the appropriate Borrowers and if requested by the Swingline Lender, the appropriate Swingline Notes executed by the appropriate Borrowers, in each case, in the amount, maturity and as otherwise provided herein. 

6.02 Officer’s Certificate. On the Effective Date, the Administrative Agent shall have received a
certificate, dated the Effective Date and signed on behalf of US Company by the chairman of the board, the chief executive officer, the president or any vice president of US Company, certifying on behalf of US Company that all of the conditions have
been satisfied on such date. 
 6.03 Opinions of Counsel. (a) On the Effective Date, the Administrative
Agent shall have received from DLA Piper LLP (US), counsel to the Credit Parties, opinions addressed to the Administrative Agent, the Collateral Agent and each of the Lenders and dated the Effective Date covering the matters set forth in Exhibit
J-1 and such other matters incident to the transactions contemplated herein as the Administrative Agent may reasonably request. 

  
 119

 (b) On the Effective Date, the Administrative Agent shall have received from
DLA Piper UK LLP, counsel to the Credit Parties, an opinion addressed to the Administrative Agent, the Collateral Agent and each of the Lenders and dated the Effective Date covering the matters set forth in Exhibit J-2 and such other matters
incident to the transactions contemplated herein as the Administrative Agent may reasonably request. 
 (c) On
the Effective Date, the Administrative Agent shall have received from DLA Piper UK LLP, Luxembourg counsel to the Credit Parties, an opinion addressed to the Administrative Agent, the Collateral Agent and each of the Lenders and dated the Effective
Date covering the matters set forth in Exhibit J-3 and such other matters incident to the transactions contemplated herein as the Administrative Agent may reasonably request. 

(d) On the Effective Date, the Administrative Agent shall have received from McMillan LLP, Ontario, Alberta and British
Columbia counsel to the Credit Parties, an opinion addressed to the Administrative Agent, the Collateral Agent and each of the Lenders and dated the Effective Date covering the matters set forth in Exhibit J-4 and such other matters incident
to the transactions contemplated herein as the Administrative Agent may reasonably request. 
 (e) On the
Effective Date, the Administrative Agent shall have received from Morris James LLP, special Delaware counsel, an opinion addressed to the Administrative Agent, the Collateral Agent, each of the Lenders and the other parties named therein, and dated
the Effective Date covering the matters set forth in Exhibit J-5 and such other matters incident to the transactions contemplated herein as the Administrative Agent may reasonably request. 

(f) On the Effective Date, the Administrative Agent shall have received from (i) DLA Piper LLP (US), local counsel
to the Credit Parties in California, Illinois and Texas, (ii) Quarles & Brady LLP, local counsel to the Credit Parties in Arizona, and (iii) McAfee & Taft, local counsel to the Credit Parties in Oklahoma, opinions
addressed to the Administrative Agent, the Collateral Agent and each of the Lenders and dated the Effective Date covering the matters set forth in Exhibit J-6 and such other matters incident to the transaction contemplated herein as the
Administrative Agent may reasonably request. 
 6.04 Company Documents; Proceedings; etc. (a) On the
Effective Date, the Administrative Agent shall have received a certificate from each Credit Party, dated the Effective Date, signed by the chairman of the board, the chief executive officer, the president, a director, or any vice president of such
Credit Party, and attested to by the secretary or any assistant secretary of such Credit Party, in the form of Exhibit K with appropriate insertions, together with copies of the certificate and memorandum and articles of incorporation or association
and by-laws and any unanimous shareholder agreement or declaration relating to such Credit Party (or other equivalent organizational documents), as applicable, of such Credit Party and the resolutions of such Credit Party referred to in such
certificate, and each of the foregoing shall be in form and substance reasonably acceptable to the Administrative Agent. 
 (b) On the Effective Date, all limited liability company and legal proceedings and all instruments and agreements in connection with the transactions contemplated by this Agreement and the other Credit
Documents shall be reasonably satisfactory in form and substance to the Administrative Agent, and the Administrative Agent shall have received all information and copies of all documents and papers, including records of limited liability company
proceedings, governmental approvals, good standing certificates (if applicable) and bring-down telegrams or facsimiles, if any, which the Administrative Agent reasonably may have requested in connection therewith, such documents and papers where
appropriate to be certified by proper limited liability company or Governmental Authorities. 

  
 120

 6.05 Consummation of the Transactions; etc. (a) On or prior to the
Effective Date, all Refinanced Indebtedness shall have been repaid in full, together with all fees and other amounts owing thereon, all commitments thereunder shall have been terminated and all letters of credit issued pursuant thereto shall have
been terminated or cash collateralized in a manner reasonably acceptable to the Administrative Agent. On the Effective Date, all security interests in respect of, and Liens securing, the Refinanced Indebtedness created pursuant to the security
documentation relating thereto shall have been terminated and released, and the Administrative Agent shall have received all such releases as may have been requested by the Administrative Agent, which releases shall be in form and substance
reasonably satisfactory to the Administrative Agent. Without limiting the foregoing, there shall have been delivered to the Administrative Agent (i) proper termination statements (Form UCC-3 or the appropriate equivalent in each relevant
jurisdiction) for filing under the UCC or equivalent statute or regulation of each relevant jurisdiction where a financing statement or application for registration (Form UCC-1 or the appropriate equivalent in each relevant jurisdiction) was filed
with respect to US Company or its Subsidiaries in connection with the Liens created with respect to the Refinanced Indebtedness, (ii) terminations or reassignments of any security interest in, or Lien on, any patents, trademarks, copyrights, or
similar interests of US Company or any of its Subsidiaries on which filings have been made and (iii) terminations of all mortgages, leasehold mortgages, hypothecs and deeds of trust created with respect to property of US Company or any of their
respective Subsidiaries, in each case, to secure the obligations under the Refinanced Indebtedness, all of which shall be in form and substance reasonably satisfactory to the Administrative Agent. After giving effect to the Transactions, US Company
and its Subsidiaries shall have no outstanding Indebtedness, Indebtedness convertible into Equity Interests, or other preferred Equity Interests except as set forth on Schedule 8.30. 

6.06 No Material Adverse Effect on US Company. There shall not have occurred any event, development or
circumstance since December 31, 2010 that has caused or could reasonably be expected to cause a material adverse effect on the business, operations, results of operations, assets, liabilities or financial condition of US Company and its
Subsidiaries, taken as a whole. 
 6.07 US Pledge Agreement. On the Effective Date, each US Credit Party
shall have duly authorized, executed and delivered the US Pledge Agreement in the form of Exhibit L (as amended, restated, modified and/or supplemented from time to time, the “US Pledge Agreement”) and shall have delivered to
the Collateral Agent, as pledgee thereunder, all of the US Pledge Agreement Collateral, if any, referred to therein and then owned by such US Credit Party, together with executed and undated endorsements for transfer in the case of promissory notes
and Equity Interests constituting certificated US Pledge Agreement Collateral, along with evidence that all other actions necessary or, in the reasonable opinion of the Collateral Agent, desirable, to perfect and protect the Liens purported to be
created by the US Pledge Agreement have been taken and the US Pledge Agreement shall be in full force and effect. 
 6.08 UK Share Charge. On the Effective Date, each US Subsidiary directly owning Equity Interests in a UK Subsidiary shall have duly authorized, executed and delivered the UK Share Charge in the
form of Exhibit M (as amended, restated, modified and/or supplemented from time to time, the “UK Share Charge”) and shall have delivered to the Collateral Agent, as pledgee thereunder, all share certificates and blank stock transfer
forms required to be delivered thereunder, along with evidence that all other actions necessary or, in the reasonable opinion of the Collateral Agent, desirable, to perfect and protect the Liens purported to be created by the UK Share Charge have
been taken and the UK Share Charge shall be in full force and effect. 

  
 121

 6.09 US Security Agreement. On the Effective Date, each US Credit
Party shall have duly authorized, executed and delivered the US Security Agreement in the form of Exhibit N, together with: 
 (a) proper financing statements (Form UCC-1 or the equivalent) fully executed for filing under the UCC, the PPSA or other appropriate filing offices of each jurisdiction as may be necessary or, in the
reasonable opinion of the Collateral Agent, desirable, to perfect the Liens purported to be created by the US Security Agreement; 
 (b) certified copies of requests for information or copies (Form UCC-11), or equivalent reports as of a recent date, listing all effective financing statements that name US Company or any of its
Subsidiaries as debtor and that are filed in the jurisdictions referred to in clause (a) above and in such other jurisdictions in which Collateral is located on the Effective Date, together with copies of such other financing statements that
name US Company or any of its Subsidiaries as debtor (none of which shall cover any of the Collateral except (i) to the extent evidencing Permitted Liens or (ii) those in respect of which the Collateral Agent shall have received
termination statements (Form UCC-3) or such other termination statements as shall be required by local law fully executed for filing); and 
 (c) evidence of the completion of all other recordings and filings of, or with respect to, the US Security Agreement as may be necessary or, in the reasonable opinion of the Collateral Agent, desirable,
to perfect and protect the Liens intended to be created by the US Security Agreement, including control agreements, access agreements and similar third party agreements as the Administrative Agent shall reasonably request (or an appropriate and
customary reserve has been established therefore), and the US Security Agreement shall be in full force and effect. 
 6.10 UK Debentures. On the Effective Date, UK Company and the UK Subsidiaries, as applicable, shall have duly authorized, executed and delivered the UK Debenture and the UK Partnership Debenture in
the form of Exhibit O, together with all share certificates, blank stock transfer forms, deeds and documents of title to property and notices of security to third parties required to be delivered thereunder along with that all other actions
necessary or, in the reasonable opinion of the Collateral Agent, desirable, to perfect and protect the Liens intended to be created by the UK Debentures have been taken and the UK Debentures shall be in full force and effect. 

6.11 Canadian Security Agreement and Canadian Share Pledge Agreement. On the Effective Date, the Canadian Company
shall have duly authorized, executed and delivered the Canadian Security Agreement in the form of Exhibit T and the Canadian Share Pledge Agreement in the form of Exhibit U, together with: 

(a) executed and undated endorsements for transfer in the case of promissory notes and Equity Interests
constituting certificated Canadian Security Agreement Collateral; 
 (b) proper financing
statements for filing under the PPSA or other appropriate filing offices of each jurisdiction as may be necessary or, in the reasonable opinion of the Collateral Agent, desirable, to perfect the Liens purported to be created by the Canadian Security
Agreement and Canadian Share Pledge Agreement; 
 (c) copies of all customary lien searches or
equivalent reports as of a recent date, listing all effective financing statements or liens that name Canadian Company or its Subsidiaries, if any, as debtor and that are filed in the jurisdictions referred to in clause (b) above and in such
other jurisdictions in which Collateral is located on the Effective Date, together with evidence of 

  
 122

 
such other financing statements or liens that name Canadian Company or its Subsidiaries, if any, as debtor (none of which shall cover any of the Collateral except (i) to the extent
evidencing Permitted Liens or (ii) those in respect of which the Collateral Agent shall have received discharge statements (Form 3C) or such other discharge statements as shall be required by local law); and 

(d) evidence of the completion of all other actions, recordings and filings of, or with respect to, the
Canadian Security Agreement as may be necessary or, in the reasonable opinion of the Collateral Agent, desirable, to perfect and protect the Liens intended to be created by the Canadian Security Agreement, including control agreements, access
agreements and similar third party agreements as the Administrative Agent shall reasonably request (or an appropriate and customary reserve has been established therefore), and the Canadian Security Agreement shall be in full force and effect.

 6.12 Luxembourg Security Agreement and Luxembourg Share Charge. On the Effective Date, UK-LP and the
Luxembourg Subsidiary shall have duly authorized, executed and delivered the Luxembourg Security Agreement in the form of Exhibit U and the Luxembourg Share Charge in the form of Exhibit V. 

6.13 Mortgages. On the Effective Date, each Credit Party that owns a Real Property listed on Schedule 6.13
shall have duly authorized, executed and delivered a Mortgage over such Real Property, which shall be in full force and effect, and shall have delivered evidence satisfactory to the Administrative Agent and the Collateral Agent that each such
Mortgage is a valid and enforceable perfected security interest in and mortgage lien on the respective Mortgaged Property in favor of the Collateral Agent (or such other trustee as may be required or desired under local law) for the benefit of the
Secured Creditors, superior and prior to the rights of all third Persons (except that the security interest and mortgage lien created on such Mortgaged Property may be subject to the Permitted Encumbrances related thereto) and subject to no other
Liens. In connection with the delivery of each such Mortgage, US Company will, and will cause each other Credit Party to, in each case unless waived by the Administrative Agent, deliver (i) a Mortgage Policy issued by a title insurer reasonably
satisfactory to the Administrative Agent, in form and substance and in an amount reasonably satisfactory to the Administrative Agent and Collateral Agent insuring that the Mortgage is a valid and enforceable First Priority Lien on the respective
property other than Permitted Encumbrances, (ii) a then current A.L.T.A. survey, certified to the Administrative Agent and the Collateral Agent by a licensed surveyor sufficient to allow the issuer of the Mortgage Policy to issue such Mortgage
Policy without a survey exception, (iii) environmental due diligence reasonably acceptable to the Administrative Agent and Collateral Agent, in form and substance satisfactory to the Administrative Agent and Collateral Agent and (iv) a
customary certificate in a form reasonably acceptable to the Administrative Agent indicating that the property is not in a flood zone, or if the property is in a flood zone, deliver appropriate insurance reasonably acceptable to the Administrative
Agent has not been obtained. 
 6.14 Financial Statements; Pro Forma Balance Sheet; Projections; etc. (a)
On or prior to the Effective Date, the Arrangers shall have received (i) audited financial statements of each of US Company and its Subsidiaries for the fiscal year ended December 31, 2010, (ii) unaudited quarterly financial
statements of US Company and its Subsidiaries for the most recent fiscal quarter ended at least 45 days prior to the Effective Date that is not the last fiscal quarter of a fiscal year, and (iii) unaudited monthly financial statements of US
Company and its Subsidiaries for the most recent month ended at least 30 days prior to the Effective Date that is not the last month of a fiscal quarter. 
 (b) On the Effective Date, the Administrative Agent shall have received and be satisfied with projected consolidated financial statements of US Company and its Subsidiaries for at least

  
 123

 
the five fiscal years ended after the Effective Date (including monthly projections for each of the first 12 months after the Effective Date (to include projected Borrowing Base and Total
Borrowing Availability, as applicable, for such periods)), which projections shall (x) reflect the forecasted consolidated financial condition of US Company and its Subsidiaries after giving effect to the Transactions and (y) be prepared
and approved by US Company. 
 6.15 Solvency Certificate; Insurance Certificates. On the Effective
Date, the Administrative Agent shall have received: 
 (a) a solvency certificate from the chief
financial officer of US Company in the form of Exhibit P; and 
 (b) certificates of insurance
complying with the requirements of Section 9.03 for the business and properties of US Company and its Subsidiaries, in form and substance reasonably satisfactory to the Administrative Agent and naming the Collateral Agent as an
additional insured and/or as loss payee, as applicable, and stating that such insurance shall not be canceled or materially revised without at least 30 days’ prior written notice by the insurer to the Collateral Agent. 

6.16 Fees, etc. On the Effective Date, the Borrowers shall have paid to the Administrative Agent (and its relevant
affiliates), the Collateral Agent and each Lender all costs, fees and expenses (including, without limitation, reasonable legal fees and expenses) and other compensation contemplated hereby and in the Fee Letter payable to the Administrative Agent
(and/or its relevant affiliates), the Collateral Agent or such Lender to the extent then invoiced. 
 6.17
Initial Borrowing Base Certificate; etc. (a) On the Effective Date, the Administrative Agent shall have received the initial Borrowing Base Certificate meeting the requirements of Section 9.01(i), which shall be calculated
after giving effect to the Transactions (and the Credit Events hereunder); and 
 (b) On the Effective Date,
after giving effect to the Transactions (and the Credit Events hereunder), the Total Borrowing Availability shall equal or exceed $350,000,000 as shown in the Borrowing Base Certificate delivered pursuant to (a) above. 

6.18 No Defaults under Senior Note Indentures. There shall not exist (on a pro forma basis before and immediately
after giving effect to the Transactions) (i) any default or event of default under the Mobile Mini 2015 Indenture or (ii) any default or event of default under the Mobile Mini 2020 Indenture, in each case relating to non-payment,
bankruptcy, material judgments or negative covenants. 
 6.19 Patriot Act. On or prior to the Effective
Date, the Administrative Agent and the Lenders shall have received from the Credit Parties, to the extent requested, all documentation and other information required by regulatory authorities under applicable “know your customer” and
anti-money laundering rules and regulations, including, without limitation, the Patriot Act. 
 6.20 Absence
of Litigation. On the Effective Date, no litigation by any entity (private or governmental) shall be pending or, to the knowledge of any Credit Party, threatened with respect to any of the Credit Documents, or the Transactions or which has had,
or could reasonably be expected to have, a Material Adverse Effect. 
 6.21 Margin Regulations. On the
Effective Date, all Loans made on the Effective Date and all other financings to the Borrowers (and all guaranties thereof and security therefor), as well as the Transactions and the consummation thereof, shall be in compliance with all applicable
requirements of law, including Regulations T, U and X of the Federal Reserve Board. 

  
 124

 In determining the satisfaction of the conditions specified in this
Section 6, to the extent any item is required to be satisfactory to any Lender, such item shall be deemed satisfactory to each Lender which has not notified the Administrative Agent in writing prior to the occurrence of the Effective Date that
the respective item or matter does not meet its satisfaction. 
 SECTION 7. Conditions Precedent to All
Credit Events. The obligation of each Lender to make Loans (including Loans made on the Effective Date), and the obligation of each Issuing Lender to issue Letters of Credit (including Letters of Credit issued on the Effective Date), are
subject, at the time of each such Credit Event (except as hereinafter indicated), to the satisfaction of the following conditions: 
 7.01 No Default; Representations and Warranties. At the time of each such Credit Event and also after giving effect thereto (a) there shall exist no Default or Event of Default, (b) all
representations and warranties contained herein and in the other Credit Documents shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on the date of such Credit Event
(it being understood and agreed that (x) any representations and warranties stated to relate to a specific earlier date shall have been true and correct in all material respects as of such earlier date and (y) any representations and
warranties qualified as to “materiality” or “Material Adverse Effect” shall be true and correct in all respects at such time), (c) the Aggregate Exposure shall not exceed the Total Revolving Loan Commitment, as then in
effect, (d) the Aggregate US Exposure shall not exceed the US Maximum Amount, as then in effect, (e) the Aggregate UK Exposure shall not exceed the UK Maximum Amount, as then in effect, (f) the Aggregate Canadian Exposure shall not
exceed the Canadian Maximum Amount, as then in effect, (g) the Aggregate Exposure shall not exceed the Aggregate Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate) (except in the case of Agent
Advances), (h) the Aggregate US Exposure shall not exceed the US Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate) (except in the case of Agent Advances), (i) the Aggregate UK Exposure shall not
exceed the UK Borrowing Base at such time (based on the most recently delivered Borrowing Base Certificate) and (j) the Aggregate Canadian Exposure shall not exceed the Canadian Borrowing Base at such time (based on the most recently delivered
Borrowing Base Certificate). 
 7.02 Notice of Borrowing; Letter of Credit Request. (a) Prior to the
making of each Loan (other than a Swingline Loan or a Revolving Loan made pursuant to a Mandatory Borrowing), the Administrative Agent shall have received a Notice of Borrowing meeting the requirements of Section 2.03(a). Prior to the
making of each Swingline Loan, the Swingline Lender shall have received the notice referred to in Section 2.03(b)(i) or (ii) as applicable. 

(b) Prior to the issuance of each Letter of Credit, the Administrative Agent and the respective Issuing Lender shall have
received a US Letter of Credit Request meeting the requirements of Section 3.07, a UK Letter of Credit Request meeting the requirements of Section 3.08 or a Canadian Letter of Credit Request meeting the requirements of
Section 3.09. 
 The acceptance of the benefits of each Credit Event shall constitute a
representation and warranty by each of US Company and the Borrowers to the Administrative Agent and each of the Lenders that all the conditions specified in Section 6 (with respect to Credit Events on the Effective Date) and in this
Section 7 (with respect to Credit Events on or after the Effective Date) and applicable to such Credit Event are satisfied as of that time. All of the Notes, certificates, legal opinions and other documents and papers referred to in
Section 6 and in this Section 7, unless otherwise specified, shall be delivered to the 

  
 125

 
Administrative Agent at the Notice Office for the account of each of the Lenders and, except for the Notes, in sufficient counterparts or copies for each of the Lenders requesting same and shall
be in form and substance reasonably satisfactory to the Administrative Agent and the Required Lenders. 

SECTION 8. Representations, Warranties and Agreements. In order to induce the Agent and the Lenders to enter into
this Agreement and to make the Loans, and issue (or participate in) the Letters of Credit as provided herein, each of US Company and each other Credit Party makes the following representations, warranties and agreements, in each case after giving
effect to the Transactions, all of which shall survive the execution and delivery of this Agreement and the Notes and the making of the Loans and the issuance of the Letters of Credit, with the occurrence of each Credit Event on or after the
Effective Date being deemed to constitute a representation and warranty that the matters specified in this Section 8 are true and correct in all material respects on and as of the Effective Date and on the date of each such other Credit
Event (it being understood and agreed that (x) any representations and warranties stated to relate to a specific earlier date shall have been true and correct in all material respects as of such earlier date and (y) any representations and
warranties qualified as to “materiality” or “Material Adverse Effect” shall be true and correct in all respects at such time). 
 8.01 Organization and Qualification. US Company and each other Credit Party is a corporation, limited partnership or limited liability company duly organized, validly existing and in good standing
(or the foreign equivalent of “good standing”, if any, in the relevant foreign jurisdiction) under the laws of the jurisdiction of its incorporation or organization. US Company and each other Credit Party is duly qualified and is
authorized to do business and is in good standing (or the foreign equivalent of “good standing”, if any, in the relevant foreign jurisdiction) as a limited liability company, limited partnership or corporation, as applicable, in each state
or jurisdiction listed on Schedule 8.01 hereto and in all other states and jurisdictions in which the failure of such Credit Party to be so qualified would reasonably be expected to have a Material Adverse Effect. 

8.02 Power and Authority; No Violation. US Company and each other Credit Party (a) is duly authorized, has
the capacity and is empowered to enter into, execute, deliver and perform this Agreement and each of the other Credit Documents to which it is a party and (b) has the power and authority to own its property and assets and to transact the
business in which it is engaged and presently proposes to engage. The execution, delivery and performance of this Agreement and each of the other Credit Documents have been duly authorized by all necessary corporate or other relevant action and do
not and will not (i) require any consent or approval of the shareholders of US Company or any of the shareholders, partners or members, as the case may be, of any other Credit Party other than such consents and approvals which have obtained
prior to the Effective Date; (ii) contravene US Company’s or any other Credit Party’s charter, articles or certificate of incorporation, partnership agreement, certificate of formation, by-laws, limited liability company agreement,
operating agreement or other organizational documents (as the case may be); (iii) violate, or cause US Company or any other Credit Party to be in default under, any provision of any law, rule, regulation, order, writ, judgment, injunction,
decree, determination or award in effect having applicability to US Company or any other Credit Party; (iv) result in a breach of or constitute a default under any indenture or loan or credit agreement or any other agreement, lease or
instrument to which US Company or any other Credit Party is a party or by which it or its properties may be bound or affected; or (v) result in, or require, the creation or imposition of any Lien (other than Permitted Liens) upon or with
respect to any of the properties now owned or hereafter acquired by US Company or any other Credit Party. 

8.03 Legally Enforceable Agreement. This Agreement is, and each of the other Credit Documents when delivered under
this Agreement will be, a legal, valid and binding obligation of each of US Company and each other Credit Party, in each case to the extent it is a party thereto, enforceable against it in accordance with its respective terms, except as limited by
applicable bankruptcy or insolvency laws, and by general principles of equity. 

  
 126

 8.04 Capital Structure. Schedule 8.04 hereto states, as of the
Effective Date, (i) the correct name of each of the Subsidiaries of US Company, its jurisdiction of incorporation or organization and the percentage of its Voting Stock owned by US Company or a Subsidiary of US Company, (ii) the name of
each of US Company’s and each other Credit Party’s corporate or joint venture relationships and the nature of the relationship, (iii) the number and nature of all outstanding Equity Interests of US Company and the number, nature and
holder of Equity Interests of each other Credit Party and (iv) the number of issued and treasury Equity Interests of US Company. US Company and each other Credit Party has good title to all of the Equity Interests it purports to own of each of
such Subsidiaries, free and clear in each case of any Lien other than Permitted Liens. All such Equity Interests have been duly issued and are fully paid and non-assessable. As of the Effective Date, there are no outstanding options to purchase, or
any rights or warrants to subscribe for, or any commitments or agreements to issue or sell any Equity Interests or obligations convertible into, or any powers of attorney relating to any Equity Interests of any of US Company’s direct or
indirect Subsidiaries. Except as set forth on Schedule 8.04, as of the Effective Date, there are no outstanding agreements or instruments binding upon any of Company’s or any other Credit Party’s partners, members or shareholders, as the
case may be, relating to the ownership of its Equity Interests. As of the Effective Date, 100% of the Equity Interests of each Credit Party (other than US Company) are owned directly or indirectly by US Company. 

8.05 Names. Neither US Company nor any other Credit Party has been known as or has used any legal, fictitious or
trade names except those listed on Schedule 8.05 hereto as such Schedule may be amended in connection with a Permitted Acquisition. Except as set forth on Schedule 8.05, neither US Company nor any other Credit Party has been the
surviving entity of a merger or consolidation or has acquired all or substantially all of the assets of any Person in the past 3 years. US Company’s and each other Credit Party’s respective states of incorporation or organization, type of
organization and organizational identification number are set forth on Schedule 8.04 or Schedule 8.05, as such Schedule may be amended in connection with a Permitted Acquisition. The respective exact legal names of US Company and each
other Credit Party are set forth on Schedule 8.04, as such Schedule may be amended in connection with a Permitted Acquisition. 
 8.06 Business Locations; Agent for Process. Each of US Company’s and each other Credit Party’s chief executive office and other places of business are as listed on Schedule 8.06
hereto, as updated from time to time by US Company. During the preceding one-year period, neither US Company nor any other Credit Party has had an office or place of business other than as listed on Schedule 8.06. All tangible Collateral is
and will at all times be kept by US Company and each other Credit Party in accordance with the applicable Security Agreement. Except as shown on Schedule 8.06, as of the date hereof, no Inventory is stored with a bailee, distributor,
warehouseman or similar party, nor is any Inventory consigned to any Person. 
 8.07 Title to Properties;
Priority of Liens. Except with respect to the fact that the LKE Joint Accounts are jointly owned by US Company or one of its Domestic Subsidiaries and the LKE Qualified Intermediary pursuant to the terms of the LKE Master Exchange, US Company
and each other Credit Party has good record, indefeasible and marketable title to and fee simple ownership of real property owned by it, or valid leasehold interests in, all of its leased real property, and good title to all of the Collateral and
all of its other Property, in each case, free and clear of all Liens except Permitted Liens. US Company and each other Credit Party has paid or discharged all lawful claims which, if unpaid, might become a Lien against any of US Company’s or
such Credit Party’s Properties that is not a Permitted Lien. The Liens granted to the Collateral Agent under the Security Documents are First Priority Liens, subject only to Permitted Liens. 

  
 127

 8.08 Accounts. Agent may rely, in determining which Accounts are
Eligible Accounts, on all statements and representations made by US Company with respect to any Account or Accounts of US Company or any other Credit Party. With respect to each of such Accounts, whether or not such Account is an Eligible Account,
unless otherwise disclosed to Agent in writing: 
 (a) It is genuine and in all respects what it
purports to be, and it is not evidenced by a judgment; 
 (b) It arises out of a completed, bona
fide sale and delivery of goods or rendition of services by US Company or the applicable Credit Party, in the ordinary course of its business and in accordance with the terms and conditions of all purchase orders, contracts or other documents
relating thereto and forming a part of the contract between US Company or the applicable Credit Party and the Account Debtor and the Account Debtor is not an Affiliate of US Company or any other Credit Party; 

(c) It is for a liquidated amount maturing as stated in the invoice covering such sale or rendition of
services; 
 (d) There are no facts, events or occurrences which in any way impair the validity
or enforceability of any Accounts or tend to reduce the amount payable thereunder from the face amount of the invoice and statements delivered or made available to Agent with respect thereto; 

(e) To US Company’s knowledge, the Account Debtor thereunder (1) had the capacity to contract
at the time any contract or other document giving rise to the Account was executed and (2) such Account Debtor is Solvent; and 
 To US Company’s knowledge, there are no proceedings or actions which are threatened or pending against the Account Debtor thereunder which might result in any material adverse change in such Account
Debtor’s financial condition or the collectability of such Account (other than non-material disputes involving de minimis amounts arising in the ordinary course of business). 

8.09 Equipment. The Equipment of US Borrower and each other Credit Party is in good operating condition and
repair, ordinary wear and tear excepted. 
 8.10 Financial Statements; Financial Condition; Undisclosed
Liabilities; Projections. (a) The audited Consolidated balance sheet of US Company as at the last day of its fiscal year ended December 31, 2010 and the related Consolidated statements of income, retained earnings, stockholders’
equity and cash flows of US Company for its fiscal year ended on such date, copies of which have been furnished to the Lenders prior to the Effective Date, present fairly in all material respects the consolidated financial position of US Company at
the date of said financial statements and the Consolidated results of its operations for the respective period covered thereby. The unaudited Consolidated balance sheet of US Company as at the last day of its fiscal quarter ended September 30,
2011 and the related Consolidated statements of income, retained earnings, stockholders’ equity and cash flows of US Company for the three-month period ended on such date, copies of which in each case have been furnished to the Lenders prior to
the Effective Date, present fairly in all material respects the Consolidated financial condition of US Company at the date of said financial statements and the Consolidated results of its operations for the period covered thereby. All of the
foregoing historical financial statements have been prepared in accordance with GAAP consistently applied except to the extent provided in the notes to said financial statements and subject, in the case of the unaudited financial statements, to
normal year-end audit adjustments (all of which are of a recurring nature and none of which, individually or in the aggregate, would be material) and the absence of footnotes. 

  
 128

 (b) On and as of the Effective Date, and after giving effect to the
Transactions and to all Indebtedness (including the Loans) being incurred or assumed and Liens created by the Credit Parties in connection therewith, US Company and each of its Subsidiaries is or are Solvent. 

(c) Except as disclosed in the financial statements delivered pursuant to Section 8.10(a), and except
purchase accounting reserves required pursuant to GAAP and except for the Indebtedness incurred under this Agreement, there were as of the Effective Date no liabilities or obligations with respect to US Company or any of its Subsidiaries of any
nature whatsoever (whether absolute, accrued, contingent or otherwise and whether or not due) known to US Company or any of its Subsidiaries which, either individually or in the aggregate, could reasonably be expected to be material to US Company
and its Subsidiaries taken as a whole. As of the Effective Date, US Company does not know of any basis for the assertion against it or any of its Subsidiaries of any liability or obligation of any nature whatsoever that is not fully disclosed in the
financial statements delivered pursuant to Section 8.10(a) or referred to in the immediately preceding sentence which, either individually or in the aggregate, could reasonably be expected to be material to US Company and its
Subsidiaries taken as a whole. 
 (d) The Projections delivered to the Administrative Agent and the Lenders
prior to the Effective Date have been prepared in good faith and are based on reasonable assumptions, and there are no statements or conclusions in the Projections which are based upon or include information known to US Company or its Subsidiaries
to be misleading in any material respect or which fail to take into account material information known to US Company or its Subsidiaries regarding the matters reported therein. On the Effective Date, US Company and its Subsidiaries believe that the
Projections are reasonable and attainable, it being recognized by the Lenders, however, that projections as to future events are not to be viewed as facts and that the actual results during the period or periods covered by the Projections may differ
from the projected results and such differences may be material. 
 (e) After giving effect to the Transactions,
since December 31, 2010, nothing has occurred that has had, or could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect with respect to the US Company and its Subsidiaries, taken as a whole.

 (f) As of the Effective Date, the fiscal year of US Company and each of its Subsidiaries ends on
December 31 of each year. 
 8.11 Full Disclosure. The financial statements referred to in
Section 8.10 hereof do not, nor does this Agreement or any other written statement of US Company to Administrative Agent or any Lender, contain any untrue statement of a material fact or omit a material fact necessary to make the
statements contained therein or herein not misleading. There is no fact which US Company has failed to disclose to Administrative Agent or any Lender in writing which would reasonably be expected to have a Material Adverse Effect. 

8.12 Surety Obligations. Except as set forth on Schedule 8.12, as of the Effective Date, neither US Company
nor any other Credit Party is obligated as surety or indemnitor under any surety or similar bond or other contract issued or entered into to assure payment, performance or completion of performance of any undertaking or obligation of any Person.

 8.13 Tax Returns and Payments. Each of US Company and each of its Subsidiaries has timely filed or
caused to be timely filed with the appropriate Governmental Authority all returns, statements, forms and reports for taxes (the “Returns”) required to be filed by, or with respect to the income, properties or operations of, US
Company and/or any of its Subsidiaries. The Returns accurately reflect all liability for taxes of US Company and its Subsidiaries, as applicable, for the periods covered thereby. Each of US Company and each of its Subsidiaries has paid all taxes and
assessments payable by 

  
 129

 
it which have become due, other than those that are being contested in good faith and adequately disclosed and for which adequate reserves have been established in accordance with GAAP. There is
no action, suit, proceeding, investigation, audit or claim now pending or, to the knowledge of US Company or any other Credit Party, threatened by any Governmental Authority regarding any taxes relating to US Company or any of its Subsidiaries.
Neither US Company nor any of its Subsidiaries is party to any tax sharing agreement. 
 8.14 Dutch Credit
Parties and Luxembourg Subsidiary. (a) Each of the Dutch Credit Parties conducts (and shall conduct) no operations and has (and shall have) no assets and no liabilities, in each case, individually or in the aggregate, with a fair market
value in excess of the Equivalent Amount of €3,000,000, other than in connection with its Obligations hereunder and other than, with respect to Mobile Mini Holding B.V. only, Equity Interests of Mobile Mini B.V. 

(b) The Luxembourg Subsidiary conducts no operations and has no liabilities or assets other than in connection with the
Luxembourg Debt (and shall not conduct any operations or have liabilities or assets) other than in connection with the Luxembourg Debt and in connection with its Obligations hereunder. 

8.15 Intellectual Property, etc. Each of US Company and each of its Subsidiaries owns or has the right to use all
the patents, trademarks, permits, domain names, service marks, trade names, copyrights, licenses, franchises, inventions, trade secrets, proprietary information and know-how of any type, whether or not written (including, but not limited to, rights
in computer programs and databases) and formulas, or rights with respect to the foregoing, and has obtained assignments of all leases, licenses and other rights of whatever nature, necessary for the present conduct of its business, without any known
conflict with the rights of others which, or the failure to own or have which, as the case may be, could reasonably be expected, either individually or in the aggregate, to have a Material Adverse Effect. 

8.16 Government Consents. US Company and each of its Subsidiaries has, and is in good standing (or the foreign
equivalent of “good standing”, if any, in the relevant foreign jurisdiction) with respect to, all governmental consents, approvals, licenses, authorizations, permits, certificates, inspections and franchises necessary to continue to
conduct its business as heretofore or proposed to be conducted by it and to own or lease and operate its Properties as now owned or leased by it. 
 8.17 Compliance with Laws. US Company and each of its Subsidiaries has duly complied in all material respects with, and its Properties, business operations and leaseholds are in compliance in all
material respects with, the provisions of all federal, state, provincial, local, foreign and other laws, rules and regulations applicable to US Company or such Subsidiary, as applicable, its Properties or the conduct of its business, and there have
been no citations, notices or orders of noncompliance issued to US Company or any of its Subsidiaries under any such law, rule or regulation. US Company and each of its Subsidiaries has established and maintains an adequate monitoring system to
insure that it remains in compliance in all material respects with all federal, state, provincial, local, foreign and other rules, laws and regulations applicable to it. No Inventory has been produced by US Company or any of its Subsidiaries in
violation of the Fair Labor Standards Act (29 USC. §201 et seq.), as amended. 
 8.18 Restrictions.
Neither US Company nor any other Credit Party is a party or subject to any contract or agreement which restricts its right or ability to incur Indebtedness, other than as set forth on Schedule 8.18 hereto, none of which prohibit the execution
of or compliance with this Agreement or the other Credit Documents by US Company or any other Credit Party, as applicable. Except as permitted in this Agreement, none of the Collateral is subject to contractual obligations that may restrict or
inhibit Collateral Agent’s or Administrative Agent’s rights or abilities to sell or dispose of the Collateral or any part thereof after the occurrence and during the continuance of an Event of Default. 

  
 130

 8.19 Litigation. Except as set forth on Schedule 8.19 hereto,
there are no actions, suits, proceedings or investigations pending, or to the knowledge of US Company or any other Credit Party, threatened, against or involving US Company or any of its Subsidiaries, or the business, operations, Properties,
prospects, profits or condition of US Company or any of its Subsidiaries which, singly or in the aggregate, would reasonably be expected to have a Material Adverse Effect. Neither US Company nor any of its Subsidiaries is in default with respect to
any order, writ, injunction, judgment, decree or rule of any court, governmental authority or arbitration board or tribunal, which, singly or in the aggregate, would reasonably be expected to have a Material Adverse Effect. 

8.20 No Defaults. No event has occurred and no condition exists which would, upon or after the execution and
delivery of this Agreement or each Credit Party’s performance hereunder, constitute a Default or an Event of Default. Neither US Company nor any other Credit Party is in default in (and no event has occurred and no condition exists which
constitutes, or which the passage of time or the giving of notice or both would constitute, a default in) the payment of any Indebtedness to any Person in excess of the lesser of $5,000,000 or the Equivalent Amount thereof or that amount which would
have a Material Adverse 
 Effect. All Obligations are permitted under the Senior Note Indentures and the other Senior Note
Documents and the Permitted Additional Financing Documents. 
 8.21 Leases. Schedule 8.21 hereto
is a complete listing of all capitalized and operating personal property leases of US Company and the other Credit Parties and all real property leases of US Company and the other Credit Parties. US Company and each other Credit Party is in full
compliance with all of the terms of each of its respective capitalized and operating leases, except where the failure to so comply would not reasonably be expected to have a Material Adverse Effect. 

8.22 Use of Proceeds; Margin Regulations. (a) All proceeds of the Loans will be used on the Effective Date to
refinance the Refinancing Indebtedness and thereafter for the working capital, Capital Expenditures, Permitted Acquisitions and general corporate purposes of US Company and its Subsidiaries, provided that the proceeds of the Loans shall not be used
for purposes which would constitute unlawful financial assistance for the purposes of Sections 678 to 679 of the United Kingdom Companies Act of 2006 (as amended or otherwise re-enacted from time to time). 

(b) No part of any Credit Event (or the proceeds thereof) will be used to purchase or carry any Margin Stock or to extend
credit for the purpose of purchasing or carrying any Margin Stock. Neither the making of any Loan nor the use of the proceeds thereof nor the occurrence of any other Credit Event will violate or be inconsistent with the provisions of Regulation T, U
or X. 
 8.23 Compliance with ERISA. (a) Schedule 8.23 sets forth a listing of each Plan as
of the Effective Date. Except as could not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect: (i) each Plan (and each related trust, insurance contract or fund) is in compliance with its terms
and with all Applicable Laws, including without limitation ERISA and the Code; (ii) each Plan which is intended to be qualified under Section 401(a) of the Code has either received a determination letter from the Internal Revenue Service
to the effect that it meets the requirements of Section 401(a) of the Code or is comprised of a master or prototype plan that is the subject of a favorable opinion letter from the Internal Revenue Service, and each trust forming a part of any
such Plan that is intended to qualify for exemption from taxation under Section 501(a) of the Internal Revenue Code is so exempt; (iii) no Reportable Event has occurred; (iv) no Multiemployer Plan is “insolvent” (as defined
under Section 4245 of ERISA), is in “reorganization” (as defined under Section 4241 of ERISA), is in “endangered or critical status” (as defined in Section 305 of ERISA) or has been 

  
 131

 
terminated (within the meaning of Title IV of ERISA); (v) no Plan has an Unfunded Current Liability; (vi) neither any US Borrower or any of its Subsidiaries nor an ERISA Affiliate has
failed to meet the minimum funding requirements of Sections 412 and 430 of the Code or Sections 302 and 303 of ERISA with respect to any Plan, whether or not waived or failed to make by its due date a required installment under Section 430(j)
of the Code or Section 303(j) of ERISA with respect to any Plan; (vii) all contributions required to be made with respect to a Plan and Multiemployer Plan each have been timely made; (viii) neither any US Borrower nor any of its
Subsidiaries nor any ERISA Affiliate has incurred any liability (including any indirect, contingent or secondary liability) to or on account of a Plan pursuant to Section 406, 409, 502(i), 502(l), 4062, 4063, 4064 or 4069 of ERISA or
Section 401(a)(29), 4971 or 4975 of the Code, or to or on account of a Multiemployer Plan pursuant to Section 515, 4201, 4204 or 4212 of ERISA or expects to incur any such liability under any of the foregoing sections with respect to any
Plan or Multiemployer Plan; (ix) no event has occurred or condition exists which presents a risk to any US Borrower or any of its Subsidiaries or 8.24 8.25 any ERISA Affiliate of incurring a liability to or on account of a Plan or Multiemployer
Plan pursuant to the foregoing provisions of ERISA and the Code; (x) there has been no filing of a notice by the plan administrator of intent to terminate, no plan amendment has been treated as a termination under Section 4041 or 4041A of
ERISA of, and no proceedings have been instituted by the PBGC to terminate or appoint a trustee to administer under Section 4042 of ERISA, any Plan or Multiemployer Plan; (xi) there has been no filing pursuant to Section 412(c) of the
Code or Section 302(c) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan; (xii) no Plan is, or is expected to be, in “at-risk” status pursuant to Section 430(i) of the Code or
Section 303(i) of ERISA; (xiii) no action, suit, proceeding, hearing, audit or investigation with respect to the administration, operation or the investment of assets of any Plan (other than routine claims for benefits) is pending,
expected or threatened; (xiv) there has been no violation of the applicable requirements of Section 404 or 405 of ERISA or the exclusive benefit rule under Section 401(a) of the Code by any fiduciary or disqualified person with
respect to any Plan for which any US Borrower or any of its Subsidiaries may be directly or indirectly liable; (xv) neither any US Borrower nor any of its Subsidiaries has filed, or is considering filing, an application under the Internal
Revenue Service Employee Plans Compliance Resolution System (the “EPCRS”) or the Department of Labor’s Voluntary Fiduciary Correction Program (the “VFCP”) with respect to any Plan; (xvi) to the knowledge of the Credit
Parties, no plan administrator or a “plan official” (as defined under VFCP) of any Multiemployer Plan has filed, or is considering filing, an application under the EPCRS or the VFCP with respect to any Multiemployer Plan; (xvii) using
actuarial assumptions and computation methods consistent with Part 1 of subtitle E of Title IV of ERISA, neither any US Borrower or any of its Subsidiaries nor any ERISA Affiliate would incur any liabilities with respect to any Multiemployer Plans
in the event of a complete or partial withdrawal (within the meanings of Sections 4203 and 4205 of ERISA) therefrom, or with respect to the withdrawal from any Plan subject to Section 4063 of ERISA during a plan year in which any such US
Borrower or any of its Subsidiaries or any ERISA Affiliate was a “substantial employer” (as defined in Section 4001(a)(2) of ERISA) or a cessation of operations that is treated as such a withdrawal under Section 4062(e) of ERISA;
(xviii) each group health plan (as defined in Section 607(1) of ERISA or Section 4980B(g)(2) of the Code) which covers or has covered employees or former employees of any US Borrower or any of its Subsidiaries or any ERISA Affiliate
has at all times been operated in compliance with the provisions of Part 6 of subtitle B of Title I of ERISA and Section 4980B of the Code; (xix) each group health plan (as defined in 45 Code of Federal Regulations Section 160.103)
which covers or has covered employees or former employees of any US Borrower or any of its Subsidiaries has at all times been operated in compliance with the provisions of the Health Insurance Portability and Accountability Act of 1996 and the
regulations promulgated thereunder; (xx) no lien imposed under the Code or ERISA on the assets of any US Borrower or any of its Subsidiaries or any ERISA Affiliate exists on account of any Plan or Multiemployer Plan and no event or condition
has occurred or exists that could reasonably be expected to result in the imposition of any such lien; (xxi) any US Borrower or any of its Subsidiaries or any ERISA Affiliate may cease contributions to or terminate any Plan maintained by any of
them without incurring any liability; and (xxii) neither any US Borrower nor any of its Subsidiaries maintain or contribute to any employee welfare benefit plan (as defined in Section 3(1) of ERISA) which provides benefits to retired
employees or other former employees (other than as required by Section 601 of ERISA). 

  
 132

 (b) Except as could not, either individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect: (i) each Foreign Pension Plan has been maintained in compliance with its terms and with the requirements of any and all Applicable Laws, statutes, rules, regulations and orders and has been
maintained, where required, in good standing with applicable regulatory authorities; (ii) neither US Company nor any of its Subsidiaries has incurred any obligation in connection with the termination of, or withdrawal from, any Foreign Pension
Plan; and (iii) the present value of the accrued benefit liabilities (whether or not vested) under each Foreign Pension Plan, determined as of the end of US Company’s most recently ended fiscal year on the basis of actuarial assumptions,
each of which is reasonable, did not exceed the current value of the assets of such Foreign Pension Plan allocable to such benefit liabilities. All contributions required to be made with respect to a Foreign Pension Plan have been timely made. No
Foreign Pension Plan contains a “defined benefit provision” as such term is defined in the Income Tax Act (Canada) (“CITA”) or is a “multi-employer pension plan” subject to the
Supplemental Pension Plans Act (Quebec). 
 8.24 Trade Relations. Except as set forth on
Schedule 8.24, there exists no actual or, to any Credit Party’s knowledge, threatened termination, cancellation or limitation of, or any modification or change in, the business relationship between US Company or any other Credit Party
and any customer or any group of customers whose purchases individually or in the aggregate are material to the business of US Company and the other Credit Parties (taken as a whole), or with any material supplier, except in each case, where the
same would not reasonably be expected to have a Material Adverse Effect, and there exists no present condition or state of facts or circumstances which would prevent US Company or any other Credit Party from conducting such business after the
consummation of the transaction contemplated by this Agreement in substantially the same manner in which it has heretofore been conducted. 
 8.25 Security Documents. (a) The provisions of the Security Agreements are effective to create in favor of the Collateral Agent for the benefit of the Secured Creditors a legal, valid and
enforceable security interest in all right, title and interest of the Credit Parties in all of the Security Agreement Collateral, and the Collateral Agent, for the benefit of the Secured Creditors, has (or within 10 days following the Effective Date
will have) a fully perfected security interest in all right, title and interest in all of the Security Agreement Collateral described therein, subject to no other Liens other than Permitted Liens. 

(b) The recordation of (i) the Grant of Security Interest in US Patents and (ii) the Grant of Security Interest
in US Trademarks in the respective form attached to the US Security Agreement, in each case in the United States Patent and Trademark Office, together with filings on Form UCC-1 made pursuant to the Security Agreement, will create, to the extent as
may be perfected by such filings and recordation, a perfected security interest in the United States trademarks and patents covered by the Security Agreement, and the recordation of the Grant of Security Interest in US Copyrights in the form
attached to the US Security Agreement with the United States Copyright Office, together with filings on Form UCC-1 made pursuant to the US Security Agreement, will create, to the extent as may be perfected by such filings and recordation, a
perfected security interest in the United States copyrights covered by the US Security Agreement. 
 (c) The
filing of the Confirmation of Security Interest in Intellectual Property in the form attached to the Canadian Security Agreement in the Canadian Intellectual Property Office, together with the filing of PPSA financing statements made pursuant to the
Canadian Security Agreement, will create, to the extent as may be perfected by such filings, a perfected security interest in the Canadian Intellectual Property (as defined in the Canadian Security Agreement) covered by the Canadian Security
Agreement. 

  
 133

 (d) The Liens created under the US Pledge Agreement in favor of the
Collateral Agent, as pledgee thereunder, for the benefit of the Secured Creditors, constitute perfected Liens in all US Pledge Agreement Collateral, subject to no Liens of any other Person. No filings or recordings are required in order to perfect
(or maintain the perfection or priority of) the Liens created in the US Pledge Agreement Collateral under the US Pledge Agreement other than with respect to that portion of the US Pledge Agreement Collateral constituting General Intangibles under
the UCC. 
 (e) The Liens created under the Canadian Security Agreement in favor of the Collateral Agent for the
benefit of the Secured Creditors, constitute perfected Liens in all Securities (as defined in the Canadian Security Agreement) and Instruments (as defined in the Canadian Security Agreement), subject to no Liens of any other Person. 

(f) Each Mortgage creates, as security for the obligations purported to be secured thereby, a valid and enforceable
perfected security interest in and mortgage lien on the respective Mortgaged Property in favor of the Collateral Agent (or such other trustee as may be required or desired under local law) for the benefit of the Secured Creditors, superior and prior
to the rights of all third Persons (except that the security interest and mortgage lien created on such Mortgaged Property may be subject to the Permitted Encumbrances related thereto) and subject to no other Liens. 

8.26 Investment Company Act. Neither US Company nor any of its Subsidiaries is an “investment company”
or a company “controlled” by an “investment company,” within the meaning of the Investment Company Act of 1940, as amended. 
 8.27 Representations and Warranties in Other Credit Documents. All representations and warranties set forth in the other Credit Documents were true and correct in all material respects at the time
as of which such representations and warranties were made (or deemed made) and shall be true and correct in all material respects as of the Effective Date as if such representations or warranties were made on and as of such date (it being understood
and agreed that (x) any representations and warranties stated to relate to a specific earlier date shall have been true and correct in all material respects as of such earlier date and (y) any representations and warranties qualified as to
“materiality” or “Material Adverse Effect” shall be true and correct in all respects at such time). 
 8.28 Environmental Matters. (a) Each of US Company and each of its Subsidiaries is in compliance in material respects with all applicable Environmental Laws and the requirements of any permits
issued under such Environmental Laws. There are no pending or, to the knowledge of US Company or any other Credit Party, threatened Environmental Claims against US Company or any of its Subsidiaries or any Real Property owned, leased or operated by
US Company or any of its Subsidiaries (including any such claim arising out of the ownership, lease or operation by US Company or any of its Subsidiaries of any Real Property formerly owned, leased or operated by US Company or any of its
Subsidiaries but no longer owned, leased or operated by US Company or any of its Subsidiaries). There are no facts, circumstances, conditions or occurrences with respect to the business or operations of US Company or any of its Subsidiaries, or any
Real Property owned, leased or operated by US Company or any of its Subsidiaries (including, to the knowledge of US Company or any other Credit Party, any Real Property formerly owned, leased or operated by US Company or any of its Subsidiaries but
no longer owned, leased or operated by US Company or any of its Subsidiaries) or, to the knowledge of US Company or any other Credit Party, any property adjoining or adjacent to any such Real Property that could be reasonably expected (i) to
form the basis of an Environmental Claim against US Company or any of its Subsidiaries or any Real Property owned, leased or operated by US Company or any of its 

  
 134

 
Subsidiaries or (ii) to cause any Real Property owned, leased or operated by US Company or any of its Subsidiaries to be subject to any restrictions on the ownership, lease, occupancy or
transferability of such Real Property by US Company or any of its Subsidiaries under any applicable Environmental Law. 
 (b) To the knowledge of US Company or any of its Subsidiaries, Hazardous Materials have not at any time been generated, used, treated or stored on, or transported to or from, or Released on or from, any
Real Property owned, leased or operated by US Company or any of its Subsidiaries or, to the knowledge of US Company or any other Credit Party, any property adjoining or adjacent to any Real Property, where such generation, use, treatment, storage,
transportation or Release has violated or could be reasonably expected to violate any applicable Environmental Law or give rise to an Environmental Claim. 
 (c) Notwithstanding anything to the contrary in this Section 8.28, the representations and warranties made in this Section 8.28 shall be untrue only if the effect of any or all
conditions, violations, claims, restrictions, failures and noncompliances of the types described above could, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

8.29 Employment and Labor Relations. Neither US Company nor any of its Subsidiaries is engaged in any unfair labor
practice that could, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There is (a) no unfair labor practice complaint pending against US Company or any of its Subsidiaries or, to the knowledge
of US Company or any other Credit Party, threatened against any of them, before the National Labor Relations Board, and no grievance or arbitration proceeding arising out of or under any collective bargaining agreement is so pending against US
Company or any of its Subsidiaries or, to the knowledge of US Company or any other Credit Party, threatened against any of them, (b) no strike, labor dispute, slowdown or stoppage pending against US Company or any of its Subsidiaries or, to the
knowledge of US Company or any other Credit Party, threatened against US Company or any of its Subsidiaries, (c) no union representation question exists with respect to the employees of US Company or any of its Subsidiaries, (d) no equal
employment opportunity charges or other claims of employment discrimination are pending or, to the knowledge of US Company or any other Credit Party, threatened against US Company or any of its Subsidiaries, and (e) no wage and hour department
investigation has been made of US Company or any of its Subsidiaries, except (with respect to any matter specified in clauses (a) – (e) above, either individually or in the aggregate) such as could not reasonably be expected to have a
Material Adverse Effect. 
 8.30 Indebtedness. Schedule 8.30 sets forth a list of all Indebtedness
(including Contingent Obligations) of US Company and its Subsidiaries as of the Effective Date and which is to remain outstanding after giving effect to the Transaction (excluding the Obligations), in each case showing the aggregate principal amount
thereof and the name of the respective borrower and any Credit Party or any of its Subsidiaries which directly or indirectly guarantees such debt (all such non-excluded Indebtedness, the “Existing Indebtedness”). 

8.31 Insurance. Schedule 8.31 sets forth a listing of all insurance maintained by US Company and its
Subsidiaries as of the Effective Date, with the amounts insured (and any deductibles) set forth therein. 
 8.32
Plans; Non-Compete Agreements; Collective Bargaining Agreements; Existing Indebtedness Agreements. Schedule 8.32 sets forth a list of all Plans, Non-Compete Agreements, Collective Bargaining Agreements and Existing Indebtedness
Agreements maintained by US Company and its Subsidiaries as of the Effective Date and which are to remain in effect after giving effect to the Transactions. 

  
 135

 8.33 Anti-Terrorism Laws. (a) Neither US Company nor any of its
Subsidiaries is in violation (other than immaterial, unknowing or unintentional violations) of any legal requirement relating to any laws with respect to terrorism or money laundering (“Anti-Terrorism Laws”), including Executive
Order No. 13224 on Terrorist Financing effective September 24, 2001 (the “Executive Order”) and the Patriot Act. Neither US Company nor any of its Subsidiaries and, to the knowledge of US Company and each Borrower, no
agent of US Company or any of its Subsidiaries acting on behalf of US Company or any of its Subsidiaries, as the case may be, is any of the following: 

(i) a Person that is listed in the annex to, or it otherwise subject to the provisions of, the Executive
Order; 
 (ii) a Person owned or controlled by, or acting for or on behalf of, any Person that
is listed in the annex to, or is otherwise subject to the provisions of, the Executive Order; 

(iii) a Person with which any Lender is prohibited from dealing or otherwise engaging in any transaction
by any Anti-Terrorism Law; 
 (iv) a Person that commits, threatens or conspires to commit or
supports “terrorism” as defined in the Executive Order; or 
 (v) a Person that is
named as a “specially designated national and blocked person” on the most current list published by the U.S. Treasury Department Office of Foreign Assets Control (“OFAC”) at its official website or any replacement website
or other replacement official publication of such list. 
 (b) Neither US Company nor any of its Subsidiaries
and, to the knowledge of US Company and each Borrower, no agent of US Company or any of its Subsidiaries acting on behalf of US Company or any of its Subsidiaries, as the case may be, (i) conducts any business or engages in making or receiving
any contribution of funds, goods or services to or for the benefit of a Person described in Section 8.33(a), (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant
to the Executive Order, or (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law.

 8.34 UK Pensions. To the knowledge of US Company or any of its Subsidiaries, no UK Subsidiary has ever
participated in a UK defined benefit pension plan or been associated or connected with the employer in relation to a UK defined benefit pension plan. 
 SECTION 9. Affirmative Covenants. Each of US Company and each other Credit Party hereby covenants and agrees that on and after the Effective Date and until the Total Revolving Loan Commitment and
all Letters of Credit have terminated and the Loans, Notes and Unpaid US Drawings and Unpaid UK Drawings (in each case together with interest thereon), Fees and all other Obligations (other than indemnities described in Section 13.13
which are not then due and payable) incurred hereunder and thereunder, are paid in full in cash: 
 9.01
Information Covenants. US Company will furnish to Administrative Agent and each Lender: 
 (a) Monthly
Reports. As soon as available, but not later than 30 days after the end of each month hereafter, excluding the last month of each fiscal quarter of US Company’s fiscal year, unaudited interim financial statements (including, but not limited
to, balance sheet, income 

  
 136

 
statement and statement of cash flows) of US Company and its Subsidiaries as of the end of such month and of the portion of the fiscal year then elapsed, on a Consolidated basis, certified by the
principal financial officer or principal accounting officer of US Company as prepared in accordance with GAAP and fairly presenting in all material respects the financial position and results of operations of US Company and its Subsidiaries for such
month and period (subject only to changes from audit and year-end adjustments and except that such statements need not contain notes) and, at the request of the Administrative Agent, unaudited interim financial statements on a consolidating basis
(A) with respect to US Company and its Domestic Subsidiaries, on the one hand and (B) the US Company’s Foreign Subsidiaries, on the other hand, in each case in a form consistent with US Company’s historical practices of
preparation of consolidating financial statements. 
 (b) Quarterly Financial Statements. As soon as
available, but not later than 45 days after the end of each fiscal quarter of US Company, excluding the last quarter of US Company’s fiscal year, unaudited quarterly financial statements (including, but not limited to, balance sheet, income
statement and statement of cash flows) of US Company and its Subsidiaries as of the end of such fiscal quarter, on a Consolidated basis, certified by the principal financial officer or principal accounting officer of US Company as prepared in
accordance with GAAP and fairly presenting in all material respects the financial position and results of operations of US Company and its Subsidiaries for such fiscal quarter and period (subject only to changes from audit and year-end adjustments
and except that such statements need not contain notes) and, at the request of the Administrative Agent, unaudited interim financial statements on a consolidating basis (A) with respect to US Company and its Domestic Subsidiaries, on the one
hand and (B) the US Company’s Foreign Subsidiaries, on the other hand, in each case in a form consistent with US Company’s historical practices of preparation of consolidating financial statements. In addition, at the time of the
delivery of the foregoing financial statements, US Company will deliver to the Collateral Agent such information and/or documents relating to intellectual property of the Credit Parties as may be required pursuant to the terms of the Security
Agreements. 
 (c) Annual Financial Statements. As soon as available, but not later than 90 days after
the close of each fiscal year of US Company, unqualified (except for a qualification for a change in accounting principles with which the accountant concurs) audited financial statements (including, but not limited to, balance sheet, income
statement and statement of cash flows) of US Company and its Subsidiaries as of the end of such year, on a Consolidated basis, certified by a firm of independent certified public accountants of recognized standing selected by US Company but
reasonably acceptable to Administrative Agent, together with, at the request of the Administrative Agent, unaudited consolidating balance sheets, income statements and statements of cash flows (A) with respect to US Company and its Domestic
Subsidiaries, on the one hand and (B) the US Company’s Foreign Subsidiaries, on the other hand, and, within a reasonable time thereafter a copy of any management letter issued in connection therewith. 

(d) Compliance Certificates. Concurrently with the delivery of the financial statements described in clause
(c) of this Section 9.01, US Company shall forward to Administrative Agent a copy of the accountants’ letter to US Company’s management (if any) that is prepared in connection with such financial statements. Concurrently
with the delivery of the financial statements described in paragraph (b) and (c) of this Section 9.01, or more frequently if reasonably requested by Agent, US Company shall cause to be prepared and furnished to Agent a
Compliance Certificate in the form of Exhibit Q hereto executed by the Chief Financial Officer or principal accounting officer of US Company. To the extent any deliverable described in Section 9.01(b) or (c) is
contained in a 10-Q or 10-K which is delivered to the Agent and each Lender pursuant to Section 9.01(h), US Company’s obligation to deliver such item shall be deemed satisfied. 

  
 137

 (e) Notice of Default, Litigation and Material Adverse Effect.
(i) Promptly, and in any event within three Business Days after any officer of US Company or any of its Subsidiaries obtains knowledge thereof, notice of the occurrence of any event which constitutes a Default or an Event of Default, and
(ii) promptly, and in any event within five Business Days after any officer of US Company or any of its Subsidiaries obtains knowledge thereof, notice of (A) any litigation or governmental investigation or proceeding pending against US
Company or any of its Subsidiaries which, either individually or in the aggregate, has had, or could reasonably be expected to have, a Material Adverse Effect, or (B) any other event, change or circumstance that has had, or could reasonably be
expected to have, a Material Adverse Effect. 
 (f) Notice of Material Changes. Promptly notify
Administrative Agent in writing of the occurrence of any event or the existence of any fact that, in either case, is known to US Company or any other Credit Party, which renders any representation or warranty in this Agreement or any of the other
Credit Documents inaccurate, incomplete or misleading in any material respect as of the date made or remade. In addition, US Company agrees to provide Administrative Agent with (i) 10 Business Days’ prior written notice of (1) any
change in the legal name of US Company or any other Credit Party, (2) the adoption by US Company or any other Credit Party of any new fictitious name or trade name and (3) any change in the chief executive office of US Company or any other
Credit Party, and (ii) prompt written notice of any change in the information disclosed in any Schedule hereto (which notice shall be deemed given in respect of information set forth within any periodic report filed by US Company with the SEC
pursuant to Section 13 or 15 of the Securities Exchange Act of 1934, as amended, upon delivery of notice to the Administrative Agent of such filing), in each case after giving effect to the materiality limits and Material Adverse Effect
qualifications contained therein. 
 (g) Other Reports and Filings. Promptly after the filing or delivery
thereof, copies of all financial information, proxy materials, reports, and, with respect to (ii) below, notices, if any, which US Company or any of its Subsidiaries shall (i) publicly file with the SEC, or any national securities
exchange, or (ii) deliver to holders (or any trustee, agent or other representative therefor) of the Convertible Preferred Stock or any of its material Indebtedness pursuant to the terms of the documentation governing the same, in each case, if
the same is not available in the SEC’s EDGAR database or, if so available, US Company has not delivered notice of such filing with the SEC to the Administrative Agent. 

(h) Environmental Matters. Promptly after any officer of US Company or any of its Subsidiaries obtains knowledge
thereof, notice of one or more of the following environmental matters to the extent that such environmental matters, either individually or when aggregated with all other such environmental matters, could reasonably be expected to have a Material
Adverse Effect: 
 (i) any pending or threatened Environmental Claim against US Company or any
of its Subsidiaries or any Real Property owned, leased or operated by US Company or any of its Subsidiaries; 
 (ii) any condition or occurrence on or arising from any Real Property owned, leased or operated by US Company or any of its Subsidiaries that (A) results in noncompliance by US Company or any of its
Subsidiaries with any applicable Environmental Law or (B) could reasonably be expected to form the basis of an Environmental Claim against US Company or any of its Subsidiaries or any such Real Property; 

  
 138

 (iii) any condition or occurrence on any Real Property
owned, leased or operated by US Company or any of its Subsidiaries that could reasonably be expected to cause such Real Property to be subject to any restrictions on the ownership, lease, occupancy, use or transferability by US Company or any of its
Subsidiaries of such Real Property under any Environmental Law; and 
 (iv) the taking of any
removal or remedial action in response to the actual or alleged presence of any Hazardous Material on any Real Property owned, leased or operated by US Company or any of its Subsidiaries as required by any Environmental Law or any governmental or
other administrative agency; provided that in any event US Company shall deliver to each Lender all notices received by US Company or any of its Subsidiaries from any government or governmental agency under, or pursuant to, CERCLA which
identify US Company or any of its Subsidiaries as potentially responsible parties for remediation costs or which otherwise notify US Company or any of its Subsidiaries of potential liability under CERCLA. 

All such notices shall describe in reasonable detail the nature of the claim, investigation, condition, occurrence or removal or remedial
action and US Company’s or such Subsidiary’s response thereto. In addition to the foregoing, prior to inclusion of any Eligible Real Property in the US Borrowing Base, provide the Administrative Agent with environmental reports, in form
and substance satisfactory to the Administrative Agent and from a firm satisfactory to Administrative Agent, relating to the properties owned by US Company or any of its Subsidiaries. 

(i) Borrowing Base Certificate. (i) On the Effective Date, (ii) not later than 5:00 P.M.
(New York time) on or before the 15th day of each month thereafter (or at such other times as the Administrative Agent may reasonably request), (iii) at the time of the consummation of a Permitted Acquisition, (iv) not later than 5:00 P.M.
(New York time) on or before each Wednesday on a weekly basis during a Compliance Period or after the occurrence and during the continuance of an Event of Default and (v) at such other times as US Company may elect (provided that if US
Company elects to deliver a borrowing base certificate at any other time pursuant to this clause (v), US Company shall deliver a borrowing base certificate on a weekly basis for the 60 day period following such delivery), a borrowing base
certificate setting forth the Borrowing Base (in each case with supporting calculations in reasonably detail) substantially in the form of Exhibit R (each, a “Borrowing Base Certificate”), which shall be prepared (A) as
of January 31, 2012 in the case of the initial Borrowing Base Certificate and (B) as of the last Business Day of the preceding month in the case of each subsequent Borrowing Base Certificate (but adjusted, in the case of a Borrowing Base
Certificate delivered in connection with a Permitted Acquisition, to reflect any Eligible Accounts, Eligible Inventory, Eligible Machinery and Equipment and Eligible Real Property acquired by a Borrowing Base Party pursuant to such Permitted
Acquisition) (or, if any such Borrowing Base Certificate is delivered more frequently than monthly, as of the last Business Day of the week preceding such delivery). Each such Borrowing Base Certificate shall include the then applicable,
marked-to-market Swap Termination Value which the Borrower intends be treated as a Qualified Swap Termination Value for purposes of Section 5.03(d), and all such supporting information as may be reasonably requested from time to time by
the Administrative Agent. 

  
 139

 (j) Notice of Compliance Period. Promptly, and in any
event within two Business Days after any officer of US Company or any of its Subsidiaries obtains knowledge thereof, notice of the commencement of a Compliance Period. 

(k) Material Real Property. Promptly upon, and in any event within ten Business Days after, US
Company or any other Credit Party acquires any Real Property the Fair Market Value of which is equal to or greater than $7,500,000 or the Equivalent Amount thereof, notice of such acquisition, together with US Company’s good faith determination
of the Fair Market Value thereof. 
 (l) Other Information. From time to time, such other
information or documents (financial or otherwise) with respect to US Company or any of its Subsidiaries as the Administrative Agent or any Lender (through the Administrative Agent) may reasonably request. 

9.02 Books, Records and Inspections; Field Examinations; Appraisals; Records and Reports of Inventory, Machinery and
Equipment. (a) US Company will, and will cause each of its Subsidiaries to, keep proper books of record and accounts in which full, true and correct entries in conformity with GAAP of all financial transactions in relation to its business
and activities. US Company will, and will cause each of its Subsidiaries to, permit representatives of Administrative Agent and Collateral Agent, and during the continuation of any Compliance Period, Default or Event of Default, any Lender, from
time to time, as often as may be reasonably requested, but only during normal business hours, (i) to visit and inspect the Properties of US Company and each of its Subsidiaries (including the Collateral), inspect, audit and make extracts from
their books and records, and discuss with their officers, their employees and their independent accountants, US Company’s and each of its Subsidiaries’ business, assets, liabilities, financial condition, business prospects and results of
operations and (ii) to verify Eligible Accounts, Eligible Machinery and Equipment, Eligible Inventory and Eligible Real Property. Neither Administrative Agent, Collateral Agent nor any Lender shall have any duty to make any such inspection and
shall not incur any liability by reason of its failure to conduct or delay in conducting any such inspection. Administrative Agent or Collateral Agent, as applicable, if no Default or Event of Default then exists, shall give US Company reasonable
prior notice of any such inspection or audit. Without limiting the foregoing, US Company will participate and will cause its key management personnel to participate in a meeting with Administrative Agent and Lenders at least once during each year or
more frequently, as Administrative Agent may reasonably request (except that during the continuation of an Event of Default such meetings may be held more frequently as requested by Administrative Agent or Required Lenders), which meeting(s) shall
be held at such times and such places as may be reasonably requested by Agent. 
 (b) In addition to
Section 9.02(a), (i) in the case of succeeding sub-clause (x), at least once during each fiscal year of US Company, (ii) in the case of succeeding sub-clause (y), at least once, and at the discretion of the Administrative
Agent, at least twice, in each fiscal year of US Company, and (iii) in the case of either succeeding sub-clause (x) or (y) at any time that a Compliance Period is in effect or any Event of Default exists, as often as the
Administrative Agent or Collateral Agent may reasonably request, US Company will, and will cause each of its Subsidiaries to, permit officers and designated representatives of the Administrative Agent, Collateral Agent or any third-party appraiser
or consultant reasonably satisfactory to the Administrative Agent and the Collateral Agent to visit and inspect (at the Borrowers’ joint and several expense), under guidance of officers of US Company or such Subsidiary, any of the properties of
US Company or such Subsidiary and to verify Eligible Accounts, Eligible Machinery and Equipment, Eligible Inventory and/or Eligible Real Property in order to complete (x) an appraisal of the Eligible Goods Inventory, Eligible Machinery and
Equipment and/or Eligible Real Property of the Borrowing Base Parties and (y) a collateral examination of the Borrowing Base Parties, and in connection therewith US Company shall provide Administrative Agent, Collateral Agent and any field
examiner or appraiser reasonable access to the books and records and the Collateral and shall cooperate with such field examiner or appraiser with respect to the foregoing. 

  
 140

 (c) When reasonably requested by Administrative Agent or Collateral Agent,
US Company shall, and cause each of its Subsidiaries to, provide the following to Administrative Agent and Collateral Agent, with a copy to any Lender which requests delivery (which, at US Company’s election, may be made by email or other
electronic means of communication, or by web posting) of such reports: a report of Eligible Container Fleet Inventory and Eligible Trailer Fleet Inventory by category and by item (in detail), a report of Inventory, based upon a physical count, which
shall describe Inventory of the Borrowing Base Parties by category and by item (in detail) and report the then appraised value of such Inventory, and a report of Equipment which shall describe Borrower’s and Guarantors’ Equipment (in
detail) and report the then appraised value of such Equipment. 
 (d) US Company shall, and shall cause its
Subsidiaries to, keep records of its Inventory and Equipment, which records shall be complete and accurate in all material respects. Borrower shall furnish to Agent and Lenders updates of Schedule 1.01(b) and Inventory and Equipment reports
concurrently with the delivery of each Borrowing Base Certificate or more frequently as requested by Administrative Agent or Collateral Agent, which reports will be in such other format and detail as Administrative Agent or Collateral Agent, as
applicable, shall request and shall include (a) a current list of all locations of Inventory and Equipment of US Company and its Subsidiaries and (b) a list of all Inventory and Equipment of US Company and its Subsidiaries which are Motor
Vehicles, which list shall specify the certificate of title holder (or the equivalent), the vehicle identification number (or equivalent) and the state or province (or equivalent) in which such Inventory or Equipment is located. US Company shall
conduct a physical inventory of all container Inventory on premises owned or leased by US Company or any of its Subsidiaries no less frequently than monthly and shall provide to Administrative Agent and Collateral Agent on request a report based on
each such physical inventory promptly thereafter, together with such supporting information as Administrative Agent or Collateral Agent, as applicable, shall reasonably request. 

9.03 Maintenance of Property; Insurance. (a) US Company will, and will cause each of its Subsidiaries to,
(i) keep all property necessary to the business of US Company and its Subsidiaries in good working order and condition, ordinary wear and tear excepted and subject to the occurrence of casualty events, (ii) maintain with financially sound
and reputable insurance companies insurance on all such property and against all such risks as is consistent and in accordance with industry practice for companies similarly situated owning similar properties and engaged in similar businesses as US
Company and its Subsidiaries, and (iii) furnish to the Administrative Agent, upon its request therefor, full information as to the insurance carried. Such insurance shall include physical damage insurance on all real and personal property
(whether now owned or hereafter acquired) on an all risk basis and business interruption insurance. The provisions of this Section 9.03 shall be deemed supplemental to, but not duplicative of, the provisions of any Security Documents that
require the maintenance of insurance. In addition to the foregoing, US Company and the Borrowers acknowledge and agree that (x) the Administrative Agent has the right, on an annual basis, to review the insurance then being maintained by US
Company and its Subsidiaries and to require US Company and its Subsidiaries to increase their levels of coverage from that which then exists to the extent that the Administrative Agent has a reasonable basis to require same and (y) it will,
within 30 days following such a request by the Administrative Agent, obtain such increased insurance coverage. 

(b) US Company will, and will cause each of its Subsidiaries to, at all times keep its property insured in favor of the
Collateral Agent, and all policies or certificates (or certified copies thereof) with respect to such insurance (and any other insurance maintained by US Company and/or such Subsidiaries) (i) shall be endorsed to the Collateral Agent’s
satisfaction for the benefit of the Collateral 

  
 141

 
Agent (including, without limitation, by naming the Collateral Agent as loss payee and/or additional insured), (ii) shall state that such insurance policies shall not be canceled without at
least 30 days’ prior written notice thereof by the respective insurer to the Collateral Agent, (iii) shall provide that the respective insurers irrevocably waive any and all rights of subrogation with respect to the Collateral Agent and
the other Secured Creditors, and (iv) shall be deposited with the Collateral Agent. 
 (c) If US Company or
any of its Subsidiaries shall fail to maintain insurance in accordance with this Section 9.03, or if US Company or any of its Subsidiaries shall fail to so endorse and deposit all policies or certificates with respect thereto, the
Administrative Agent shall have the right (but shall be under no obligation) to procure such insurance and the Borrowers jointly and severally agree to reimburse the Administrative Agent for all costs and expenses of procuring such insurance.

 9.04 Administration of Equipment; Maintenance of Equipment. (a) US Company shall, and shall cause
its Subsidiaries to, keep records of its Equipment which shall be complete and accurate in all material respects itemizing and describing the kind, type, quality, quantity and book value of its Equipment and all dispositions made in accordance with
this Agreement, and US Company shall, and shall cause its Subsidiaries to, furnish Administrative Agent with a current schedule containing the foregoing information on at least an annual basis and more often if reasonably requested by Administrative
Agent. Promptly after the reasonable request therefore by Administrative Agent, US Company shall deliver to Administrative Agent any and all evidence of ownership, if any, of any Equipment. 

(b) US Company shall, and shall cause its Subsidiaries to, make or cause to be made all necessary
replacements of and repairs to Equipment so that the operating efficiency thereof shall be maintained and preserved, reasonable wear and tear excepted, except where the failure to so maintain the same would not reasonably be expected to have a
Material Adverse Effect. US Company will not, and will not allow any other Credit Party to, permit any Equipment to become affixed to any Real Property leased to US Company or any other Credit Party so that an interest arises therein under the real
estate laws of the applicable jurisdiction unless the landlord of such Real Property has executed a landlord waiver or leasehold mortgage in favor of and in form reasonably acceptable to Administrative Agent, and US Company will not permit, nor will
it allow any other Credit Party to permit, any of the Equipment of US Company or any other Credit Party to become an accession to any personal Property other than Equipment that is subject to First Priority (except for Permitted Liens) Liens in
favor of Administrative Agent. 
 9.05 Existence; Franchises. US Company will, and will cause each of its
Subsidiaries to, do or cause to be done, all things necessary to preserve and keep in full force and effect its existence and its material rights, franchises, licenses, permits, copyrights, trademarks and patents; provided, however,
that nothing in this Section 9.05 shall prevent (a) sales of assets and other transactions by US Company or any of its Subsidiaries in accordance with Section 10.03, (b) the withdrawal by US Company or any of its
Subsidiaries of its qualification as a foreign limited liability company (or other applicable entity) in any jurisdiction if such withdrawal could not, either individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect, or (c) dissolution of the Luxembourg Subsidiary so long as, in the case of clause (c) only, all of the following conditions are met: (1) no Default or Event of Default shall exist at the time of such dissolution and after
giving effect to such dissolution, (2) any Subsidiary of the UK Company that assumes any of the rights or obligations under the Luxembourg Debt in connection with the transactions that effect such dissolution shall become a Non-US Obligation
Guarantor and shall become a party to each of the Credit Documents to which the UK Company, UK-LP or the Luxembourg Subsidiary, as applicable, was a party immediately prior to the dissolution of the Luxembourg Subsidiary, (3) all other Liens
under the Security Documents in favor of the Collateral Agent immediately prior to the dissolution of the Luxembourg Subsidiary shall remain perfected, and the 

  
 142

 
Borrowers shall cause any Subsidiary of the UK Company that assumes any rights or obligations under the Luxembourg Debt in connection with the transactions that effect such dissolution to execute
and deliver to the Collateral Agent such documents, instruments, financing statements, and amendments to Credit Documents as the Collateral Agent may reasonably request to continue the perfection of such Liens, (4) such dissolution shall not
result in any Indebtedness permitted to be incurred pursuant to, and incurred in compliance with, Section 10.04(1) hereof; and (5) such dissolution shall otherwise not create any covenants, undertakings or obligations on the part of
any Credit Party any more onerous than the covenants, undertakings or obligations contained in the Luxembourg Debt. 
 9.06 Compliance with Statutes, etc. US Company will, and will cause each of its Subsidiaries to, comply with all applicable statutes, regulations and orders of, and all applicable restrictions
imposed by, all Governmental Authorities in respect of the conduct of its business and the ownership of its property in any jurisdiction (including applicable statutes, regulations, orders and restrictions relating to environmental standards and
controls), except such non-compliances as could not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 
 9.07 Compliance with Environmental Laws. (a) US Company will comply, and will cause each of its Subsidiaries to comply, with all Environmental Laws and permits applicable to, or required by,
the ownership, lease or use of its Real Property now or hereafter owned, leased or operated by US Company or any of its Subsidiaries, except such noncompliances as could not, either individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect, and will promptly pay or cause to be paid all costs and expenses incurred in connection with such compliance, and will keep or cause to be kept all such Real Property free and clear of any Liens imposed pursuant to such
Environmental Laws. Neither US Company nor any of its Subsidiaries will generate, use, treat, store, Release or dispose of, or permit the generation, use, treatment, storage, Release or disposal of Hazardous Materials on any Real Property now or
hereafter owned, leased or operated by US Company or any of its Subsidiaries, or transport or permit the transportation of Hazardous Materials to or from any such Real Property, except for Hazardous Materials generated, used, treated, stored,
Released or disposed of at any such Real Properties in compliance in all material respects with all applicable Environmental Laws and as required in connection with the normal operation, use and maintenance of the business or operations of US
Company or any of its Subsidiaries. 
 (b) (i) After the receipt by the Administrative Agent or any Lender of
any notice of the type described in Section 9.01(h), (ii) at any time that US Company or any of its Subsidiaries are not in compliance with Section 9.07(a) or (iii) in the event that the Administrative Agent or the
Lenders have exercised any of the remedies pursuant to the last paragraph of Section 11, the Borrowers will provide, at the sole joint and several expense of the Borrowers and at the request of the Administrative Agent, an environmental
site assessment report concerning any Real Property owned, leased or operated by US Company or any of its Subsidiaries, prepared by an environmental consulting firm reasonably approved by the Administrative Agent, indicating the presence or absence
of Hazardous Materials and the potential cost of any removal or remedial action in connection with such Hazardous Materials on such Real Property. If the Borrowers fail to provide the same within 30 days after such request was made, the
Administrative Agent may order the same, the cost of which shall be borne by the Borrowers on a joint and several basis, and the Borrowers shall grant and hereby grant to the Administrative Agent and the Lenders and their respective agents access to
such Real Property and specifically grant the Administrative Agent and the Lenders an irrevocable non-exclusive license, subject to the rights of tenants, to undertake such an assessment at any reasonable time upon reasonable notice to US Company,
all at the sole joint and several expense of the Borrowers. 
 9.8 ERISA. (a) As soon as possible
and, in any event, within ten (10) days after any US Borrower or any of its Subsidiaries or any ERISA Affiliate knows or has reason to know of the 

  
 143

 
occurrence of any of the following ERISA matters could reasonably be expected to result in a material liability to any US Borrower or any other Loan Party, US Company will deliver to each of the
Lenders a certificate of any Authorized Officer of US Company setting forth the full details as to such occurrence and the action, if any, that any such US Borrower, such Subsidiary or such ERISA Affiliate is required or proposes to take, together
with any notices required or proposed to be given or filed by such US Borrower, such Subsidiary, such ERISA Affiliate or the applicable plan administrator to or with the PBGC or any other Governmental Authority, or a Plan or Multiemployer Plan
participant and any notices received by any such US Borrower, such Subsidiary or such ERISA Affiliate from the PBGC or any other Governmental Authority, or a Plan or Multiemployer Plan participant with respect thereto: (i) that a Reportable
Event has occurred or is reasonably expected to occur; (ii) that any US Borrower or any of its Subsidiaries nor an ERISA Affiliate has failed to meet the minimum funding requirements of Sections 412 and 430 of the Code or Sections 302 and 303
of ERISA with respect to any Plan, whether or not waived or failed to make by its due date a required installment under Section 430(j) of the Code or Section 303(j) of ERISA with respect to any Plan; (iii) that a filing pursuant to
Section 412(c) of the Code or Section 302(c) of ERISA of an application for a waiver of the minimum funding standard has been made with respect to any Plan; (iv) that any contribution required to be made with respect to a Plan,
Multiemployer Plan or Foreign Pension Plan has not been timely made; (v) that a Plan or Multiemployer Plan has been terminated (within the meaning of Title IV of ERISA), that a Multiemployer Plan has been reorganized (within the meaning of
Section 4241 of ERISA) or declared “insolvent” (within the meaning of Section 4245 of ERISA) or in “endangered or critical status” (within the meaning of Section 305 of ERISA), or that a Plan has been is, or is
expected to be, in “at-risk” status pursuant to Section 430(i) of the Code or Section 303(i) of ERISA; (vi) that a Plan has an Unfunded Current Liability; (vii) that proceedings have been instituted by the PBGC to
terminate or appoint a trustee to administer under Section 4042 of ERISA any Plan or Multiemployer Plan; (vii) that a proceeding has been instituted pursuant to Section 515 of ERISA to collect a delinquent contribution to a
Multiemployer Plan; that any US Borrower or any of its Subsidiaries or any ERISA Affiliate will or may incur any liability (including any indirect, contingent, or secondary liability) to or on account of the termination of or withdrawal from a Plan
under Section 4062, 4063, 4064 or 4069 of ERISA, or to or on account of a Multiemployer Plan under Section 4201, 4204 or 4212 of ERISA or with respect to a Plan under Section 401(a)(29), 4971, 4975 or 4980 of the Code or
Section 409, 502(i) or 502(l) of ERISA or with respect to a group health plan (as defined in Section 607(1) of ERISA, Section 4980B(g)(2) of the Code or 45 Code of Federal Regulations Section 160.103) under Section 4980B of
the Code and/or the Health Insurance Portability and Accountability Act of 1996; or (viii) that any US Borrower or any of its Subsidiaries may incur any liability pursuant to any employee welfare benefit plan (as defined in Section 3(1) of
ERISA) that provides benefits to retired employees or other former employees (other than as required by Section 601 of ERISA). US Company will deliver to each of the Lenders (i) a copy of each application for a waiver of the minimum
funding standard filed with the Internal Revenue Service or any other Governmental Authority with respect to any Plan and all communications received by any US Borrower or any of its Subsidiaries or any ERISA Affiliate from the Internal Revenue
Service or any other Governmental Authority with respect to such Plan of any US Borrower or any of its Subsidiaries or any ERISA Affiliate, (ii) copies of any records, documents or other information that must be furnished to the PBGC with
respect to any Plan pursuant to Section 4010 of ERISA and (iii) upon the request of the Administrative Agent, a complete copy of the annual report (on Internal Revenue Service Form 5500-series) of each Plan (including, to the extent
required, the related financial and actuarial statements and opinions and other supporting statements, certifications, schedules and information) required to be filed with the US Department of Labor. In addition to any certificates or notices
delivered to the Lenders pursuant to the first sentence hereof, copies of annual reports and any records, documents or other information required to be furnished to the PBGC, and any material notices received by any US Borrower or any of its
Subsidiaries or any ERISA Affiliate with respect to any Plan or Foreign Pension Plan or received from any government agency or plan administrator or sponsor or trustee with respect to any Multiemployer Plan, shall be delivered to the Lenders no
later than ten (10) days after the date such annual report has been filed or such records, documents and/or information has been furnished to the PBGC or such notice has been received by any such US Borrower or such Subsidiaries or such ERISA
Affiliate, as applicable. 

  
 144

 (b) US Company and each of its applicable Subsidiaries shall ensure that all
Foreign Pension Plans administered by it or into which it makes payments obtains or retains (as applicable) registered status under and as required by Applicable Law and is administered in a timely manner in all respects in compliance with all
Applicable Laws, except where the failure to do any of the foregoing, either individually or in the aggregate, could not be reasonably likely to result in a Material Adverse Effect. 

9.09 End of Fiscal Years; Fiscal Quarters. US Company will cause (i) its and each of its Subsidiaries’
fiscal years to end on December 31 of each calendar year and (ii) its and each of its Subsidiaries’ fiscal quarters to end on March 31, June 30, September 30 and December 31 of each calendar year.

 9.10 Performance of Obligations. US Company will, and will cause each of its Subsidiaries to, perform
all of its obligations under the terms of each mortgage, indenture, security agreement, loan agreement or credit agreement and each other agreement, contract or instrument by which it is bound, except such non-performances as could not, either
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 
 9.11 Payment
of Taxes. US Company will timely pay and discharge, and will cause each of its Subsidiaries to timely pay and discharge all its obligations and liabilities, including (a) all material taxes, assessments and governmental charges or levies
imposed upon it or upon its income or profits or upon any properties belonging to it, and (b) all lawful claims which, if unpaid, might become a Lien or charge upon any properties of US Company or any of its Subsidiaries not otherwise permitted
under Section 10.02; provided that neither US Company nor any of its Subsidiaries shall be required to pay any such tax, assessment, charge, levy or claim which is being contested in good faith and by proper proceedings if it has
maintained adequate reserves with respect thereto in accordance with GAAP. 
 9.12 Use of Proceeds. The
Borrowers will use the proceeds of the Loans only as provided in Section 8.22. 
 9.13 Additional
Security; Further Assurances; etc. (a) US Company will, and will cause each other Credit Party to, grant to the Collateral Agent for the benefit of the Secured Creditors Liens, hypothecs and Mortgages in such assets and owned Real Property of US
Company and such other Credit Party as are not covered by the original Security Documents and as may be reasonably requested from time to time by the Administrative Agent or the Required Lenders (collectively, the “Additional Security
Documents”). All such Liens, hypothecs and Mortgages shall be granted pursuant to documentation reasonably satisfactory in form and substance to the Administrative Agent and Collateral Agent and shall constitute valid and enforceable
perfected Liens, hypothecations and Mortgages superior to and prior to the rights of all third Persons and enforceable against third parties and subject to no other Liens except for Permitted Liens or, in the case of Real Property, the Permitted
Encumbrances related thereto (provided that Administrative Agent’s Liens on the LKE Joint Accounts need not be perfected). The Additional Security Documents or instruments related thereto shall have been duly recorded or filed in such
manner and in such places as are required by law to establish, perfect, preserve and protect the Liens in favor of the Collateral Agent required to be granted pursuant to the Additional Security Documents and all taxes, fees and other charges
payable in connection therewith shall have been paid in full. In connection with the delivery of any Mortgage, US Company will, and will cause each other Credit Party to, to the extent reasonably requested from time to time by the Administrative
Agent, Collateral Agent or the Required Lenders, deliver (i) a Mortgage Policy issued by a title insurer 

  
 145

 
reasonably satisfactory to the Administrative Agent, in form and substance and in an amount reasonably satisfactory to the Administrative Agent and Collateral Agent insuring that the Mortgage is
a valid and enforceable First Priority Lien on the respective property other than Permitted Encumbrances, (ii) a then current A.L.T.A. survey, certified to the Administrative Agent and the Collateral Agent by a licensed surveyor sufficient to
allow the issuer of the Mortgage Policy to issue such Mortgage Policy without a survey exception, (iii) an environmental site assessment prepared by a qualified firm reasonably acceptable to the Administrative Agent and Collateral Agent, in
form and substance satisfactory to the Administrative Agent and Collateral Agent and (iv) a certificate in a form reasonably acceptable to the Administrative Agent indicating that the property is not in a flood zone, or if the property is in a
flood zone, evidence that appropriate insurance reasonably acceptable to the Administrative Agent has been obtained. Notwithstanding the foregoing, this Section 9.13(a) shall not apply to (and US Company and the other Credit Parties
shall not be required to grant a Mortgage in) any Real Property the Fair Market Value of which is less than $7,500,000 or the Equivalent Amount thereof. 
 (b) US Company will, and will cause each of the other Credit Parties to, at the expense of US Company, make, execute, endorse, acknowledge, file and/or deliver to the Collateral Agent from time to time
such vouchers, invoices, schedules, confirmatory assignments, conveyances, financing statements, transfer endorsements, powers of attorney, certificates, real property surveys, reports, landlord waivers, bailee agreements, control agreements and
other assurances or instruments and take such further steps relating to the Collateral covered by any of the Security Documents as the Administrative Agent and the Collateral Agent may reasonably require. Furthermore, US Company will, and will cause
the other Credit Parties to, deliver to the Administrative Agent and the Collateral Agent such opinions of counsel, title insurance and other related documents as may be reasonably requested by the Administrative Agent and the Collateral Agent to
assure itself that this Section 9.13 has been complied with. 
 (c) If the Administrative Agent, the
Collateral Agent or the Required Lenders reasonably determine that they are required by law or regulation to have appraisals prepared in respect of any Real Property of US Company and the other Credit Parties constituting Collateral, US Company
will, at its own expense, provide to the Administrative Agent and the Collateral Agent appraisals which satisfy the applicable requirements of the Real Estate Appraisal Reform Amendments of the Financial Institution Reform, Recovery and Enforcement
Act of 1989, as amended, and which shall otherwise be in form and substance reasonably satisfactory to the Administrative Agent. 
 (d) US Company agrees that each action required by clauses (a) through (c) of this Section 9.13 shall be completed as soon as possible, but in no event later than 60 days after such
action is requested to be taken by the Administrative Agent, the Collateral Agent or the Required Lenders; provided that, in no event will US Company or any of its Subsidiaries be required to take any action, other than using its commercially
reasonable efforts, to obtain consents from third parties with respect to its compliance with this Section. 

(e) Notwithstanding anything contained in this Section 9.13 or this Agreement to the contrary, in no event
shall (i) the assets of any of the UK Company, the Canadian Company or any other Foreign Subsidiary be pledged to secure the US Obligations or (ii) more than 65% of the voting securities of any first-tier Foreign Subsidiary held by the US
Company or any Domestic Subsidiary be pledged to secure the US Obligations. 
 9.14 Convertible Preferred
Stock. US Company will pay all dividends on its Convertible Preferred Stock solely through the issuance of additional shares of such Convertible Preferred Stock (but not in cash or Cash Equivalents or other Property). 

  
 146

 9.15 Projections. US Company shall, no later than 60 days after the
end of each fiscal year of US Company, deliver to Administrative Agent Projections of US Company and each of its Subsidiaries for the forthcoming three (3) fiscal years, month by month (including, but not limited to, projected balance sheets,
income statements, statements of cash flows and Total Borrowing Availability, US Borrowing Availability, UK Borrowing Availability, Canadian Borrowing Availability and calculations of projected covenant compliance. 

9.16 Landlord, Processor and Storage Agreements. US Company shall provide Administrative Agent on request with
copies of all agreements between US Company or any other Credit Party and any landlord, processor, distributor, warehouseman or consignee which owns any premises at which any Collateral may, from time to time, be kept. 

9.17 Deposit and Brokerage Accounts. For each deposit account or brokerage account that US Company or any other
Credit Party that is a Domestic Subsidiary of US Company at any time opens or maintains (including, without limitation, any LKE Joint Account, but excluding any account for which such a Cash Management Control Agreement is expressly not required
pursuant to Section 3.9 of the US Security Agreement), US Company shall, at Administrative Agent’s or Collateral Agent’s request and option, pursuant to a Cash Management Control Agreement in form and substance satisfactory to
Administrative Agent, cause the depository bank or securities intermediary, as applicable, to agree to comply at any time with instructions from Collateral Agent to such depository bank or securities intermediary, as applicable, directing the
disposition of funds from time to time credited to such deposit or brokerage account, without further consent of US Company or such other Credit Party, during the continuance of a Compliance Period, a Default or an Event of Default. 

9.18 Credit Party Financial Statements. US Company shall deliver or cause to be delivered to Administrative Agent
financial statements, if any, for each other Credit Party (to the extent not consolidated or combined with the financial statements delivered to Administrative Agent under Section 9.01) in form and substance reasonably satisfactory to
Agent at such intervals and covering such time periods as Administrative Agent may request. 
 9.19 Qualified
Derivative Obligations. Prior to or concurrently with US Company or any other Credit Party entering into any Derivative Obligation or any modification of such Derivative Obligation with any Lender or any Affiliate of a Lender (other than
Administrative Agent or any Affiliate of Administrative Agent), US Company shall provide, or shall cause such Lender or such Affiliate to provide, written notice to Administrative Agent specifying, in a manner reasonably acceptable to Administrative
Agent, the terms and conditions of such Derivative Obligations. In addition, any Lender that enters into any Derivative Obligation or any modification of a Derivative Obligation with a Credit Party may provide notice thereof to the Administrative
Agent. 
 9.20 Centre of Main Interest. Each UK Subsidiary and the Luxembourg Subsidiary shall have and
maintain its centre of main interest (as that term is used in Article 3(1) of the Regulation) for purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings within respectively, the United Kingdom and
Luxembourg. 
 9.21 Administration of Accounts. (a) US Company shall, and shall cause each of its
Subsidiaries to, keep accurate and complete records of its Accounts and all payments and collections thereon and shall submit to Administrative Agent on such periodic basis as Administrative Agent shall request a sales and collections report for the
preceding period, in form consistent with the reports currently prepared by US Company with respect to such information. When requested by Administrative Agent, from and after the date hereof, US Company shall deliver to Administrative Agent a
detailed aging of all of Accounts of US Company and its Subsidiaries, and upon Administrative Agent’s request 

  
 147

 
therefore, copies of proof of delivery and the original copy of all documents, including, without limitation, repayment histories and present status reports relating to the Accounts so scheduled
and such other matters and information relating to the status of then existing Accounts as Administrative Agent shall reasonably request. 
 (b) If an Account includes a charge for any tax payable to any governmental taxing authority, Administrative Agent is authorized, in its sole discretion, to pay the amount thereof to the proper taxing
authority for the account of US Company or its Subsidiaries and to charge US Company therefore, except for taxes that (i) are being actively contested in good faith and by appropriate proceedings and with respect to which US Company or such
Subsidiary maintains reasonable reserves on its books therefore and (ii) would not reasonably be expected to result in any Lien other than a Permitted Lien. In no event shall Administrative Agent or any Lender be liable for any taxes to any
governmental taxing authority that may be due by US Company or any of its Subsidiaries or Affiliates. 
 SECTION
10. Negative Covenants. Each of US Company and each other Credit Party hereby covenants and agrees that on and after the Effective Date and until the Total Revolving Loan Commitment and all Letters of Credit have terminated and the Loans,
Notes and Unpaid US Drawings, Unpaid UK Drawings and Unpaid Canadian Drawings (in each case, together with interest thereon), Fees and all other Obligations (other than any indemnities described in Section 13.13 which are not then due
and payable) incurred hereunder and thereunder, are paid in full in cash: 
 10.01 [Reserved].

 10.02 Liens. US Company will not, and will not permit any of its Subsidiaries to, create, incur,
assume or suffer to exist any Lien upon or with respect to any property or assets (real or personal, tangible or intangible) of US Company or any of its Subsidiaries, whether now owned or hereafter acquired, or sell any such property or assets
subject to an understanding or agreement, contingent or otherwise, to repurchase such property or assets (including sales of accounts receivable with recourse to US Company or any of its Subsidiaries), or assign any right to receive income or permit
the filing of any financing statement under the UCC or any other similar notice of Lien under any similar recording or notice statute; provided that the provisions of this Section 10.02 shall not prevent the creation, incurrence,
assumption or existence of the following (Liens described below are herein referred to as “Permitted Liens”): 
 (a) Liens granted to Collateral Agent for the benefit of the Secured Creditors under the Security Documents to secure the Obligations; 

(b) Liens listed on Schedule 10.02; 

(c) Liens for taxes not yet due or being contested in good faith and by appropriate proceedings to the
extent permitted under this Agreement; 
 (d) Purchase Money Liens and Leases; 

(e) Liens of warehousemen, mechanics, materialmen, workers, repairmen, common carriers, or landlords,
liens for taxes, assessments or other governmental charges, and other similar Liens (other than Liens arising under ERISA) arising by operation of law for amounts that are not yet due and payable or which are being diligently contested in good faith
by a Credit Party, and for which adequate reserves are maintained by US Company for their payment in accordance with GAAP; 

  
 148

 (f) Attachment or judgment Liens not to exceed an aggregate
of $10,000,000 or the Equivalent Amount thereof excluding in each case amounts (i) bonded to the reasonable satisfaction of Administrative Agent or (ii) covered by insurance to the reasonable satisfaction of Administrative Agent;

 (g) Deposits or pledges to secure obligations under worker’s compensation, social
security or similar laws, or under unemployment insurance, not to exceed an aggregate of $10,000,000 or the Equivalent Amount thereof; 
 (h) Deposits or pledges to secure bids, tenders, contracts (other than contracts for the payment of money), leases, statutory obligations, surety and appeal bonds and other obligations of like nature
arising in the ordinary course of business not to exceed an aggregate of $10,000,000 or the Equivalent Amount thereof; 
 (i) Easements, rights of way, restrictions and other similar encumbrances incurred in the ordinary course of business which, in the aggregate, are not substantial in amount and which do not materially
detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of US Company or any of its Subsidiaries; 

(j) Liens securing Indebtedness described in Section 10.05(d) which has been refinanced so
long as such refinanced Indebtedness is not secured by any collateral which did not secure the Indebtedness prior to such refinancing; 
 (k) Liens securing Indebtedness described in Section 10.05(j) and (k); 
 (l) Extensions and renewals of any of the foregoing so long as the aggregate amount of extended or renewed Liens are not increased and are on terms and conditions no more restrictive than the terms and
conditions of the Liens extended or renewed; 
 (m) Liens securing Indebtedness of a Foreign
Subsidiary permitted under Section 10.05(e)(iii); 
 (n) Liens securing Capitalized
Lease Obligations permitted pursuant to Section 10.05(m); 
 (o) Liens securing
Indebtedness permitted pursuant to Section 10.05(n); provided that such Liens do not extend to any real or personal property other than the property acquired in such Permitted Acquisition; and 

(p) (i) statutory and common law rights of set-off and other similar rights and remedies as to deposits
of cash, securities, commodities and other funds in favor of banks, other depositary institutions, securities or commodities intermediaries or brokerages and (ii) Liens of a collecting bank arising in the ordinary course of business under
Section 4-208 of the UCC in effect in the relevant jurisdiction and covering only the items being collected upon. 
 10.03 Sale of Assets. US Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly, sell, lease, assign, transfer, liquidate or otherwise dispose of any assets (an
“Asset Sale”) other than (i) Inventory (including containers held for lease) in the ordinary course of business, (ii) individual items of Collateral with a book value of less than $10,000,000 or the Equivalent Amount
thereof in the aggregate during any fiscal year, (iii) obsolete or worn out property disposed of in the ordinary course of business, (iv) Asset Sales (including, without limitation, transfers of

  
 149

 
Inventory, Equipment or Real Property from US Company to a Credit Party) from US Company to a Credit Party, or from one Credit Party to another Credit Party or to US Company, provided, in
each case, that any transfer of Inventory, Equipment or Real Property from a Borrower shall be made to another Credit Party that is or, concurrently with such transfer, becomes, a Borrower, (v) sales of Trailers acquired in Permitted
Acquisitions or owned by US Company or a Credit Party on the date hereof, (vi) so long as no Default or Event of Default has occurred and is continuing, to the extent permitted by the Senior Note Indentures and the Permitted Additional
Financing Documents, sales of container Inventory held for lease pursuant to sale and leaseback transactions (with the “leaseback” portion of such transaction being permitted pursuant to Section 10.05(m)), provided that
the Orderly Liquidation Value of such container Inventory sold during the term of this Agreement shall not exceed $50,000,000 or the Equivalent Amount thereof, (vii) dispositions of assets not otherwise addressed by this
Section 10.03 with an aggregate Fair Market Value not in excess of $10,000,000 or the Equivalent Amount thereof in the aggregate in any fiscal year; provided that, with respect to clauses (ii), (iii), (iv), (v), (vi) and
(vii), (a) such dispositions are for fair value, (b) the aggregate consideration is paid in full in cash at the time of disposition and is either reinvested in the business of US Company or its Subsidiaries (subject to the limitations of
this Agreement) or used to repay Revolving Loans in accordance with Section 5.02(c), (viii) sales of Equipment which US Company or a Credit Party will lease back under a capital lease permitted under Section 10.05(d) or
an operating lease permitted under Section 10.12; (ix) sales of Real Property not in excess of $25,000,000 in the aggregate for the term of this Agreement that US Company or a Credit Party promptly leases back and (x) sales or
other dispositions of Inventory or Equipment to the extent that (i) such property is exchanged for credit against the purchase price of similar replacement property or (ii) the proceeds of such sale or other disposition are applied to the
purchase price of such replacement property (or otherwise applied in accordance with Section 5.02(c)(ii)), in each case as part of a LKE Transaction and pursuant to the terms and conditions of the LKE Master Exchange Agreement. 

10.04 Restricted Payments. US Company shall not, and shall not permit any of its Subsidiaries to, directly or
indirectly: 
 (a) declare or pay any dividend (other than dividends payable solely in common
stock of US Company) on, or make any payment on account of, or set apart assets for a sinking or other analogous fund for, the purchase, redemption, defeasance, retirement or other acquisition of, any shares of any class of Equity Interests of US
Company or any warrants, options or rights to purchase any such Equity Interests, whether now or hereafter outstanding, or make any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations
of US Company or any of its Subsidiaries (each of the foregoing, a “Restricted Payment”); provided, (i) any Subsidiary may declare and pay dividends or distributions to US Company or any other Domestic Subsidiary of US
Company which is a US Credit Party; (ii) any Foreign Subsidiary may declare and pay dividends or distributions to UK Company, Canadian Company or any other Foreign Subsidiary, (iii) US Company may purchase on the open market or in
privately-negotiated transactions Equity Interests consisting of its common stock for an aggregate amount not to exceed $10,000,000 if, (A) both before and after giving effect to such purchase, no Default or Event of Default exists or would
result therefrom and US Company has Total Borrowing Availability of at least $90,000,000, (B) all shares of such Equity Interests so purchased are thereafter immediately cancelled or shall have the status of treasury stock of US Company and
(C) if the Restricted Payment under this clause (iii) is to be made with the proceeds of a Loan, the request for such Loan shall be made under a separate request for borrowing and shall be accompanied by calculations in reasonable detail
evidencing that US Company may make any Restricted Payment in compliance with this Section 10.04(a); and (iv) US Company may make any Restricted Payment permitted pursuant to the Senior Note Documents and the Permitted Additional
Financing Documents so long as at the time of such Restricted Payment, the Payment Conditions shall have been satisfied; or 

  
 150

 (b) make any payment or prepayment of principal of, or any
prepayment of interest on, or any redemption (including, without limitation, by making payments to a sinking or analogous fund), repurchase or defeasance of, any Indebtedness (other than the Obligations) or of any Mandatory Redeemable Obligation;
provided that (i) any Subsidiary may make payments on account of Indebtedness owing to US Company or any other Credit Party, (ii) the US Company may repurchase or redeem up to 35% of the aggregate principal amount of the Senior
Notes outstanding on the Effective Date and pay accrued interest and premium thereon with the proceeds of the issuance of US Company’s Equity Interests in an “Equity Offering” under and as defined in the Senior Notes Indentures if,
both before and after giving effect to such repurchase or redemption, (x) no Default or Event of Default exists and (y) US Company has Total Borrowing Availability of at least $90,000,000, (iii) US Company and its Subsidiaries may
make scheduled principal and interest payments on Indebtedness permitted under Sections 10.05(a), (b), (c), (d), (g), (h), (i), (j), (k) and (l) and scheduled interest
payments on the Senior Notes and the Permitted Additional Financing Indebtedness, (iv) US Company may prepay, repurchase or redeem any Indebtedness permitted to be prepaid, repurchased or redeemed pursuant to the Senior Note Documents
(including, without limitation, any Indebtedness outstanding under any such Senior Note Documents to the extent so permitted) so long as at the time of such prepayments, repurchases or redemptions, the Payment Conditions shall have been satisfied,
(v) US Company may prepay, repurchase or redeem any Indebtedness outstanding under the Senior Note Documents with the proceeds of any Permitted Senior Notes Refinancing incurred in accordance with Section 10.05(f), (vi) US Company may
prepay, repurchase or redeem any Indebtedness permitted to be prepaid, repurchased or redeemed pursuant to the Permitted Additional Financing Documents (including, without limitation, any Indebtedness outstanding under any such Permitted Additional
Financing Documents to the extent so permitted) so long as at the time of such prepayments, repurchases or redemptions, the Payment Conditions shall have been satisfied, and (vii) US Company may prepay, repurchase or redeem any Permitted
Additional Financing Indebtedness with the proceeds of any Permitted Additional Financing incurred in accordance with Section 10.05(h) or (j). 

10.05 Indebtedness. US Company will not, and will not permit any of its Subsidiaries to, contract, create, incur,
assume or suffer to exist any Indebtedness, except: 
 (a) Indebtedness under the Credit
Documents and Derivative Obligations under which a Lender or an Agent (or one of their respective Affiliates) is the counterparty incurred in the ordinary course of business; 

(b) Unsecured Derivative Obligations incurred in the ordinary course of business; 

(c) Indebtedness described on Schedule 10.05, and any refinancing of such Indebtedness, so long as
the aggregate principal amount of the Indebtedness so refinanced shall not be increased and the refinancing shall be on terms and conditions no more restrictive than the terms and conditions of the Indebtedness to be refinanced; 

(d) Indebtedness, including Capitalized Lease Obligations, secured by purchase money liens on Equipment
the title to or leasehold interest in which is acquired after the Effective Date, not to exceed $40,000,000 or the Equivalent Amount thereof in the aggregate (irrespective of when due) outstanding at any one time (“Purchase Money Liens and
Leases”) so long as each Purchase Money Lien or Lease shall attach or relate only to the property (and accessions thereto and proceeds thereof) to be acquired or the acquisition cost of which is financed through leasing and the principal
amount of the debt incurred (including the principal component of lease payments) shall not exceed one hundred percent (100%) of the purchase price of the item or items of equipment; 

  
 151

 (e) (i) Indebtedness consisting of loans and advances by US
Company or any Subsidiary of US Company to US Company or any Domestic Subsidiary that is a Credit Party; (ii) Indebtedness consisting of loans and advances by the UK Company, the Canadian Company or any Foreign Subsidiary to UK Company,
Canadian Company or any Foreign Subsidiary that is a Credit Party; (iii) Indebtedness consisting of loans and advances by the US Company or any Domestic Subsidiary to UK Company, Canadian Company or any Foreign Subsidiary that is a Credit
Party, in an amount, together with Investments under Section 10.07(b)(iii), not to exceed $50,000,000 or the Equivalent Amount thereof at any time outstanding; (iv) Indebtedness of any Foreign Subsidiary (other than a Credit Party)
for which none of a US Borrower, a UK Borrower, a Canadian Borrower or any Credit Party has provided credit support (by guarantee, granting of Liens on its assets or otherwise) in an amount not to exceed $25,000,000 or the Equivalent Amount thereof
at any time outstanding, and (v) other Indebtedness consisting of loans and advances to Foreign Subsidiaries, which together with Investments made by any Credit Party in Foreign Subsidiaries under Section 10.07(b)(iv) (such loans
and advances to Foreign Subsidiaries, together with Investments made under Section 10.07(b)(iv), “Restricted Foreign Funding”), does not exceed $10,000,000 or the Equivalent Amount thereof in the aggregate at any time
outstanding; provided that (X) all loans and advances described under (i), (ii), (iii) and (v) are evidenced by an intercompany note, which is pledged to the Collateral Agent and are subordinated to the Obligations on terms and
conditions reasonably acceptable to the Administrative Agent and the Collateral Agent and (Y) US Company may make any Restricted Foreign Funding in excess of the limitations in the foregoing clause (v) which are otherwise permitted
pursuant to the Senior Note Documents so long as at the time of such Restricted Foreign Funding, the Payment Conditions shall have been satisfied. 

(f) Indebtedness under (i) the Senior Note Documents and (ii) any Permitted Senior Notes
Refinancing in respect thereof; provided that in connection with the incurrence of any Permitted Senior Notes Refinancing, immediately following the incurrence of any such Permitted Senior Notes Refinancing, the aggregate amount of all such
Indebtedness incurred pursuant to this Section 10.05(f) does not exceed the aggregate principal amount of all such Indebtedness under the Senior Note Documents and any previously incurred Permitted Senior Notes Refinancing thereof (plus accrued
and unpaid interest with respect to such Indebtedness and reasonable fees, premium and expenses relating to the applicable extension, renewal or refinancing) immediately prior to the incurrence of any such Permitted Senior Notes Refinancing;
provided further that notwithstanding the foregoing, the aggregate amount of all Indebtedness incurred pursuant to this Section 10.05(f) may exceed the aggregate principal amount of all such Indebtedness under the Senior Note Documents
and any previously incurred Permitted Senior Notes Refinancing thereof (plus accrued and unpaid interest with respect to such Indebtedness and reasonable fees, premium and expenses relating to the applicable extension, renewal or refinancing)
immediately prior to the incurrence of any such Permitted Senior Notes Refinancing so long as (a) the Revolving Loans, if any, shall have been (or shall concurrently be) prepaid in the amount of such excess at the time of the incurrence of any
such Permitted Senior Notes Refinancing, and (b) both before and after giving effect to the incurrence of any such Permitted Senior Notes Refinancing, US Company and its Subsidiaries shall be in compliance, on a pro forma basis (after giving
effect to such Permitted Senior Notes Refinancing and such other customary adjustments requested by US Company and reasonably acceptable to the Administrative Agent) with the covenant set forth in Section 10.23 (Debt Ratio), as of the
last day of the most recently ended fiscal quarter, whether or not a Compliance Period is then in effect; 

  
 152

 (g) Indebtedness (other than Indebtedness under this
Agreement) incurred to finance insurance premiums, not to exceed $10,000,000 or the Equivalent Amount thereof in any fiscal year; 
 (h) (i) unsecured Permitted Ratio Debt and (ii) unsecured Permitted Capped Debt, in each case, so long as (A) the creditors with respect to such Indebtedness enter into an intercreditor
agreement or other customary arrangements in form and substance satisfactory to Administrative Agent (B) before and immediately after giving effect to the incurrence of such Indebtedness and any contemporaneous use of the proceeds thereof, no
Default or Event of Default has occurred and is continuing or would be created thereby, and (C) such Indebtedness is not prohibited by the Senior Note Documents; 

(i) unsecured Indebtedness in an aggregate principal amount not to exceed $25,000,000 or the Equivalent
Amount thereof so long as (i) before and immediately after giving effect to the incurrence of such Indebtedness and any contemporaneous use of the proceeds thereof, no Default or Event of Default has occurred and is continuing or would be
created thereby, and (ii) such Indebtedness is not prohibited by the Senior Note Documents or the Permitted Additional Financing Documents. 

(j) (i) Permitted Ratio Debt which is secured by a Lien junior to the Lien granted to Administrative
Agent for the benefit of the Secured Creditors under the Security Documents and (ii) Permitted Capped Debt which is secured by a Lien junior to the Lien granted to Administrative Agent for the benefit of the Secured Creditors under the Security
Documents, in each case, so long as (A) the creditors with respect to such Indebtedness enter into an intercreditor agreement or other customary arrangements in form and substance reasonably satisfactory to Administrative Agent, (B) before
and immediately after giving effect to the incurrence of such Indebtedness and any contemporaneous use of the proceeds thereof, no Default or Event of Default has occurred and is continuing or would be created thereby and (C) such Indebtedness
is not prohibited by the Senior Notes Documents; 
 (k) Indebtedness which is secured by a first
or second priority Lien on the assets of the US Company or other Credit Party, in an aggregate principal amount for all Credit Parties not to exceed $10,000,000 or the Equivalent Amount thereof so long as (i) the creditors with respect to such
Indebtedness enter into an intercreditor agreement in form and substance satisfactory to Administrative Agent, (ii) before and immediately after giving effect to the incurrence of such Indebtedness and any contemporaneous use of the proceeds
thereof, no Default or Event of Default has occurred and is continuing or would be created thereby, and (iii) such Indebtedness is not prohibited by the Senior Notes Documents or the Permitted Additional Financing Documents; 

(l) the Luxembourg Debt; provided that (A) such Indebtedness will be evidenced by a revolving
credit facility agreement in the form existing as at the date hereof with claims thereunder assigned in favor of the Collateral Agent and shall be subordinated to the Obligations of the Credit Parties on terms and conditions satisfactory to the
Administrative Agent and (B) the creditors with respect to such Indebtedness shall have entered into and delivered to the Administrative Agent for the benefit of the Secured Creditors the UK Intercreditor Deed in the form attached hereto as
Exhibit S; 
 (m) Capitalized Lease Obligations in respect of leasehold interest in
container Inventory which is sold in a sale and leaseback transaction (with the sale portion of such transaction being permitted pursuant to Section 10.03(vi)) so long as each lease shall attach or relate only to the property subject to
such sale leaseback transaction and the principal amount of the debt incurred (including the principal component of lease payments) shall not exceed one hundred percent (100%) of the purchase price of the item or items of container Inventory;

  
 153

 (n) assumed Indebtedness incurred in connection with a
Permitted Acquisition in an aggregate amount not to exceed $25,000,000 in the aggregate at any time outstanding, so long as such Indebtedness (A) constitutes either purchase money Indebtedness incurred in connection with the purchase of
fixtures and Equipment or Capitalized Lease Obligations and (B) was not incurred in anticipation of such Permitted Acquisition; and 
 (o) Indebtedness under Banking Products Agreements incurred in the ordinary course of business and consistent with past practices of the Credit Parties. 

10.06 Contingent Obligations. Neither US Company nor any of its Subsidiaries shall directly or indirectly incur,
assume, or suffer to exist any Contingent Obligation, excluding indemnities given in connection with the sale of Inventory or other asset dispositions permitted hereunder and Contingent Obligations for Indebtedness permitted to be incurred under
Section 10.05 hereof 
 10.07 Advances, Investments and Loans. US Company shall not, and
shall not permit any of its Subsidiaries to, directly or indirectly, make any Investment in any Person, whether in cash, securities, or other property of any kind including, without limitation, any Subsidiary or Affiliate of US Company, other than:

 (a) Advances or loans (but not sales on open account on ordinary course of business terms)
made in the ordinary course of business, including those made to finance the sale of Inventory, not to exceed $1,000,000 or the Equivalent Amount thereof outstanding at any one time to any one Person and $5,000,000 or the Equivalent Amount thereof
in the aggregate outstanding at any one time; 
 (b) Investments (including in the form of loans
or advances permitted by Section 10.5(e)): (i) by US Company or any Subsidiary of US Company in US Company or any Domestic Subsidiary that is a Credit Party, (ii) by the UK Company, the Canadian Company or any Foreign
Subsidiary in UK Company, the Canadian Company or any Foreign Subsidiary that is a Credit Party, (iii) by US Company or a Domestic Subsidiary in UK Company, Canadian Company or a Foreign Subsidiary that is a Credit Party; provided that
all Investments in such Foreign Subsidiaries, together with Indebtedness of Foreign Subsidiaries permitted under Section 10.05(e)(iii), shall not exceed $50,000,000 or the Equivalent Amount thereof at any time outstanding and
(iv) in Foreign Subsidiaries, which together with Indebtedness incurred in reliance on Section 10.05(e)(v), does not exceed $10,000,000 or the Equivalent Amount thereof in the aggregate at any time outstanding; provided that
(X) all Investments in the form of loans and advances described under (i), (ii), (iii) and (iv) are evidenced by an intercompany note in accordance with Section 10.05(e)(v) and (Y) US Company may make any Restricted
Foreign Funding in excess of the limitations set forth in the foregoing clause (iv) which are otherwise permitted pursuant to the Senior Note Documents and the Permitted Additional Financing Documents so long as at the time of such Restricted
Foreign Funding, the Payment Conditions shall have been satisfied; 
 (c) Cash Equivalents;

 (d) Permitted Acquisitions; 

  
 154

 (e) Deposits with financial institutions, disclosed on
Schedule 10.07, and which are insured by the Federal Deposit Insurance Corporation (“FDIC”) or a similar federal insurance program; provided, however, that US Company may, in the ordinary course of its business,
maintain in its disbursement accounts from time to time amounts in excess of then applicable FDIC or other program insurance limits; and 
 (f) Such other Investments as Required Lenders may approve in writing in their sole discretion. 
 10.08 Transactions with Affiliates. US Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly, enter into any transaction with, including, without limitation,
the purchase, sale or exchange of property or the rendering of any service to, any Subsidiary or Affiliate of US Company, except (a) the transactions in existence on the Effective Date as described on Schedule 10.08,
(b) transactions between or among US Company and its wholly-owned Subsidiaries which are Credit Parties and (c) transactions in the ordinary course of and pursuant to the reasonable requirements of US Company’s or such
Subsidiary’s or Affiliate’s business, as the case may be, and upon fair and reasonable terms no less favorable to US Company or such Subsidiary than could be obtained in a comparable arm’s-length transaction with an unaffiliated
Person. 
 10.09 Registered Pension Plans. None of the Borrowers or any other Credit Party shall
establish or commence contributing to or become otherwise obligated in respect of a Foreign Pension Plan which contains a “defined benefit provision” as such term is defined in the CITA or which is a “multi-employer pension” plan
subject to the Supplemental Pension Plans Act (Quebec). 
 10.10 Additional Negative Pledges. US
Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly, create or otherwise cause or suffer to exist or become effective, (i) any prohibition or restriction (including any agreement to provide equal and
ratable security to any other Person in the event a Lien is granted to or for the benefit of Collateral Agent and the Secured Creditors) on the creation or existence of any Lien upon the assets of US Company or its Subsidiaries or (ii) any
contractual obligation which may restrict or inhibit Administrative Agent’s or Collateral Agent’s rights or ability to sell or otherwise dispose of the Collateral or any part thereof after the occurrence of an Event of Default, other than
pursuant to the Senior Note Documents and pursuant to the Permitted Additional Financing Documents as in effect on the date on which the Senior Notes were issued. 

10.11 No Subsidiaries. US Company shall not, directly or indirectly, form or acquire any new Subsidiaries, except
(a) in connection with Permitted Acquisitions in compliance with Section 10.13 and (b) if each of the following conditions is met: 
 (i) each new Subsidiary is a Wholly-Owned Subsidiary of US Company created to conduct business in a specific jurisdiction; 

(ii) both before and after giving effect to the creation of such Subsidiary and the transfer of any assets from US
Company or its Subsidiaries to such Subsidiary, all representations and warranties of US Company and its Subsidiaries contained in any Credit Document are true and correct in all material respects, on and as of such date as if made as of such date
(except (x) such revisions as are necessary to reflect the formation of such new Subsidiary and (y) it being understood and agreed that (A) any representations and warranties stated to relate to a specific earlier date shall have been
true and correct in all material respects as of such earlier date and (B) any representations and warranties qualified as to “materiality” or “Material Adverse Effect” shall be true and correct in all respects at such time),
no Default or Event of Default shall have occurred and be continuing, and US Company and its Subsidiaries shall be Solvent; 

  
 155

 (iii) US Company shall have delivered to Administrative Agent written notice
at least fifteen (15) Business Days prior to consummation of any transfer of assets to, or acquisition of assets by, such new Subsidiary, describing in reasonable detail the proposed new Subsidiary and its assets; 

(iv) any such new Subsidiary shall have executed and delivered to Administrative Agent such Security Documents (or
joinders thereto, in form and substance satisfactory to Administrative Agent and Collateral Agent) and other documents as are necessary (or advisable in Administrative Agent’s and Collateral Agent’s judgment) under Applicable Law in order
to grant Collateral Agent for the benefit of the Secured Creditors a perfected First Priority security interest and Lien in the assets of, and ownership interests in, such Subsidiary and US Company or the applicable Credit Party shall execute and
deliver an amendment to the applicable pledge agreement in form and substance satisfactory to Administrative Agent and Collateral Agent, together with stock certificates and promissory notes and other instruments endorsed in blank, to pledge its
equity interests in such new Subsidiary and all intercompany Loans to such Subsidiary; 
 (v) each such new
Subsidiary that is a Domestic Subsidiary shall become a party to this Agreement, either as a US Borrower or a US Guarantor, as determined by the Administrative Agent or the Required Lenders, in each case by executing and delivering to the
Administrative Agent a counterpart of a Joinder Agreement, and in the event that the Subsidiary is to become a US Borrower hereunder, by executing and delivering to the Administrative Agent a counterpart to the US Revolving Note and the US Swingline
Note; 
 (vi) (i) each such new Subsidiary that is a UK Subsidiary shall become a party to this Agreement,
either as a UK Borrower or a Non-US Obligation Guarantor, as determined by the Administrative Agent or the Required Lenders, in each case by executing and delivering to the Administrative Agent a counterpart of a Joinder Agreement, and in the event
that the Subsidiary is to become a UK Borrower hereunder, by executing and delivering to the Administrative Agent a counterpart to the UK Revolving Note and the UK Swingline Note, (ii) each such new Subsidiary that is a Canadian Subsidiary
shall become a party to this Agreement, either as a Canadian Borrower or a Non-US Obligation Guarantor, as determined by the Administrative Agent or the Required Lenders, in each case by executing and delivering to the Administrative Agent a
counterpart of a Joinder Agreement, and in the event that the Subsidiary is to become a Canadian Borrower hereunder, by executing and delivering to the Administrative Agent a counterpart to the Canadian Revolving Note, and (iii) each such new
Subsidiary that is a Foreign Subsidiary other than a UK Subsidiary or a Canadian Subsidiary shall become a party to this Agreement as a Non-US Obligation Guarantor by executing and delivering to the Administrative Agent a counterpart of a Joinder
Agreement; and 
 (vii) if required by Administrative Agent, Administrative Agent shall have received opinions
of counsel, in form and substance satisfactory to it, as to the due execution, delivery and enforceability of the Credit Documents executed by such new Subsidiary, together with such evidences of solvency, certificates, Certificates of Title, and
other documents and instruments reasonably requested by Administrative Agent. 
 10.12 Operating Leases;
Off-Balance Sheet Financing. Neither US Company nor any of its Subsidiaries shall directly or indirectly incur, create, assume or suffer to exist any liabilities for operating leases or other indebtedness or liabilities not reflected as such on
their financial statements other than liabilities described on Schedule 10.12, and any refinancing of such liabilities, so long as the aggregate amount thereof so refinanced shall not be increased and the refinancing shall be on terms and
conditions no more restrictive than the terms and conditions of the liabilities to be refinanced; provided, however, that US Company and its Subsidiaries may incur liabilities in connection with operating leases of real property
(including office and yard space) and office Equipment in the ordinary course of business 

  
 156

 
and of other Equipment with values of up to $20,000,000 or the Equivalent Amount thereof in any fiscal year (exclusive of Equipment acquired under operating leases executed prior to the Effective
Date and listed on Schedule 10.12) (and up to 50% of any amount not incurred in any fiscal year may be carried over to the next fiscal year). 
 10.13 Permitted Acquisitions. US Company shall not, and shall not permit any of its Subsidiaries to, make an Acquisition unless each of the following conditions is satisfied: 

(a) such Acquisition is made by US Company or another Credit Party; 

(b) such Acquisition shall be consensual and, if required under state law, shall have been approved by the board of
directors or other governing body of the Person to be acquired (if there is such a governing body) and shall be permitted by the Senior Note Documents and the Permitted Additional Financing Documents; 

(c) both before and after giving effect to such Acquisition, all representations and warranties of US Company and its
Subsidiaries contained in any Credit Document are true and correct in all material respects on such date as if made as of such date (it being understood and agreed that (i) any representations and warranties stated to relate to a specific
earlier date shall have been true and correct in all material respects as of such earlier date and (ii) any representations and warranties qualified as to “materiality” or “Material Adverse Effect” shall be true and correct
in all respects at such time) and no Default or Event of Default shall have occurred and be continuing, and Administrative Agent shall receive a certificate of US Company to such effect on the date on which such Acquisition is consummated;

 (d) both before and after giving effect to such Acquisition and the incurrence of Indebtedness in connection
therewith, US Company and its Subsidiaries (including any Subsidiary acquired in such Acquisition) shall be Solvent; 
 (e) no Default or Event of Default shall have occurred and be continuing or shall be created thereby and the Payment Conditions shall have been satisfied, each calculated on a pro forma basis (whether or
not Section 10.21 hereof would then require compliance with such covenant) immediately after giving effect to such payments and any Indebtedness incurred in connection therewith, and Administrative Agent shall receive a certificate of US
Company to such effect on the date on which such Acquisition is consummated; 
 (f) if a Revolving Loan is to be
made in connection with such Acquisition, Administrative Agent shall have received a Notice of Borrowing and, if US Company desires to include the assets to be acquired in the US Borrowing Base, the UK Borrowing Base or the Canadian Borrowing Base
for such Revolving Loan, a Borrowing Base Certificate; 
 (g) as soon as reasonably practicable following
consummation of the Acquisition, Administrative Agent and Collateral Agent shall have received such financing statements, filings, Certificates of Title and other Security Documents as required (or advisable in Administrative Agent’s or
Collateral Agent’s judgment) to create and perfect Liens on any assets to be acquired, including assets of any new Subsidiary, together with evidence (including Lien search results) satisfactory to Administrative Agent and Collateral Agent that
such Liens are first and prior Liens subject only to Permitted Liens; 
 (h) all new Subsidiaries formed or
acquired in such Permitted Acquisition shall be Wholly-Owned Subsidiaries, directly or indirectly, of US Company; 

  
 157

 (i) the business and assets to be acquired in such Acquisition shall be
acquired free and clear of all Liens (other than Permitted Liens); 
 (j) any new Domestic Subsidiary shall
become a Borrower or Guarantor and all new Domestic Subsidiaries shall execute and deliver to Administrative Agent and Collateral Agent such Security Documents as are required to be executed by a Guarantor (or joinder agreements in form and
substance satisfactory to Administrative Agent and Collateral Agent) and such other documents as are necessary (or advisable in Administrative Agent’s or Collateral Agent’s judgment) under Applicable Law in order to grant Collateral Agent
for the benefit of the Secured Creditors a perfected First Priority security interest and Lien in the assets of, and ownership interests in, such Subsidiary (subject only to Permitted Liens); and US Company or its Subsidiary, as applicable, shall
execute and deliver an amendment to the Pledge Agreement in form and substance satisfactory to Administrative Agent and Collateral Agent, together with stock certificates and promissory notes and other instruments endorsed in blank in accordance
therewith; 
 (k) prior to inclusion in the US Borrowing Base, the UK Borrowing Base or the Canadian
Borrowing Base of any assets acquired in connection with one or more Acquisitions which, individually or in aggregate, causes the US Borrowing Base, the UK Borrowing Base or the Canadian Borrowing Base, in the aggregate, to increase by more than
$30,000,000 or the Equivalent Amount thereof above the amount of the US Borrowing Base, the UK Borrowing Base or the Canadian Borrowing Base, as applicable, reflecting the most recent appraisals delivered or required to be delivered under
Section 9.02, Administrative Agent shall have received appraisals, in form and substance reasonably satisfactory to Administrative Agent, of all Inventory, Equipment and Real Property to be included in the Borrowing Base and shall have
completed such review of Accounts, Inventory, Equipment and Real Property as it deems necessary or desirable for inclusion in the applicable Borrowing Base; 

(l) the Person or business to be acquired is engaged in the business conducted by US Company and its Subsidiaries
immediately prior to the Effective Date or similar activities related or incidental thereto; and 
 (m) in the
case of any Acquisition with a purchase price of $20,000,000 or the Equivalent Amount thereof or more, on or prior to the date of such Acquisition, Administrative Agent shall have received, in form and substance satisfactory to Administrative Agent,
all acquisition documents related thereto and certificates, and other documents and instruments reasonably requested by Administrative Agent, which collectively shall confirm, to Administrative Agent’s reasonable satisfaction, that the
conditions set forth herein have been satisfied. 
 10.14 Modifications of Certificate of Incorporation,
By-Laws and Certain Other Agreements, etc. US Company will not, and will not permit any of its Subsidiaries to: 
 (a) amend, modify, change or waive any term or provision of any Senior Note Document or any Permitted Additional Financing Document, unless such amendment, modification, change or waiver could not
reasonably be expected to be adverse to the interests of the Lenders; or 
 (b) amend, modify or change its
certificate or articles of incorporation (including, without limitation, by the filing or modification of any certificate or articles of designation), certificate of formation, limited liability company agreement or by-laws (or the equivalent
organizational documents), as applicable, or any agreement entered into by it with respect to its capital stock or other Equity Interests (including the Convertible Preferred Stock, any shareholders’ agreement or any Qualified Preferred Stock),
or enter into any new agreement with respect to its capital stock or other Equity Interests, unless such amendment, modification, change or other action contemplated by this clause (b) could not reasonably be expected to be adverse to the
interests of the Lenders in any material respect and the terms of any such amendment, modification, change or other action will not violate any of the other provisions of this Agreement or any other Credit Document. 

  
 158

 10.15 Limitation on Certain Restrictions on Subsidiaries. US Company
will not, and will not permit any of its Subsidiaries to, directly or indirectly, create or otherwise cause or suffer to exist or become effective any encumbrance or restriction on the ability of any such Subsidiary to (a) pay dividends or make
any other distributions on its capital stock or any other Equity Interest or participation in its profits owned by US Company or any of its Subsidiaries, or pay any Indebtedness owed to US Company or any of its Subsidiaries, (b) make loans or
advances to US Company or any of its Subsidiaries or (c) transfer any of its properties or assets to US Company or any of its Subsidiaries, except for such encumbrances or restrictions existing under or by reason of (i) Applicable Law,
(ii) this Agreement and the other Credit Documents, (iii) customary provisions restricting subletting or assignment of any lease governing any leasehold interest of US Company or any of its Subsidiaries, (iv) customary provisions
restricting assignment of any licensing agreement (in which US Company or any of its Subsidiaries is the licensee) or other contract entered into by US Company or any of its Subsidiaries in the ordinary course of business, and (v) restrictions
on the transfer of any asset pending the close of the sale of such asset. 
 10.16 Limitation on Issuance of
Equity Interests. (a) US Company will not, and will not permit any of its Subsidiaries to, issue (i) any Preferred Equity other than issuance by US Company of the Convertible Preferred Stock or Qualified Preferred Stock or
(ii) any redeemable common stock or other redeemable common Equity Interests other than common stock or other redeemable common Equity Interests that is or are redeemable at the sole option of US Company or such Subsidiary, as the case may be.

 (b) US Company will not permit any of its Subsidiaries to issue any capital stock or other Equity Interests
(including by way of sales of treasury stock) or any options or warrants to purchase, or securities convertible into, capital stock or other Equity Interests, except (i) for transfers and replacements of then outstanding shares of capital stock
or other Equity Interests, (ii) for stock splits, stock dividends and other issuances which do not decrease the aggregate percentage ownership of US Company or any of its Subsidiaries in any class of the capital stock or other Equity Interests
of such Subsidiary, (iii) in the case of Foreign Subsidiaries of US Company, to qualifying directors to the extent required by Applicable Law and for other nominal share issuances to Persons other than US Company and its Subsidiaries to the
extent required under Applicable Law and (iv) for issuances by Subsidiaries of US Company which are newly created or acquired in accordance with the terms of this Agreement. 

10.17 Business; etc. US Company will not, and will not permit any of its Subsidiaries to, engage
directly or indirectly in any business other than the businesses engaged in by US Company and its Subsidiaries as of the Effective Date and reasonable extensions thereof and businesses ancillary or complimentary thereto. 

10.18 No Additional Deposit Accounts; etc. US Company will not, and will not permit any other Credit Party to,
directly or indirectly, open, maintain or otherwise have any checking, savings, deposit, securities or other accounts at any bank or other financial institution where cash or Cash Equivalents are or may be deposited or maintained with any Person,
other than (a) the Concentration Accounts set forth on Part A of Schedule 10.18, (b) the Collection Accounts set forth on Part B of Schedule 10.18, (c) the Disbursement Accounts set forth on Part C of Schedule
10.18, (d) the Designated Petty Cash Accounts set forth on Part D of Schedule 10.18, (e) the Designated Payroll Accounts set forth on Part E of Schedule 10.18 and (f) the Foreign Accounts set forth on Part F of
Schedule 10.18; provided that any US Credit Party, any UK Subsidiary and any Canadian Subsidiary may open a new Concentration Account, Collection Account, Disbursement Account, Designated Petty Cash Account, Designated Payroll Account
or LKE Joint Account not set forth in such Schedule 10.18, so long as prior to opening any such account (i) the Administrative Agent has consented in writing to such opening (which consent shall not be unreasonably withheld or delayed),
(ii) US Company has delivered an updated Schedule 10.18 to the Administrative Agent listing such new account and (iii) in the case of any new Concentration Account, Collection Account,

  
 159

 
Disbursement Account, Designated Petty Cash Account, Designated Payroll Account or LKE Joint Account, (A) opened by a US Credit Party, the financial institution with which such account is
opened, together with US Company or such other US Credit Party which has opened such account and the Collateral Agent have executed and delivered to the Administrative Agent and the Collateral Agent a Cash Management Control Agreement reasonably
acceptable to the Administrative Agent and Collateral Agent if and to the extent required by the US Security Agreement and (B) opened by a UK Subsidiary, such Subsidiary has complied with its obligations under clauses 4.1 and 10 of the UK
Debenture and the UK Partnership Debenture. 
 10.19 Tax Consolidation. US Company shall not file or
consent to the filing of any consolidated income tax return with any Person other than US Company’s Subsidiaries. 
 10.20 Fiscal Year End. US Company shall not change, or permit any Subsidiary of US Company to change, its fiscal year end. 

10.21 Applicability of Financial Covenants. During the term of this agreement, and thereafter for so long as there
are any Obligations outstanding, US Company covenants that if a Compliance Period is in effect, then as of the end of the most recent fiscal quarter for which financial statements shall have been required to be delivered pursuant to
Section 9.01(b) and (c) and as of the end of each subsequent fiscal quarter until a Compliance Period is not in effect, US Company shall comply with all of the financial covenants set forth in Sections 10.22 and
10.23 hereof. If GAAP changes from the basis used in preparing the audited financial statements delivered to Administrative Agent by US Company on or before the Effective Date, US Company will provide Administrative Agent with certificates
demonstrating compliance with such financial covenants and will include, at the election of US Company or upon the request of Administrative Agent, calculations setting forth the adjustments necessary to demonstrate how US Company is in compliance
with such financial covenants based upon GAAP as in effect on the Effective Date. 
 10.22 Fixed Charge
Coverage Ratio. Subject to the provisions of Section 10.21, as of the end of each fiscal quarter set forth below, US Company and its Subsidiaries shall maintain a Fixed Charge Coverage Ratio of not less than the ratio set forth below
opposite such date: 
  

				September 30,	
	 Fiscal Quarter
 Ended on
	    	Fixed Charge
Coverage 
Ratio	 
	 December 31, 2011 and thereafter
	    	 	1.00:1.00	  

 10.23 Debt Ratio. Subject to the provisions of Section 10.21, as of
the end of each fiscal quarter, US Company and its Subsidiaries shall maintain a Debt Ratio of not more than the ratio set forth below opposite such date: 

  
 160

  

				September 30,	
	 Fiscal Quarter
 Ended on
	    	Debt Ratio	 
	 December 30, 2011
	    	 	5.50:1.00	  
	 March 31, 2012
	    	 	5.50:1.00	  
	 June 30, 2012
	    	 	5.50:1.00	  
	 September 30, 2012
	    	 	5.50:1.00	  
	 December 31, 2012
	    	 	5.50:1.00	  
	 March 31, 2013
	    	 	5.00:1.00	  
	 June 30, 2013
	    	 	5.00:1.00	  
	 September 30, 2013
	    	 	5.00:1.00	  
	 December 31, 2013
	    	 	5.00:1.00	  
	 March 31, 2014 and thereafter
	    	 	4.50:1.00	  

 SECTION 11. Events of Default. The occurrence of one or more of the following
events shall constitute an “Event of Default”: 
 11.01 Payment of Obligations. Any Credit
Party shall fail to pay (i) any principal or Face Amount of, as the case may be, on the Loans or any reimbursement obligation in respect of any Letter of Credit on the due date thereof or (ii) any interest or Drawing Fees, as the case may
be, on the Loans or any other Obligation within three (3) Business Days of the date the same becomes due and payable; 
 11.02 Misrepresentations. Any representation, warranty or other statement made or furnished to Administrative Agent or any Lender by or on behalf of US Company, or any other Credit Party in this
Agreement, any of the other Credit Documents or any instrument, certificate or financial statement furnished in compliance with or in reference thereto proves to have been false or misleading in any material respect (or any such representation,
warranty or other statement qualified by “materiality” or “Material Adverse Effect” proves to have been false or misleading in any respect) when made, furnished or remade; 

11.03 Breach of Specific Covenants. US Company shall (i) fail or neglect to perform, keep or observe any
covenant contained in Section 5.03(c) and (d) (Method and Place of Payment), Sections 9.03 (Maintenance of Property; Insurance), 9.02 (Books, Records and Inspections; Field Examinations; Appraisals),
9.01(i) (Borrowing Base Certificates), or Section 10 (Negative Covenants) hereof on the date that US Company is required to perform, keep or observe such covenant or (ii) fail or neglect to perform, keep or observe any
covenant contained in Section 9.01 (Information Covenants) other than Section 9.01(i) hereof within ten (10) Business Days following the date on which US Company is required to perform, keep or observe such covenant;

  
 161

 11.04 Breach of Other Covenants. Any Credit Party shall fail or
neglect to perform, keep or observe any covenant contained in this Agreement (other than a covenant which is dealt with specifically elsewhere in Section 11 hereof) or any other Credit Document and the breach of such other covenant is
not cured to Administrative Agent’s satisfaction by the earlier to occur of ten (10) Business Days after (i) the date US Company or such Subsidiary thereof or Credit Party knew or should have known of such occurrence and (ii) the
date of giving of notice thereof by Administrative Agent to US Company. 
 11.05 Default Under Other
Agreements. A default or event of default shall occur (and continue beyond any applicable grace period) under any note, agreement or instrument evidencing any other Indebtedness of US Company or any of its Subsidiaries, which default or event of
default permits the acceleration of its maturity, provided that the aggregate principal amount of all such Indebtedness for which the default or event of default has occurred exceeds $30,000,000 or the Equivalent Amount thereof; 

11.06 Failure of Enforceability of Credit Documents; Security. Any material covenant, agreement or Obligation of
US Company or any other Credit Party contained in or evidenced by any of the Credit Documents shall cease to be enforceable, or shall be determined to be unenforceable, in accordance with its terms; US Company or any other Credit Party 

shall deny or disaffirm any of its material Obligations under any of the Credit Documents or any Liens granted in connection therewith;
or, any Liens granted in any of the Collateral shall be determined to be void, voidable, invalid or unperfected, are subordinated or not given the priority contemplated by this Agreement (except where such circumstance arises as a result of any
action or inaction by any Lender); 
 11.07 Canadian Insolvency and Related Proceedings. The US Company,
any Subsidiary of the US Company, any Canadian Borrower or any other Credit Party (other than an Immaterial Subsidiary) (i) institutes or has instituted against it any proceeding seeking (x) to adjudicate it a bankrupt or insolvent,
(y) liquidation, winding up, administration, reorganization, arrangement, adjustment, protection, relief or composition of it or its debts under any applicable law relating to bankruptcy, insolvency, reorganization, arrangement, adjustment,
protection, relief or composition of it or its debtors including any Canadian Insolvency Law, or (z) the entry of an order for relief or the appointment of a receiver, receiver-manager, administrator, custodian, monitor, trustee or other
similar official for it or for any substantial part of its assets, and in the case of any such proceeding instituted against it (but not instituted by it), either the proceeding remains undismissed or unstayed for a period of 90 days, such Person
fails to diligently and actively oppose such proceeding, or any of the actions sought in such proceeding (including the entry of an order for relief against it or the appointment of a receiver, receiver-manager, administrator, custodian, monitor,
trustee or other similar official for it or for any substantial part of its properties and assets) occurs, or (ii) takes any corporate action to authorize any of the above actions. 

11.08 Insolvency and Related Proceedings. US Company, any Subsidiary of US Company or any other Credit Party
(other than an Immaterial Subsidiary) shall cease to be Solvent or shall suffer the appointment of a receiver, trustee, custodian or similar fiduciary, or shall make an assignment for the benefit of creditors, or any petition for an order for relief
shall be filed by or against a Credit Party (other than an Immaterial Subsidiary) under the federal bankruptcy laws and such proceeding shall continue for more than 30 days, or a Credit Party (other than an Immaterial Subsidiary) shall make any
offer of settlement, extension or composition to their respective unsecured creditors generally; or, with respect to the UK Subsidiaries: (in addition to the preceding provisions of this Section 11.08 such provisions not to be deemed to
otherwise limit the following) (i) such UK Subsidiary stops or suspends or threatens or announces an intention to stop or suspend payment of its debts or is for the purpose of section 123(1) of the Insolvency Act 1986 of England and Wales (on
the basis that the words “proved to the 

  
 162

 
satisfaction of the court” are deemed omitted from section 123(1)(e)) or any other Applicable Law deemed to be unable or shall admit in writing its inability to pay its debts as they fall
due or shall become insolvent or a moratorium is declared in respect of its indebtedness; (ii) a petition is presented or meeting convened or application made for the purpose of appointing an administrator (either in or out of court) or
receiver or other similar officer of, or for the making of an administration order in respect of, any UK Subsidiary and (A) (other than in the case of a petition to appoint an administrator) such petition or application is not discharged within
14 days; or (B) in the case of a petition to appoint an administrator, the Administrative Agent is not satisfied that it will be discharged before it is heard; (iii) any UK Subsidiary convenes a meeting of its creditors generally or
proposes or makes any arrangement or composition with, or any assignment for the benefit of, its creditors generally or in relation to a scheme of arrangement or voluntary arrangement; (iv) any UK Subsidiary enters into any negotiations for or
in connection with the re-scheduling, restructuring or readjustment of any Indebtedness by reason of, or with a view to avoiding, financial difficulties; (v) any meeting of any UK Subsidiary is convened for the purpose of considering any
resolution for (or to petition for) its winding up or any UK Subsidiary passes such a resolution; (vi) a petition is presented for the winding-up of any UK Subsidiary (other than a frivolous or vexatious petition discharged within 14 days of
being presented or any other petition which is contested on bona fide grounds and discharged at least 7 days before its hearing date); or (vi) any order is made or resolution passed or other action taken for the suspension of payments,
protection from creditors or bankruptcy or insolvency of any UK Subsidiary; 
 11.09 Business Disruption;
Condemnation. There shall occur a cessation of a substantial part of the business of US Company, any Subsidiary of US Company or any Credit Party for a period which materially adversely affects the capacity of US Company and its Subsidiaries,
taken as a whole, to continue its business on a profitable basis; or US Company, any Subsidiary of US Company or any Credit Party shall suffer the loss or revocation of any material license or permit now held or hereafter acquired by US Company, any
Subsidiary of US Company or any Credit Party which is necessary to the continued or lawful operation of its business; or US Company, any Subsidiary of US Company or any Credit Party shall be enjoined, restrained or in any way prevented by court,
governmental or administrative order from conducting all or any material part of its business affairs; or any material lease or agreement pursuant to which US Company, any Subsidiary of US Company or any Credit Party leases, uses or occupies any
Property shall be canceled or terminated prior to the expiration of its stated term, except any such lease or agreement the cancellation or termination of which would not reasonably be expected to have a Material Adverse Effect; or any material
portion of the Collateral shall be taken through condemnation or the value of such Property shall be impaired through condemnation; 
 11.10 ERISA. The occurrence of any of the following: (i) any Plan shall fail to satisfy the minimum funding requirements for any plan year or part thereof under Sections 412 and 430 of the
Code or Sections 302 and 303 of ERISA or a waiver of such standard is sought or granted under Section 412(c) of the Code or Section 302(c) of ERISA, (ii) a contribution failure occurs with respect to any Plan sufficient to give rise
to a lien under Section 302(f) of ERISA on assets of any Credit Party or any ERISA Affiliate, (iii) a Reportable Event shall have occurred, (iv) a contributing sponsor (as defined in Section 4001(a)(13) of ERISA) of a Plan
subject to Title IV of ERISA shall be subject to the advance reporting requirement of PBGC Regulation Section 4043.61 (without regard to subparagraph (b)(1) thereof) and an event described in subsection .62, .63, .64, .65, .66, .67 or .68 of
PBGC Regulation Section 4043 shall be reasonably expected to occur with respect to such Plan within the following 30 days, (v) any Plan shall have had or is likely to have a trustee appointed to administer such Plan, under
Section 4042 of ERISA, (vi) any Plan or any Multiemployer Plan is or shall have been or is likely to be terminated or to be the subject of termination proceedings under Section 4042 of ERISA, (vii) any Plan shall have an Unfunded
Current Liability, (viii) a contribution required to be made with respect to a Plan or a Foreign Pension Plan has not been timely made, (ix) any US Borrower or any of its Subsidiaries or any ERISA Affiliate has incurred or is likely to
incur any liability to or on account of a Plan under Section 406, 409, 502(i), 

  
 163

 
502(l), 4062, 4063, 4064 or 4069 of ERISA or Section 401(a)(29), 4971 or 4975 of the Code or on account of a Multiemployer Plan under Section 515, 4201, 4204 or 4212 of ERISA or on
account of a group health plan (as defined in Section 607(1) of ERISA, Section 4980B(g)(2) of the Code or 45 Code of Federal Regulations Section 160.103) under Section 4980B of the Code and/or the Health Insurance Portability and
Accountability Act of 1996, (x) any US Borrower or any of its Subsidiaries has incurred or is likely to incur liabilities pursuant to one or more employee welfare benefit plans (as defined in Section 3(1) of ERISA) that provide benefits to
retired employees or other former employees (other than as required by Section 601 of ERISA), (xi) a “default,” within the meaning of Section 4219(c)(5) of ERISA, shall occur with respect to any Plan (xii) any
Applicable Law, rule or regulation is adopted, changed or interpreted, or the interpretation or administration thereof is changed, in each case after the date hereof, by any Governmental Authority (a “Change in Law”), or, as a
result of a Change in Law, an event occurs following a Change in Law, with respect to or otherwise affecting any Plan; in each case, which event or events, either individually or in the aggregate, has had, or could reasonably be expected to have, a
Material Adverse Effect; 
 11.11 Guarantee. Any Guarantee or any provision thereof shall cease to be in
full force or effect as to any Guarantor (except as a result of a release of any Guarantor in accordance with the terms thereof and hereof), or any Guarantor or any Person acting for or on behalf of such Guarantor shall deny or disaffirm such
Guarantor’s obligations under the Guarantee to which it is a party or any Guarantor shall default in the due performance or observance of any term, covenant or agreement on its part to be performed or observed pursuant to the Guarantee to which
it is a party; 
 11.12 Criminal Forfeiture. US Company, any Subsidiary of US Company or any Credit Party
shall be criminally indicted or convicted under any law that could lead to a forfeiture of any Property of US Company, any Subsidiary of US Company or any other Credit Party; 

11.13 Judgments. Any money judgments, writ of attachment or similar processes (collectively,
“Judgments”) are issued or rendered against US Company, any Subsidiary of US Company or any other Credit Party, or any of their respective Property (i) in the case of money judgments in an amount of $10,000,000 or the
Equivalent Amount thereof or more for any single judgment, attachment or process or $30,000,000 or the Equivalent Amount thereof or more for all such judgments, attachments or processes in the aggregate, in each case in excess of any applicable
insurance with respect to which the insurer has admitted liability, and (ii) in the case of non-monetary Judgments, such Judgment or Judgments (in the aggregate) would reasonably be expected to have a Material Adverse Effect, in each case which
Judgment is not stayed, released or discharged within 30 days; or 
 11.14 Change of Control. A Change of
Control shall occur; 
 then, and in any such event, and at any time thereafter, if any Event of Default shall
then be continuing, the Administrative Agent, upon the written request of the Required Lenders, shall by written notice to the US Company, take any or all of the following actions, without prejudice to the rights of the Administrative Agent, any
Lender or the holder of any Note to enforce its claims against any Credit Party (provided that, if an Event of Default specified in Section 11.08 shall occur with respect to any Credit Party, the result which would occur upon the
giving of written notice by the Administrative Agent as specified in clauses (a) and (b) below, shall occur automatically without the giving of any such notice): (a) declare the Total Revolving Loan Commitment terminated, whereupon
the Revolving Loan Commitment of each Lender shall forthwith terminate immediately and any Commitment Commission shall forthwith become due and payable without any other notice of any kind; (b) declare the principal or Face Amount, as the case
may be, of and any accrued interest in respect of all Loans and the Notes and all Obligations owing hereunder and thereunder to be, whereupon the same shall become, forthwith due and payable without presentment, demand, protest or other notice of
any kind, all of which are hereby waived 

  
 164

 
by each Credit Party; (c) terminate any Letter of Credit which may be terminated in accordance with its terms; (d) direct the Borrowers to pay (and the Borrowers jointly and severally
agree that upon receipt of such notice, or upon the occurrence of an Event of Default specified in Section 11.08 with respect to any Borrower, they will pay) to the Collateral Agent at the Payment Office such additional amount of cash or

 Cash Equivalents, to be held as security by the Collateral Agent, as is equal to the aggregate Stated Amount of all Letters of
Credit issued for the account of the Borrowers and then outstanding; (e) enforce, as Collateral Agent, all of the Liens and security interests created pursuant to the Security Documents; and (f) apply any cash collateral held by the
Administrative Agent pursuant to Section 5.02 to the repayment of the Obligations 
 SECTION 12.
The Administrative Agent and the Collateral Agent. 
 12.01 Appointment. The Lenders hereby
irrevocably designate and appoint Deutsche Bank AG New York Branch as Administrative Agent (for purposes of this Section 12 and Section 13.01, the term “Administrative Agent” also shall include DBNY in its capacity
as Collateral Agent pursuant to the Security Documents) to act as specified herein and in the other Credit Documents. The Lenders hereby irrevocably designate and appoint Deutsche Bank AG New York Branch as Collateral Agent to act as specified
herein and in the other Credit Documents. Each Lender hereby irrevocably authorizes, and each holder of any Note by the acceptance of such Note shall be deemed irrevocably to authorize, the Administrative Agent to take such action on its behalf
under the provisions of this Agreement, the other Credit Documents and any other instruments and agreements referred to herein or therein and to exercise such powers and to perform such duties hereunder and thereunder as are specifically delegated
to or required of the Administrative Agent by the terms hereof and thereof and such other powers as are reasonably incidental thereto. Each Lender hereby irrevocably authorizes, each holder of any Note by the acceptance of such Note, and each other
Secured Creditor by the acceptance of the Obligations secured by the Security Documents, shall be deemed irrevocably to authorize, the Collateral Agent to take such action on its behalf under the provisions of this Agreement and any other
instruments and agreements referred to herein and to exercise such powers and to perform such duties hereunder as are specifically delegated or required of the Collateral Agent by the terms hereof and such other powers as are reasonably incidental
thereto. The Lenders hereby authorize the Collateral Agent (and any sub-agents appointed in accordance with Section 12.13 below), at its option and in its sole discretion, to execute powers of attorney in favor of US Company and/or its
Subsidiaries with respect to the release of Liens on Collateral constituting Motor Vehicles which are sold in accordance with the terms of the Credit Documents. The Administrative Agent and the Collateral Agent may perform any of their respective
duties hereunder or under any other Credit Document by or through its officers, directors, agents, employees or affiliates. 
 12.02 Nature of Duties. (a) Neither the Administrative Agent nor the Collateral Agent shall have any duties or responsibilities except those expressly set forth in this Agreement and in the
other Credit Documents. Neither the Administrative Agent nor the Collateral Agent nor any of their respective officers, directors, agents, employees or affiliates shall be liable for any action taken or omitted by it or them hereunder or under any
other Credit Document or in connection herewith or therewith, unless caused by its or their gross negligence or willful misconduct (as determined by a court of competent jurisdiction in a final and non-appealable decision). The duties of the
Administrative Agent and the Collateral Agent shall be mechanical and administrative in nature; neither the Administrative Agent nor the Collateral Agent shall have by reason of this Agreement or any other Credit Document a fiduciary relationship in
respect of any Lender or the holder of any Note; and nothing in this Agreement or in any other Credit Document, expressed or implied, is intended to or shall be so construed as to impose upon the Administrative Agent or the Collateral Agent any
obligations in respect of this Agreement or any other Credit Document except as expressly set forth herein or therein. 

  
 165

 (b) Notwithstanding any other provision of this Agreement or any provision
of any other Credit Document, each of the Lead Arrangers, the Joint Bookrunners, the Co-Syndication Agents, the Senior Managing Agents and the Co-Documentation Agents are named as such for recognition purposes only, and each in its respective
capacity as such shall have no powers, duties, responsibilities or liabilities with respect to this Agreement or the other Credit Documents or the transactions contemplated hereby and thereby except as explicitly provided for herein; it being
understood and agreed that each of the Lead Arrangers, the Joint Bookrunners, the Co-Syndication Agents, the Senior Managing Agents and the Co-Documentation Agents shall be entitled to all indemnification and reimbursement rights in favor of the
Administrative Agent and the Collateral Agent as, and to the extent, provided for under Sections 12.06 and 13.01. Without limitation of the foregoing, each of the Lead Arrangers, the Joint Bookrunners, the Co-Syndication Agents, the
Senior Managing Agents and the Co-Documentation Agents shall not, solely by reason of this Agreement or any other Credit Documents, have any fiduciary relationship in respect of any Lender or any other Person. 

12.03 Lack of Reliance on the Administrative Agent and the Collateral Agent. Independently and without reliance
upon the Administrative Agent or the Collateral Agent, each Lender and the holder of each Note, to the extent it deems appropriate, has made and shall continue to make (a) its own independent investigation of the financial condition and affairs
of US Company and its Subsidiaries in connection with the making and the continuance of the Loans and the participation in the Letters of Credit and the taking or not taking of any action in connection herewith and (b) its own appraisal of the
creditworthiness of US Company and its Subsidiaries and, except as expressly provided in this Agreement, the Administrative Agent and the Collateral Agent shall not have any duty or responsibility, either initially or on a continuing basis, to
provide any Lender or the holder of any Note with any credit or other information with respect thereto, whether coming into its possession before the making of the Loans or the issuance of any Letter of Credit or at any time or times thereafter.
Neither the Administrative Agent nor the Collateral Agent shall be responsible to any Lender or the holder of any Note for any recitals, statements, information, representations or warranties herein or in any document, certificate or other writing
delivered in connection herewith or for the execution, effectiveness, genuineness, validity, enforceability, perfection, collectability, priority or sufficiency of this Agreement or any other Credit Document or the financial condition of US Company
or any of its Subsidiaries or be required to make any inquiry concerning either the performance or observance of any of the terms, provisions or conditions of this Agreement or any other Credit Document, or the financial condition of US Company or
any of its Subsidiaries or the existence or possible existence of any Default or Event of Default. 
 12.04
Certain Rights of the Agents. If the Administrative Agent or the Collateral Agent shall request instructions from the Required Lenders with respect to any act or action (including failure to act) in connection with this Agreement or any other
Credit Document, the Administrative Agent and the Collateral Agent shall be entitled to refrain from such act or taking such action unless and until the Administrative Agent or the Collateral Agent, as applicable, shall have received instructions
from the Required Lenders; and the Administrative Agent and the Collateral Agent shall not incur liability to any Lender by reason of so refraining. Without limiting the foregoing, neither any Lender nor the holder of any Note shall have any right
of action whatsoever against the Administrative Agent or the Collateral Agent as a result of the Administrative Agent or the Collateral Agent acting or refraining from acting hereunder or under any other Credit Document in accordance with the
instructions of the Required Lenders. 
 12.05 Reliance. The Administrative Agent and the Collateral
Agent shall be entitled to rely, and shall be fully protected in relying, upon any note, writing, resolution, notice, statement, certificate, telex, teletype or telecopier message, cablegram, radiogram, order or other document or telephone message
signed, sent or made by any Person that the Administrative Agent or the Collateral 

  
 166

 
Agent believed to be the proper Person, and, with respect to all legal matters pertaining to this Agreement and any other Credit Document and its duties hereunder and thereunder, upon advice of
counsel selected by the Administrative Agent or the Collateral Agent, as the case may be. 
 12.06
Indemnification. To the extent the Administrative Agent (or any affiliate thereof) or the Collateral Agent (or any affiliate thereof) is not reimbursed and indemnified by US Company or the Borrowers, the Lenders will reimburse and indemnify
the Administrative Agent (and any affiliate thereof) or the Collateral Agent (and any affiliate thereof) in proportion to their respective “percentage” as used in determining the Required Lenders (determined as if there were no Defaulting
Lenders) for and against any and all liabilities, obligations, losses, damages, Taxes, penalties, claims, actions, judgments, costs, expenses or disbursements of whatsoever kind or nature which may be imposed on, asserted against or incurred by the
Administrative Agent (or any affiliate thereof) or the Collateral Agent (or any affiliate thereof) in performing its respective duties hereunder or under any other Credit Document or in any way relating to or arising out of this Agreement or any
other Credit Document; provided that no Lender shall be liable for any portion of such liabilities, obligations, losses, damages, Taxes, penalties, claims, actions, judgments, suits, costs, expenses or disbursements resulting from the
Administrative Agent’s (or such affiliates’ thereof) or the Collateral Agent’s (or such affiliates’ thereof) gross negligence or willful misconduct (as determined by a court of competent jurisdiction in a final and non-appealable
decision); provided further, that nothing contained in this Section 12.06 shall be deemed to limit the obligations of the Borrowers pursuant to Section 13.01. 

12.07 The Administrative Agent and the Collateral Agent in their Individual Capacities. With respect to their
obligation to make Loans, or issue or participate in Letters of Credit, under this Agreement, the Administrative Agent and the Collateral Agent shall have the rights and powers specified herein for a “Lender” and may exercise the
same rights and powers as though it were not performing the duties specified herein; and the term “Lender,” “Required Lenders,” “Supermajority Lenders,” “holders of Notes” or any
similar terms shall, unless the context clearly indicates otherwise, include the Administrative Agent and the Collateral Agent in their respective individual capacities. The Administrative Agent and the Collateral Agent and their respective
affiliates may accept deposits from, lend money to, and generally engage in any kind of banking, investment banking, trust or other business with, or provide debt financing, equity capital or other services (including financial advisory services) to
any Credit Party or any Affiliate of any Credit Party (or any Person engaged in a similar business with any Credit Party or any Affiliate thereof) as if they were not performing the duties specified herein, and may accept fees and other
consideration from any Credit Party or any Affiliate of any Credit Party for services in connection with this Agreement and otherwise without having to account for the same to the Lenders. 

12.08 Holders. The Administrative Agent and the Collateral Agent may deem and treat the payee of any Note as the
owner thereof for all purposes hereof unless and until a written notice of the assignment, transfer or endorsement thereof, as the case may be, shall have been filed with the Administrative Agent. Any request, authority or consent of any Person who,
at the time of making such request or giving such authority or consent, is the holder of any Note shall be conclusive and binding on any subsequent holder, 
 transferee, assignee or endorsee, as the case may be, of such Note or of any Note or Notes issued in exchange therefor. 

12.09 Resignation by the Administrative Agent and the Collateral Agent. (a) The Administrative Agent and/or
the Collateral Agent may resign from the performance of all their respective functions and duties hereunder and/or under the other Credit Documents at any time by giving 15 Business Days’ prior written notice to the Lenders and, unless a
Default or an Event of Default under Section 11.08 then exists, the US Company. Any such resignation by the Administrative Agent hereunder shall also constitute its resignation as an Issuing Lender and the Swingline Lender, in which

  
 167

 
case the resigning Administrative Agent (x) shall not be required to issue any further Letters of Credit or make any additional Swingline Loans hereunder and (y) shall maintain all of
its rights as Issuing Lender or Swingline Lender, as the case may be, with respect to any Letters of Credit issued by it, or Swingline Loans made by it, prior to the date of such resignation. Such resignation of the Administrative Agent and/or
Collateral Agent shall take effect upon the appointment of a successor Administrative Agent and/or Collateral Agent, as applicable, pursuant to clauses (b) and (c) below or as otherwise provided below. 

(b) Upon any such notice of resignation by the Administrative Agent and/or Collateral Agent, the Required Lenders shall
appoint a successor Administrative Agent and/or Collateral Agent, as applicable, hereunder and under the other Credit Documents who shall be a commercial bank or trust company reasonably acceptable to US Company, which acceptance shall not be
unreasonably withheld or delayed (provided that US Company’s approval shall not be required if an Event of Default then exists). 
 (c) If a successor Administrative Agent and/or Collateral Agent shall not have been so appointed within such 15 Business Day period, the Administrative Agent and/or Collateral Agent, as applicable, with
the consent of US Company (which consent shall not be unreasonably withheld or delayed, provided that US Company’s consent shall not be required if an Event of Default then exists), shall then appoint a successor Administrative Agent
and/or Collateral Agent, as applicable, who shall serve as Administrative Agent and/or Collateral Agent, as applicable, hereunder and under the other Credit Documents until such time, if any, as the Required Lenders appoint a successor
Administrative Agent and/or Collateral Agent, as applicable, as provided above. 
 (d) If no successor
Administrative Agent and/or Collateral Agent, as applicable, has been appointed pursuant to clause (b) or (c) above by the 20th day after the date such notice of resignation was given by the Administrative Agent and/or Collateral Agent, as
applicable, the Administrative Agent’s and/or Collateral Agent’s, as applicable, resignation shall become effective and the Required Lenders shall thereafter perform all the duties of the Administrative Agent and/or Collateral Agent, as
applicable, hereunder and/or under any other Credit Document until such time, if any, as the Required Lenders appoint a successor Administrative Agent and/or Collateral Agent, as applicable, as provided above. 

(e) Upon a resignation of the Administrative Agent or the Collateral Agent pursuant to this Section 12.09,
such Agent shall remain indemnified to the extent provided in this Agreement and the other Credit Documents and the provisions of this Section 12 (and the analogous provisions of the other Credit Documents) shall continue in effect for
the benefit of such Agent for all of its actions and inactions while serving as an Agent hereunder and under the other Credit Documents. 
 12.10 Collateral Matters. (a) Each Lender authorizes and directs the Collateral Agent to enter into the Security Documents for the benefit of the Lenders and the other Secured Creditors. Each
Lender hereby agrees, and each holder of any Note by the acceptance thereof will be deemed to agree, that, except as otherwise set forth herein, any action taken by the Required Lenders in accordance with the provisions of this Agreement and the
Security Documents, and the exercise by the Required Lenders of the powers set forth herein or therein, together with such other powers as are reasonably incidental thereto, shall be authorized and binding upon all of the Lenders. The Collateral
Agent is hereby authorized on behalf of all of the Lenders, without the necessity of any notice to or further consent from any Lender, from time to time prior to an Event of Default, to take any action with respect to any Collateral or Security
Documents which may be necessary to perfect and maintain perfected the security interest in and liens upon the Collateral granted pursuant to the Security Documents. Without prejudice to the foregoing, each of the Administrative Agent and the
Lenders hereby acknowledges, agrees and accepts that the Collateral Agent holds Collateral which is the subject of the UK Security Agreements as 

  
 168

 
trustee for and on behalf of the Lenders in accordance with the terms of the declaration of trust set out in the UK Security Agreements and that the terms of its appointment, and such trust,
shall be as set out (or referred to) in the UK Security Agreements and this Agreement. 
 (b) The Lenders hereby
authorize the Collateral Agent, at its option and in its discretion, to release any Lien granted to or held by the Collateral Agent upon any Collateral (i) upon termination of the Total Revolving Loan Commitment (and all Letters of Credit) and
payment and satisfaction of all of the Obligations (other than inchoate indemnification obligations) at any time arising under or in respect of this Agreement or the Credit Documents or the transactions contemplated hereby or thereby,
(ii) constituting property being sold or otherwise disposed of (to Persons other than US Company and its Subsidiaries) upon the sale or other disposition thereof in compliance with Section 10.03, (iii) if approved, authorized
or ratified in writing by the Required Lenders (or all of the Lenders hereunder, to the extent required by Section 13.12(a)) or (iv) as otherwise may be expressly provided in the relevant Security Documents. Lenders hereby
irrevocably authorize the Collateral Agent, at its option and in its discretion, to subordinate any Lien granted to Collateral Agent on Collateral if required by the holder of any Indebtedness (including Capitalized Lease Obligations) secured by
Purchase Money Liens and Leases permitted hereunder or Liens permitted by Section 10.02(n). Upon request by the Administrative Agent at any time, the Lenders will confirm in writing the Collateral Agent’s authority to release
particular types or items of Collateral pursuant to this Section 12.10. 
 (c) The Collateral Agent
shall have no obligation whatsoever to the Lenders or to any other Person to assure that the Collateral exists or is owned by any Credit Party or is cared for, protected or insured or that the Liens granted to the Collateral Agent herein or pursuant
hereto have been properly or sufficiently or lawfully created, perfected, protected or enforced or are entitled to any particular priority, or to exercise or to continue exercising at all or in any manner or under any duty of care, disclosure or
fidelity any of the rights, authorities and powers granted or available to the Collateral Agent in this Section 12.10, or in any of the Security Documents, it being understood and agreed that in respect of the Collateral, or any act,
omission or event related thereto, the Collateral Agent may act in any manner it may deem appropriate, in its sole discretion, given the Collateral Agent’s own interest in the Collateral as one of the Lenders and that the Collateral Agent shall
have no duty or liability whatsoever to the Lenders, except for its gross negligence or willful misconduct (as determined by a court of competent jurisdiction in a final and non-appealable decision). 

(d) The Administrative Agent shall hold the benefit of the security interests created by the Luxembourg Security
Documents as agent for the Secured Creditors in accordance with article 2 (4) of the Luxembourg law of 5 August 2005 on financial collateral arrangements. 

12.11 Delivery of Information. Neither the Administrative Agent nor the Collateral Agent shall be required to
deliver to any Lender originals or copies of any documents, instruments, notices, communications or other information received by the Administrative Agent or the Collateral Agent from any Credit Party, any Subsidiary thereof, the Required Lenders,
any Lender or any other Person under or in connection with this Agreement or any other Credit Document except (a) as specifically provided in this Agreement or any other Credit Document and (b) as specifically requested from time to time
in writing by any Lender with respect to a specific document, instrument, notice or other written communication received by and in the possession of the Administrative Agent or the Collateral Agent, as the case may be, at the time of receipt of such
request and then only in accordance with such specific request. 
 12.12 Withholding. To the extent
required by Applicable Law, the Administrative Agent may withhold from any payment to any Lender or other Person receiving a payment under the Credit Documents an amount equivalent to any applicable withholding tax. If the Internal Revenue

  
 169

 
Service or any other Governmental Authority asserts a claim that the Administrative Agent did not properly withhold tax from amounts paid to or for the account of any Lender or other Person
receiving payment under the Credit Documents because such Lender or other Person failed to notify the Administrative Agent that withholding on payments was required, including, without limitation, because of a change in circumstances which rendered
an exemption from or reduction of withholding tax ineffective or for any other reason, such Lender shall indemnify the Administrative Agent fully for all amounts paid, directly or indirectly, by the Administrative Agent as tax or otherwise,
including any penalties or interest and together with all expenses incurred. 
 12.13 Delegation of
Duties. Each of Administrative Agent and Collateral Agent may perform any and all of its duties and exercise its rights and powers under this Agreement or under any other Credit Document by or through any one or more sub-agents appointed by
Administrative Agent or Collateral Agent, as applicable. Administrative Agent, Collateral Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Affiliates. The
exculpatory, indemnification and other provisions of Section 12.02 and of Section 12.06 shall apply to any the Affiliates of Administrative Agent or Collateral Agent and shall apply to their respective activities in
connection with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent and Collateral Agent. All of the rights, benefits, and privileges (including the exculpatory and indemnification provisions)
of Section 12.02 and of Section 12.06 shall apply to any such sub-agent and to the Affiliates of any such sub-agent, and shall apply to their respective activities as sub-agent as if such sub-agent and Affiliates were named
herein. Notwithstanding anything herein to the contrary, with respect to each sub-agent appointed by Administrative Agent or Collateral Agent, as applicable (i) such sub-agent shall be a third party beneficiary under this Agreement with respect
to all such rights, benefits and privileges (including exculpatory rights and rights to indemnification) and shall have all of the rights and benefits of a third party beneficiary, including an independent right of action to enforce such rights,
benefits and privileges (including exculpatory rights and rights to indemnification) directly, without the consent or joinder of any other Person, against any or all of Credit Parties and the Lenders, (ii) such rights, benefits and privileges
(including exculpatory rights and rights to indemnification) shall not be modified or amended without the consent of such sub-agent, and (iii) such sub-agent shall only have obligations to Administrative Agent or Collateral Agent, as
applicable, and not to any Credit Party, Lender or any other Person and no Credit Party, Lender or any other Person shall have any rights, directly or indirectly, as a third party beneficiary or otherwise, against such sub-agent. 

12.14 Quebec Security. Without limiting the powers of the Collateral Agent hereunder or under any of the other
Credit Documents, each Lender (for its benefit and the benefit of its Affiliates), each Issuing Lender, the Administrative Agent, the Collateral Agent and each other Agent (all such Lenders (for their benefit and the benefit of their respective
Affiliates), Issuing Lender, Administrative Agent, Collateral Agent and other Agents are collectively called, for purposes of this Section 12.14, the “Quebec Secured Parties”) hereby acknowledges and agrees that DBNY
shall, for purposes of holding any security granted by any Borrower or by any Affiliate or Subsidiary of any Borrower on property pursuant to the laws of the Province of Quebec to secure obligations of such Borrower or such Affiliate or Subsidiary
under any bond or debenture (the “Quebec Secured Obligations”), be the holder of an irrevocable power of attorney (fondé de pouvoir) (within the meaning of the Civil Code of Quebec) for all present and future
Quebec Secured Parties and holders of any bond or debenture. Each of the Quebec Secured Parties, for itself and for all present and future Affiliates that are or may become Quebec Secured Parties hereby irrevocably constitutes, to the extent
necessary, DBNY as the holder of an irrevocable power of attorney (fondé de pouvoir) (within the meaning of Article 2692 of the Civil Code of Quebec) in order to hold security granted by any of the Borrowers or by any of their
Affiliates or Subsidiaries in the Province of Quebec to secure the Quebec Secured Obligations. Furthermore, each of the Quebec Secured Parties hereby appoints DBNY to act in the capacity of the holder and depositary of such bond or 

  
 170

 
debenture on its own behalf as Collateral Agent and for and on behalf and for the benefit of all present and future Quebec Secured Parties. Each assignee (for itself and for all present and
future Affiliates) of a Quebec Secured Party shall be deemed to have confirmed and ratified the constitution of the Collateral Agent as the holder of such irrevocable power of attorney (fondé de pouvoir) by execution of the relevant
Assignment and Assumption Agreement or other relevant documentation relating to such assignment. Notwithstanding the provisions of Section 32 of the An Act respecting the special powers of legal persons (Quebec), DBNY may acquire and be
the holder of any bond or debenture. The Borrowers hereby acknowledge that such bond or debenture constitutes a title of indebtedness, as such term is used in Article 2692 of the Civil Code of Quebec. 

SECTION 13. Miscellaneous. 

13.01 Payment of Expenses, etc. The Credit Parties hereby jointly and severally agree to: (a) whether or not
the transactions herein contemplated are consummated, pay all reasonable out-of-pocket costs and expenses (including Expenses) of the Administrative Agent and the Collateral Agent (including, without limitation, the reasonable fees and disbursements
of Latham & Watkins LLP and the Administrative Agent’s and Collateral Agent’s other counsel and consultants and the fees and expenses in connection with the appraisals and collateral examinations required pursuant to
Section 9.02) in connection with the preparation, execution, delivery and administration of this Agreement and the other Credit Documents and the documents and instruments referred to herein and therein and any amendment, waiver or
consent relating hereto or thereto, of the Administrative Agent and its Affiliates in connection with its or their syndication efforts with respect to this Agreement and of the Administrative Agent and the Collateral Agent and, after the occurrence
of an Event of Default, each of the Issuing Lenders and Lenders in connection with the enforcement of this Agreement and the other Credit Documents and the documents and instruments referred to herein and therein or in connection with any
refinancing or restructuring of the credit arrangements provided under this Agreement in the nature of a “work-out” or pursuant to any insolvency or bankruptcy proceedings (including, in each case without limitation, the reasonable fees
and disbursements of counsel and consultants for the Administrative Agent and the Collateral Agent and, after the occurrence of an Event of Default, counsel for each of the Issuing Lenders and Lenders); (b) pay and hold the Administrative
Agent, each of the Issuing Lenders and each of the Lenders harmless from and against any and all present and future stamp, excise, court or documentary, intangible, recording, filing and other similar documentary taxes with respect to the foregoing
matters (collectively, the “Other Taxes”) and save the Administrative Agent, each of the Issuing Lenders and each of the Lenders harmless from and against any and all liabilities with respect to or resulting from any delay or
omission (other than to the extent attributable to the Administrative Agent, such Issuing Lender or such Lender) to pay such Other Taxes; and (c) indemnify the Administrative Agent, the Collateral Agent, each Issuing Lender and each Lender, and
each of their respective officers, directors, employees, representatives, agents, affiliates, trustees and investment advisors (collectively, the “Indemnified Persons”) from and hold each of them harmless against any and all
liabilities, obligations (including removal or remedial actions), losses, damages, penalties, claims, actions, judgments, suits, costs, expenses and disbursements (including reasonable attorneys’ and consultants’ fees and disbursements)
incurred by, imposed on or assessed against any of them as a result of, or arising out of, or in any way related to, or by reason of, (i) any investigation, litigation or other proceeding (whether or not the Administrative Agent, the Collateral
Agent, any Issuing Lender or any Lender is a party thereto and whether or not such investigation, litigation or other proceeding is brought by or on behalf of any Credit Party) related to the entering into and/or performance of this Agreement or any
other Credit Document or the use of any Letter of Credit or the proceeds of any Loans hereunder or the consummation of the Transactions or any other transactions contemplated herein or in any other Credit Document or the exercise of any of their
rights or remedies provided herein or in the other Credit Documents, or (ii) the actual or alleged presence of Hazardous Materials in the air, surface water or groundwater or on the surface or subsurface of any Real Property at any time owned,
leased or operated by US Company or any of its Subsidiaries, the generation, 

  
 171

 
storage, transportation, handling or disposal of Hazardous Materials by US Company or any of its Subsidiaries at any location, whether or not owned, leased or operated by US Company or any of its
Subsidiaries, the non-compliance by US Company or any of its Subsidiaries with any Environmental Law (including applicable permits thereunder) applicable to any Real Property, or any Environmental Claim asserted against US Company, any of its
Subsidiaries or any Real Property at any time owned, leased or operated by US Company or any of its Subsidiaries, including, in each case, without limitation, the reasonable fees and disbursements of counsel and other consultants incurred in
connection with any such investigation, litigation or other proceeding (but excluding any losses, liabilities, claims, damages or expenses to the extent incurred by reason of the gross negligence or willful misconduct of the Person to be indemnified
(as determined by a court of competent jurisdiction in a final and non-appealable decision)). To the extent that the undertaking to indemnify, pay or hold harmless any Indemnified Person set forth in the preceding sentence may be unenforceable
because it is violative of any law or public policy, the Credit Parties jointly and severally shall make the maximum contribution to the payment and satisfaction of each of the indemnified liabilities which is permissible under Applicable Law. In
addition, the Credit Parties jointly and severally agree to reimburse the Administrative Agent and the Collateral Agent for all reasonable third party administrative, audit and monitory expenses incurred in connection with the Borrowing Base and
determinations thereunder. For the avoidance of doubt, except with respect to Other Taxes, this Section 13.01 shall not apply to Taxes which shall be governed by Section 5.04, Section 5.05 or
Section 5.06, as applicable, other than any Taxes that represent losses, claims, damages, etc. arising from any non-Tax claim. 
 To the full extent permitted by applicable law, each of US Company and each other Credit Party shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability,
for special, indirect, consequential or incidental damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement or any agreement or instrument contemplated hereby, the transactions
contemplated hereby or thereby, any Loan or the use of the proceeds thereof. No Indemnified Person shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through
telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Credit Documents or the transactions contemplated hereby or thereby, except to the extent the liability of such Indemnified
Person results from such Indemnified Person’s gross negligence or willful misconduct (as determined by a court of competent jurisdiction in a final and non-appealable decision). 

13.02 Right of Setoff. (a) In addition to any rights now or hereafter granted under Applicable Law or
otherwise, and not by way of limitation of any such rights, upon the occurrence and during the continuance of an Event of Default, the Administrative Agent, the Collateral Agent, each Issuing Lender and each Lender is hereby authorized at any time
or from time to time, without presentment, demand, protest or other notice of any kind to any Credit Party or to any other Person, any such notice being hereby expressly waived, to set off and to appropriate and apply any and all deposits (general
or special) and any other Indebtedness at any time held or owing by the Administrative Agent, the Collateral Agent, such Issuing Lender or such Lender (including, without limitation, by branches and agencies of the Administrative Agent, the
Collateral Agent, such Issuing Lender or such Lender wherever located) to or for the credit or the account of US Company or any of its Subsidiaries against and on account of the Obligations and liabilities of the Credit Parties to the Administrative
Agent, the Collateral Agent, such Issuing Lender or such Lender under this Agreement or under any of the other Credit Documents, including, without limitation, all interests in Obligations purchased by such Lender pursuant to
Section 13.04(b), and all other claims of any nature or description arising out of or connected with this Agreement or any other Credit Document, irrespective of whether or not the Administrative Agent, the Collateral Agent, such Issuing
Lender or such Lender shall have made any demand hereunder and although said Obligations, liabilities or claims, or any of them, shall be contingent or unmatured; provided that notwithstanding anything to the contrary contained in this
Section 13.02(a), the 
 Administrative Agent and each Lender hereby waive all rights of setoff, whether granted hereunder,
pursuant to any Applicable Law or otherwise, with respect to any LKE Proceeds. 

  
 172

 (b) NOTWITHSTANDING THE FOREGOING SUBSECTION (a), AT ANY TIME THAT THE
LOANS OR ANY OTHER OBLIGATION SHALL BE SECURED BY REAL PROPERTY LOCATED IN CALIFORNIA, NO LENDER SHALL EXERCISE A RIGHT OF SETOFF, LIEN OR COUNTERCLAIM OR TAKE ANY COURT OR ADMINISTRATIVE ACTION OR INSTITUTE ANY PROCEEDING TO ENFORCE ANY PROVISION
OF THIS AGREEMENT OR ANY NOTE UNLESS IT IS TAKEN WITH THE CONSENT OF THE REQUIRED LENDERS OR APPROVED IN WRITING BY THE ADMINISTRATIVE AGENT, IF SUCH SETOFF OR ACTION OR PROCEEDING WOULD OR MIGHT (PURSUANT TO CALIFORNIA CODE OF CIVIL PROCEDURE
SECTIONS 580a, 580b, 580d AND 726 OF THE CALIFORNIA CODE OF CIVIL PROCEDURE OR SECTION 2924 OF THE CALIFORNIA CIVIL CODE, IF APPLICABLE, OR OTHERWISE) AFFECT OR IMPAIR THE VALIDITY, PRIORITY OR ENFORCEABILITY OF THE LIENS GRANTED TO THE COLLATERAL
AGENT PURSUANT TO THE SECURITY DOCUMENTS OR THE ENFORCEABILITY OF THE NOTES AND OTHER OBLIGATIONS HEREUNDER, AND ANY ATTEMPTED EXERCISE BY ANY LENDER OF ANY SUCH RIGHT WITHOUT OBTAINING SUCH CONSENT OF THE REQUIRED LENDERS OR THE ADMINISTRATIVE
AGENT SHALL BE NULL AND VOID. THIS SUBSECTION (b) SHALL BE SOLELY FOR THE BENEFIT OF EACH OF THE LENDERS AND THE ADMINISTRATIVE AGENT HEREUNDER. 
 13.03 Notices. (a) Except as otherwise expressly provided herein, all notices and other communications provided for hereunder shall be in writing (including telegraphic, telecopier or cable
communication) and mailed, telegraphed, telecopied, cabled or delivered: (i) if to any Credit Party, at the following address: 
 Mobile Mini, Inc. 
 7420 South Kyrene Road, Suite 101 

Tempe, Arizona 85283 
 Attention: Chief Financial Officer 
 Email: MFunk@mobilemini.com

 Phone: (480) 477-0241 

Fax: (480) 281-3451 
 With a copy to: 
 DLA Piper LLP (US) 

1251 Avenue of the Americas 
 New York, New York 10020 
 Attention: Jamie Knox 

Phone: (212) 335-4500 
 Fax: (212) 335-4501 
 (ii) if to any Lender, at its address specified on
Schedule 13.03; and (c) if to the Administrative Agent or the Collateral Agent, at the Notice Office; or, as to any Credit Party or the Administrative Agent or the Collateral Agent, at such other address as shall be designated by such
party in a written notice to the other parties hereto and, as to each Lender, at such other address as shall be designated by such Lender in a written notice to US Company and the Administrative Agent; provided that any notice to the
Administrative Agent of the filing by a Credit Party of a document with the SEC pursuant to Section 9.01(f) or (g) may be given by email. All such notices and communications shall, when mailed,

  
 173

 
telegraphed, telecopied, or cabled or sent by overnight courier, be effective when deposited in the mails, delivered to the telegraph company, cable company or overnight courier, as the case may
be, or sent by telecopier, except that notices and communications to the Administrative Agent, the Collateral Agent, US Company, UK Company and Canadian Company shall not be effective until received by the Administrative Agent, US Company, UK
Company or Canadian Company, as the case may be. 
 (b) Notices and other communications to the Lenders
hereunder may be delivered or furnished by electronic communications pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to notices pursuant to Section 2 unless otherwise agreed by the
Administrative Agent and the applicable Lender. Each of the Administrative Agent, the US Company and the other Borrowers may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant
to procedures approved by it; provided that approval of such procedures may be limited to particular notices or communications. 
 13.04 Benefit of Agreement; Assignments; Participations. (a) This Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective successors and assigns of the
parties hereto; provided, however, that neither US Company nor any other Credit Party may assign or transfer any of its rights, obligations or interest hereunder without the prior written consent of the Lenders (and any other attempted assignment or
transfer by US Company or any other Credit Party shall be null and void) and, provided further, that, although any Lender may transfer, assign or grant participations in its rights hereunder, such Lender shall remain a “Lender” for all
purposes hereunder (and may not transfer or assign all or any portion of its Revolving Loan Commitment hereunder except as provided in Sections 2.13 and 13.04(b)) and the transferee, assignee or participant, as the case may be, shall not constitute
a “Lender” hereunder and, provided further, that no Lender shall transfer or grant any participation under which the participant shall have rights to approve any amendment to or waiver of this Agreement or any other Credit Document except
to the extent such amendment or waiver would (i) extend the final scheduled maturity of any Loan, Note or Letter of Credit (unless such Letter of Credit is not extended beyond the Final Maturity Date) in which such participant is participating
or reduce the rate or extend the time of payment of interest or Fees thereon (except in connection with a waiver of applicability of any post-default increase in interest rates) or reduce the principal amount thereof (it being understood that any
amendment or modification to the financial definitions in this Agreement or to Section 13.07(a) shall not constitute a reduction in the rate of interest or Fees payable hereunder), or increase the amount of the participant’s participation
over the amount thereof then in effect (it being understood that a waiver of any Default or Event of Default or of a mandatory reduction in the Total Revolving Loan Commitment shall not constitute a change in the terms of such participation, and
that an increase in any Revolving Loan Commitment (or the available portion thereof) or Loan shall be permitted without the consent of any participant if the participant’s participation is not increased as a result thereof), (ii) consent
to the assignment or transfer by US Company or any Credit Party of any of its rights and obligations under this Agreement or (iii) release all or substantially all of the Collateral under all of the Security Documents (except as expressly
provided in the Credit Documents) supporting the Loans or Letters of Credit hereunder in which such participant is participating. In the case of any such participation, the participant shall not have any rights under this Agreement or any of the
other Credit Documents (the participant’s rights against such Lender in respect of such participation to be those set forth in the agreement executed by such Lender in favor of the participant relating thereto) and all amounts payable by the
Credit Parties hereunder shall be determined as if such Lender had not sold such participation. Notwithstanding the foregoing, a participant that holds a US Obligation shall be entitled to the benefits, and bound by the obligations, of
Section 5.04 as though it were a Lender; provided, however, that such participant shall not be entitled to receive any greater payment under Section 5.04 than the applicable Lender would have been entitled to receive with respect to the
participation transferred to such participant. Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrowers, maintain a register on which it enters the name and address of each participant
and the principal amounts (and stated 

  
 174

 
interest) of each participant’s interest in the Loans or other obligations under the Credit Documents (the “Participant Register”); provided that no Lender shall have any
obligation to disclose all or any portion of the Participant Register (including the identity of any participant or any information relating to a participant’s interest in any commitments, loans, letters of credit or its other obligations under
any Credit Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States
Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes
of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register. 

(b) Notwithstanding the foregoing, any Lender (or any Lender together with one or more other Lenders) may (x) assign
all or a portion of its Revolving Loan Commitment and related outstanding Obligations (or, if the Revolving Loan Commitment has terminated, outstanding Obligations) hereunder to (i) (A) its parent company and/or any affiliate of such
Lender which is at least 50% owned by such Lender or its parent company or (B) to one or more other Lenders or any affiliate of any such other Lender which is at least 50% owned by such other Lender or its parent company (provided that
any fund that invests in loans and is managed or advised by the same investment advisor of another fund which is a Lender (or by an Affiliate of such investment advisor) shall be treated as an affiliate of such other Lender for the purposes of this
sub-clause (x)(i)(B)), provided, that no such assignment may be made to any such Person that is, or would at such time constitute, a Defaulting Lender or (ii) in the case of any Lender that is a fund that invests in loans, any other fund that
invests in loans and is managed or advised by the same investment advisor of any Lender or by an Affiliate of such investment advisor or (y) assign all, or if less than all, a portion equal to at least $5,000,000 or the Equivalent Amount
thereof in the aggregate for the assigning Lender or assigning Lenders, of such Revolving Loan Commitments and related outstanding Obligations (or, if the Revolving Loan Commitments have terminated, outstanding Obligations) hereunder to one or more
Eligible Transferees (treating any fund that invests in loans and any other fund that invests in loans and is managed or advised by the same investment advisor of such fund or by an Affiliate of such investment advisor as a single Eligible
Transferee), each of which assignees shall become a party to this Agreement as a Lender by execution of an Assignment and Assumption Agreement, provided that (i) at such time, Schedule 1.01(a) shall be deemed modified to reflect
the Revolving Loan Commitments and/or outstanding Revolving Loans, as the case may be, of such new Lender and of the existing Lenders, (ii) upon the surrender of the relevant Notes by the assigning Lender (or, upon such assigning Lender’s
indemnifying the Borrowers for any lost Note pursuant to a customary indemnification agreement) new Notes will be issued, at the Borrowers’ joint and several expense, to such new Lender and to the assigning Lender upon the request of such new
Lender or assigning Lender, such new Notes to be in conformity with the requirements of Section 2.05 (with appropriate modifications) to the extent needed to reflect the revised Revolving Loan Commitments and/or outstanding Revolving
Loans, as the case may be, (iii) the consent of the Administrative Agent and, so long as no Event of Default then exists, the US Company, shall be required in connection with any such assignment pursuant to clause (y) above (such consents,
in any case, not to be unreasonably withheld, delayed or conditioned); provided that the US Company shall be deemed to have consented to any such assignment unless it shall object thereto by written notice to the Administrative Agent within 5
Business Days after having received notice thereof, (iv) the consent of each Issuing Lender shall be required in connection with any such assignment of Revolving Loan Commitments (and related Obligations) pursuant to clause (y) above (such
consent, in any case, not to be unreasonably withheld), (v) the Administrative Agent shall receive at the time of each such assignment, from the assigning or assignee Lender, the payment of a non-refundable assignment fee of $3,500 (provided
that only one such fee shall be payable in the case of one or more concurrent assignments by or to investment funds managed or advised by the same investment advisor or an affiliated investment advisor) and (vi) no such transfer or

  
 175

 
assignment will be effective until recorded by the Administrative Agent on the Register pursuant to Section 13.15. To the extent of any assignment pursuant to this
Section 13.04(b), the assigning Lender shall be relieved of its obligations hereunder with respect to its assigned Revolving Loan Commitment and outstanding Revolving Loans. At the time of each assignment of a US Obligation pursuant to
this Section 13.04(b) to a Person which is not already a Lender hereunder which is a Non-U.S. Lender, the respective assignee Lender shall, to the extent legally entitled to do so, provide to the US Company the appropriate Internal
Revenue Service Forms (and, if applicable, a Section 5.04(b)(ii) Certificate) described in Section 5.04(b). To the extent that an assignment of all or any portion of a Lender’s Revolving Loan Commitment and related outstanding
Obligations pursuant to Section 2.13 or this Section 13.04(b) would, at the time of such assignment, result in increased costs under Section 2.10, 3.16, 3.17, 3.18, 5.04, 5.05 or
5.06 from those being charged by the respective assigning Lender prior to such assignment, then the Borrowers shall not be obligated to pay such increased costs (although the Borrowers, in accordance with and pursuant to the other provisions
of this Agreement, shall be obligated to pay any other increased costs of the type described above resulting from changes after the date of the respective assignment). 

(c) Nothing in this Agreement shall prevent or prohibit any Lender from pledging its Loans and Notes hereunder to a
Federal Reserve Bank in support of borrowings made by such Lender from such Federal Reserve Bank and, with prior notification to the Administrative Agent (but without the consent of the Administrative Agent or US Company), any Lender which is a fund
may pledge all or any portion of its Loans and Notes to its trustee or to a collateral agent providing credit or credit support to such Lender in support of its obligations to such trustee, such collateral agent or a holder of such obligations, as
the case may be. No pledge pursuant to this clause (c) shall release the transferor Lender from any of its obligations hereunder. 
 (d) Any Lender which assigns all of its Revolving Loan Commitment and/or Loans hereunder in accordance with Section 13.04(b) shall cease to constitute a “Lender” hereunder, except
with respect to indemnification provisions under this Agreement (including, without limitation, Sections 2.10, 2.11, 3.16, 3.17, 3.18, 5.04, 5.05, 12.06, 13.01 and 13.06), which
shall survive as to such assigning Lender. 
 (e) In case of assignment, transfer or novation by the assigning
Lender to the assignee of all or any part of its rights and obligations under any of the Revolving Loan Commitment, the assigning Lender and the assignee shall agree that, for the purposes of Article 1278 of the Luxembourg Civil Code (to the extent
applicable), the Security Interests created under the Luxembourg Security Documents, securing the rights assigned, transferred or novated thereby, will be preserved for the benefit of the assignee. 

13.05 No Waiver; Remedies Cumulative. No failure or delay on the part of the Administrative Agent, the Collateral
Agent, any Issuing Lender or any Lender in exercising any right, power or privilege hereunder or under any other Credit Document and no course of dealing between US Company or any other Credit Party and the Administrative Agent, the Collateral
Agent, any Issuing Lender or any Lender shall operate as a waiver thereof; nor shall any single or partial exercise of any right, power or privilege hereunder or under any other Credit Document preclude any other or further exercise thereof or the
exercise of any other right, power or privilege hereunder or thereunder. The rights, powers and remedies herein or in any other Credit Document expressly provided are cumulative and not exclusive of any rights, powers or remedies which the
Administrative Agent, the Collateral Agent, any Issuing Lender or any Lender would otherwise have. No notice to or demand on any Credit Party in any case shall entitle any Credit Party to any other or further notice or demand in similar or other
circumstances or constitute a waiver of the rights of the Administrative Agent, the Collateral Agent, any Issuing Lender or any Lender to any other or further action in any circumstances without notice or demand. 

  
 176

 13.06 Payments Pro Rata. (a) Except as otherwise provided in
this Agreement, the Administrative Agent agrees that promptly after its receipt of each payment from or on behalf of any Borrower in respect of any Obligations hereunder, the Administrative Agent shall distribute such payment to the Lenders entitled
thereto (other than any Lender that has consented in writing to waive its pro rata share of any such payment) pro rata based upon their respective shares, if any, of the Obligations with respect to which such payment was received.

 (b) Each of the Lenders agrees that, if it should receive any amount hereunder (whether by voluntary payment,
by realization upon security, by the exercise of the right of setoff or banker’s lien, by counterclaim or cross action, by the enforcement of any right under the Credit Documents, or otherwise), which is applicable to the payment of the
principal of, or interest on, the Loans, Unpaid US Drawings, Unpaid UK Drawings, Unpaid Canadian Drawings, Commitment Commission or Letter of Credit Fees, of a sum which with respect to the related sum or sums received by other Lenders is in a
greater proportion than the total of such Obligation then owed and due to such Lender bears to the total of such Obligation then owed and due to all of the Lenders immediately prior to such receipt, then such Lender receiving such excess payment
shall purchase for cash without recourse or warranty from the other Lenders an interest in the Obligations of the respective Credit Party to such Lenders in such amount as shall result in a proportional participation by all the Lenders in such
amount; provided that if all or any portion of such excess amount is thereafter recovered from such Lenders, such purchase shall be rescinded and the purchase price restored to the extent of such recovery, but without interest. 

(c) Notwithstanding anything to the contrary contained herein, the provisions of the preceding Sections 13.06(a)
and (b) shall be subject to the express provisions of this Agreement which require, or permit, differing payments to be made to Non-Defaulting Lenders as opposed to Defaulting Lenders. 

13.07 Calculations; Computations. (a) The financial statements to be furnished to the Lenders pursuant hereto
shall be made and prepared in accordance with GAAP consistently applied throughout the periods involved (except as set forth in the notes thereto or as otherwise disclosed in writing by US Company to the Lenders); provided that,
(i) except as otherwise specifically provided herein, all computations and all definitions (including accounting terms) shall utilize GAAP and policies in conformity with those used to prepare the audited financial statements of US Company
referred to in Section 8.10(a) for the fiscal year ended December 31, 2010 and (ii) to the extent expressly provided herein, certain calculations shall be made on a pro forma basis. 

(b) All computations of interest, Commitment Commission and other Fees hereunder shall be made on the basis of a year of
360 days for the actual number of days (including the first day but excluding the last day; except that in the case of Letter of Credit Fees and Facing Fees, the last day shall be included) occurring in the period for which such interest, Commitment
Commission or Fees are payable; provided, however, all computations of interest on Base Rate Loans and Canadian Prime Rate Loans determined by reference to the Prime Lending Rate or the Canadian Prime Rate, as applicable, shall be made
on the basis of a year of 365/366 days (as applicable) for the actual number of days occurring in the period for which such interest is payable. 
 (c) For purposes of the Interest Act (Canada), (i) whenever any interest or fee under this Agreement or any Note is calculated using a rate based on a year of 360 or 365 days, the rate
determined pursuant to such calculation, when expressed as an annual rate, is equivalent to (x) the 

  
 177

 
applicable rate based on a year of 360 or 365 days, as the case may be, (y) multiplied by the actual number of days in the calendar year in which the period for which such interest or fee is
payable (or compounded) ends, and (z) divided by 360 or 365, as the case may be, (ii) the principle of deemed reinvestment of interest does not apply to any interest or fee calculation under this Agreement and any Note, and (iii) the
rates of interest stipulated in this Agreement and any Note are intended to be nominal rates and not effective rates or yields. 
 13.08 GOVERNING LAW; SUBMISSION TO JURISDICTION; VENUE; WAIVER OF JURY TRIAL. (a) THIS AGREEMENT AND THE OTHER CREDIT DOCUMENTS AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND
THEREUNDER SHALL, EXCEPT AS OTHERWISE PROVIDED IN ANY MORTGAGE, BE CONSTRUED IN ACCORDANCE WITH AND BE GOVERNED BY THE LAW OF THE STATE OF NEW YORK (WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES). ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS
AGREEMENT OR ANY OTHER CREDIT DOCUMENT MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK OR OF THE UNITED STATES FOR THE SOUTHERN DISTRICT OF NEW YORK, IN EACH CASE WHICH ARE LOCATED IN THE COUNTY OF NEW YORK, AND, BY EXECUTION AND DELIVERY OF
THIS AGREEMENT OR ANY OTHER CREDIT DOCUMENT, EACH BORROWER HEREBY IRREVOCABLY ACCEPTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, THE JURISDICTION OF THE AFORESAID COURTS. EACH BORROWER HEREBY FURTHER IRREVOCABLY WAIVES
ANY CLAIM THAT ANY SUCH COURTS LACK PERSONAL JURISDICTION OVER SUCH CREDIT PARTY, AND AGREES NOT TO PLEAD OR CLAIM, IN ANY LEGAL ACTION PROCEEDING WITH RESPECT TO THIS AGREEMENT OR ANY OTHER CREDIT DOCUMENT BROUGHT IN ANY OF THE AFOREMENTIONED
COURTS, THAT SUCH COURTS LACK PERSONAL JURISDICTION OVER SUCH BORROWER. EACH BORROWER FURTHER IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS OUT OF ANY OF THE AFOREMENTIONED COURTS IN ANY SUCH ACTION OR PROCEEDING BY THE MAILING OF COPIES THEREOF BY
REGISTERED OR CERTIFIED MAIL, POSTAGE PREPAID, TO SUCH BORROWER AT ITS ADDRESS SET FORTH OPPOSITE ITS SIGNATURE BELOW, SUCH SERVICE TO BECOME EFFECTIVE 30 DAYS AFTER SUCH MAILING. EACH BORROWER HEREBY IRREVOCABLY WAIVES ANY OBJECTION TO SUCH SERVICE
OF PROCESS AND FURTHER IRREVOCABLY WAIVES AND AGREES NOT TO PLEAD OR CLAIM IN ANY ACTION OR PROCEEDING COMMENCED HEREUNDER OR UNDER ANY OTHER CREDIT DOCUMENT THAT SERVICE OF PROCESS WAS IN ANY WAY INVALID OR INEFFECTIVE. NOTHING HEREIN SHALL AFFECT
THE RIGHT OF THE ADMINISTRATIVE AGENT, THE COLLATERAL AGENT, ANY ISSUING LENDER ANY LENDER OR THE HOLDER OF ANY NOTE TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO COMMENCE LEGAL PROCEEDINGS OR OTHERWISE PROCEED AGAINST EACH BORROWER IN
ANY OTHER JURISDICTION. 
 (b) EACH BORROWER IRREVOCABLY WAIVES ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE
TO THE LAYING OF VENUE OF ANY OF THE AFORESAID ACTIONS OR PROCEEDINGS ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR ANY OTHER CREDIT DOCUMENT BROUGHT IN THE COURTS REFERRED TO IN CLAUSE (a) ABOVE AND HEREBY FURTHER IRREVOCABLY WAIVES
AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. 
 (c) EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE OTHER CREDIT
DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. 

  
 178

 13.09 Counterparts. This Agreement may be executed in any number of
counterparts and by the different parties hereto on separate counterparts, each of which when so executed and delivered shall be an original, but all of which shall together constitute one and the same instrument. A set of counterparts executed by
all the parties hereto shall be lodged with US Company, the Borrowers and the Administrative Agent. Delivery of an executed counterpart hereof by facsimile or other electronic transmission shall be as effective as delivery of an original executed
counterpart hereof. 
 13.10 Effectiveness. This Agreement shall become effective on the date (the
“Effective Date”) on which (i) US Company, the Borrowers, the Administrative Agent and each of the Lenders shall have signed a counterpart hereof (whether the same or different counterparts) and shall have delivered the same to
the Administrative Agent at the Notice Office or, in the case of the Lenders, shall have given to the Administrative Agent telephonic (confirmed in writing), written or telex notice (actually received) at such office that the same has been signed
and mailed to it and (ii) each of the other conditions set forth in Section 6 shall have been met to the reasonable satisfaction of the Administrative Agent. Unless the Administrative Agent has received actual notice from any Lender
that the conditions described in clause (ii) of the preceding sentence have not been met to its satisfaction, upon the satisfaction of the condition described in clause (i) of the immediately preceding sentence and upon the Administrative
Agent’s good faith determination that the conditions described in clause (ii) of the immediately preceding sentence have been met, then the Effective Date shall have deemed to have occurred, regardless of any subsequent determination that
one or more of the conditions thereto had not been met (although the occurrence of the Effective Date shall not release the Borrowers from any liability for failure to satisfy one or more of the applicable conditions contained in
Section 6, other than any condition that must be satisfied to the Administrative Agent’s satisfaction or other subjective standard of similar effect). The Administrative Agent will give US Company, US Company, the other Borrowers
and each Lender prompt written notice of the occurrence of the Effective Date. 
 13.11 Headings
Descriptive. The headings of the several sections and subsections of this Agreement are inserted for convenience only and shall not in any way affect the meaning or construction of any provision of this Agreement. 

13.12 Amendment or Waiver; etc. (a) Neither this Agreement nor any other Credit Document nor any terms hereof or
thereof may be changed, waived, discharged or terminated unless such change, waiver, discharge or termination is in writing signed by the respective Credit Parties party hereto or thereto and the Required Lenders although additional parties may be
added to (and annexes may be modified to reflect such additions) and, other than as further set forth below, Subsidiaries of the US Company may be deleted from, the Guaranty and the Security Documents in accordance with the provisions hereof and
thereof without the consent of the other Credit Parties party thereto or the Required Lenders, provided that no such change, waiver, discharge or termination shall, without the consent of each Lender (other than, except with respect to the following
clause (i), a Defaulting Lender) (with Obligations being directly affected in the case of following clause (i)), (i) extend the final scheduled maturity of any Loan or Note, extend the final expiration date of the Revolving Loan Commitment of
any Lender, or extend the stated expiration date of any Letter of Credit beyond the Final Maturity Date, or reduce the rate or extend the time of payment of interest or Fees thereon (except in connection with the waiver of applicability of any
post-default increase in interest rates), or reduce (or forgive) the principal amount thereof (it being understood that any amendment or modification to the financial definitions in this Agreement or to Section 13.07(a) shall not constitute a
reduction in the rate of interest or Fees for the purposes of this clause (i)), (ii) release all or substantially all of the Collateral (except as expressly provided in the Credit Documents) under all the Security Documents, (iii) amend,
modify or waive any 

  
 179

 
provision of this Section 13.12(a) (except for technical amendments with respect to additional extensions of credit pursuant to this Agreement which afford the protections to such additional
extensions of credit of the type provided to the Revolving Loan Commitments and the Loans on the Effective Date), (iv) reduce the “majority” voting threshold specified in the definition of Required Lenders (it being understood that,
with the consent of the Required Lenders, additional extensions of credit pursuant to this Agreement may be included in the determination of the Required Lenders on substantially the same basis as the extensions of Revolving Loan Commitments are
included on the Effective Date), (v) consent to the assignment or transfer by US Company or any Borrower of any of their rights and obligations under this Agreement, (vi) amend, change or modify this Agreement or any Security Document in
any manner that would change the effect of Section 5.03(d) hereof, Section 8.4 of the US Security Agreement, Section 9 of the US Pledge Agreement, Clause 20 of the UK Debenture, Clause 19 of the UK Partnership Debenture, Clause 14 of
the UK Share Charge, Section 8.7 of the Canadian Security Agreement, Section 21(15) of the Canadian Share Pledge Agreement, Section 11 of the Luxembourg Share Pledge, Section 10 of the Luxembourg Security Agreement or any similar
provision of any Security Document, (vii) amend, change or modify the provisions of Section 2.17 or 5.02(a)(i), (ii), (iii), (iv), (v) or (vi); or (viii) subordinate the Liens granted for the benefit of the Secured Creditors in
respect of the Collateral under any of the Security Documents; provided further, that no such change, waiver, discharge or termination shall (1) increase the Revolving Loan Commitment of any Lender over the amount thereof then in effect without
the consent of such Lender (it being understood that waivers or modifications of conditions precedent, covenants, Defaults or Events of Default or of a mandatory reduction in the Total Revolving Loan Commitment shall not constitute an increase of
the Revolving Loan Commitment of any Lender, and that an increase in the available portion of the Revolving Loan Commitment of any Lender shall not constitute an increase of the Revolving Loan Commitment of such Lender), (2) without the consent
of each Issuing Lender, amend, modify or waive any provision of Section 2 or alter its rights or obligations with respect to Letters of Credit, (3) without the consent of the Swingline Lender, alter the Swingline Lender’s rights or
obligations with respect to Swingline Loans, (4) without the consent of the Administrative Agent, amend, modify or waive any provision of Section 12 or any other provision of this Agreement or any other Credit Document as same relates to
the rights or obligations of the Administrative Agent, (5) without the consent of the Collateral Agent, amend, modify or waive any provision relating to the rights or obligations of the Collateral Agent, or (6) without the consent of the
Supermajority Lenders, (w) release any Guarantor with assets in the US Borrowing Base, UK Borrowing Base or Canadian Borrowing Base from any obligations arising under the Guarantees, (x) amend the definition of Supermajority Lenders (it
being understood that, with the consent of the Required Lenders, additional extensions of credit pursuant to this Agreement may be included in the determination of the Supermajority Lenders on substantially the same basis as the extensions of Loans
and Revolving Loan Commitments are included on the Effective Date), (y) amend the definition of Aggregate Borrowing Base, US Borrowing Base, UK Borrowing Base or Canadian Borrowing Base (or, in each case, any defined terms as used therein) as
such definitions are set forth herein on the Effective Date (or as same may be amended from time to time pursuant to this clause (y)) in any manner which would have the effect of increasing availability thereunder as determined in good faith by the
Administrative Agent (it being understood that the establishment, modification or elimination of Reserves and adjustment, establishment and elimination of criteria for Eligible Accounts, Eligible Container Fleet Inventory, Eligible Cabin Fleet
Inventory, Eligible Container Inventory Held For Sale, Eligible Goods Inventory, Eligible Machinery and Equipment, Eligible Raw Materials Inventory, Eligible Real Property, Eligible Trailer Fleet Inventory and Eligible Work-In-Process Container
Inventory, in each case by the Administrative Agent or the Collateral Agent in accordance with the terms hereof, will not be deemed such an increase in advance rates) or (z) increase the percentage of the US Borrowing Base for which Agent
Advances may be made pursuant to Section 2.01(i). 
 (b) If, in connection with any proposed change,
waiver, discharge or termination of or to any of the provisions of this Agreement as contemplated by clauses (i) through (v), inclusive, of the 

  
 180

 
first proviso to Section 13.12(a), the consent of the Required Lenders is obtained but the consent of one or more of such other Lenders whose consent is required is not obtained, then
the Borrowers shall have the right, so long as all non-consenting Lenders whose individual consent is required are treated as described in either clause (A) or (B) below, to either (A) replace each such non-consenting Lender or
Lenders with one or more Replacement Lenders pursuant to Section 2.13 so long as at the time of such replacement, each such Replacement Lender consents to the proposed change, waiver, discharge or termination or (B) terminate such
non-consenting Lender’s Revolving Loan Commitment and/or repay all outstanding Revolving Loans of such Lender and/or cash collateralize its applicable RL Percentage of the Letter of Credit of Outstandings in accordance with Sections 4.02(b)
and/or 5.01(b), provided that, unless the Revolving Loan Commitments which are terminated and Revolving Loans which are repaid pursuant to preceding clause (B) are immediately replaced in full at such time through the addition
of new Lenders or the increase of the Revolving Loan Commitments and/or outstanding Revolving Loans of existing Lenders (who in each case must specifically consent thereto), then in the case of any action pursuant to preceding clause (B), the
Required Lenders (determined after giving effect to the proposed action) shall specifically consent thereto, provided further, that the Borrowers shall not have the right to replace a Lender, terminate its Revolving Loan Commitment or repay
its Revolving Loans solely as a result of the exercise of such Lender’s rights (and the withholding of any required consent by such Lender) pursuant to the second proviso to Section 13.12(a). 

(c) Notwithstanding the foregoing, any provision of this Agreement may be amended by an agreement in writing entered into
by the Borrowers, the Required Lenders and the Administrative Agent (and, if their rights or obligations are affected thereby, each Issuing Lender and the Swingline Lender) if (i) by the terms of such agreement the Commitment of each Lender not
consenting to the amendment provided for therein shall terminate upon the effectiveness of such amendment and (ii) at the time such amendment becomes effective, each Lender not consenting thereto receives payment (including pursuant to an
assignment to a replacement Lender in accordance with Section 13.04) in full of this principal of and interest accrued on each Loan made by it and all other amounts owing to it or accrued for its account under this Agreement. 

(d) Notwithstanding anything to the contrary contained in this Section 13.12, (x) Security Documents (including
any Additional Security Documents) and related documents executed by Subsidiaries in connection with this Agreement may be in a form reasonably determined by the Administrative Agent and may be amended, supplemented and waived with the consent of
the Administrative Agent and the Borrowers without the need to obtain the consent of any other Person if such amendment, supplement or waiver is delivered in order (i) to comply with local Law or advice of local counsel, (ii) to cure
ambiguities, omissions, mistakes or defects or (iii) to cause such Security Document or other document to be consistent with this Agreement and the other Credit Documents and (y) if following the Effective Date, the Administrative Agent
and any Credit Party shall have jointly identified an ambiguity, inconsistency, obvious error or any error or omission of a technical or immaterial nature, in each case, in any provision of the Credit Documents (other than the Security Documents),
then the Administrative Agent and the Credit Parties shall be permitted to amend such provision and such amendment shall become effective without any further action or consent of any other party to any Credit Documents if the same is not objected to
in writing by the Required Lenders within five (5) Business Days following receipt of notice thereof. 

13.13 Survival. All indemnities set forth herein including, without limitation, in Sections 2.10,
2.11, 3.16, 3.17, 3.18, 5.04, 5.05, 12.06 and 13.01 shall survive the execution, delivery and termination of this Agreement and the Notes and the making and repayment of the Obligations.

 13.14 Domicile of Loans. Each Lender may transfer and carry its Loans at, to or for the account of any
office, Subsidiary or Affiliate of such Lender. Notwithstanding anything to the contrary 

  
 181

 
contained herein, to the extent that a transfer of Loans pursuant to this Section 13.14 would, at the time of such transfer, result in increased costs under Section 2.10,
2.11, 3.16, 3.17, 3.18, 5.04 or 5.05 from those being charged by the respective Lender prior to such transfer, then the Borrowers shall not be obligated to pay such increased costs (although the Borrowers
shall be jointly and severally obligated to pay any other increased costs of the type described above resulting from changes after the date of the respective transfer). 

13.15 Register. The Borrowers hereby designate the Administrative Agent to serve as its agent, solely for purposes
of this Section 13.15, to maintain a register (the “Register”) on which it will record the Revolving Loan Commitments from time to time of each of the Lenders, the Loans made by each of the Lenders (and stated interest
thereon) and each repayment in respect of the principal or interest amount of the Loans of each Lender. Failure to make any such recordation, or any error in such recordation, shall not affect the Borrowers’ obligations in respect of such
Loans. With respect to any Lender, the transfer of the Revolving Loan Commitment of such Lender and the rights to the principal of, and interest on, any Loan made pursuant to such Revolving Loan Commitment shall not be effective until such transfer
is recorded on the Register maintained by the Administrative Agent with respect to ownership of such Revolving Loan Commitment and Loans and prior to such recordation all amounts owing to the transferor with respect to such Revolving Loan Commitment
and Loans shall remain owing to the transferor. The registration of assignment or transfer of all or part of any Revolving Loan Commitments and Loans shall be recorded by the Administrative Agent on the Register only upon the acceptance by the
Administrative Agent of a properly executed and delivered Assignment and Assumption Agreement pursuant to Section 13.04(b). Upon such acceptance and recordation, the assignee specified therein shall be treated as a Lender for all
purposes of this Agreement. Coincident with the delivery of such an Assignment and Assumption Agreement to the Administrative Agent for acceptance and registration of assignment or transfer of all or part of a Loan, or as soon thereafter as
practicable, the assigning or transferor Lender shall surrender the Note (if any) evidencing such Loan, and thereupon one or more new Notes in the same aggregate principal amount shall be issued to the assigning or transferor Lender and/or the new
Lender at the request of any such Lender. The Borrowers jointly and severally agree to indemnify the Administrative Agent from and against any and all losses, claims, damages and liabilities of whatsoever nature which may be imposed on, asserted
against or incurred by the Administrative Agent in performing its duties under this Section 13.15. Upon the request of any Lender, the Administrative Agent shall provide such Lender with the Revolving Loan Commitment and outstanding Loan
amount of such Lender as such information has been recorded in the Register. 
 13.16 Confidentiality.
(a) Subject to the provisions of clause (b) of this Section 13.16, each Lender agrees that it will use its reasonable efforts not to disclose without the prior consent of the US Company (other than to its employees, auditors,
advisors or counsel or to another Lender if such Lender or such Lender’s holding or parent company in its sole discretion determines that any such party should have access to such information, provided such Persons shall be subject to
the provisions of this Section 13.16 to the same extent as such Lender) any information with respect to US Company or any of its Subsidiaries which is now or in the future furnished pursuant to this Agreement or any other Credit
Document, provided that any Lender may disclose any such information (i) as has become generally available to the public other than by virtue of a breach of this Section 13.16(a) by the respective Lender, (ii) as may be
required or appropriate in any report, statement or testimony submitted to any municipal, state or Federal regulatory body having or claiming to have jurisdiction over such Lender or to the Federal Reserve Board or the Federal Deposit Insurance
Corporation or similar organizations (whether in the United States or elsewhere) or their successors, (iii) as may be required or appropriate in respect to any summons or subpoena or in connection with any litigation, (iv) in order to
comply with any law, order, regulation or ruling applicable to such Lender, (v) to the Administrative Agent or the Collateral Agent, (vi) to any direct or indirect contractual counterparty in any swap, hedge or similar agreement (or to any
such contractual counterparty’s professional advisor), so long as such contractual counterparty (or 

  
 182

 
such professional advisor) agrees to be bound by the provisions of this Section 13.16 and (vii) to any prospective or actual transferee, pledgee or participant in connection with
any contemplated transfer, pledge or participation of any of the Notes or Revolving Loan Commitments or any interest therein by such Lender, provided that such prospective transferee, pledgee or participant agrees to be bound by the
confidentiality provisions contained in this Section 13.16. 
 (b) US Company and the Borrowers
hereby acknowledge and agree that each Lender may share with any of its affiliates, and such affiliates may share with such Lender, any information related to US Company or any of its Subsidiaries (including, without limitation, any non-public
customer information regarding the creditworthiness of US Company and its Subsidiaries), provided such Persons shall be subject to the provisions of this Section 13.16 to the same extent as such Lender. 

13.17 No Fiduciary Duty. Each Agent, each Lender and their respective Affiliates (collectively, solely for
purposes of this paragraph, the “Lenders”), may have economic interests that conflict with those of the Credit Parties, their stockholders and/or their respective affiliates. Each Credit Party agrees that nothing in the Credit Documents or
otherwise will be deemed to create an advisory, fiduciary or agency relationship or fiduciary or other implied duty between any Lender, on the one hand, and any Credit Party, its respective stockholders or its respective affiliates, on the other.
The Credit Parties acknowledge and agree that: (i) the transactions contemplated by the Credit Documents (including the exercise of rights and remedies hereunder and thereunder) are arm’s-length commercial transactions between the Lenders,
on the one hand, each Credit Party, on the other, and (ii) in connection therewith and with the process leading thereto, (x) no Lender has assumed an advisory or fiduciary responsibility in favor of any Credit Party, its respective
stockholders or its respective affiliates with respect to the transactions contemplated hereby (or the exercise of rights or remedies with respect thereto) or the process leading thereto (irrespective of whether any Lender has advised, is currently
advising or will advise any Credit Party, its respective stockholders or its respective Affiliates on other matters) or any other obligation to any Credit Party except the obligations expressly set forth in the Credit Documents and (y) each
Lender is acting solely as principal and not as the agent or fiduciary of such Credit Party, its respective management, stockholders, creditors or any other Person. Each Credit Party acknowledges and agrees that such Credit Party has consulted its
own legal and financial advisors to the extent it deemed appropriate and that it is responsible for making its own independent judgment with respect to such transactions and the process leading thereto. Each Credit Party agrees that it will not
claim that any Lender has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to such Credit Party, in connection with such transaction or the process leading thereto. 

13.18 Patriot Act. Each Lender subject to the USA PATRIOT ACT (Title 111 of Pub. L. 107-56 (signed into law
October 26, 2001)) (the “Patriot Act”) hereby notifies US Company and the Borrowers that pursuant to the requirements of the Patriot Act, they are required to obtain, verify and record information that identifies US Company,
the Borrowers and the other Credit Parties and other information that will allow such Lender to identify US Company, the Borrowers and the other Credit Parties in accordance with the Patriot Act. 

13.19 Interest Rate Limitation. Notwithstanding anything to the contrary contained in any Credit Document, the
interest paid or agreed to be paid under the Credit Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable law (the “Maximum Rate”). If the Administrative Agent or any Lender shall receive interest in
an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal, refunded to the Borrowers. In determining whether the interest contracted for, charged, or received
by the Administrative Agent or a Lender exceeds the Maximum Rate, such Person may, to the extent permitted by applicable law, (a) characterize any payment that is not principal as an expense, fee, or premium rather than interest,
(b) exclude voluntary prepayments and the effects thereof, and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of the Obligations hereunder. 

  
 183

 13.20 Release of Borrowers. In the event that all of the Equity
Interests of one or more Borrowers (other than the US Company) is sold or otherwise disposed of or liquidated in compliance with the requirements of Section 10.03 (or such sale, other disposition or liquidation has been approved in
writing by the Required Lenders (or all Lenders if required by Section 13.12)) and the proceeds of such sale, disposition or liquidation are applied in accordance with the provisions of Section 5.02(c), to the extent
applicable, such Borrower shall, upon consummation of such sale or other disposition (except to the extent that such sale or disposition is to US Company or any of its Wholly-Owned Subsidiaries), be released from this Agreement and each remaining
Borrower agrees that, with no action on its part required, the remaining Borrowers shall remain jointly and severally liable for all Obligations. 
 SECTION 14. Nature of Borrower Obligations. 
 14.01
Nature of Borrower Obligations. (a) Notwithstanding anything to the contrary contained elsewhere in this Agreement, it is understood and agreed by the various parties to this Agreement that all US Obligations to repay principal of,
interest on, and all other amounts with respect to, all US Revolving Loans, US Swingline Loans, US Letters of Credit and all other US Obligations pursuant to this Agreement and each other Credit Document (including, without limitation, all fees,
indemnities, taxes and other US Obligations in connection therewith or in connection with the related Revolving Loan Commitments) shall constitute the joint and several obligations of each of the US Borrowers. In addition to the direct (and joint
and several) obligations of the US Borrowers with respect to US Obligations as described above, all such US Obligations shall be guaranteed pursuant to, and in accordance with the terms of, the Guaranties. 

(b) Notwithstanding anything to the contrary contained elsewhere in this Agreement, it is understood and agreed by the
various parties to this Agreement that all UK Obligations to repay principal of, interest on, and all other amounts with respect to, all UK Revolving Loans, UK Swingline Loans, UK Letters of Credit and all other UK Obligations pursuant to this
Agreement and each other Credit Document (including, without limitation, all fees, indemnities, taxes and other UK Obligations in connection therewith or in connection with the related Revolving Loan Commitments) shall constitute the joint and
several obligations of each of the US Borrowers, the UK Borrowers and the Canadian Borrowers. In addition to the direct (and joint and several) obligations of the US Borrowers, the UK Borrowers and the Canadian Borrowers with respect to UK
Obligations as described above, all such UK Obligations shall be guaranteed pursuant to, and in accordance with the terms of, the Guaranties. 
 (c) Notwithstanding anything to the contrary contained elsewhere in this Agreement, it is understood and agreed by the various parties to this Agreement that all Canadian Obligations to repay principal
of, interest on, and all other amounts with respect to, all Canadian Revolving Loans, Canadian Letters of Credit and all other Canadian Obligations pursuant to this Agreement and each other Credit Document (including, without limitation, all fees,
indemnities, taxes and other Canadian Obligations in connection therewith or in connection with the related Revolving Loan Commitments) shall constitute the joint and several obligations of each of the US Borrowers, the UK Borrowers and the Canadian
Borrowers. In addition to the direct (and joint and several) obligations of the US Borrowers, the UK Borrowers and the Canadian Borrowers with respect to Canadian Obligations as described above, all such Canadian Obligations shall be guaranteed
pursuant to, and in accordance with the terms of, the Guaranties 
 14.02 Independent Obligation. The
obligations of each Borrower with respect to the Obligations are independent of the obligations of each other Borrower or any Guarantor under the Guaranty of such Obligations, and a separate action or actions may be brought and prosecuted against

  
 184

 
each Borrower, whether or not any other Borrower or any Guarantor is joined in any such action or actions. Each Borrower waives, to the fullest extent permitted by law, the benefit of any statute
of limitations affecting its liability hereunder or the enforcement thereof. Any payment by any Borrower or other circumstance which operates to toll any statute of limitations as to any Borrower shall, to the fullest extent permitted by law,
operate to toll the statute of limitations as to each Borrower. 
 14.03 Authorization. Each of the
Borrowers authorizes the Administrative Agent, the Collateral Agent, the Issuing Lenders and the Lenders without notice or demand (except as shall be required by applicable statute and cannot be waived), and without affecting or impairing its
liability hereunder, from time to time to: 
 (a) exercise or refrain from exercising any rights
against any other Borrower or any Guarantor or others or otherwise act or refrain from acting; 

(b) release or substitute any other Borrower, endorsers, Guarantors or other obligors; 

(c) settle or compromise any of the Obligations of any other Borrower or any other Credit Party, any
security therefor or any liability (including any of those hereunder) incurred directly or indirectly in respect thereof or hereof, and may subordinate the payment of all or any part thereof to the payment of any liability (whether due or not) of
any Borrower to its creditors other than the Lenders; 
 (d) apply any sums paid by any other
Borrower or any other Person, howsoever realized to any liability or liabilities of such other Borrower or other Person regardless of what liability or liabilities of such other Borrower or other Person remain unpaid; and/or 

(e) consent to or waive any breach of, or act, omission or default under, this Agreement or any of the
instruments or agreements referred to herein, or otherwise, by any other Borrower or any other Person. 
 14.04
Reliance. It is not necessary for the Administrative Agent, the Collateral Agent, any Issuing Lender or any Lender to inquire into the capacity or powers of US Company, any Borrower or any of its Subsidiaries or the officers, directors,
members, partners or agents acting or purporting to act on its behalf, and any Obligations made or created in reliance upon the professed exercise of such powers shall constitute the joint and several obligations of the Borrowers hereunder.

 14.05 Contribution; Subrogation. No Borrower shall have any rights of contribution or subrogation with
respect to any other Borrower as a result of payments made by it hereunder, in each case unless and until the Total Revolving 

Loan Commitment and all Letters of Credit have been terminated and all Obligations have been paid in full in cash. 

14.06 Waiver. Each Borrower waives any right to require the Administrative Agent, the Collateral Agent, the
Issuing Lenders or the Lenders to (i) proceed against any other Borrower, any Guarantor or any other party, (ii) proceed against or exhaust any security held from any Borrower, any Guarantor or any other party or (iii) pursue any
other remedy in the Administrative Agent’s, the Collateral Agent’s, any Issuing Lender’s or Lenders’ power whatsoever. Each Borrower waives any defense based on or arising out of suretyship or any impairment of security held from
any Borrower, any Guarantor or any other party or on or arising out of any defense of any other Borrower, any Guarantor or any other party other than payment in full in cash of the Obligations, including, without limitation, any defense based on or
arising out of the disability of any other Borrower, any Guarantor or any other party, or the unenforceability of the Obligations or any part thereof from any cause, or the cessation from any cause of the liability of any other Borrower, in each
case other than as a result of the payment in full in cash of the Obligations. 

  
 185

 SECTION 15. Guarantee. 

15.01 The Guarantees. (a) The US Guarantors hereby jointly and severally guarantee, as a primary obligor and
not as a surety to each Secured Creditor and their respective successors and assigns, the prompt payment in full when due (whether at stated maturity, by required prepayment, declaration, demand, by acceleration or otherwise) of the principal of and
interest (including any interest, fees, costs or charges that would accrue but for the provisions of the Title 11 of the United States Code after any bankruptcy or insolvency petition under Title 11 of the United States Code) on the US Revolving
Loans made by the Lenders to, and the corresponding Notes held by each Lender of, the US Borrowers, and all other US Obligations from time to time owing to the Secured Creditors by any US Credit Party (such obligations being herein collectively
called the “US Guaranteed Obligations”). The US Guarantors hereby jointly and severally agree that if any US Borrower or any US Guarantor shall fail to pay in full when due (whether at stated maturity, by acceleration or otherwise)
any of the US Guaranteed Obligations, the US Guarantors will promptly pay the same in cash, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the US Guaranteed Obligations, the
same will be promptly paid in full when due (whether at extended maturity, by acceleration or otherwise) in accordance with the terms of such extension or renewal. 

(b) The Non-US Obligation Guarantors hereby jointly and severally guarantee, as a primary obligor and not as a surety to
each Secured Creditor and their respective successors and assigns, the prompt payment in full when due (whether at stated maturity, by required prepayment, declaration, demand, by acceleration or otherwise) of the principal of and interest
(including any interest, fees, costs or charges that would accrue but for the provisions of the Title 11 of the United States Code after any bankruptcy or insolvency petition under Title 11 of the United States Code) on the UK Revolving Loans and
the Canadian Revolving Loans made by the Lenders to, and the corresponding Notes held by each Lender of, each UK Borrower and each Canadian Borrower, and all other UK Obligations and Canadian Obligations from time to time owing to the Secured
Creditors by any UK Credit Party or Canadian Credit Party (such obligations being herein collectively called the “Non-US Guaranteed Obligations”). The Non-US Obligation Guarantors hereby jointly and severally agree that if any UK
Borrower or any Canadian Borrower or any other Non-US Obligation Guarantor shall fail to pay in full when due (whether at stated maturity, by acceleration or otherwise) any of the Non-US Guaranteed Obligations, the Non-US Obligation Guarantors will
promptly pay the same in cash, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the Non-US Guaranteed Obligations, the same will be promptly paid in full when due (whether at
extended maturity, by acceleration or otherwise) in accordance with the terms of such extension or renewal. 

15.02 Obligations Unconditional. (a) The obligations of the US Guarantors under Section 15.01(a)
shall constitute a guaranty of payment (and not of collection) and to the fullest extent permitted by Applicable Law, are absolute, irrevocable and unconditional, joint and several, irrespective of the value, genuineness, validity, regularity or
enforceability of the US Guaranteed Obligations under this Agreement, the corresponding Notes, if any, or any other agreement or instrument referred to herein or therein, or any substitution, release or exchange of any other guarantee of or security
for any of the US Guaranteed Obligations, and, irrespective of any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge or defense of a surety or US Guarantor (except for payment in full). Without limiting the
generality of the foregoing, it is agreed that the occurrence of any one or more of the following shall not alter or impair the liability of the US Guarantors hereunder which shall remain absolute, irrevocable and unconditional under any and all
circumstances as described above: 

  
 186

 (i) at any time or from time to time, without notice to the
US Guarantors, the time for any performance of or compliance with any of the US Guaranteed Obligations shall be extended, or such performance or compliance shall be waived; 

(ii) any of the acts mentioned in any of the provisions of this Agreement or the Notes, if any, or any
other agreement or instrument referred to herein or therein shall be done or omitted; 
 (iii)
the maturity of any of the US Guaranteed Obligations shall be accelerated, or any of the US Guaranteed Obligations shall be amended in any respect, or any right under the Credit Documents or any other agreement or instrument referred to herein or
therein shall be amended or waived in any respect or any other guarantee of any of the US Guaranteed Obligations or any security therefor shall be released or exchanged in whole or in part or otherwise dealt with; 

(iv) any Lien or security interest granted to, or in favor of, any US Issuing Lender or any Lender or
Collateral Agent as security for any of the US Guaranteed Obligations shall fail to be perfected; or 
 (v) the release of any other US Guarantor pursuant to Section 15.09(a). 
 The US Guarantors hereby expressly waive diligence, presentment, demand of payment, protest and all notices whatsoever, and any requirement that any Secured Creditor exhaust any right, power or remedy or
proceed against any US Borrower, UK Borrower or Canadian Borrower under this Agreement or the Notes, if any, or any other agreement or instrument referred to herein or therein, or against any other person under any other guarantee of, or security
for, any of the US Guaranteed Obligations. The US Guarantors waive any and all notice of the creation, renewal, extension, waiver, termination or accrual of any of the US Guaranteed Obligations and notice of or proof of reliance by any Secured
Creditor upon this US Guarantee or acceptance of this Guarantee, and the US Guaranteed Obligations, and any of them, shall conclusively be deemed to have been created, contracted or incurred in reliance upon this Guarantee, and all dealings between
US Borrowers and the Secured Creditors shall likewise be conclusively presumed to have been had or consummated in reliance upon this Guarantee. This Guarantee shall be construed as a continuing, absolute, irrevocable and unconditional guarantee of
payment (and not of collection) without regard to any right of offset with respect to the US Guaranteed Obligations at any time or from time to time held by Secured Creditors, and the obligations and liabilities of the US Guarantors hereunder shall
not be conditioned or contingent upon the pursuit by the Secured Creditors or any other person at any time of any right or remedy against the US Borrowers or against any other person which may be or become liable in respect of all or any part of the
US Guaranteed Obligations or against any collateral security or guarantee therefor or right of offset with respect thereto. This Guarantee shall remain in full force and effect and be binding in accordance with and to the extent of its terms upon
the US Guarantors and the successors and assigns thereof, and shall inure to the benefit of the Lenders, and their respective successors and assigns, notwithstanding that from time to time during the term of this Agreement there may be no US
Guaranteed Obligations outstanding. 
 (b) The obligations of the Non-US Obligation Guarantors under
Section 15.01(b) shall constitute a guaranty of payment (and not of collection) and to the fullest extent permitted by Applicable Law, are absolute, irrevocable and unconditional, joint and several, irrespective of the value,
genuineness, validity, regularity or enforceability of the Non-US Guaranteed Obligations under this Agreement, the corresponding Notes, if any, or any other agreement or instrument referred to herein or therein, or any substitution, release or
exchange of any other guarantee of or security for any of the Non-US Guaranteed Obligations, and, irrespective of any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge or defense of a surety or Non-US
Obligation Guarantor (except 

  
 187

 
for payment in full). Without limiting the generality of the foregoing, it is agreed that the occurrence of any one or more of the following shall not alter or impair the liability of the Non-US
Obligation Guarantors hereunder which shall remain absolute, irrevocable and unconditional under any and all circumstances as described above: 
 (i) at any time or from time to time, without notice to the Non-US Obligation Guarantors, the time for any performance of or compliance with any of the Non-US Guaranteed Obligations shall be extended, or
such performance or compliance shall be waived; 
 (ii) any of the acts mentioned in any of the
provisions of this Agreement or the Notes, if any, or any other agreement or instrument referred to herein or therein shall be done or omitted; 
 (iii) the maturity of any of the Non-US Guaranteed Obligations shall be accelerated, or any of the Non-US Guaranteed Obligations shall be amended in any respect, or any right under the Credit Documents or
any other agreement or instrument referred to herein or therein shall be amended or waived in any respect or any other guarantee of any of the Non-US Guaranteed Obligations or any security therefor shall be released or exchanged in whole or in part
or otherwise dealt with; 
 (iv) any Lien or security interest granted to, or in favor of, any
UK Issuing Lender, Canadian Issuing Lender or any Lender or Collateral Agent as security for any of the Non-US Guaranteed Obligations shall fail to be perfected; or 

(v) the release of any other Non-US Obligation Guarantor pursuant to Section 15.09(b).

 (c) The Non-US Obligation Guarantors hereby expressly waive any requirement that any Secured Creditor exhaust
any right, power or remedy or proceed against the UK Borrowers and the Canadian Borrowers under this Agreement or the Notes, if any, or any other agreement or instrument referred to herein or therein, or against any other person under any other
guarantee of, or security for, any of the Non-US Guaranteed Obligations. The Non-US Obligation Guarantors waive any and all notice of the creation, renewal, extension, waiver, termination or accrual of any of the Non-US Guaranteed Obligations and
notice of or proof of reliance by any Secured Creditor upon this Guarantee or acceptance of this Guarantee, and the Non-US Guaranteed Obligations, and any of them, shall conclusively be deemed to have been created, contracted or incurred in reliance
upon this Guarantee, and all dealings between any UK Borrower any Canadian Borrower and the Secured Creditors shall likewise be conclusively presumed to have been had or consummated in reliance upon this Guarantee. This Guarantee shall be construed
as a continuing, absolute, irrevocable and unconditional guarantee of payment (and not of collection) without regard to any right of offset with respect to the Non-US Guaranteed Obligations at any time or from time to time held by Secured Creditors,
and the obligations and liabilities of the Non-US Obligation Guarantors hereunder shall not be conditioned or contingent upon the pursuit by the Secured Creditors or any other person at any time of any right or remedy against any UK Borrower or
Canadian Borrower or against any other person which may be or become liable in respect of all or any part of the Non-US Guaranteed Obligations or against any collateral security or guarantee therefor or right of offset with respect thereto. This
Guarantee shall remain in full force and effect and be binding in accordance with and to the extent of its terms upon the Non-US Obligation Guarantors and the successors and assigns thereof, and shall inure to the benefit of the Lenders, and their
respective successors and assigns, notwithstanding that from time to time during the term of this Agreement there may be no Non-US Guaranteed Obligations outstanding. 

  
 188

 15.03 Reinstatement. (a) The obligations of the US Guarantors
under this Section 15 shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of any US Borrower, any UK Borrower, any Canadian Borrower or any US Guarantor in respect of the US Guaranteed
Obligations is rescinded or must be otherwise restored by any holder of any of the US Guaranteed Obligations, whether as a result of any proceedings in bankruptcy or reorganization or otherwise. 

(b) The obligations of the Non-US Obligation Guarantors under this Section 15 shall be automatically
reinstated if and to the extent that for any reason any payment by or on behalf of any of the UK Borrowers, the Canadian Borrowers or any Non-US Obligation Guarantor in respect of the Non-US Guaranteed Obligations is rescinded or must be otherwise
restored by any holder of any of the Non-US Guaranteed Obligations, whether as a result of any proceedings in bankruptcy or reorganization or otherwise. 
 15.04 Subrogation; Subordination. (a) Each US Guarantor hereby agrees that until the indefeasible payment and satisfaction in full in cash of all US Guaranteed Obligations and the expiration
and termination of the Revolving Loan Commitments of the Lenders under this Agreement it shall waive any claim and shall not exercise any right or remedy, direct or indirect, arising by reason of any performance by it of its guarantee in
Section 15.01(a), whether by subrogation or otherwise, against US Borrower, UK Borrower, Canadian Borrower or any other US Guarantor of any of the US Guaranteed Obligations or any security for any of the US Guaranteed Obligations. Any
Indebtedness of any US Credit Party permitted pursuant to Section 10.05(e) shall be subordinated to such US Credit Party’s US Obligations, UK Obligation and Canadian Obligations in the manner set forth in the intercompany note
evidencing such Indebtedness (in a form reasonably acceptable to the Administrative Agent). 
 (b) Each Non-US
Obligation Guarantor hereby agrees that until the indefeasible payment and satisfaction in full in cash of all Non-US Guaranteed Obligations and the expiration and termination of the Revolving Loan Commitments of the Lenders to make UK Revolving
Loans and Canadian Revolving Loans under this Agreement it shall waive any claim and shall not exercise any right or remedy, direct or indirect, arising by reason of any performance by it of its guarantee in Section 15.01(b), whether by
subrogation or otherwise, against any of the UK Borrowers, Canadian Borrowers or any other Non-US Obligation Guarantor of any of the Non-US Guaranteed Obligations or any security for any of the Non-US Guaranteed Obligations. Any Indebtedness of any
Credit Party permitted pursuant to Section 10.05(e) shall be subordinated to such Credit Party’s UK Obligations or Canadian Obligations in the manner set forth in the intercompany note evidencing such Indebtedness (in a form
reasonably acceptable to the Administrative Agent). 
 15.05 Remedies. (a) The US Guarantors jointly
and severally agree that, as between the US Guarantors and the Lenders, the obligations of the US Borrowers, UK Borrowers and Canadian Borrowers under this Agreement and the corresponding Notes, if any, may be declared to be forthwith due and
payable as provided in Section 11 (and shall be deemed to have become automatically due and payable in the circumstances provided in Section 11) for purposes of Section 15.01(a), notwithstanding any stay,
injunction or other prohibition preventing such declaration (or such obligations from becoming automatically due and payable) as against any US Borrower, UK Borrower or Canadian Borrower and that, in the event of such declaration (or such
obligations being deemed to have become automatically due and payable), such obligations (whether or not due and payable by US Borrower, UK Borrower or Canadian Borrower) shall forthwith become due and payable by the US Guarantors for purposes of
Section 15.01(a). 
 (b) The Non-US Obligation Guarantors jointly and severally agree that, as
between the Non-US Obligation Guarantors and the Lenders, the obligations of the UK Borrowers and the 

  
 189

 
Canadian Borrowers under this Agreement and the corresponding Notes, if any, may be declared to be forthwith due and payable as provided in Section 11 (and shall be deemed to have
become automatically due and payable in the circumstances provided in Section 11) for purposes of Section 15.01(b), notwithstanding any stay, injunction or other prohibition preventing such declaration (or such obligations
from becoming automatically due and payable) as against any UK Borrower or Canadian Borrower and that, in the event of such declaration (or such obligations being deemed to have become automatically due and payable), such obligations (whether or not
due and payable by a UK Borrower) shall forthwith become due and payable by the Non-US Obligation Guarantors for purposes of Section 15.01(b). 
 15.06 Instrument for Payment of Money. (a) Each US Guarantor hereby acknowledges that the guarantee in this Section 15 constitutes an instrument for the payment of money, and consents and
agrees that any Lender or Administrative Agent, at its sole option, in the event of a dispute by such US Guarantor in the payment of any moneys due hereunder, shall have the right to bring a motion-action under New York CPLR Section 3213.

 (b) Each Non-US Obligation Guarantor hereby acknowledges that the guarantee in this Section 15
constitutes an instrument for the payment of money, and consents and agrees that any Lender or Administrative Agent, at its sole option, in the event of a dispute by such Non-US Obligation Guarantor in the payment of any moneys due hereunder, shall
have the right to bring a motion-action under New York CPLR Section 3213. 
 15.07 Continuing
Guarantee. (a) The guarantee in this Section 15.01(a) is a continuing guarantee of payment (and not of collection), and shall apply to all US Guaranteed Obligations whenever arising. 

(b) The guarantee in this Section 15.01(b) is a continuing guarantee of payment (and not of collection), and
shall apply to all Non-US Guaranteed Obligations whenever arising. 
 15.08 General Limitation on Guarantee
Obligations. (a) In any action or proceeding involving any state corporate limited partnership or limited liability company law, or any applicable state, federal or foreign bankruptcy, insolvency, reorganization or other law affecting the
rights of creditors generally, if the obligations of any US Guarantor under Section 15.01(a) would otherwise be held or determined to be void, voidable, invalid or unenforceable, or subordinated to the claims of any other creditors, on
account of the amount of its liability under Section 15.01(a), then, notwithstanding any other provision to the contrary, the amount of such liability shall, without any further action by such US Guarantor, any US Credit Party, UK Credit
Party or Canadian Credit Party or any other person, be automatically limited and reduced to the highest amount (after giving effect to the right of contribution established in Section 15.10(a)) that is valid and enforceable and not
subordinated to the claims of other creditors as determined in such action or proceeding. 
 (b) In any action
or proceeding involving any state corporate limited partnership or limited liability company law, or any applicable state, federal or foreign bankruptcy, insolvency, reorganization or other law affecting the rights of creditors generally, if the
obligations of any Non-US Obligation Guarantor under Section 15.01(b) would otherwise be held or determined to be void, voidable, invalid or unenforceable, or subordinated to the claims of any other creditors, on account of the amount of
its liability under Section 15.01(b), then, notwithstanding any other provision to the contrary, the amount of such liability shall, without any further action by such Non-US Obligation Guarantor, any US Credit Party, any UK Credit
Party, Canadian Credit Party or any other person, be automatically limited and reduced to the highest amount (after giving effect to the right of contribution established in Section 15.10(b)) that is valid and enforceable and not
subordinated to the claims of other creditors as determined in such action or proceeding. 

  
 190

 (c) The guarantee provided under Section 15.01(b) by any Non-US
Obligation Guarantor organized under the laws of the Netherlands shall be limited to the extent required so that such guarantee does not constitute a breach of the financial assistance prohibitions contained in Section 2:98c or 2:207c of the
Dutch Civil Code. For the avoidance of any doubt it is expressly acknowledged that such Non-US Obligation Guarantors will continue to provide a guarantee to the extent doing so does not constitute a violation of aforementioned Dutch financial
assistance prohibitions. 
 (d) Notwithstanding any provision to the contrary contained in this agreement or in
any Credit Document, the liability of the Luxembourg Subsidiary under this section 15 shall be limited at any time to a maximum aggregate amount equal to 90 per cent. of the greater of the Luxembourg Subsidiary’s own funds
(“capitaux propres”) as mentioned in its most recently approved financial statements, or existing as at the date of this agreement. 
 (e) Notwithstanding any provision to the contrary in contained in this agreement or in any Credit Document, the guarantee provided under Section 15.01(b) by any Canadian Loan Party shall be an
unlimited, unconditional full recourse guarantee of the Non-US Guaranteed Obligations. 
 15.09 Release of
Guarantors. (a) If, in compliance with the terms and provisions of the Credit Documents, all or substantially all of the Equity Interests or property of any US Guarantor are sold or otherwise transferred (a “US Transferred
Guarantor”) to a person or persons, none of which is a US Borrower or a Domestic Subsidiary of US Company, or liquidated in a transaction permitted under the Credit Documents, such US Transferred Guarantor shall, upon the consummation of
such sale or transfer, be automatically released from its obligations under this Agreement and its obligations to pledge and grant any Collateral owned by it pursuant to any Security Document or Pledge Agreement and, in the case of a sale of all or
substantially all of the Equity Interests of the US Transferred Guarantor, the pledge of such Equity Interests to the Collateral Agent pursuant to the Security Agreements or Pledge Agreements shall be automatically released, and the Collateral Agent
shall take such actions as are necessary to effect each release described in this Section 15.09 in accordance with the relevant provisions of the Security Documents or Pledge Agreement, so long as US Company shall have provided the
Administrative Agent such certifications or documents as Administrative Agent shall reasonably request in order to demonstrate compliance with this Agreement. 
 (b) If, in compliance with the terms and provisions of the Credit Documents, all or substantially all of the Equity Interests or property of any Non-US Obligation Guarantor are sold or otherwise
transferred (a “Non-US Obligation Transferred Guarantor”) to a person or persons, none of which is a UK Borrower, Canadian Borrower, UK Credit Party or Canadian Credit Party, such Non-US Obligation Transferred Guarantor shall, upon
the consummation of such sale or transfer, be automatically released from its obligations under this Agreement and its obligations to pledge and grant any Collateral owned by it pursuant to any Security Document and, in the case of a sale of all or
substantially all of the Equity Interests of the Non-US Obligation Transferred Guarantor, the pledge of such Equity Interests to the Collateral Agent pursuant to the Security Agreements or Pledge Agreement shall be automatically released, and the
Collateral Agent shall take such actions as are necessary to effect each release described in this Section 15.09 in accordance with the relevant provisions of the Security Documents or Pledge Agreement, so long as the applicable Borrower
shall have provided the Administrative Agent such certifications or documents as the Administrative Agent shall reasonably request in order to demonstrate compliance with this Agreement. 

15.10 Right of Contribution. (a) Each US Guarantor hereby agrees that to the extent that a US Guarantor shall
have paid more than its proportionate share of any payment made hereunder, such US Guarantor shall be entitled to seek and receive contribution from and against any other US Guarantor hereunder which has not paid its proportionate share of such
payment. Each US Guarantor’s 

  
 191

 
right of contribution shall be subject to the terms and conditions of Section 15.04(a). The provisions of this Section 15.10(a) shall in no respect limit the obligations and liabilities
of any US Guarantor to the Secured Creditors, and each US Guarantor shall remain liable to the Secured Creditors for the full amount guaranteed by such US Guarantor hereunder. 

(b) Each Non-US Obligation Guarantor hereby agrees that to the extent that a Non-US Obligation Guarantor shall have paid
more than its proportionate share of any payment made hereunder, such Non-US Obligation Guarantor shall be entitled to seek and receive contribution from and against any other Non-US Obligation Guarantor hereunder which has not paid its
proportionate share of such payment. Each Non-US Obligation Guarantor’s right of contribution shall be subject to the terms and conditions of Section 15.04(b). The provisions of this Section 15.10(b) shall in no respect
limit the obligations and liabilities of any Non-US Obligation Guarantor to the Secured Creditors, and each Non-US Obligation Guarantor shall remain liable to the Secured Creditors for the full amount guaranteed by such Non-US Obligation Guarantor
hereunder. 

  
 192

 IN WITNESS WHEREOF, the parties hereto have caused their duly authorized
officers to execute and deliver this Agreement as of the date first above written. 
  

							
	Address:	 		 	US BORROWERS:
			
		 		 	MOBILE MINI, INC.
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	MOBILE STORAGE GROUP, INC.
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	MSG INVESTMENTS, INC.
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	MOBILE MINI I, INC.
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	MOBILE MINI, LLC
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	MOBILE MINI, LLC
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO

  
 [ABL Credit
Agreement] 

  

							
	Address:	 		 	US BORROWERS:
			
		 		 	RAVENSTOCK MSG LIMITED
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	MOBILE MINI UK LIMITED
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO

  

							
	Address:	 		 	CANADIAN BORROWERS:
			
		 		 	MOBILE MINI CANADA ULC
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO

  
 [ABL Credit
Agreement] 

							
	Address:	 		 	US BORROWERS:
			
		 		 	 A BETTER MOBILE STORAGE COMPANY, a
 California corporation

	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	 MOBILE MINI DEALER, INC., an arizona
 corporation

	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	 A ROYAL WOLF PORTABLE STORAGE, INC.,
 a California corporation

	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	 TEMPORARY MOBILE STORAGE, INC.,
 California corporation

	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	 MOBILE STORAGE GROUP (TEXAS), L.P., a
 Texas limited partnership

	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO

  
 [ABL Credit
Agreement] 

  

							
	Address:	 		 	NON-US OBLIGATION GUARANTORS:
			
		 		 	MOBILE MINI UK HOLDINGS LIMITED
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	MOBILE STORAGE (U.K.) LIMITED
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	RAVENSTOCK TAM (HIRE) LIMITED
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	 MOBILE STORAGE UK FINANCE LIMITED
 PARTNERSHIP

	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO
			
		 		 	 LIKO LUXEMBOURG INTERNATIONAL
 S.A.R.L.

	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Chris Miner         
		 		 		 	Name: Chris Miner
		 		 		 	Title: Director
			
		 		 	MOBILE MINI HOLDING B.V.
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO

  
 [ABL Credit
Agreement] 

  

							
			
		 		 	MOBILE MINI B.V.
	 Attention: Chief Financial Officer
 Phone: (480) 477-0241
 Fax: (480) 281-3451
	 		 	By:	 	/s/ Mark E. Funk        
		 		 		 	Name: Mark E. Funk
		 		 		 	Title: CFO

  
 [ABL Credit
Agreement] 

  

			
	
	 DEUTSCHE BANK AG NEW YORK BRANCH Individually and as Administrative
 Agent and as Collateral Agent

		
	By:	 	/s/ Marguerite Sutton        
		 	Name: Marguerite Sutton
		 	Title: Director
		
	By:	 	/s/ Carin Keegan        
		 	Name: Carin Keegan
		 	Title: Director

  
 [ABL Credit
Agreement] 

  

			
	SIGNATURE PAGE TO THE CREDIT AGREEMENT DATED AS OF THE DATE FIRST WRITTEN ABOVE, AMONG MOBILE MINI, INC., CERTAIN OF ITS SUBSIDIARIES FROM TIME TO TIME
PARTY HERETO, THE LENDERS PARTY HERETO FROM TIME TO TIME AND DEUTSCHE BANK AG NEW YORK BRANCH, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
	
	BANK OF AMERICA, N.A.
		
	By:	 	/s/ Robert J. Lund        
		 	Name: Robert J. Lund
		 	Title: Senior Vice President
	
	 BANK OF AMERICA, N.A.
 (acting through its Canadian Branch)

		
	By:	 	/s/ Medina Sales de Andrade        
		 	Name: Medina Sales de Andrade
		 	Title: Vice President

  
 [ABL Credit
Agreement] 

  

			
	SIGNATURE PAGE TO THE CREDIT AGREEMENT DATED AS OF THE DATE FIRST WRITTEN ABOVE, AMONG MOBILE MINI, INC., CERTAIN OF ITS SUBSIDIARIES FROM TIME TO TIME
PARTY HERETO, THE LENDERS PARTY HERETO FROM TIME TO TIME AND DEUTSCHE BANK AG NEW YORK BRANCH, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
	
	JPM Morgan Chase Bank, N.A.:
		
	By:	 	/s/ Teresa B. Keckler        
		 	Name: Teresa B. Keckler
		 	Title: Authorized Officer
	
	JPM Morgan Chase Bank, N.A., Toronto Branch:
		
	By:	 	/s/ John P. Freeman        
		 	Name: John P. Freeman
		 	Title: Authorized Officer

  
 [ABL Credit
Agreement] 

  

			
	SIGNATURE PAGE TO THE CREDIT AGREEMENT DATED AS OF THE DATE FIRST WRITTEN ABOVE, AMONG MOBILE MINI, INC., CERTAIN OF ITS SUBSIDIARIES FROM TIME TO TIME
PARTY HERETO, THE LENDERS PARTY HERETO FROM TIME TO TIME AND DEUTSCHE BANK AG NEW YORK BRANCH, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
	
	WELLS FARGO CAPITAL FINANCE, LLC
		
	By:	 	/s/ Kevin Cox        
		 	Name: Kevin Cox
		 	Title: Vice President
	
	NAME OF CANADIAN CORRESPONDING LENDER:
	
	 WELLS FARGO CAPITAL FINANCE
 CORPORATION CANADA

		
	By:	 	/s/ Domenic Cosentino        
		 	Name: Domenic Cosentino
		 	Title: Vice President

  
 [ABL Credit
Agreement] 

  

			
	SIGNATURE PAGE TO THE CREDIT AGREEMENT DATED AS OF THE DATE FIRST WRITTEN ABOVE, AMONG MOBILE MINI, INC., CERTAIN OF ITS SUBSIDIARIES FROM TIME TO TIME
PARTY HERETO, THE LENDERS PARTY HERETO FROM TIME TO TIME AND DEUTSCHE BANK AG NEW YORK BRANCH, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
	
	PNC BANK, NATIONAL ASSOCIATION:
		
	By:	 	/s/ Robin L. Arriola        
		 	Name: Robin L. Arriola
		 	Title: Senior Vice President
	
	PNC BANK CANADA BRANCH, a lender:
		
	By:	 	/s/ Mike Danby        
		 	Name: Mike Danby
		 	Title: Assistant Vice President

  
 [ABL Credit
Agreement] 

  

			
	SIGNATURE PAGE TO THE CREDIT AGREEMENT DATED AS OF THE DATE FIRST WRITTEN ABOVE, AMONG MOBILE MINI, INC., CERTAIN OF ITS SUBSIDIARIES FROM TIME TO TIME
PARTY HERETO, THE LENDERS PARTY HERETO FROM TIME TO TIME AND DEUTSCHE BANK AG NEW YORK BRANCH, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
	
	NAME OF INSTITUTION:
	
	UNION BANK, N.A.
		
	By:	 	/s/ Gina M. West        
		 	Name: Gina M. West
		 	Title: Vice President
	
	NAME OF CANADIAN CORRESPONDING LENDER:
	
	UNION BANK, CANADA BRANCH
		
	By:	 	/s/ Phil Taylor        
		 	Name: Phil Taylor
		 	Title: Senior Vice President

  
 [ABL Credit
Agreement] 

  

			
	
	 BARCLAYS BANK PLC,

as Lender

		
	By:	 	/s/ Michael Mozer        
		 	Name: Michael Mozer
		 	Title: Vice President
	
	 SUNTRUST BANK,
 as Lender

		
	By:	 	/s/ C. Graham Sones        
		 	Name: C. Graham Sones
		 	Title: Senior Vice President
	
	 FIFTH THIRD BANK,

as Lender

		
	By:	 	/s/ Gregory S Calhoun        
		 	Name: Gregory S Calhoun
		 	Title: Officer
	
	 SIEMENS FINANCIAL SERVICES, INC.,
 as Lender

		
	By:	 	/s/ Douglas Maher        
		 	Name: Douglas Maher
		 	Title: Managing Director
		
	By:	 	/s/ Paul Ramaeur        
		 	Name: Paul Ramaeur
		 	Title: Vice President/Head of Risk Mgt.
	
	 RBS CITIZENS BUSINESS CAPITAL, A
 DIVISION OF RBS ASSET FINANCE, INC., A
 SUBSIDIARY OF RBS CITIZENS, N.A.,

as Lender

		
	By:	 	/s/ Patrick Aarons        
		 	Name: Patrick Aarons
		 	Title: Senior Vice President

  
 [ABL Credit
Agreement] 

  

			
	
	 CITY NATIONAL BANK,

as Lender

		
	By:	 	/s/ Robert Yasuda        
		 	Name: Robert Yasuda
		 	Title: Vice President
	
	 HSBC BANK USA NATIONAL
 ASSOCIATION, as Lender

		
	By:	 	/s/ Steven F. Larsen        
		 	Name: Steven F. Larsen
		 	Title: Vice President
	
	 FLAGSTAR BANK, FSB,

as Lender

		
	By:	 	/s/ Willard D. Dickerson, Jr.        
		 	Name: Willard D. Dickerson, Jr.
		 	Title: Senior Vice President
	
	 COMPASS BANK
 as
Lender

		
	By:	 	/s/ Nancy Zezza        
		 	Name: Nancy Zezza
		 	Title: Senior Vice President
	
	 BANK OF THE WEST,

as Lender

		
	By:	 	/s/ Cecile Segovia
		 	Name: Cecile Segovia
		 	Title: Vice President & Senior Relationship Mgr.
	
	 CIT BANK,
 as
Lender

		
	By:	 	/s/ Benjamin Haslam        
		 	Name: Benjamin Haslam
		 	Title: Authorized Signatory

  

  
 [ABL Credit
Agreement] 

  

			
	
	 ISRAEL DISCOUNT BANK OF NEW YORK
 as Lender

		
	By:	 	/s/ Daniel Aviv        
		 	Name: Daniel Aviv
		 	Title: Assistant Vice President
		
	By:	 	/s/ Jeffrey Ackerman        
		 	Name: Jeffrey Ackerman
		 	Title: Senior Vice President
	
	 THE NORTHERN TRUST COMPANY,
 as Lender

		
	By:	 	/s/ John Lascody        
		 	Name: John Lascody
		 	Title: Vice President

  
 [ABL Credit
Agreement]License Agreement (between Q-Med AB and Q-Med Scandinavia)

 Exhibit 10.87 
 Portions of this exhibit marked [*] are omitted and 
 are requested to be treated
confidentially. 
 Execution Copy 
  

 
 LICENSE
AGREEMENT 
 BETWEEN 

Q-MED SCANDINAVIA INC. 

AND 
 Q-MED AB 
  

 

 LICENSE AGREEMENT 

This License Agreement is made and entered into this 2nd day of June, 2009 by and between Q-MED AB, a corporation of organized under the
laws of the Kingdom of Sweden with corporate registration number 556258-6882 (“Q-Med”), and Q-MED SCANDINAVIA INC., a corporation organized under the laws of the State of Delaware (“QMS”). Each of Q-Med and QMS
shall be referred to herein as a “Party” and collectively as the “Parties.” 
 BACKGROUND: 

Q-Med and QMS are each engaged in the research, development and commercialization of pharmaceutical products and/or
medical devices. Q-Med has developed its Deflux® and Solesta® products containing polymerized and cross-linked hyaluronic acid and dextranomer microspheres, wherein the hyaluronic acid is derived from non-animal sources, for the
treatment of urinal incontinence and vesicoureteral reflux and fecal incontinence respectively. QMS possesses capabilities in the promotion and marketing of pharmaceutical products and/or medical devices. Q-Med desires to grant, and QMS desires to
obtain, the rights and licenses set forth herein with respect to Licensed Products (as defined herein), upon the terms and conditions set forth in this Agreement (as defined herein). 

The Parties agree as follows: 
 ARTICLE I 
 DEFINITIONS 

1.1 Definitions. All capitalized terms not otherwise defined in this Agreement shall have the meaning given to such term in the
QMS Supply Agreement. For the purposes of this Agreement, the following words and phrases shall have the following meanings: 

“937 Patent” means the patent bearing U.S. Patent No. 5,827,937 and entitled “Polysaccharide gel
composition” and any of its foreign counterparts, together with any extensions, reissues, continuations, divisionals, continuations-in-part, reexamination certificates, substitutions or renewals, supplemental protection certificates or
certificates of inventions thereof. 

  
 2 

 “Actions” means any action, claim, suit, litigation, arbitration,
investigation, notification or other proceeding brought by a Governmental Authority or other person. 

“Affiliate” of an entity means any other entity that, directly or indirectly, controls, is controlled by, or is under
common control with, the entity. For purposes of this definition, the ownership of 50% or more of the equity or voting interests in such other entity shall presumptively mean that such entity “controls” such other entity. An entity that is
an investment company (including, for the avoidance of doubt, Oceana Holding, LLC), whether or not registered under the Investment Company Act of 1940, as amended, shall not be deemed an Affiliate of QMS. 

“Agreement” means this Agreement and all schedules and exhibits attached hereto, as the same may be amended or
supplemented from time to time in accordance with the terms hereof. 
 “ASP” means the Average Sales Price,
which shall be calculated by dividing the Net Sales of Licensed Product in the applicable territory in a quarter or other measurement period agreed to by the parties, by the number of Units of Licensed Product reflected in such Net Sales.

 “Business Day” means any day between and including Monday through Friday; provided, that, with respect to
any payment to be made or forecast or notice to be provided hereunder by a Party, if the date on which such payment, forecast or notice is due falls on a national bank holiday (by law or executive order) in the country in which the principal place
of business of either Party (or, in the case of a payment, only the paying Party) is located, such payment, forecast or notice shall be due on the next day on which banks in such country(ies) are open for business. 

  
 3 

 “Commercialization” or “Commercialize” means any and all
activities directed to: (i) marketing, promoting, distributing, importing, offering to sell and/or selling the Licensed Products, including market research, seeking appropriate reimbursement, billing and coding support for physicians and
clinics, product related public relations, planning, detailing, marketing, distribution, creative development of visual sales aids, direct mail, telemarketing and teledetailing, media placement and advertising, field marketing events, and sales
meetings; and (ii) medical affairs support (including medical education programs, medical meetings and educational grants), regulatory affairs and quality assurance support (including adverse event reporting and post-market surveillance
studies, whether for marketing purposes, post-marketing experience investigations, regulatory compliance or as a condition to obtaining, maintaining or amending a Regulatory Approval). For purposes of clause (i) of this definition, in reading
Sections 2.4 and 3.1(b) below, this term shall include products other than Licensed Products. 
 “Commercially
Reasonable Efforts” means, with respect to QMS, exerting such effort and employing such resources as would normally be exerted or employed by a U.S. specialty pharmaceutical company of comparable revenues, assets and committed capital
resources as QMS, or, with respect to Q-Med, a Swedish medical device company, taking into account all relevant considerations including, the phase of development of, and technical risks relating to, the product, the development and proprietary
positions of Third Parties, the regulatory structure involved, the likely cost of goods, the competitiveness and size of the relevant marketplace, and the potential profitability of the Licensed Product, when utilizing sound and reasonable
scientific, business and medical practice and judgment. 

  
 4 

 “Confidential Information” shall have the meaning set forth in
Section 10.1. 
 “Control” or “Controlled” means, with respect to any item of Information
or any intellectual property right, the possession (other than pursuant to this Agreement) of the right or ability of a Party or any of its Affiliates to grant to the other Party or a Third Party access to and/or a license under such item or right
as provided herein without violating the terms of any agreement or arrangement with any Third Party existing before or after the Effective Date. 
 “Deflux Product” means the product containing a biocompatible gel composition formed from polymerized and cross-linked hyaluronic acid and dextranomer microspheres, wherein the hyaluronic
acid is derived from non-animal sources, that is a formulation contained in a disposable syringe, excluding the Deflux needle, as more specifically described on Schedule B attached to the QMS Supply Agreement, and as such Schedule B may be amended
from time to time in accordance with Section 2.3 of the QMS Supply Agreement. 
 “Development Costs” means
all expenses incurred by a Party or its Affiliates with respect to a particular development activity conducted under this Agreement and the activities referred to in Article III in accordance with the applicable protocols and/or Project Plans,
including related budgets, as approved by the JSC, or as agreed in each case, measured as follows: (a) with respect to services provided directly by a Party or its Affiliates, at applicable standard hourly rates for each employee; and
(b) all amounts paid to Third Parties with respect to such development, including payments to investigators and contract research organizations, data management, statistical designs and studies, document preparation and the acquisition of
materials. 
 “Effective Date” means the date of the consummation of the transactions set forth in the SPA.

  
 5 

 “FDA” means the U.S. Food and Drug Administration, or any successor
regulatory agency in the U.S. 
 “FDCA” means the U.S. Federal Food, Drug, and Cosmetic Act of 1938, as amended
(21 U.S.C. §§ 301 et. seq.), and its implementing regulations. 
 “GAAP” means U.S. generally
accepted accounting principles, consistently applied. 
 “Governmental Authority” means any supranational,
national, federal, state, provincial or local judicial, legislative, executive or regulatory authority. 

“IDE” means an investigational device exemption or other application required to be submitted to Regulatory Authorities
and be approved or otherwise legally effective before the commencement of any human clinical study of a Licensed Product. 

“Improvements” means any improvement or modification of a then-existing Licensed Product
(including new clinical uses of and modifications to the formulation), whether or not patented, in the Licensed Field.  
 “Information” means any and all know-how and information, trade secrets, clinical development and other technical and marketing information related to the Licensed Products (whether or
not confidential, proprietary, patented or patentable), and all tangible embodiments of any of the foregoing in written, electronic or any other form, that are necessary or reasonably useful, in the ordinary course of business, for the use,
distribution, importation or Commercialization of a Licensed Product in the Territory, including sales and marketing materials, and medical, clinical, pre-clinical, product development, stability, toxicological testing and other scientific data,
relating to the Licensed Products; provided, however, that Information shall not include information that either Party is under an obligation to unrelated Third Parties not to disclose, such as patient data, and Information shall not include
any non-public 

  
 6 

 
information from which any manufacturing process employed by or on behalf of Q-Med in the production of a Licensed Product can be derived by one reasonably skilled in the art and science of
medical device, chemical and/or pharmaceutical manufacturing. 
 “Ireland Supply Agreement” means the Supply
Agreement, dated as of the date hereof, between Cetacea Limited and Q-Med, as the same may be amended or supplemented from time to time in accordance with the terms thereof. 
 “Joint Patents” means any patent or patent application in the Territory claiming a Joint Invention, together with any extensions, reissues, continuations, divisionals,
continuations-in-part, reexamination certificates, substitutions or renewals, supplemental protection certificates or certificates of inventions thereof. 
 “Licensed Field” means diagnosis, treatment or prevention of (a) urological indications including urinary and fecal incontinence, (b) gastroenterology focused indications
involving the gastrointestinal tract including umbilical hernia, below, but not including, the vocal chords or (c) any combination of the foregoing. 
 “Licensed Product” means (a) the Deflux Product and Solesta Product and all Improvements thereof, and (b) all other biocompatible gel compositions containing polymerized and
cross-linked hyaluronic acid, derived from a non-animal source, and dextranomer microspheres, and all Improvements thereof, that, in all such cases, is a formulation that is capable of being administered by an injection through a needle for use in
the Licensed Field. 
 “Losses” means Q-Med Losses or QMS Losses, each as defined below, as the context
requires. 
 “Manufacture” and “Manufacturing” and other forms of such words means the
manufacturing, processing, filling, handling, storage, packaging and quality control testing (including in-process, raw materials, component, manufacturing product release and stability testing) of Licensed Products. 

  
 7 

 “Market Launch” means the first offer of a Licensed Product other than the
Deflux Product for commercial sale to the public following Regulatory Approval. 
 “NASHA Trademark” has the
meaning given in Section 2.1(c) below. For purposes of clarity, the NASHA Trademark shall not be deemed a Q-Med Trademark. 

“Net Sales” means the gross sales invoiced to Third Parties by QMS, its Affiliates or Sublicensees for the Licensed
Products in finished packaged form, less the following deductions, in accordance with GAAP (to the extent such amounts are included in the amount invoiced for such Licensed Product and are customary and reasonable): 

(a) any refunds for rejects, defects and returned product (including those subject to recall), and trade, quantity, promotional, early
payment and other customary discounts actually allowed and taken directly with respect to such sales; provided, that where any such discount is based on sales of a bundled set of products in which Licensed Product is included, the discount
shall be allocated to such Licensed Product on a pro rata basis based upon the sales value (i.e. the unit average selling price in the prior quarter multiplied by the unit volume) of such Licensed Product relative to the sales value contributed by
the other constituent products in the bundled set, with respect to such sale; 
 (b) any rebates or chargebacks (including
rebates to governmental authorities and managed care organizations); 
 (c) any sales, use, occupation, or excise taxes, duties
or other governmental charges imposed and paid with respect to the sale (including VAT), delivery or use of such Licensed Products (excluding national, state or local taxes based on net income or gross receipts taxes imposed in lieu of net income
taxes); 

  
 8 

 (d) any freight, postage, or transportation insurance charges; and 

(e) wholesaler or distributor fees for physical distribution of Licensed Products. 

Notwithstanding the foregoing, (i) no discount, allowance, rebate, chargeback, or any similar amount, however designated, that is
given or associated with the purchase by the Third Party of any product other than the Licensed Product, or with the purchase or provision of any service, shall be taken into consideration in calculating any deductions from the invoiced amount, and
(ii) no deductions shall be taken for sales commissions and fees and other marketing and sales costs. Such amounts shall be determined from the books and records of QMS, its Affiliates and Sublicensees, all of which shall be maintained in
accordance with generally accepted accounting principles, consistently applied. In the case of any sale of a Licensed Product for consideration other than cash, such as barter or countertrade, Net Sales shall be calculated on the fair market value
of the consideration received. For the avoidance of doubt, sales on a named patient basis or for compassionate use shall be included in Net Sales. 
 For purposes of clarity, in calculating Net Sales of Licensed Products: (i) to a person who renders any service to a Selling Party, in no event shall the price of the Licensed Product be discounted
to reflect any portion of such services, except for incidental distribution services customarily rendered by a seller of comparable products without charge; and (ii) sold in a bundle with other products, the price shall reflect the discount
permitted under Section 5.8 below. 
 “Old Technology” has the meaning ascribed to the term
“Technology” as defined in and as limited by the Biomatrix License Agreement. 

  
 9 

 “PMA Application” means a premarket approval application or submission
under Section 510(k) or 515(c) of the FDCA requesting FDA’s approval to commercially sell and distribute a Licensed Product in the U.S., including all information submitted with or incorporated by reference therein. 

“Prior Agreements” means, collectively: 
 (a) that certain Settlement Agreement dated as of September 28, 1999 by and between Biomatrix, Inc., and Bengt Agerup, Q-Med AB (publ), Medinvent, Qymed Sarl, Q-Med (UK) Ltd., Q-Med GmbH, Q-Med
(Sweden) Australia Pty Ltd., Qvestor AB, Spectra Lab AB, Q-Med Inc., and Q-Med Scandinavia Inc.; 
 (b) that certain License
Agreement dated as of September 28, 1999 by and between Biomatrix, Inc., and Bengt Agerup, Q-Med AB (publ), Medinvent, Qymed Sarl, Q-Med (UK) Ltd., Q-Med GmbH, Q-Med (Sweden) Australia Pty Ltd., Qvestor AB, Spectra Lab AB, Q-Med Inc., and Q-Med
Scandinavia Inc. (the “Biomatrix License Agreement”); and 
 (c) that certain Royalty Agreement dated as of
September 28, 1999, by and between by and between Biomatrix, Inc., and Bengt Agerup, Q-Med AB (publ), Medinvent, Qymed Sarl, Q-Med (UK) Ltd., Q-Med GmbH, Q-Med (Sweden) Australia Pty Ltd., Qvestor AB, Spectra Lab AB, Q-Med Inc., and Q-Med
Scandinavia Inc., 
 as each has been amended by that certain Amendment dated as of September 10, 2004 between and among Genzyme
Corporation, as successor in interest to Biomatrix, Inc., and the other parties to each of the foregoing agreements. 

“Project” shall have the meaning set forth in Section 3.1(a). 

“Project Invention” means all Improvements, inventions, discoveries and improvements (whether or not patentable) that
are conceived or first reduced to practice in the course of conducting a Project or otherwise performing services related to this Agreement by one or more individuals who are employees, agents, consultants or subcontractors of one of the Parties.

  
 10 

 “Project Plan” shall have the meaning set forth in Section 3.4.

 “Q-Med Copyrights” means any published or unpublished work related to Commercialization of the Licensed
Products that is Controlled by Q-Med or any of its Affiliates at any time during the Term. 
 “Q-Med Domain
Names” means all internet uniform resource locators and domain names related to the Commercialization of the Licensed Products that are Controlled by Q-Med or any of its Affiliates at any time during the Term. The Q-Med Domain Names in
existence as of the Effective Date are as set forth on Schedule C hereto. 
 “Q-Med Field” means all uses
outside the Licensed Field for: (a) the Solesta Product and all Improvements thereof; (b) the Deflux Product and all Improvements thereof; and (c) all other biocompatible gel compositions containing polymerized and cross-linked
hyaluronic acid, derived from a non-animal source, and dextranomer microspheres, and all Improvements thereof that, in all such cases, is a formulation that can be administered by an injection through a needle. 

“Q-Med Information” means all Information that is Controlled by Q-Med or any of its Affiliates at any time during the
Term. 
 “Q-Med IP” means the Q-Med Copyrights, Q-Med Domain Names, Q-Med Patents, the Q-Med Trademarks and the
Q-Med Information. 
 “Q-Med Losses” has the meaning given in Section 9.2 below. 

“Q-Med Patents” means the patent and patent applications set forth on Schedule A hereto and any other patent or
patent application in the Territory Controlled by Q-Med or any of its Affiliates at any time during the Term that covers the Licensed Product for use in the 

  
 11 

 
Licensed Field, including composition of matter, formulations, kits, delivery devices, method of manufacturing or use, together with any extensions, reissues, continuations, divisionals,
continuations-in-part, reexamination certificates, substitutions or renewals, supplemental protection certificates or certificates of inventions thereof. 
 “Q-Med Trademarks” means each trademark set forth on Schedule B, including marks subsequently added by Q-Med and such other trademarks as the Parties may mutually agree. 

“QMS Losses” has the meaning given in Section 9.1 below. 

“QMS Supply Agreement” means the Supply Agreement, dated as of the date hereof, between QMS and Q-Med, as the same may
be amended or supplemented from time to time in accordance with the terms thereof. 
 “Regulatory Approval”
means any and all approvals (including any necessary governmental price or reimbursement approvals), clearances, exemptions, licenses, registrations or authorizations of the applicable Regulatory Authority, necessary for the use, storage, import,
promotion, marketing and sale of Licensed Product in the Licensed Field in the Territory, including approval of a PMA Application, provided, however, that for purposes of Article III, the phrase “in the Territory” shall be
omitted. 
 “Regulatory Authority” means any competent or other governmental authority (whether supranational,
national, foreign, federal, state, provincial, municipal or other) administrative agency or commission regulating the exportation, importation, use, or Commercialization of medical devices such as Licensed Products in any jurisdiction within the
Territory, including the FDA, provided, however, that for purposes of Article III, the phrase “within the Territory” shall be omitted. 

  
 12 

 “Regulatory Filing” means the relevant application or submission for
Regulatory Approval of a Licensed Product, including a PMA Application and all supplements, modifications, amendments, reports, submissions, records and other documents required to be filed with a Regulatory Authority in connection therewith.

 “SEK” means Swedish Krona, the currency currently used in Sweden or the equivalent value in Euro if the Euro
is adopted as the official currency used in Sweden at the official exchange rate. 
 “Solesta PMA Approval Clinical
Trial” means the trial bearing identification number of 33 DA 0404 entitled “Randomized, Subject and Evaluator Blinded, Sham-Controlled, Multi-Center Study to Evaluate Efficacy and Safety of NASHA/Dx for the Treatment of Fecal
Incontinence.” 
 “Solesta PMCS Trial” means the trial bearing identification number 33DA0605, called
“Open Non-comparative Post-Marketing Multi-Center Study to Evaluate Safety and Efficacy of Solesta for the Treatment of Fecal Incontinence. 
 “Solesta Product” means the product containing a biocompatible gel composition formed from polymerized and cross-linked hyaluronic acid and dextranomer microspheres, wherein the
hyaluronic acid is derived from non-animal sources, that is a formulation contained in a disposable syringe, as more specifically described on Schedule B attached to the QMS Supply Agreement, and as such Schedule B may be amended from time to time
in accordance with Section 2.3 of the QMS Supply Agreement. Schedule B includes descriptions of the Solesta Product (i) as sold by Q-Med on the Effective Date and (ii) as currently being used in the PMA Approval Clinical Trial with
respect to the gel composition and as intended to be sold in the Territory. 

  
 13 

 “SPA” means that certain Stock Purchase Agreement, dated as of
April 22, 2009, entered into between Q-Med and Oceana Therapeutics LLC. 
 “Sublicensee” means an entity
to which QMS grants a sublicense of its rights pursuant to Section 2.2 of this Agreement. 
 “Supply
Agreements” means the Ireland Supply Agreement and the QMS Supply Agreement. 
 “Term” shall have the
meaning set forth in Section 11.1. 
 “Territory” means the U.S. 

“Third Party” means any person or entity other than Q-Med, QMS or their respective Affiliates or Sublicensees.

 “Third Party IP” means any copyrights, domain names, patents and patent applications, trademarks and
Information or other intellectual property rights owned or controlled by a Third Party. 
 “Units” means with
respect to (a) the Solesta Product: a package containing four pre-filled syringes, each containing 1 ml of gel, plus five needles plus a package insert or instructions for use, or such other definition as the Parties shall designate in the
event of modifications to the Solesta Product hereunder or pursuant to the QMS Supply Agreement; (b) the Deflux Product: a package containing one pre-filled syringe, containing 1 ml of gel, plus a package insert or instructions for use, or such
other definition as the Parties shall designate in the event of modifications to the Deflux Product hereunder or pursuant to the QMS Supply Agreement, (c) other Licensed Products, such other definition as the Parties shall designate.

 “U.S.” means the United States and its territories and possessions, including Puerto Rico. 

  
 14 

 1.2 Interpretation 

(a) Whenever any provision of this Agreement uses the term “including” (or “includes”), such term shall be deemed to
mean “including without limitation” or “including but not limited to” (or “includes without limitation” and “includes but is not limited to”) regardless of whether the words “without limitation” or
“but not limited to” actually follow the term “including” (or “includes”); 
 (b)
“Herein,” “hereby,” “hereunder,” “hereof,” and other equivalent words shall refer to this Agreement as an entirety and not solely to the particular portion of this Agreement in which any such word is used;

 (c) All definitions set forth herein shall be deemed applicable whether the words defined are used herein in the singular or
the plural; 
 (d) Unless otherwise provided, all references to Sections, Articles, Schedules and Appendices are to Sections,
Articles, Schedules and Appendices of and to this Agreement; 
 (e) All references to days, months, quarters, or years are
references to calendar days, calendar months, calendar quarters, or calendar years unless the term “Business Days” is used; and 
 (f) Any reference to any supranational, national, federal, state, local, or foreign statute or law shall be deemed to also refer to all rules and regulations promulgated thereunder, within any
jurisdiction or jurisdictions subject thereto unless the context requires otherwise. 

  
 15 

 ARTICLE II 
 LICENSE GRANTS 
 2.1 Grant. Q-Med hereby grants to QMS: 

(a) the exclusive (including with respect to Q-Med) license under the Q-Med IP to Commercialize, but not to develop or manufacture, the
Licensed Products in the Territory for the Term of this Agreement. The exclusive nature of the foregoing license is subject to the rights granted pursuant to the Prior Agreements with respect to the Old Technology, including U.S. Patent
No. 5,633,001. The foregoing includes the license described in Section 7.1 below. For avoidance of doubt, in no event shall QMS have any rights whatsoever outside of the Licensed Field. QMS may sublicense the rights granted under this
Section 2.1(a) only to the extent provided in Section 2.2; 
 (b) a royalty-free, co-exclusive license with Q-Med
under the Q-Med IP to conduct each Project or the activities in Section 3.5(b), for the account of Q-Med, which for the purpose of this Section 2.1(b) shall be considered a Project. The co-exclusive nature of the foregoing license is
subject to the rights granted pursuant to the Prior Agreements with respect to the Old Technology, including U.S. Patent No. 5,633,001. QMS may grant sublicenses to such licenses to such Third Parties it may delegate the performance of work in
respect of any Project to the extent permitted under, and subject to, the terms of Section 3.5(c); and 
 (c) a
royalty-free, nonexclusive license to use the trademark “NASHA” (the “NASHA Trademark”) in accordance with and subject to the guidelines set forth in Schedule 2.1(c) hereto in connection with the exercise by QMS of
the licenses granted in Section 2.1(a) above. 
 2.2 Right to Sublicense. 

(a) QMS may sublicense the rights granted under Section 2.1(a), without any further right of sublicense, only as follows: to an
Affiliate without the consent of Q-Med but may not grant a sublicense to a Third Party except upon the consent of Q-Med, which may not be unreasonably withheld, delayed or conditioned. Consent of Q-Med shall be deemed given if Q-Med fails to notify
QMS in writing, of its refusal to consent within twenty (20) days of its receipt of notice of request for consent, accompanied by reasonably detailed and accurate information about the prospective sublicensee. 

 

  
 16 

 (b) Notwithstanding any sublicense granted hereunder, QMS shall in all events remain jointly
and severally liable to Q-Med for compliance with the terms of this Agreement, including all diligence, payment and reporting obligations. 
 (c) QMS shall promptly provide Q-Med with a copy of all provisions of any sublicense agreement entered into pursuant to this Section 2.2, (which copy may redact financial terms) each of which shall
include provisions regarding confidentiality, indemnity, reporting, audit rights, access to data and informational obligations (collectively “Required Provisions”) no less protective or comprehensive than those set forth in
this Agreement and in the QMS Supply Agreement, and which shall name Q-Med as an intended third party beneficiary of such Required Provisions. No such agreement shall contain any provision purporting or having the effect of mitigating, abating or
ameliorating the effect of the Required Provisions, or granting to such sublicensee the right to grant further sublicenses. All sublicenses granted in violation of this Section 2.2 are void ab initio. 

2.3 [INTENTIONALLY OMITTED] 
 2.4 Exclusivity. During the Term of this Agreement: (a) except as expressly permitted in this Agreement, neither QMS nor any of its Affiliates shall conduct (nor grant any rights to Third
Parties to conduct) any research, development, manufacturing or Commercialization activities, alone or with Third Parties, with respect to injectible bulking agent products for use in the Licensed Field; and (b) except as expressly permitted in
this Agreement, neither Q-Med nor any of its Affiliates shall (i) Commercialize the Licensed Product in the Licensed Field, or (ii) exploit the Solesta or Deflux trademarks within or outside of the Licensed Field. Notwithstanding the
foregoing, nothing herein shall in any way restrict the right of Q-Med to exploit the Q-Med Trademarks to identify itself as the manufacturer and developer of the Licensed Products. 

  
 17 

 2.5 Improvements. 

(a) Q-Med. All Improvements Controlled by Q-Med or any of its Affiliates during the Term shall be included under the licenses
granted to QMS under Section 2.1. 
 (b) QMS. To the extent permitted by any contractual arrangement by which QMS
acquires Control of any Improvement, QMS hereby grants Q-Med a non-exclusive license, to use in the Q-Med Field throughout the Territory any Improvements Controlled by QMS or any of its Affiliates during the Term upon terms and conditions to be
mutually agreed upon by the parties. Q-Med may further sublicense any of its rights granted under this Section 2.5(b) other than to a Third Person reasonably determined by QMS to be then competing with QMS. 

2.6 Reservation of Rights; No Implied Rights. Except as expressly stated herein, QMS shall have no other right to use, or interest
in, the Q-Med IP or the Licensed Products. 
 ARTICLE III 

DEVELOPMENT 
 3.1 Development of Licensed Products. 
 (a) Subject to Section 3.5
below, the Parties shall conduct collaborative development projects (i) to control or conduct any then on-going or future clinical trials with respect to Licensed Products, and (ii) to identify and develop Improvements to the Deflux
Product and Solesta Product and additional Licensed Products, including additional clinical uses and new formulations or product design in the Licensed Field (each such development project in (i) and (ii) above shall be referred to as a
“Project”). Q-Med will participate in assisting QMS in performing clinical studies as agreed between the parties in each case at QMS’ cost, unless otherwise agreed. For clarity, any pre-clinical and clinical activities
associated with the first Solesta Product in the U.S., including the Solesta PMA Approval Clinical Trial, shall not be a Project. 

  
 18 

 (b) Notwithstanding the foregoing or anything else to the contrary in this Article III,
Article IV or otherwise, (i) the Parties shall not develop a Project or Licensed Product if Q-Med upon written notice and explanation to QMS, reasonably determines that such development may adversely affect the Commercialization of Q-Med’s
other products containing polymerized and cross-linked hyaluronic acid and with or without dextranomer microspheres, wherein the hyaluronic acid is derived from non-animal sources; and (ii) subject to Section 2.5, Q-Med may undertake any
preclinical development of such Improvements and other Licensed Products on its own if it so chooses; provided, however, that upon the determination by Q-Med in its reasonable discretion that such development may have commercial application
in the Licensed Field, Q-Med will in good faith discuss further development of such Improvement or Licensed Product with the JSC (as defined in Section 3.2 below). 
 3.2 Joint Steering Committee. The Parties shall create a Joint Steering Committee (the “JSC”) to oversee and coordinate the performance of the Projects and the Commercialization of
the Licensed Products. The tasks of the JSC will be (a) to facilitate the management and implementation of activities under each Project Plan, (b) to review and approve updated versions of each Project Plan (including related budgets),
(c) to review pre-clinical and clinical development activities related to Licensed Products and Improvements thereto, (d) to provide a mechanism for exchange of information, including information related to development of Licensed
Products, including Improvements thereto and the Q-Med IP licensed hereunder or under that certain license agreement between Q-Med and Cetacea Limited of even date 

  
 19 

 
(“Ireland License Agreement”), (e) to review and discuss the annual global Marketing Plans, and (f) to review and consider regulatory strategy and cooperative
regulatory compliance for the period prior to the receipt of the relevant Regulatory Approvals and thereafter; provided that nothing in this Article III is intended to relieve either Party of its obligation to ensure that its own activities
comply in all material respects with the FDCA and FDA’s regulations thereunder and other comparable regulatory requirements throughout the world. 
 3.3 Committee Membership and Procedures. 
 (a) Membership. Each Party
will designate two representatives to serve as members of the JSC, one of which shall be employed in a business or commercial management position and one of which shall be employed in a research and development function. Each Party may replace its
Committee representatives at any time upon written notice to the other Party. Q-Med shall designate one of its representatives on the JSC as the chairperson. The chairperson shall be responsible for calling meetings, preparing and circulating an
agenda in advance of each meeting of the JSC, and preparing and issuing minutes of each meeting within 30 days thereafter; provided, that the chairperson shall call a meeting promptly upon the written request of QMS to convene such a meeting.
Such minutes will not be formalized until the chairperson and a representative of QMS review and confirm the accuracy of such minutes in writing. 
 (b) Meetings. The JSC shall hold meetings at such times as it elects to do so, but at least semi-annually or at such other times as the Parties may mutually agree. Meetings may be held in person or
by means of telecommunication (telephone, video, or web conferences). Other employees of 

  
 20 

 
each Party involved in the development or Commercialization of Licensed Products may attend meetings as nonvoting participants, and, with the consent of each Party, consultants, representatives,
or advisors involved in the development or Commercialization of the Licensed Products may attend meetings as nonvoting observers; provided, that such Third Party representatives are under obligations of confidentiality and non-use comparable
to those imposed on the Parties herein. 
 (c) Limitations of Committee Powers. The JSC shall have only
such powers as are specifically delegated to it hereunder and will not be a substitute for the rights of the Parties. Without limiting the generality of the foregoing, the JSC shall not have any power to amend this Agreement. 

(d) Decision-Making. The JSC shall take all actions by unanimous vote with each Party having a single vote,
irrespective of the number of representatives actually in attendance at a meeting, or by a written unanimous resolution signed by all designated representatives of each of the Parties. If the JSC fails to reach unanimous consent on a particular
matter within [*] days of a Party having requested a formal vote on such matter, then either Party may provide written notice of such failure to the Chief Executive Officer of the other Party. The Chief Executive Officers of each of the Parties will
discuss such matter on which the JSC failed to reach unanimous consent and use their good faith efforts to resolve the matter within [*] days after receipt of such notice. Notwithstanding the foregoing, if the Chief Executive Officers are unable to
reach an agreement within such [*] day period, regarding a matter that is primarily related to Commercialization then, subject to the provisions of Section 3.1(b) and 3.5(a) with respect to Q-Med’s right not to perform certain development
work, QMS shall have final decision making authority on such matter. 
  

 

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  
 21 

 3.4 Projects and Project Plans. Either Party may make a written proposal to the JSC
regarding the development of a Project. Such proposal shall include (a) any data and other information in its possession which may be relevant to the proposed Project, (b) a reasonably detailed outline of the major development activities
(including any activities required to obtain Regulatory Approval for such proposed Project, if applicable) including a timeline for performing such activities, (c) actual Development Costs previously incurred (if any) and an estimated budget
for the anticipated Development Costs for such proposed Project, and (d) preliminary information about the commercialization of such proposed Project, such as projected sales, projected costs of goods sold and projected ASP. The Parties shall
establish and maintain a written plan for the development of each Project the JSC elects to undertake, which plan shall identify the tasks to be conducted by each Party consistent with this Article III, timelines and budgets for Development Costs (a
“Project Plan”). Upon inclusion of each Project for which Q-Med may have commenced work prior to its designation as a Project, QMS shall reimburse Q-Med for all actual Development Costs incurred prior to such inclusion as described
in the associated Project Plan. 
 3.5 Project Activities. In respect of each Project, each of the Parties shall use
Commercially Reasonable Efforts to conduct such activities as are assigned to it in the applicable Project Plan. The Parties shall generally conduct the following activities: 
 (a) Q-Med. Q-Med shall conduct: (i) all pre-clinical development activities that are required by a PMA Application or other Regulatory Approval, (ii) all development of all formulations
(including any mutually agreed changes) of a Licensed Product, (iii) all development and other activities related to any commercial manufacturing of a Licensed Product, including the production of validation batches and conducting stability
studies, and (iv)

  
 22 

 
clinical work with respect to a Licensed Product, if and to the extent the Parties so agree. Notwithstanding the foregoing, Q-Med shall not be required to perform any development work to the
extent a Licensed Product or any component thereof, in the Project as then proposed, is not a “device” under the FDCA or a “medical device” under the EU Medical Device Directive (93/42/EEC). The Parties agree that the immediately
preceding sentence shall not apply to the current Solesta Product and its components. 
 (b) QMS. QMS shall conduct, for
the account of Q-Med, (i) all clinical work with respect to a Licensed Product (except as otherwise agreed by the Parties or as otherwise set forth in subsection (a)(iv) above), and (ii) except as provided in Section 3.5(a) above, all
other development activities required to obtain Regulatory Approval, including clinical development and, subject to Section 4.3(b), the preparation and submission of all Regulatory Filings. QMS shall inform Q-Med, through the JSC and in
writing, of the draft protocols for such clinical studies, or for clinical studies for which Q-Med is responsible pursuant to Section 3.5(a)(iv), for Q-Med’s timely review and input before commencement of any clinical studies and will
consider in good faith all comments provided by Q-Med. QMS shall have the right to determine all final protocols so long as they conform to GCP (“Good Clinical Practice”), the then current Project Plan, if applicable, and the other
requirements under this Agreement. 
 (c) Third Parties. Each Party may use Third Parties to perform portions of the
development work assigned to it under a Project Plan, provided, that a Party shall have the right to consent to any such Third Party proposed to be used by the other Party to which the other Party would disclose any Confidential Information
of the non-disclosing Party; further provided, that if consent is required, such consent may be granted or withheld in such party’s sole discretion and, if such consent is given, (i) each Party shall provide in any agreement for
such 

  
 23 

 
Third Party services allocations of intellectual property rights and for obligations of confidentiality and record-keeping that are consistent with the terms of this Agreement; and (ii) the
delegating Party shall be jointly and severally liable hereunder to the other Party for the performance of all obligations of the delegating Party and grant of all rights by the delegating Party as if the delegating Party were performing such work
itself. 
 (d) Development Costs. QMS shall perform its activities under each Project Plan at its own expense. QMS shall
reimburse Q-Med for all actual Development Costs incurred by Q-Med to conduct its activities in accordance with any approved Project Plan, including Third Parties engaged by Q-Med to conduct pre-clinical activities on its behalf, or to conduct
activities otherwise requested by QMS. All Development Costs so required to be reimbursed by QMS shall be paid monthly as invoiced by Q-Med specifying such Development Costs with reasonable particularity with payment due within [*] days from the
date of receipt of the invoice. An invoice sent by Q-Med to QMS in the manner described in the introductory provisions of Section 12.6 below shall be deemed received on the relevant date determined in accordance with Section 12.6. Invoices
shall be directed to: Chief Operating Officer and copies need not be sent to counsel. 
 (e) Audit Rights. Each Party
shall keep, and cause its Affiliates and any permitted Third Parties to keep, complete and accurate records in sufficient detail to enable a calculation of Development Costs. For the sole purpose of verifying such Development Costs, a Party (the
“Auditing Party”) shall have the right no more than one time each year during the Term and for a period of one year thereafter, at the Auditing Party’s own expense, to have an independent certified public accountant reasonably
acceptable to the other Party examine the 
  
  

	*	 Confidential treatment requested; certain information omitted and filed separately with the SEC.

  
 24 

 
relevant books and records of the other Party for the [*] preceding such examination in the location(s) where such records are maintained by the other Party or its Affiliates (the
“Audited Party”) upon reasonable notice and during regular business hours. Results of such review shall be made available to the Audited Party. The records and results of such audits shall be deemed Confidential Information of the
Audited Party. Any overpayment or underpayment of the Development Costs as required under this Agreement shall be promptly rectified, together with interest calculated in the manner provided in Section 6.6. The Auditing Party shall pay for all
costs associated with any audit; provided that if a determination is made that the Development Costs reimbursed with respect to any year was more than [*] of the actual Development Costs properly reimbursable with respect to such year, the
Audited Party shall promptly reimburse the Auditing Party for the reasonable costs, fees and expenses of such examination. 

3.6 Intellectual Property. 
 (a) Hyaluronic Acid. Subject to the licenses granted to QMS under Section 2.1 or under the Ireland License Agreement, Q-Med shall own the entire right, title and interest in and to all Project
Inventions (and patents and other intellectual property rights thereto) comprising formulations or methods of manufacturing of polymerized and cross-linked hyaluronic acid, with or without dextranomer microspheres, wherein the hyaluronic acid is
derived from non-animal sources, that are made by employees or others acting on behalf of either Party (or solely by such persons and Third Parties performing work under a Project). 

(b) Other Q-Med Sole Inventions. Subject to the licenses granted under Section 2.1 or under the Ireland License Agreement,
Q-Med shall own the entire right, title and interest in and to all Project Inventions (and patents and other intellectual property rights thereto) 
  

 

	*	 Confidential treatment requested; certain information omitted and filed separately with the SEC.

  
 25 

 
made solely by its employees or others (other than QMS and its Affiliates, and their employees and consultants) acting on behalf of Q-Med (or solely by such persons and Third Parties performing
work under a Project), and all Project Inventions (and patents and other intellectual property rights thereto), regardless of by whom made, that relate to the formulation of a Licensed Product. 

(c) Other QMS Sole Inventions. Except as provided in paragraphs (a) and (b) above and subject to the licenses granted to
Q-Med under Sections 2.1(b) and 2.5(b) and under the Ireland License Agreement, QMS shall own the entire right, title and interest in and to all Project Inventions (and patents and other intellectual property rights thereto) made solely by its
employees or others (other than Q-Med and its Affiliates, and their employees and consultants) acting on behalf of QMS (or solely by such persons and Third Parties performing work under a Project). 

(d) Other Joint Inventions. Except as provided in paragraph (a) above, the Parties shall jointly own all Joint Inventions
(and patents and other intellectual property rights thereto). “Joint Inventions” means all Project Inventions for which it is determined that both: (i) one or more employees, consultants or agents of Q-Med or any of its
Affiliates or any other persons obliged to assign such Project Invention to Q-Med or any of its Affiliates; and (ii) one or more employees, consultants or agents of QMS or any of its Affiliates or any other persons obliged to assign such
Project Invention to QMS or any of its Affiliates, are joint inventors of such Project Invention under applicable patent laws, exclusive, however, of Project Inventions that would otherwise qualify as Joint Inventions but which shall be Q-Med
Inventions pursuant to paragraph (b) above. Subject to the rights granted each Party under this Agreement, each Party shall have the right to use Joint Inventions and Joint Patents without the consent of or accounting to the other Party unless
the law of such country does not allow the parties to waive such accounting. 

  
 26 

 (e) Invention Assignments. Each Party hereby assigns to the other Party all of its
right, title and interest in and to the Information and all associated intellectual property rights to be solely owned by the other Party in accordance with this Section 3.6. Each Party hereby assigns to the other Party an undivided one-half
interest in all of its right, title and interest in and to the Information and all associated intellectual property rights to be jointly owned by the other Party in accordance with this Section 3.6. Each Party agrees to take all necessary and
proper acts, and shall cause its employees, Affiliates, contractors and consultants to take such necessary and proper acts, to effectuate the ownership provisions set forth in this Section 3.6, including obtaining all assignments from, and
making all payments to, all the inventors of any invention included within the intellectual property rights referred to in this Section 3.6 as required under its contractual obligations or under any applicable laws. 

ARTICLE IV 

REGULATORY 

4.1 QMS Regulatory Obligations. Except as set forth in Section 4.3(b), as between the Parties, QMS will be responsible for
seeking Regulatory Approvals of Licensed Products in the Territory that have not heretofore been obtained, including any PMA Application, and for maintaining all Regulatory Approval of Licensed Products, in all cases at its expense, and to take all
necessary steps appertaining thereto. QMS will use Commercially Reasonable Efforts to compile, submit, and prosecute in a timely manner, all necessary data, documents and Regulatory Filings (including labeling) in a format acceptable to the FDA.

  
 27 

 4.2 Q-Med Obligations. 

(a) Solesta. 
 (i) Pre-Clinical Studies. In connection with the further development activities conducted pursuant to Article III or as may be required for approval of the Solesta Product in the U.S., Q-Med,
itself or through Third Parties, shall conduct all pre-clinical development activities concerning the biocompatible gel composition containing polymerized and cross-linked hyaluronic acid, derived from a non-animal source, and dextranomer
microspheres used as a Licensed Product (or as an ingredient thereof) that are necessary for achieving Regulatory Approval of such Licensed Product in the U.S. for any indication in the Licensed Field. Q-Med will bear all Development Costs for all
such current pre-clinical studies required to be conducted by the FDA relating to the approval of the first Solesta Product in the U.S. Should FDA require additional pre-clinical studies to be performed, the parties shall share the costs for such
additional pre-clinical studies. 
 (ii) Clinical Studies. Notwithstanding anything herein to the contrary, Q-Med will
continue to conduct the ongoing Solesta PMA Approval Clinical Trial relating to obtaining Regulatory Approval for the Solesta Product in the U.S. and the Solesta PMCS Trial in a timely manner. Q-Med shall, additionally, provide updates to QMS from
time to time concerning the status of the Solesta PMA Approval Clinical Trial and Solesta PMCS Trial, as reasonably requested by QMS. For clarity, such ongoing Solesta PMA Approval Clinical Trial and Solesta PMCS Trial shall not be a Project or
proposed under a Project Plan. The Parties shall share the Development Costs relating to the clinical studies in accordance with and identified on Schedule 4.2(a)(ii) hereto. 

(b) Information. Q-Med shall provide to QMS any information required and reasonably necessary for QMS to prepare or maintain any
Regulatory Approval. 

  
 28 

 4.3 Ownership of Regulatory Approvals. 

(a) [INTENTIONALLY OMITTED]  
 (b) Future Approvals. 
 (i) Solesta. Q-Med will prepare the PMA
Application in a timely manner for the first Solesta Product in the U.S. (the “Solesta PMA”) and will consider in good faith all comments provided by QMS with respect thereto. Q-Med shall appoint QMS, and QMS agrees to be appointed,
as Q-Med’s local agent for purposes of the PMA Application. Final labeling with respect to such Solesta Product shall be subject to the consent of QMS, which shall not be unreasonably withheld, delayed or conditioned. In all events, QMS shall
permit and enable Q-Med to participate in all communications with the FDA with respect to the Solesta PMA. Upon its issuance, Q-Med shall assign the Solesta Product PMA to QMS. 

(ii) Other Licensed Products. All other IDE’s, PMA Applications and other Regulatory Approvals for the sale of Licensed
Products during the Term of this Agreement submitted or amended after the Effective Date shall be prepared and submitted by QMS in its name. 
 (iii) Costs. Except as provided in Subsection 4.2(a) QMS shall bear all Development Costs incurred with respect to achieving Regulatory Approvals of the first Solesta product in the Territory,
including PMA submission fees, and all Development Costs incurred with respect to achieving Regulatory Approval of all other Licensed Products. 
 (iv) Cooperation. Q-Med shall use Commercially Reasonable Efforts to provide Information to QMS to assist QMS to respond to questions from the FDA and other Regulatory Authorities. 

  
 29 

 4.4 Adverse Event Reporting. Promptly after the date hereof, each Party shall develop
and agree upon safety data exchange procedures governing the coordination of collection, investigation, reporting, and exchange of information concerning adverse events, and product complaints involving adverse events, sufficient to permit each
Party to comply with its vigilance and medical device reporting and other legal obligations to the appropriate Regulatory Authorities, including, in the case of Q-Med, any such obligations in respect of other products containing hyaluronic acid that
are manufactured or sold by Q-Med and in respect of the activities related to the Licensed Products undertaken by Q-Med prior to the Effective Date. The safety data exchange procedures will be promptly updated if required by changes in legal
requirements or by agreement between the Parties. QMS shall be responsible for reporting all adverse events to the appropriate Regulatory Authorities in the Territory in accordance with applicable laws and regulatory requirements and for
establishing and maintaining all required files of product complaints and reportable events. QMS shall ensure that its Affiliates and Sublicensees comply with all such reporting obligations. 

ARTICLE V 

COMMERCIALIZATION 
 5.1 Commercialization and Market Launch 
 (a) General. QMS shall use
Commercially Reasonable Efforts to optimize Commercialization of the Licensed Products in the Territory. 
 (b) Deflux
Product and Solesta Product in the Territory. QMS shall undertake the following activities, at appropriate times during the Solesta Product and Deflux Product life cycle: (i) provide a U.S. sales organization to promote the Deflux Product
and the Solesta Product, including sales, sales training and marketing management personnel and product related injection procedure training for users; (ii) conduct marketing programs in the U.S., including advertising and creative development
of visual sales aids, product and disease/defect related public relations, direct mail, media placement, and field marketing events; 

  
 30 

 
(iii) sponsor or provide medical education, advocate development and training relating to the Deflux Product and Solesta Product in the U.S., including support from scientific affairs liaisons;
(iv) seek appropriate reimbursement coding in the U.S., including appropriate billing and coding support to physicians and clinics, and use Commercially Reasonable Efforts to obtain separate product codes issued by, for example, the Centers for
Medicare and Medicaid Services (CMS), and specific procedure codes for the Solesta Product and procedures for use in the Licensed Field in the U.S., including support from account management personnel with appropriate managed care or third party
payor organizations; and (v) to support the market opportunity for the Deflux Product and Solesta Product in the U.S. For purposes of this Section 5.1(b), subsections (i) through (v) above shall be defined as
“Commercialization Activities.” 
 (c) Certain Solesta Product Obligations. Within [*] months of receipt of
Regulatory Approval in the U.S., QMS shall cause the Market Launch for the Solesta Product (or any other time as the Parties may agree upon in writing and subject to receipt by QMS of launch supplies of the Solesta Product from Q-Med ordered under
the QMS Supply Agreement). 
 (d) Other Licensed Products in the Territory. QMS shall use Commercially Reasonable Efforts
to Commercialize any Improvement to the Deflux Product and Solesta Product, and any other Licensed Product, in the U.S. within [*] months (or any other time as the Parties may agree upon in writing) following the grant of Regulatory Approval with
respect thereto. 
 5.2 Performance Requirements and Commercialization Activities for the Deflux Product and Solesta Product
and Improvements thereof. 
 (a) Solesta Product and Improvements in the Territory.  

 
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

 

  
 31 

 (i) Without limiting the foregoing, QMS shall spend not less than an aggregate of U.S. [*]
on Commercialization Activities with respect to the Solesta Product (including Improvements thereof) in the U.S. during the period from the Effective Date through the first anniversary of Market Launch of the Solesta Product in the U.S. less the
expenses for the Solesta PMCS Trial and the Solesta PMA Approval Clinical Trial (collectively, the “Solesta Clinical Trials”) paid by QMS. 
 (ii) In addition, for the initial [*] month period after the [*] anniversary of Market Launch of the Solesta Product in the U.S. QMS shall expend an amount on Commercialization Activities for Solesta
Products (including Improvements thereof) that is not less than [*] of the Net Sales of all such Solesta Products during such [*] month period, less the expenses for the Solesta Clinical Trials paid by QMS. 

(iii) For each subsequent [*] month period, and no later than [*] days prior to the commencement of each such [*] month period, Q-Med
and QMS will in good faith agree upon Unit target sales goals in the Territory for such period, which target, for the first [*] such periods, shall in no event be lower than the higher of [*] in the immediately preceding period. 

(b) INTENTIONALLY OMITTED 
 (c) Deflux Product and Improvements in the Territory. Commencing on [*] and for each subsequent [*] month period, and no later than [*], and [*] days prior to the commencement of each such
subsequent month period, Q-Med and QMS will in good faith agree upon Unit target sales goals in the U.S. for such period, which target, for the first [*] such periods, shall in no event be lower than [*] Units. 

 
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  
 32 

 (d) INTENTIONALLY OMITTED 

(e) Elimination of Minimum Unit Sales Requirements. Notwithstanding the foregoing, if Unit sales of Deflux equal or exceed [*] in
the U.S. for any corresponding [*] month period, then any further minimum Unit sales requirements hereunder will be eliminated for such Product in the U.S. 
 (f) Sales of Other Licensed Products. The Parties will negotiate in good faith the establishment of performance requirements with respect to Commercialization Activities for other Licensed
Products, if any, anywhere in the Territory. 
 5.3 Failure to Commercialize. 

(a) Loss of Exclusivity. If QMS fails timely to expend the amounts required under Sections 5.2(a)(i) or 5.2(a)(ii) above, or fails
in any [*] years to achieve the sales targets set forth in Section 5.2(a)(iii), Q-Med shall have an exclusive right, but not an obligation, at its sole discretion, to convert the license granted under section 2.1 with respect to the Solesta
Product and its Improvements into a non-exclusive license for the balance of the Term. If QMS fails in any [*] years to achieve the sales targets set forth in Section 5.2(c) or 5.2(d), Q-Med shall have the right (the “Sales Shortage
Conversion Right”), but not an obligation, at its sole discretion, to convert the license granted under Section 2.1, with respect to the Deflux Product and its Improvements into a non-exclusive license for the balance of the Term.
Q-Med shall give QMS at least [*] days’ written notice prior to exercising such right (“Conversion Date”). QMS shall thereupon have the right to terminate the Sales Shortage Conversion Right by paying to Q-Med, prior to the
Conversion Date, an amount [*]. 
  
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  
 33 

 (b) Regulatory Approvals. If at any time a license granted hereunder by Q-Med to QMS
with respect to a Licensed Product shall cease to be exclusive, QMS shall take such actions, at the expense of Q-Med, as are within its control as shall be reasonably necessary to enable Q-Med to Commercialize such Licensed Product in the
relevant jurisdiction. 
 5.4 Marketing Plans. Commencing in October, 2009 and thereafter prior to October 31 of
each year, QMS shall submit to Q-Med its regularly prepared annual marketing plans for the Licensed Products for the following year, such plans to include plans relating to the pre-launch, Market Launch, promotion and sale of the Licensed Products,
including the number of sales representatives and the general nature of the marketing and advertising campaigns proposed to be conducted (the “Marketing Plans”). The Marketing Plans shall be designed to fulfill QMS’
undertakings pursuant to this Article V. 
 5.5 Prohibited Marketing and Sales Activities. 

(a) QMS shall cause its and its Affiliates’ and permitted Sublicensees’ sales representatives to Commercialize a Licensed
Product only for use in the Licensed Field. For purposes of clarity, QMS (and its Affiliates and permitted Sublicensees) shall have the right to promote Licensed Products to physicians and medical health care professionals in practice areas other
than gastroenterology and urology, so long as the promotional messages are related to the use of the Licensed Products in the Licensed Field. 

  
 34 

 (b) Each Party shall use Commercially Reasonable Efforts to police the Commercialization of
the Licensed Products to ensure that (i) as to QMS, Licensed Products sold by QMS, its Affiliates and Sublicensees and distributors are not used outside the Licensed Field, and (ii) as to Q-Med, Licensed Products sold by Q-Med, its
Affiliates and sublicensees and distributors are not used in the Licensed Field (in each of (i) and (ii), an “Out of Field Use”). If either Party believes that Licensed Products have been or are being used or Commercialized for
an Out-of-Field Use, such Party, without limiting its rights or remedies otherwise available under this Agreement, shall present the other Party with such evidence of such Out-of-Field Use available to such Party. Subject to the right to dispute
such claim, the other Party shall use Commercially Reasonable Efforts promptly to cause such Out-of-Field Use to cease. 

5.6 Compliance with Laws. Each Party shall, and shall cause its Affiliates and Sublicensees to, comply in all material respects
with all applicable laws, statutes, rules, regulations, ordinances, and compulsory directives, guidances, policies or pronouncements of law, of any Governmental Authority, including the federal Anti-kickback Statute (42 U.S.C. § 1320a-7b(b)),
the administrative simplification provisions of the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. § 1320d et seq.), and the FDCA, and the regulations promulgated pursuant to such laws, and comparable foreign, national,
multi-national, supranational, provincial and local laws, statutes, rules, regulations, ordinances and compulsory directives, guidances, policies or pronouncements of law, of any Governmental Authority (collectively “Laws”) that
pertain to the activities for which such Party is responsible under this Agreement or the QMS Supply Agreement, including maintaining in full force and effect or renewing any permits or applications necessary for such activities. The termination or
expiration of this Agreement shall not relieve either Party of its responsibility to comply in all material respects with any regulatory requirements associated with Licensed Products. 

  
 35 

 5.7 Marketing and Promotion. Commercialization of the Deflux Products and Solesta
Products by QMS shall prominently incorporate the Deflux trademark and the Solesta Trademark, as the case may be. To the extent permitted by Law, and if reasonably practicable, all labeling, packaging and promotional materials for the Licensed
Products shall identify Q-Med as the manufacturer and licensor of such Licensed Products. 
 5.8 Discounting. [*]

 ARTICLE VI 
 CONSIDERATION 
 6.1 [INTENTIONALLY OMITTED] 

6.2 Royalties. QMS shall pay a royalty, following first commercial sale of each Licensed Product by QMS through the expiration of
the last-to-expire issued patent included in the License Agreement and valid on each market, equal to the percentage shown below of Net Sales of the Licensed Products and Improvements thereof as described below (the “Royalties”)
and, thereafter, in accordance with Section 6.4 below. Net Sales shall be determined on an annual basis separately for direct sales by QMS, its Affiliates or Sublicensees but shall then be aggregated (see column (A) and the applicable
Royalty Rate as set forth in column (B)) as follows: 
  

			
	 Deflux

 

	 Annual Net Sales in the Territory

(US$)
	 	Royalty Rate
		
	All	 	[*]

  
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  
 36 

  

			
	 Solesta
  

	 Annual Net Sales in the Territory

(US$)
	 	Royalty Rate
		
	Up to and including [*]	 	[*]
		
	In excess of [*]	 	[*]

 If actual Unit sales in any calendar year were less than the target Unit sales for such year
(“Shortage”), QMS shall also pay Royalties in respect of the Shortage by multiplying the [*] or [*] by the [*] for all [*], and shall pay such Royalty together with the year-end report delivered under Section 6.5 below.

 Royalties for all other Licensed Products and the term for which such royalties shall be payable shall be agreed upon by the
Parties prior to Commercialization of any such Licensed Product. 
 6.3 Royalty Term. 

(a) Royalties shall be payable following the first commercial sale by QMS of the applicable Licensed Product, and
throughout the Term of this Agreement, subject to reduction pursuant to Section 6.4. 
 (b) QMS
acknowledges that Q-Med may not own or control patents covering the Licensed Products throughout the Territory and/or throughout the Term of this Agreement, and agrees that in addition to the license under the Q-Med Patents granted to QMS pursuant
to Section 2.1(a), substantial commercial value has been and will be contributed by the license under Q-Med Information (including know-how) granted to QMS in Section 2.1(a) and the marketing and branding of Licensed Products under the
Q-Med Trademarks. For their mutual 
  
  

	*	 Confidential treatment requested; certain information omitted and filed separately with the SEC.

  
 37 

 
convenience, the Parties have agreed to the royalty rates and payment obligations set forth in Section 6.2, regardless of whether the development, manufacture, use or Commercialization of
such Licensed Products is covered by patents owned or Controlled by Q-Med. 
 6.4 Reduction of Royalties in Certain
Circumstances. Commencing on such date as the Q-Med Patents have expired or have been finally adjudicated invalid by a court of competent jurisdiction, the royalty rates payable under Section 6.2 for Net Sales in the U.S. on a Licensed
Product-by-Licensed Product basis shall be reduced by [*] from the rates otherwise specified in Section 6.2, above. If at such time or thereafter, there exists Substantial Competition in the Territory from a competitor with a product that in
all relevant respects is substantially similar to the Licensed Product, the parties will in good faith discuss whether there is a need to further reduce applicable royalties. As used herein, “Substantial Competition” means that a
Third Party is selling a competing bulking agent product in the Licensed Field that has a material adverse effect on QMS’ sales of such Licensed Product. QMS shall notify Q-Med in writing within ten (10) days after QMS becomes aware of any
Substantial Competition. 
 6.5 Reports and Payments. Commencing immediately with respect to the Deflux Product and
otherwise after the Market Launch of any other Licensed Product, within [*] days after June 30, and [*] days after December 31 of each year, QMS shall deliver to Q-Med reports true and accurate in all material respects providing the
following information on a country-by-country basis and for each Unit size and for the sales tiers set forth in the table in Section 6.2: (a) total number of Units of each such Licensed Product disposed of by QMS, its Affiliates or
Sublicensees during the [*] months then ended; (b) Net Sales; and (c) Royalties payable. All Royalties shall be payable at the times such reports are due to Q-Med. The report for the year 

 
  

	*	 Confidential treatment requested; certain information omitted and filed separately with the SEC.

  
 38 

 
then ended shall include all information required above on a cumulative basis for such year, including any adjustment required in the amount of Royalties payable, including true up with regards
to royalty on sales of the Deflux Product and the Solesta Product in the Territory. 
 6.6 Interest. In addition to any
other remedies available to a Party, any required payment hereunder not made on or before the date specified in this Agreement shall bear interest from the date such payment is due until the date it is actually received by a Party at an annual rate
equal to the rate of interest per annum publicly announced from time to time by JPMorgan Chase Bank as its prime rate in effect on the date such payment is due at its principal office in New York City, plus [*]. 

6.7 Records. QMS, its Affiliates and Sublicensees shall, during the Term and for a period of [*] years thereafter, maintain
complete and accurate books and records of account relating to the sale of the Licensed Product in the Territory, the achievement of the milestone events in Section 6.1, and the calculation of Net Sales in sufficient detail to permit the
accurate calculation of the payments due to Q-Med hereunder and their compliance with and adherence to the terms and conditions of this Agreement. 
 6.8 Audits. For the sole purpose of verifying the calculation of Net Sales hereunder, Q-Med shall have the right no more than [*] each year during the Term and for a period of [*] thereafter, to
have an independent certified public accountant reasonably acceptable to QMS examine the relevant books and records of QMS and its Affiliates in the location(s) where such records are maintained by QMS upon reasonable notice and during regular
business hours. Results of such examination shall be made available to QMS. The records and results of such audits shall be deemed Confidential Information of QMS. In the event a determination is made 

 
  

	*	 Confidential treatment requested; certain information omitted and filed separately with the SEC.

  
 39 

 
that Q-Med has been underpaid or has overpaid, QMS or Q-Med, as the case may be, shall promptly pay the amount by which Q-Med was underpaid or overpaid, together with interest thereon as provided
in Section 6.6. The fees and expenses of the accountant performing any verification pursuant to this Section 6.8 shall be paid by Q-Med; provided, that, if a determination is made that the amount paid to Q-Med with respect to any
year was less than [*] of the amount properly due to Q-Med, QMS shall promptly reimburse Q-Med for the reasonable costs, fees and expenses of such examination. 
 6.9 Currency for Payments. All payments by QMS to Q-Med under Article VI (including royalties on sales by QMS’ Affiliates and Sublicensees) shall be made by QMS, and such payments, and all
calculations of Net Sales, shall be made in U.S. Dollars. 
 6.10 Taxes. If QMS or any of its affiliates is required by
Law to withhold and remit any amount to the tax or revenue authorities in the U.S. regarding any payments or royalties, such amount shall be deducted from the amounts to be paid by QMS, and QMS shall notify Q-Med and promptly furnish Q-Med with
copies of any tax certificate or other documentation evidencing such withholding. Each Party agrees to reasonably cooperate with the other Party in claiming exemptions from or collecting such deductions or withholdings under any agreement or treaty
from time to time in effect. Q-Med shall, prior to receiving any payment from QMS or any of its Affiliates provide to QMS: (i) an Internal Revenue Service Form W-8 BEN or W-8ECI evidencing complete exemption from U.S. federal withholding and
(ii) any other forms reasonably requested by QMS to establish any exemption from or reduction in applicable withholding. Q-Med shall update such forms as reasonably requested or required by law. 

 
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  
 40 

 ARTICLE VII 
 INTELLECTUAL PROPERTY 
 7.1 Ownership of Q-Med IP. QMS agrees and
acknowledges that: (a) neither QMS nor its Affiliates or Sublicensees shall have any interest, right, or title in the Q-Med IP, other than the licenses granted in Sections 2.1 and Article III; (b) neither QMS nor its Affiliates or
Sublicensees shall obtain any rights in or to the Q-Med Trademarks through their use in connection with the Licensed Products, other than the licenses granted in Section 2.1; and (c) all goodwill associated with or attached to the Q-Med
Trademarks arising out of the use thereof by QMS, its Affiliates and Sublicensees shall inure to the benefit of Q-Med. Q-Med hereby grants to QMS the right and license during the Term, subject to Section 7.3 below, to operate one or more
websites dedicated to the Commercialization of the Licensed Products using a Q-Med Trademark as its second-level domain name, provided, an employee or other nominee of Q-Med shall at all times be identified with the domain name registrar as
the technical contact and administrative contact of each uniform resource locator associated with such domain name, and such domain name shall be considered a Q-Med Domain Name. Q-Med agrees to maintain registration for such domain names, at the
expense of QMS. 
 7.2 No Contest. QMS agrees that neither QMS nor its Affiliates or Sublicensees will, without the
consent of Q-Med: (a) contest, oppose or challenge, or assist any party in contesting, opposing or challenging, Q-Med’s ownership of the applicable Q-Med Trademarks (or the distinctiveness or validity of the applicable Q-Med Trademarks) or
the Q-Med Patents or otherwise take any action or omit to take any action that interferes with Q-Med’s enforcement, exploitation or protection of the Q-Med Trademarks; (b) register or attempt to register any Q-Med Trademark or Q-Med
Patents in any jurisdiction; (c) oppose Q-Med’s registration of any applicable Q-Med Trademark (alone or with other words or designs) in any jurisdiction; or (d)

  
 41 

 
make any application for or register any trademark, service mark, trade name, business name, domain, URL or any other name, term, design or designation identical, incorporating or confusingly
similar to the Q-Med Trademarks for the applicable Licensed Products; or (e) otherwise challenge in any way Q-Med’s ownership, enforceability or validity of any Q-Med IP. Nothing herein shall preclude QMS from complying with lawfully
issued legal process or requests of Governmental Authorities or for discovery in connection with a Third Party Action, provided QMS promptly notifies Q-Med of the service or receipt of such legal process of discovery request and uses Commercially
Reasonable Efforts to assist any effort undertaken by Q-Med to quash or limit the scope of such process or request, at Q-Med’s expense. 
 7.3 Use of the Q-Med Trademarks. QMS agrees to comply in all material respects with all Laws pertaining to the proper use and designation of the Q-Med Trademarks and in all use of the Q-Med
Trademarks under this Agreement and make Commercially Reasonable Efforts to protect, improve and increase the goodwill and reputation of the Q-Med Trademarks. Additionally to the extent not prohibited by Law, QMS, and its Sublicensees, shall:

 (a) use Commercially Reasonable Efforts to use the Q-Med Trademarks upon or in relation to the Licensed Products and then
only in such manner that the distinctiveness, reputation, and validity of the Q-Med Trademarks shall not be impaired and shall ensure in particular that each Q-Med Trademark is accompanied by words accurately describing the nature of the goods or
services to which it relates; 
 (b) not use any Q-Med Trademark in any proximate relation to vulgar, pornographic, profane or
indecent articles, content or materials or in any other context that might reasonably be viewed as impairing the reputation of the Q-Med Trademark. QMS may not make any use of the Q-Med Trademark in direct or indirect marketing that is not directly
related to the Licensed Field without the prior written consent of Q-Med, which may not be unreasonably withheld or delayed; 

  
 42 

 (c) display the proper form of trademark and service mark notice associated with the Q-Med
Trademarks in accordance with any reasonable instructions received from Q-Med; 
 (d) include where permissible, on any item
which bears a Q-Med Trademark, a statement identifying Q-Med as the owner of such Q-Med Trademark and where possible indicating that QMS or its Affiliate or Sublicensee, as applicable, is an authorized user of such Q-Med Trademark, consistent with
the provisions of Section 5.7; 
 (e) not conduct, without the written consent of Q-Med, any part of its business under a
business name or trade name that incorporates any of the Q-Med Trademarks; 
 (f) neither use nor display any of the Q-Med
Trademarks in such relation to any other mark or marks owned by any Third Party or QMS or its Affiliates as to suggest that the multiple marks constitute a single or composite trademark, service mark, or are under the same proprietorship; and

 (g) to the extent that the use of any of the Q-Med Trademarks violates any controlling law in any jurisdiction within the
Territory, QMS must not commence nor continue any use it has begun, and shall make reasonable efforts to prevent any use that contravenes controlling laws or mores. 
 7.4 Prosecution and Maintenance. Q-Med shall be responsible, at Q-Med’s sole expense, and shall use Commercially Reasonable Efforts, to prepare, file, prosecute, procure, maintain and defend
(in any interference, revocation, opposition or other proceeding challenging validity) all Q-Med Patents, Q-Med Trademarks and Q-Med Domain Names in (a) the Major 

  
 43 

 
Markets and (b) solely with respect to the Q-Med Trademarks, in those jurisdictions within which QMS has applied for Regulatory Approval for purposes of Commercializing the Licensed Product
in such jurisdiction. Q-Med additionally agrees to use Commercially Reasonable Efforts to maintain and defend all Q-Med Patents that have issued for which patent registration has been filed on the Effective Date. 

7.5 Infringement Claims against Third Parties. 
 (a) To the extent either Party becomes aware that any of the Q-Med IP or Joint Patents is being infringed by a Third Party’s manufacture, importation, sale, offer for sale or use of a product in the
Territory, and such actual or suspected infringement does or is reasonably likely to adversely affect the Commercialization of a Licensed Product (the “Infringement”), the Party first having knowledge of such Infringement shall
promptly notify the other in writing. The notice shall set forth the facts of such Infringement in reasonable detail. 
 (b) If
the Infringement is within the Licensed Field (the “Field Infringement”), the Parties shall thereafter consult and cooperate fully to determine a course of action, including the commencement of legal action by either or both
Parties, to terminate any such infringement in accordance with the terms set forth below. If the Infringement is outside the Licensed Field, Q-Med will keep QMS reasonably informed of the status of and the activities in any litigation or settlement
concerning the Q-Med IP, but QMS shall have no right to commence or maintain any Action in respect of such Infringement, nor shall QMS have any right to any proceeds of such Action. 

  
 44 

 (c) Q-Med shall have the first right, but not the obligation, to bring an Action or take
other appropriate steps in respect of the Field Infringement. If Q-Med fails to undertake efforts to investigate a Field Infringement within [*] days after it receives a written request from QMS to do so, or if Q-Med fails to bring an Action to
abate a Field Infringement within [*] days after it receives a written request from QMS to do so, or if Q-Med notifies QMS in writing before such periods expire that Q-Med does not intend to take any action, or if Q-Med discontinues the prosecution
of any such Action after filing, QMS may, in its discretion, and at its cost and expense, undertake such Action as it deems necessary to enforce the Q-Med IP or Joint Patents in respect of such Field Infringement. In no event shall either Party
settle any action referred to in this Section 7.5 with any Third Party if such settlement would materially affect any of the rights of the other Party (as determined by that Party in its reasonable discretion) under this Agreement, without the
prior written approval of the other Party, which approval shall not be unreasonably conditioned, withheld or delayed. 
 (d) In
connection with any Action contemplated under this Section 7.5, the Parties shall cooperate fully and shall provide each other with any information or assistance that either may reasonably request. Each Party shall keep the other informed of
developments in any such Action, including the status of any settlement negotiations and the terms of any offer related thereto. If the enforcing Party reasonably determines that the other Party is an indispensable party to the Action or it would
otherwise be desirable for such other Party to join such Action to obtain a more effective remedy, such other Party shall consent to be joined. In such event, such other Party shall have the right, at its expense, to be represented in that Action by
counsel of its own choice. 
  
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  
 45 

 (e) In an Action with respect to a Field Infringement, all damages, proceeds or other sums
of any recovery under such Action related to such Field Infringement, whether by judgment, award or settlement, shall first be applied to all out-of-pocket costs and expenses, including attorneys fees, incurred by the Party bringing the Action and
next shall be applied to all out-of-pocket costs and expenses incurred by the other Party, if any. All remaining proceeds awarded as compensatory damage shall be considered royalty-bearing Net Sales of Licensed Products and shall be allocated
between Q-Med and QMS pursuant to Article VI above. All other proceeds, including exemplary, statutory or punitive damages, shall be allocated [*] percent ([*]%) to Q-Med and [*] percent ([*]%) to QMS. 

ARTICLE VIII 
 REPRESENTATIONS AND WARRANTIES 
 8.1 Q-Med Representations and
Warranties. Q-Med represents, warrants and covenants, as of the Effective Date, that: 
 (a) Q-Med has the
legal power and right to extend the rights granted to QMS under this Agreement and that it has not made, and throughout the term of this Agreement will not make, any commitments to others inconsistent with such rights; 

(b) Q-Med or one or more of its Affiliates is the sole and exclusive owner of, and has all, subject to such rights as have
been granted pursuant to the Prior Agreements, rights, title and interest in and to the Q-Med Patents and Q-Med Trademarks in the jurisdictions in which such Q-Med Trademarks are registered, free and clear of all liens, security interests, charges,
encumbrances or other adverse claims and Schedule 8.1(c) sets forth a true and complete list of all such Q-Med Trademarks and the jurisdictions in which they are registered; 

 
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  
 46 

 (c) To Q-Med’s knowledge, the clinical trials conducted by Q-Med with
respect to the Deflux Product and Solesta Product were performed in accordance in all material respects with all applicable rules and good clinical practices when they were performed; 

(d) All issued Q-Med Patents and registered Q-Med Trademarks are in full force and effect, all fees required to have been
paid to maintain the validity of such Q-Med Patents and Q-Med Trademarks have been paid and Q-Med has not taken any action intended to result in the abandonment thereof; 

(e) Except for rights that have expired or were terminated in writing prior to the Effective Date and no longer have any
force or effect, and subject to such rights as have been granted pursuant to the Prior Agreements, Q-Med has not granted a right to any Third Party to market, sell, promote, or distribute in the Territory a Licensed Product for use in the Licensed
Field; 
 (f) None of the Q-Med IP, the Solesta Product or the Deflux Product is the subject of any notice or
claim (including pending or, to Q-Med’s knowledge, unasserted, claims) to Q-Med regarding any infringement, misappropriation or misuse of any Third Party IP, and, to the knowledge of Q-Med, no Third Party is infringing any Q-Med IP in respect
of any manufacture, use or sale of any product or process in the Licensed Field or Q-Med Field; 
 (g) Q-Med has
no knowledge that any issued Q-Med Patents that are part of the Q-Med IP are invalid or unenforceable; and Q-Med has not made any claims, which are now outstanding, against a Third Party alleging infringement of any of the Q-Med Patents or Q-Med
Trademarks in the Licensed Field; 

  
 47 

 (h) Neither this Agreement nor the transactions contemplated hereby shall
result in Q-Med granting to any Third Party any right with respect to any Q-Med IP in the Licensed Field or Q-Med being bound by, or subject to, any non-compete or other restriction on the use of the Q-Med IP in the Licensed Field; 

(i) Q-Med has received no notice from any governmental authority to the effect that it has not materially complied with or
is not now in material compliance with material laws and regulations relating to the manufacture, use or sale of the Deflux Product or Solesta Product; 
 (j) There are no claims, actions, suits or other proceedings pending, or to the knowledge of Q-Med, threatened which, would reasonably be expected to materially and adversely affect the ability of Q-Med
to perform its obligations hereunder; 
 (k) Q-Med is duly organized, validly existing and in good standing under
the laws of its jurisdiction of organization and has all requisite corporate power and authority to own and operate its properties and assets, to execute and deliver this Agreement and to perform its obligation hereunder; 

(l) Q-Med’s execution, delivery and performance of this Agreement and the Supply Agreements have been duly authorized
by Q-Med and this Agreement and the Supply Agreements will be, upon its execution and delivery, a valid and binding legal obligation of Q-Med, enforceable in accordance with its terms; 

  
 48 

 (m) The execution, delivery and performance of this Agreement and the Supply
Agreements do not and will not (i) violate, conflict with or result in the breach of any provision of its corporate charter or by-laws (or similar organizational documents) of Q-Med, (ii) violate or conflict with any law or governmental
order applicable to Q-Med or its assets, properties or businesses, or (iii) conflict with, result in a breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under, require
any consent under, or give to others any rights of termination, amendment, acceleration, suspension, revocation or cancellation of, or result in the creation of any encumbrance on any of its outstanding shares of capital stock or any of the assets
or properties of Q-Med pursuant to any note, bond, mortgage, indenture, contract, agreement, lease, sublease, license, permit, franchise or other instrument or arrangement to which it is a party or by which any of Q-Med’s shares of capital
stock or any of Q-Med’s assets or properties is bound or affected including any and all of the Prior Agreement; and 
 (n) Other than as expressly stated in this Agreement, no permit, approval, authorization or consent of any person is required in connection with the execution, delivery and performance by Q-Med of this
Agreement and the QMS Supply Agreement or the consummation of the transactions contemplated hereby; and 
 (o)
The Deflux trademark and the Deflux Product for use in the treatment of VUR in children in the U.S. does not infringe upon any patent or trademark rights of any Third Party. To Q-Med’s knowledge, none of the Q-Med IP, the Deflux Product or the
Solesta Product infringes upon, misappropriates, or misuses the intellectual property rights of any Third Party. 

  
 49 

 8.2 QMS Representations and Warranties. QMS represents, warrants and covenants, as of
the Effective Date, that: 
 (a) QMS is duly organized, validly existing and in good standing under the laws of
its jurisdiction of organization and has all requisite corporate power and authority to own and operate its properties and assets, to execute and deliver this Agreement and to perform its obligation hereunder; 

(b) QMS’ execution, delivery and performance of this Agreement have been duly authorized by QMS and this Agreement
will be, upon its execution and delivery, a valid and binding legal obligation of QMS, enforceable in accordance with its terms; 
 (c) The execution, delivery and performance of this Agreement do not and will not (i) violate, conflict with or result in the breach of any provision of its corporate charter or by-laws (or similar
organizational documents) of QMS, (ii) violate or conflict with any law or governmental order applicable to QMS or its assets, properties or businesses, or (iii) conflict with, result in a breach of, constitute a default (or event which
with the giving of notice or lapse of time, or both, would become a default) under, require any consent under, or give to others any rights of termination, amendment, acceleration, suspension, revocation or cancellation of, or result in the creation
of any encumbrance on any of its outstanding shares of capital stock or any of the assets or properties of QMS pursuant to any note, bond, mortgage, indenture, contract, agreement, lease, sublease, license, permit, franchise or other instrument or
arrangement to which it is a party or by which any of QMS’ shares of capital stock or any of QMS’ assets or properties is bound or affected; and 

  
 50 

 (d) Other than as expressly stated in this Agreement, no permit, approval,
authorization or consent of any person is required in connection with the execution, delivery and performance by QMS of this Agreement or the consummation of the transactions contemplated hereby. 

8.3 Limitations on Warranties. EXCEPT AS EXPRESSLY SET FORTH IN SECTION 8.1 ABOVE, Q-MED HEREBY DISCLAIMS ALL WARRANTIES WITH
RESPECT TO THE Q-MED PATENTS AND THE LICENSED PRODUCT, EITHER EXPRESS OR IMPLIED. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, THERE ARE NO IMPLIED WARRANTIES WHATSOEVER, INCLUDING, WITHOUT LIMTIATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY
OR FITNESS FOR A PARTICULAR PURPOSE. 
 ARTICLE IX 
 INDEMNIFICATION 
 9.1 Q-Med Indemnification. Except to the extent
provided in Sections 9.2 and 9.3, and subject to Section 12.1 below, Q-Med shall indemnify, defend and hold harmless QMS and its Affiliates and Sublicensees, and its and their respective officers, directors, shareholders, successors, assigns,
agents, employees and insurers in such capacity (collectively the “QMS Indemnified Parties”) from and against any and all liabilities, claims, damages, losses or expenses (including reasonable attorneys’ and expert fees and
expenses incurred by QMS) solely in respect of Actions against QMS Indemnified Parties by Third Parties (collectively “QMS Losses”) in respect of, without duplication (including any remedy or indemnification under any other
agreement between the Parties): 
 (a) the breach by Q-Med of any of its representations, warranties, covenants and other
agreements made hereunder; 

  
 51 

 (b) the Commercialization of a Licensed Product by Q-Med, its Affiliates or Third Party
Licensees, including with respect to the Solesta Product or Deflux Product solely occurring prior to the Effective Date; 
 (c)
the infringement, misappropriation or impairment to any Third Party’s intellectual property rights arising out of the exercise by QMS of the rights to Q-Med IP licensed hereunder (including any such claims arising out of the Prior Agreements),
which exercise, with respect to Q-Med Patents and Q-Med Trademarks, occurred solely in those jurisdictions in which such Q-Med IP is registered or from which it is issued; and 
 (d) the use by Q-Med, its Affiliates or Third Party licensees of any Joint Invention or the practice of any Joint Patent pursuant to its rights in Section 3.6(e). 

9.2 QMS Indemnification. Except to the extent provided in Sections 9.1 and 9.3 and subject to Section 12.1 below, QMS shall
indemnify, defend and hold harmless Q-Med and its Affiliates and its and their respective officers, directors, shareholders, successors, assigns, agents, employees and insurers in such capacity (collectively “Q-Med Indemnified
Parties”) from and against any and all liabilities, claims, damages, losses or expenses (including reasonable attorneys’ and expert fees and expenses incurred by Q-Med) solely in respect of Actions against Q-Med Indemnified Parties by
Third Parties (collectively “Q-Med Losses”) in respect of: 
 (a) the breach by QMS of any of its
representations, warranties, covenants or other agreements made hereunder; 

  
 52 

 (b) QMS’ (or its Affiliates’ or Sublicensees’) marketing, use, distribution,
importation, sale, disposition or other Commercialization activities for Licensed Products; 
 (c) the conduct of development
activities by QMS, its Affiliates or Sublicensees under this Agreement; and 
 (d) use by QMS, its Affiliates or Sublicensees of
any Joint Invention or the practice of any Joint Patent pursuant to its rights in Section 3.6(e). 
 9.3 Limitations on
Indemnification. Notwithstanding anything to the contrary set forth elsewhere herein neither Party shall be obligated to indemnify the other Party under Sections 9.1 or 9.2: (a) to the extent any indemnifiable Losses thereunder are caused
by such other Party’s, or its Affiliates’, sublicensees’ or assigns’ negligence, intentional misconduct or breach of such other Party’s obligations, warranties or representations set forth herein; (b) with respect to
any claim by a sublicensee, distributor, wholesaler or other person in the business of purchasing products such as a Licensed Product for resale and not for use; or (c) with respect to any Third Party Action seeking, directly or indirectly, to
recover consequential, incidental, punitive or liquidated damages (collectively “Special Damages”) pursuant to contract with a Party, the terms of which fail to exclude the right of such Third Party to recover such Special Damages,
provided, however, to the extent such contract contains such an exclusionary terms but such terms are avoided or annulled in the Third Party Action under applicable principles of law or equity, the indemnifying Party’s liability shall
equal 50% of the Special Damages awarded therein, and, provided further, that none of the provisions of Section 9.1, Section 9.2 or Section 9.3 shall limit any other rights or remedies either Party may have against the other
under this Agreement in respect of such other Party’s negligence, intentional misconduct or breach of any provision of this Agreement except to the extent any claim or remedy is otherwise expressly barred under the terms of this Agreement.

  
 53 

 9.4 Procedure. The Party seeking indemnification shall provide the indemnifying Party
with written notice of any claim or action within [*] business days of its receipt thereof, and may issue a notice demanding indemnity prior to the commencement of any claim or action, at any time following its receipt of any written communication
threatening a claim or action, and shall afford the indemnifying Party the right to control the defense and settlement of such claim, action or threatened claim or action. A failure by the Party seeking indemnification to give notice and to tender
the defense in a timely manner pursuant to this Section 9.4 shall not limit the obligation of the indemnifying Party under this Article IX, except to the extent such indemnifying Party is materially prejudiced thereby. The Party seeking
indemnification shall provide reasonable assistance to the indemnifying Party in the defense of such claim or action at its own expense. If the defendants in any such action include both Parties, and the indemnified Party concludes that there may be
legal defenses available to it which are different from, additional to, or inconsistent with, those available to the indemnifying Party, the indemnified Party shall have the right to select separate counsel to participate in the defense of such
action on its behalf, and the indemnified Party shall bear the cost and expense of such separate defense, unless and to the extent the Parties otherwise agree or it is determined through dispute resolution hereunder that such costs and expense are
or were required to be indemnified by the indemnifying Party and are or were required to be incurred separately due to such different, additional, or inconsistent defenses. Should the indemnifying Party determine not to defend such claim or action,
the indemnified Party shall have the right to maintain the defense of such claim 
  

 

	*	 Confidential treatment requested; certain information omitted and filed separately with the SEC.

  
 54 

 
or action and the indemnifying Party shall provide reasonable assistance to it in the defense of such claim or action and shall bear the reasonable cost and expense of such defense (including
reasonable attorneys’ fees). Neither Party shall settle any such claim or action in a way that prejudices or adversely impacts the other Party without the prior approval of such other Party (which approval shall not be unreasonably conditioned,
withheld or delayed). Following issuance of a notice of demand for indemnity by the indemnified Party, to the extent requested by the indemnifying Party, the indemnified Party must, as soon as reasonably practicable, discontinue any conduct that
forms the basis for the claim or claims in any such action or threatened action. 
 ARTICLE X 

CONFIDENTIAL INFORMATION 
 10.1 Treatment of Confidential Information. QMS agrees to be subject to the terms of a Confidentiality Agreement, dated as of September 25, 2008, between Oceana Therapeutics, Inc. and Q-Med
(the “Confidentiality Agreement”), the terms of which are incorporated herein by reference; provided, however, following the Effective Date, the Confidentiality Agreement will not apply to QMS’ use of documents and
information concerning Oceana Therapeutics LLC and its Affiliates, the U.S. Business, the ROW Assets and the ROW Liabilities (as such terms are defined in the SPA) (except to the extent that such documents and information contain information related
to Q-Med, its post-Effective Date Affiliates or the Licensed Products or development activities of any of them). Without limiting the effect of the previous sentence, each Party receiving Confidential Information of the other Party shall
(a) maintain in confidence such Confidential Information to the same extent such Party maintains its own proprietary industrial information of similar kind and value (but at a minimum each Party shall use commercially reasonable efforts),
(b) not disclose such Confidential Information to any Third Party without 

  
 55 

 
prior consent of the other Party, and (c) not use such Confidential Information for any purpose except for the purpose for which it was disclosed. “Confidential Information”
means all non-public, proprietary data or information and materials received by either Party from the other Party pursuant to this Agreement that are designated as confidential in writing by the disclosing Party. Notwithstanding the foregoing,
information that is orally, electronically or visually disclosed by a Party, or is disclosed in writing without an appropriate letter, stamp or legend, shall constitute Confidential Information of a Party (i) if the disclosing Party, within
thirty (30) days after such disclosure, delivers to the other Party a written document describing the information and referencing the place and date of such oral, visual, electronic or written disclosure and the names of the persons to whom
such disclosure was made, or (ii) such information is of the type that is customarily considered to be confidential information by persons engaged in activities that are substantially similar to the activities being engaged in by the Parties.
QMS further agrees to cause each person who is member of or who has the right to observe meetings of its board of directors or other governing body, who is an employee, officer, director, partner, or member of or consultant to an investment company,
whether or not registered under the Investment Company Act of 1940, that would be an Affiliate of QMS but for the last sentence of the definition thereof, to execute a non-disclosure and confidentiality agreement substantially in the form annexed
hereto as Schedule D. 
 10.2 Exceptions. A Party shall not have the obligations set forth in Section 10.1 with
respect to any portion of such Confidential Information that it can show by adequate documentation: (a) is publicly disclosed by the disclosing Party, either before or after it becomes known to the receiving Party; (b) was known to the
receiving Party, without obligation to keep it confidential, prior to when it was received from the disclosing Party; (c) is subsequently 

  
 56 

 
disclosed to the receiving Party by a Third Party lawfully in possession thereof without obligation to keep it confidential; (d) has been lawfully published by a Third Party; or (e) has
been independently developed by the receiving Party without the aid, application or use of Confidential Information. Information that is otherwise Confidential Information and consists of a combination of information shall not be deemed to be in the
public domain if individual elements of such information are in the public domain, unless the specific combination of those elements is also in the public domain. 
 10.3 Required Disclosures. This Article X shall not be construed to prohibit disclosure of Confidential Information to the extent that such disclosure is required to by law or valid order of a
court or other governmental authority; provided, that the responding Party shall first have given notice to the other Party and shall have made a reasonable effort to obtain a protective order requiring that the Confidential Information so disclosed
be used only for the purposes for which the order was issued. 
 10.4 Permitted Disclosures. Nothing contained herein
shall prevent either Party from disclosing information to the extent such information is required to be disclosed (a) for the purposes of QMS’ compliance with governmental regulations, or (b) to Sublicensees for the purpose of
sublicensing; provided, that the Sublicensee is subject to confidentiality obligations commensurate with those in this Article X. 
 10.5 Disclosure of Financial and Other Terms. Except as required by applicable laws, treaties, and regulations (including securities laws), the Parties agree that the terms of this Agreement will
be considered Confidential Information of both Parties. Notwithstanding the foregoing, (a) either Party may disclose such terms as are required to be disclosed in its publicly-filed financial statements or other public statements pursuant to
applicable laws, regulations, and 

  
 57 

 
stock exchange rules (e.g., the U.S. Securities and Exchange Commission, Nasdaq OMX Nordic Exchange in Stockholm, or any other stock exchange on which securities issued by either Party may be
issued) or otherwise disclosed pursuant to applicable law; provided, that (i) the terms of this Agreement shall be redacted to the greatest extent reasonably possible and (ii) to the extent practicable under the circumstances, such
Party shall provide the other Party with a copy of the proposed text of such statements or disclosure (including any exhibits containing this Agreement) sufficiently in advance of the scheduled release or publication thereof to afford such other
Party a reasonable opportunity to review and comment upon the proposed text (including redacted versions of this Agreement), (b) either Party shall have the further right to disclose the material financial terms of this Agreement under
confidentiality undertakings to any actual or potential acquirer, merger partner, or providers of financing (whether in the form of debt, equity or otherwise) and their advisors, and (c) either Party shall have the right to disclose information
regarding the development and Commercialization status of the Licensed Products to the extent such disclosure is made under a confidentiality undertaking to actual or prospective investors, or required by applicable Laws or stock exchange rules.
Neither Party shall make any other statement to the public regarding the execution and/or any other aspect of the subject matter of this Agreement, except: (x) where a Party reasonably believes disclosure is required under applicable laws or
ethical commercial practice, (y) for customary discussions with current or prospective investors and analysts, and (z) either Party may disclose the content of or use the text of a statement previously approved by the other Party or
otherwise publicly disclosed in accordance with this Article X. 

  
 58 

 10.6 Publicity. Promptly following the execution of this Agreement, the Parties shall
issue a mutually agreed upon press release. Except for subsequent disclosures of substantially similar information or disclosures required by law, regulation or stock exchange requirements, neither Party shall have the right to make any other public
announcements with respect to this Agreement without the prior written consent of the other Party, which consent shall not be unreasonably withheld, delayed or conditioned, except as provided in this Section 10.6. The Parties agree that any
announcement made in respect of this Agreement shall not contain the other Party’s Confidential Information or, if disclosure of Confidential Information is required by law or regulation, shall make reasonable efforts to minimize such
disclosure and obtain confidential treatment for any such information which is disclosed to a government agency, it being understood that the other Party shall have the right, to the extent in accordance with applicable law, to review such
Party’s disclosures to government agencies and require redaction of any information the other Party reasonably deems inappropriate for disclosure, including key financial terms not previously disclosed as permitted hereunder. Subject to
applicable law and stock exchange requirements, each Party agrees to provide the other Party with a copy of any public announcement as far in advance of its scheduled release as reasonably practicable and such other Party shall have the right to
expeditiously review and recommend changes to any announcement regarding this Agreement; provided, that such right of review and recommendation shall only apply for the first time that specific information is disclosed and shall not apply to
the subsequent disclosure of substantially similar information that has been previously disclosed. 
 ARTICLE XI

 TERMINATION 
 11.1 Term. Unless previously terminated in accordance with this Article XI, this Agreement shall expire on June 30, 2030 (“Initial Term”). Notwithstanding the foregoing, and
with respect to each of the group of Solesta Products and the group of Deflux Products 

  
 59 

 
considered separately, and provided: (a) QMS has made all applicable Sales Milestone payments under Section 2.1(b) of the SPA; and (b) (i) applicable Net Sales for year 2029
in the U.S., or (ii) the average applicable Net Sales for the years 2028 and 2029 in the U.S., is no less than [*] Dollars, the Initial Term, if not so previously terminated, with respect to each such product group will be extended by a period
of an additional ten (10) years from the end of the Initial Term (such Initial Term, as extended, if applicable (or as previously terminated in accordance with this Article XI), being the “Term”). 

11.2 Termination by QMS. QMS may terminate this Agreement, effective upon not less than [*] months’ prior written notice to
Q-Med if all Regulatory Approvals necessary for marketing and sale of the Solesta Product in the U.S. have not been achieved by [*], or at any time upon not less than [*] month’s prior written notice to Q-Med given following the [*] anniversary
of the Market Launch of the Solesta Product. 
 11.3 Termination for Default. If either Party (“Breaching
Party”) commits a material breach of a material obligation under this Agreement, the other Party (“Terminating Party”) may terminate this Agreement. The Terminating Party shall provide written notice to the Breaching Party,
which notice shall identify the material breach and the intent to so terminate. The Breaching Party shall have a period of [*] days [*] days in respect of any payment default, other than disputes in good faith that are diligently pursued) after such
written notice is provided to cure such material breach. If such material breach is not cured within such [*] (or [*] days as the case may be), or if such material breach is not capable of cure, the Terminating Party may terminate this Agreement,
and all of the Breaching Party’s rights hereunder, upon [*] days written notice to the Breaching Party. To the extent such breach is a 
  

 

	*	 Confidential treatment requested; certain information omitted and filed separately with the SEC.

  
 60 

 material breach by QMS and relates to its obligations hereunder in one or more countries other than the
U.S., but not the entire Territory, and/or is limited to one or more Licensed Products, but not all of QMS’ obligations generally, such termination shall apply solely to QMS’ rights in such country or countries and with respect to such
Licensed Product or Licensed Products. All of the foregoing in this Section 11.3 shall not apply to a failure by QMS to perform its obligations under Sections 5.2(a)–(d) if Q-Med has exercised its rights under Section 5.3(a) above.

 11.4 Termination Upon Bankruptcy or Insolvency. The Parties agree that in the event a Party becomes a debtor under
Title 11 of the U.S. Code (“Title 11”), this Agreement shall be deemed to be, for purposes of Section 365(n) of Title 11, a license to rights to “intellectual property” as defined therein. Each Party as a licensee hereunder
shall have the rights and elections as specified in Title 11. Any agreements supplemental hereto shall be deemed to be “agreements supplementary to” this Agreement for purposes of Section 365(n) of Title 11. 

11.5 Termination of the Supply Agreements. If either Supply Agreement is validly terminated, the Terminating Party (as defined in
such Supply Agreement) thereunder may terminate this Agreement simultaneously with such termination of such Supply Agreement. 

11.6 Termination for Patent Challenge. If QMS or any of its Affiliates commences or otherwise, directly or indirectly, pursues (or
voluntarily assists Third Parties to do so, other than as required by Law or legal process) any proceeding seeking to have any of the Q-Med Patents or other Q-Med IP revoked or declared invalid, unpatentable, or unenforceable, Q-Med may declare a
material breach hereunder and shall then have the right to terminate this Agreement with immediate effect and without further notice or right to cure. 

  
 61 

 11.7 Effect of Termination. 

(a) Termination of this Agreement, for whatever reason, shall not affect any rights or obligations accrued by either party prior to the
effective date of termination. The following provisions shall survive any expiration or termination of this Agreement: Sections 3.6, 6.7, 6.8, 7.1-7.3, inclusive, 8.3, Article IX, Article X, this Section 11.7, and Article XII. Termination is
not the sole remedy under this Agreement and, whether or not termination is effected, all other remedies will remain available, except as agreed to or otherwise expressly provided for herein. 

(b) Upon termination of this Agreement: 
 (i) all rights and licenses granted by Q-Med to QMS shall terminate, except to the extent provided in Sections 11.4; 
 (ii) QMS shall assign or transfer, at Q-Med’s cost and expense, to Q-Med all Regulatory Filings and Regulatory Approvals and all Information Controlled by QMS that relates solely to the Licensed
Products, or, if such assignment is not legally permissible or such filings, approvals and Information do not relate solely to the Licensed Products, grant Q-Med the exclusive license and right to access, use, and cross-reference such filings,
approvals and Information for the development and Commercialization of the Licensed Products; 
 (iii) QMS shall assign or
otherwise grant, at Q-Med’s cost and expense, all rights required to be assigned or granted under this Section 11.7 promptly and shall promptly (but not later than sixty (60) days following the effective date of termination) transfer
all tangible embodiments to which Q-Med has rights under this Section 11.7; 
 (iv) QMS shall cooperate, at Q-Med’s
cost and expense, in any reasonable manner requested by Q-Med to achieve a smooth and expeditious transition of the Commercialization of the Licensed Products to Q-Med or its licensees; and 

  
 62 

 (v) Each of QMS and Q-Med will immediately at its expense return to the other Party all
proprietary and confidential documents, work papers and other material of the other Party and its Affiliates relating to the transactions contemplated hereby obtained from that other Party or its Affiliates pursuant to this Agreement, whether so
obtained before or after the execution hereof, and all copies, extracts or other reproductions, in whole or in part thereof which may have been made by or on behalf of QMS or Q-Med or their respective representatives, as the case may be, and shall
deliver to the other Party or destroy all notes or memorandum or other stored information of any kind containing, reflecting or derived from such documents, work papers and other material, except that one archival copy may be retained by each
Party’s outside counsel or in-house counsel. The return or destruction, as applicable, of such documents, work papers and other material (and all copies, extracts or other reproductions in whole or in part thereof) pursuant to this
Section 11.7(b)(v) shall be certified in writing by an authorized officer supervising the same. Notwithstanding such return or destruction, each Party will continue to be bound by its obligations of confidentiality under Article X herein.

 ARTICLE XII 
 MISCELLANEOUS 
 12.1 Disclaimers. IN NO EVENT SHALL EITHER PARTY OR
THEIR AFFILIATES BE LIABLE FOR SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES OF THE OTHER PARTY OR THEIR AFFILIATES, WHETHER BASED ON CONTRACT, TORT OR ANY OTHER LEGAL THEORY; provided, however, the foregoing shall not
limit the ability of an indemnified Party to recover indemnity of Special Damages paid to Third Parties to the extent permitted under Section 9.3 above; and, provided further, nothing in this Section 12.1 is intended to limit
QMS’ payment obligations under Article VI. The Parties agree that the actual, direct costs incurred to perform development 

  
 63 

 
or Commercialization obligations hereunder that the other Party was obligated but failed to perform (subject to the right of such other Party to cure) shall be deemed to be direct damages and not
subject to this limitation. 
 12.2 Governing Law; Jurisdiction, Arbitration and Venue. This Agreement and the exhibits
and schedules hereto shall be governed by and interpreted and enforced in accordance with the substantive laws of the State of New York, without giving effect to any choice of law or conflict of laws rules or provisions (whether of the State of New
York or any other jurisdiction) that would cause the application of the substantive laws of any jurisdiction other than the State of New York, except that questions affecting the construction and effect of any patent or trademark shall be determined
by the law of the country in which the patent or trademark was granted. Any dispute, controversy or claim arising out of or in connection with this contract, or the breach, termination or invalidity thereof, shall be finally settled by arbitration
in accordance with the Arbitration Rules of the Arbitration Institute of the Stockholm Chamber of Commerce. The arbitral tribunal shall be composed of three (3) arbitrators. The seat of arbitration shall be Stockholm. The language to be used in
the arbitral proceedings shall be English. The foregoing notwithstanding, either Party may commence an Action to seek declaratory or equitable relief to enjoin a breach of threatened breach of this Agreement, which Action shall be brought solely in
the United States District Court for the Southern District of New York. 
 12.3 Consent to Jurisdiction. EACH PARTY
HERETO IRREVOCABLY AND UNCONDITIONALLY (A) SUBMITS, FOR ITSELF AND ITS PROPERTY, TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK WITH RESPECT TO ANY CLAIM SEEKING

  
 64 

 
DECLARATORY OR EQUITABLE RELIEF ARISING UNDER OR RELATING TO THIS AGREEMENT; PROVIDED, HOWEVER, THAT SUCH CONSENT TO JURISDICTION IS SOLELY FOR THE PURPOSE REFERRED TO IN THIS
SECTION 12.3 AND SHALL NOT BE DEEMED TO BE A GENERAL SUBMISSION TO THE JURISDICTION OF SAID COURT OR IN THE STATE OF NEW YORK OTHER THAN FOR SUCH PURPOSE, (B) WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS UPON IT, (C) CONSENTS THAT ALL
SERVICES OF PROCESS BE MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, DIRECTED TO IT AT ITS ADDRESS AS SET FORTH IN SECTION 12.6, AND (D) ACKNOWLEDGES THAT SERVICE SO MADE SHALL BE TREATED AS COMPLETED WHEN RECEIVED. EACH PARTY
HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE BASED ON FORUM NON CONVENIENS AND WAIVES ANY OBJECTION TO VENUE OF ANY ACTION INSTITUTED HEREUNDER. NOTHING IN THIS SECTION SHALL
AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. 
 12.4 Assignment.
Neither this Agreement nor any of the rights and obligations arising hereunder may be assigned or transferred by either Party by merger, sale of stock or assets, operation of law or otherwise, without the prior written consent of the other Party,
which shall not be unreasonably conditioned, withheld or delayed; provided, however, that (a) QMS may assign this Agreement without such consent in connection with the sale or transfer of all or substantially all of the business or
assets relating to or associated with the Licensed Field to any Third Party, whether by merger, sale of stock or assets, operation of law or otherwise, provided  

  
 65 

 
that such assignment occurs in connection with a substantially contemporaneous permitted assignment of the Ireland License Agreement to the same assignee, (b) the stock of QMS, or QMS’
interest in this Agreement may be collaterally pledged without such consent to a financial institution or syndicate of financial institutions represented by a single lenders’ agent to secure obligations to such lender(s) in connection with a
bona fide financing (the “QMS Pledge”), which pledge will include the right of the lender(s) and their assigns to foreclose upon such pledge, provided that such pledge occurs in connection with a substantially contemporaneous
permitted pledge of at least 65% of the voting stock of Cetacea Limited (“Cetacea Control Stock”) to the same lenders represented by the same lenders’ agent (the “Cetacea Pledge”), and provided further
that, notwithstanding any other provision hereof, unless such lenders foreclose upon both the QMS Pledge and the Cetacea Pledge, and at all times after any such foreclosure the assignee of QMS’ interest in this Agreement is also the owner of
the Cetacea Control Stock or an affiliate thereof, this Agreement shall immediately terminate upon notice thereof from Q-Med to QMS, and (c) Q-Med may assign this Agreement without such consent to any Third Party which acquires all or
substantially all of Q-Med’s NASHA DX business, whether by merger, sale of stock or assets, operation of law or otherwise, provided that such assignment occurs in connection with a substantially contemporaneous permitted assignment by
Q-Med of the Ireland License Agreement to the same assignee. Any attempted assignment, sale or transfer in violation of the prior sentence will be void. Upon any permitted assignment or transfer of this Agreement by either Party, (i) the other
Party shall be given prompt written notice of such assignment and (ii) the assignee shall agree in writing to be bound by the terms and conditions set forth herein. Notwithstanding the foregoing, either Party may assign this Agreement to any
Affiliate of such Party; provided, that such Affiliate assumes such assignment in writing to the other Party and the assigning Party shall remain joint and severally liable with such Affiliate for all of its obligations under this Agreement.

  
 66 

 12.5 Change of Control. 

(a) Definition of Change of Control. For the purpose of this Section 12.5, “Change of Control” means:
(i) a sale to a Third Person reasonably determined in good faith by Q-Med to be then competing with Q-Med of all or substantially all of QMS’ assets; (ii) a merger, reorganization or consolidation involving QMS or any of its
Affiliates and such Third Person in which the stockholders or any Affiliate of QMS immediately prior to such transaction cease to own, directly or indirectly, collectively a majority of the voting or equity rights or interests of a successor entity
to QMS; or (iii) the acquisition, directly or indirectly through one or more Affiliates, by such Person or group of Persons (including such Third Person reasonably determined in good faith to be competing with Q-Med) acting in concert of 50% or
more of the voting or equity rights or interests of QMS. 
 (b) Effect of Change of Control. Upon the Change of Control,
Q-Med may: (i) terminate all rights to any Improvements that are thereafter acquired or developed by Q-Med (other than those described in (ii) below), and (ii) terminate all further development under Article III, except the completion
of development and obtaining Regulatory Approvals for such Licensed Products and Improvements for which IDE’s were then in effect, including the development and Regulatory Approval contemplated hereunder for the Solesta Product. 

12.6 Notice. Any notice to be given by one Party to the other shall be in writing and shall be deemed given when delivered
personally (such notice to be effective on the date of delivery) or sent by reputable international courier (such notice to be effective on the date which is three (3) Business Days after the date of delivery to such courier), or sent by
facsimile (such 

  
 67 

 
facsimile notice to be effective upon receipt of confirmation (a) on the date so confirmed if prior to 5 p.m. local time on a local Business Day, or (b) if not so confirmed prior to 5
p.m. local time on a local business day, the following Business Day), and addressed as follows (or to such other address as a Party may designate as to itself by written notice to the other Party): 

If to Q-Med: 

Q-Med AB 

Seminariegatan 21 
 SE-752 28 Uppsala 
 Sweden 

Attention: Director Legal Affairs 
 Telephone: +46 18 474 90 00 
 Facsimile: +46 18 474 90 97 

With a copy to (which shall not constitute notice for purposes hereunder): 

Michael Martell, Esq. 
 Morrison Cohen LLP 
 909 Third Avenue, 27th Floor 

New York, New York 10022 
 USA 
 Telephone: +01 212 735 8652 

Facsimile: +01 212 735 8600 
 If to QMS: 
 Q-Med Scandinavia Inc. 

2035 Lincoln Highway 
 Edison, NJ 08817 
 Attention: Steven M. Bosacki 

Telephone: +1 732 318 3811 
 Telefax: +1 732 318 3801 
 With a copy to (which shall not constitute notice for
purposes hereunder): 
 Milbank, Tweed, Hadley & McCloy LLP 

One Chase Manhattan Plaza 
 New York, NY 10005-1413 
 Attention: Robert S. Reder, Esq. 

Telephone: +1 212 530 5680 
 Telefax: +1 212 822 5680 

  
 68 

 12.7 Force Majeure. Neither Party shall be responsible or liable in any way for
failure or delay in carrying out the terms of this Agreement (other than any payment or confidentiality obligations) resulting from any cause or circumstance beyond its reasonable control, including acts of God, embargoes, fire, flood, other natural
disasters, war, labor difficulties, interruption of transit, accident, explosion, civil commotion, delays in performance or supplies from its suppliers and subcontractors (where such delays in performance or supplies are attributable to an event of
force majeure suffered by such supplier or subcontractor) and acts of any governmental authority (“Force Majeure”); provided, that the Party so affected shall give prompt notice thereof to the other including the period for
which the Force Majeure is expected to continue . Any time for performance hereunder (other than any time for payment) shall be extended by the actual time of delay caused by the Force Majeure event. Except as provided in the preceding sentence, no
such failure or delay shall terminate this Agreement, and each Party shall use its Commercially Reasonable Efforts to mitigate any damages incurred by the other Party as a result of the Force Majeure event and to complete its obligations hereunder
as promptly as reasonably practicable following cessation of the cause or circumstances of such failure or delay. 
 12.8
Amendment. This Agreement may be modified or amended only by written agreement of the Parties hereto signed by authorized representatives of the Parties hereto and specifically referencing this Agreement. 

12.9 Entire Agreement. This Agreement together with the QMS Supply Agreement and the Quality Agreement, each of their appendices,
exhibits, schedules and certificates, and all documents and certificates delivered or contemplated in connection herewith and therewith constitute the entire agreement between the Parties with respect to the subject matter hereof and

  
 69 

 
supersede all prior agreements, representations or understandings of the Parties relating thereto. There are no other representations, oral or written, except as set forth herein, or when the
Parties are relying to enter into this Agreement. 
 12.10 Severability. The provisions of this Agreement are severable,
and in the event that any provisions of this Agreement shall be determined to be invalid or unenforceable under any controlling body of the law in any jurisdiction or jurisdictions within the Territory, such invalidity or unenforceability shall not
in any way affect the validity or enforceability of the remaining provisions of this Agreement in such jurisdiction, provided that the essential purpose of this Agreement is not frustrated. 

12.11 Expenses. Q-Med and QMS will each bear their own expenses and the expenses of their respective Affiliates incurred in
connection with the negotiation and preparation of this Agreement and, except as set forth in this Agreement, the performance of the obligations contemplated hereby. In connection with any Action brought to enforce or invalidate any right or
obligation arising hereunder, the Party against whom a judgment is entered shall, in addition to any other remedy awarded, be obligated to pay the prevailing Party all costs and expenses of its prosecution or defense of such Action, including
attorneys’ fees. 
 12.12 Further Actions. Q-Med and QMS each hereby agrees to use all reasonable efforts to take,
or cause to be taken, all actions and to do, or cause to be done, all things necessary or proper and execute and deliver such documents and other papers as may be required to make effective the transactions contemplated by this Agreement.

 12.13 Waiver. Any term or provision of this Agreement may be waived at any time by the Party entitled to the benefit
thereof only by a written instrument executed by such Party. No delay on the part of Q-Med or QMS in exercising any right, power or privilege hereunder will 

  
 70 

 
operate as a waiver thereof, nor will any waiver on the part of either Q-Med or QMS of any right, power or privilege hereunder operate as a waiver of any other right, power or privilege hereunder
nor will any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder. 

12.14 Relationship of the Parties. The Parties shall each be an independent contractor in the performance of their respective
obligations hereunder, and, the provisions hereof are not intended to create any partnership, joint venture, agency or employment relationship between the Parties. Each Party shall be responsible for and shall comply with all state, local, federal
and foreign laws pertaining to employment taxes, income withholding and other employment related statutes applicable to that Party. Except as is expressly set forth herein, neither Party will have any right by virtue of this Agreement to bind the
other Party in any manner whatsoever. 
 12.15 No Third Party Rights. Other than with respect to the rights of the Q-Med
Indemnified Parties and the QMS Indemnified Parties, no provision of this Agreement will be deemed or construed in any way to result in the creation of any rights or obligations in any person not a Party to this Agreement. 

12.16 Construction. This Agreement will be deemed to have been drafted by both Q-Med and QMS and will not be construed against
either Party as the draftsperson hereof. 
 12.17 Enforcement. The Parties agree that irreparable damage would occur in
the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the Parties shall be entitled to specific performance of the terms of this Agreement, this being in
addition to any other remedy to which they are entitled at law or in equity. 

  
 71 

 12.18 Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall be deemed an original, and all of which shall constitute one and the same agreement. 
 12.19 Headings.
The heading references herein are for convenience purposes only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. 

12.20 Appendices, Exhibits, Schedules and Certificates. Each appendix, exhibit, schedule and certificate attached hereto is
incorporated herein by reference and made a part of this Agreement. 
 [Remainder of Page Intentionally Left Blank]

  
 72 

 IN WITNESS WHEREOF, the Parties execute this Agreement as of the Effective Date.

  

									
	Q-MED AB	 		 	Q-MED SCANDINAVIA INC.
					
	By:	 	 /s/Bengt Agerup
	 		 	By:	 	 /s/ Carina Bolin

					
	Name:	 	Bengt Agerup	 		 	Name:	 	Carina Bolin
					
	Title:	 	CEO	 		 	Title:	 	Vice President

  
 73 

 SCHEDULE A 

[*] 
  

 

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

 SCHEDULE B 

[*] 
  

 

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

 SCHEDULE C 

[*] 
  

 

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

 SCHEDULE D 

STRICTLY CONFIDENTIAL 
 FORM OF CONFIDENTIALITY AGREEMENT 
 (Individual) 

CONFIDENTIALITY AGREEMENT, dated as of             , 2009 (this
“Agreement”), by and between from Q-Med AB, a company formed under the laws of Sweden (the “Company”), and [INDIVIDUAL], an individual located at [ADDRESS OF INDIVIDUAL] (the
“Recipient”). 
  

	 	A.	WHEREAS, pursuant to a Stock Purchase Agreement (the “Purchase Agreement”) dated as of April [__], 2009, [Oceana Therapeutics LLC], a
Delaware limited liability company (“Buyer”), has acquired the stock of Q-Med Scandinavia Inc., a Delaware corporation (“QMS”), from the Company. 

 

	 	B.	WHEREAS, after giving effect to the acquisition contemplated by the Purchase Agreement, the Company has and will continue to develop and manufacture certain products
and, as a result, pursuant to a Supply Agreement to be entered into between Buyer and the Company (the “Supply Agreement”), Buyer and certain of its affiliates have had and will continue to have access to certain non-public,
proprietary information of the Company. 

  

	 	C.	WHEREAS, as a condition to the Company entering into the Purchase Agreement, the Company is requiring that certain persons, including Recipient, who is or will become a
member of or observer to the board of directors or board of managers of Buyer or any of its subsidiaries (including, without limitation, QMS), enter into this Agreement to ensure that certain proprietary information remain confidential and retains
its commercial value. 

 NOW, THEREFORE, in consideration of the foregoing premises and the respective
representations and warranties, covenants and agreements contained herein, the parties hereto agree as follows: 
 1.
Definitions. For purpose of this Agreement, the following terms shall have the following meanings: 
 a.
“Commercialization” means any and all activities directed to: (i) marketing, promoting, distributing, importing, offering to sell and/or selling the Products, including market research, seeking appropriate reimbursement, billing and
coding support for physicians and clinics, product related public relations, planning, detailing, marketing, distribution, creative development of visual sales aids, direct mail, telemarketing and teledetailing, media placement and advertising,
field marketing events, and sales meetings; and (ii) medical affairs support (including medical education programs, medical meetings and educational grants), regulatory affairs and quality assurance support (including adverse event reporting
and post-market surveillance studies, whether for marketing purposes, post-marketing experience investigations, regulatory compliance or as a condition to obtaining, maintaining or amending a regulatory approval). 

 b. “Confidential Material” shall mean any and all Confidential Information, as
that term is defined in the License Agreement by and between the Company and QMS. “Confidential Material” does not include information (i) that is or becomes generally available to the public other than as a result of an act or
omission by Recipient or any of its Representatives, (ii) that Recipient receives or has received on a non-confidential basis from a source other than the Company or any of its Representatives, provided that such source is not known to
Recipient to be subject to a contractual, legal, fiduciary or other obligation of confidentiality with respect to such information or (iii) information which is independently developed, discovered or arrived at by such Recipient without use of
Confidential Material. 
 c. “Licensed Field” means diagnosis, treatment or prevention of (i) urological
indications including urinary and fecal incontinence, (ii) gastroenterology focused indications involving the gastrointestinal tract including umbilical hernia, below, but not including, the vocal chords or (iii) any combination of the
foregoing. 
 d. “Product” means any and all biocompatible gel compositions containing polymerized and cross-linked
hyaluronic acid, derived from a non-animal source, and dextranomer microspheres, and all improvements thereof, that, in all such cases, is a formulation that is capable of being administered by an injection through a needle for use in the Licensed
Field. 
 e. “Representative” means any employee, officer, director, manager, partner, agent, advisor, consultant,
representative or nominee. 
 2. Non-Disclosure; Non-Use. Recipient hereby agrees that the Confidential Material will be
kept confidential and that Recipient will not disclose any of the Confidential Material to any other person and will not use the Confidential Material other than solely in connection with satisfying Recipient’s lawful obligations as a member of
or observer to the board of directors (or equivalent governing body) of the Buyer or any of its subsidiaries (including, without limitation, QMS), as applicable. In any event, Recipient agrees to undertake precautions to safeguard and protect the
confidentiality of the Confidential Material. 
 3. Permitted Disclosure. In the event that Recipient is requested or
required (by oral questions, interrogatories, requests for information or documents in legal, administrative, regulatory or other similar proceedings; subpoena, civil investigative demand or other similar process) to disclose any of the Confidential
Material, Recipient shall provide the Company with prompt written notice of any such request or requirement so that the Company may in its sole discretion seek a protective order or other appropriate remedy and/or waive compliance with the
provisions of this letter agreement. If, in the absence of a protective order or other remedy or the receipt of a waiver by the Company, Recipient is nonetheless legally compelled to disclose Confidential Material, Recipient may, without liability
hereunder, disclose only that portion of the Confidential Material which is legally required to be disclosed, provided that Recipient use reasonable efforts to preserve the confidentiality of the Confidential Material, including, without
limitation, by using commercially reasonable efforts to cooperate with the Company, at the Company’s sole expense, to obtain an appropriate protective order or other reliable assurance that confidential treatment will be accorded the
Confidential Material. 

 4. Injunctive Relief. It is further understood and agreed that money damages would
not be a sufficient remedy for any breach of this Agreement by Recipient and that the Company shall be entitled to equitable relief, including, without limitation, injunction and specific performance, as a remedy for any such breach. Such remedies
shall not be deemed to be the exclusive remedies for a breach by Recipient of this Agreement but shall be in addition to all other remedies available at law or equity to the Company. Recipient further agrees not to raise as a defense or objection to
the request or granting of such relief that any breach of this agreement is or would be compensable by an award of money damages and agree to waive any requirements for the securing or posting of any bond in connection with such remedy. 

5. Waiver. It is understood and agreed that no failure or delay by the Company in exercising any right, power or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or future exercise thereof or the exercise of any other right, power or privilege hereunder. 

6. Term; Reasonableness of Restrictions. Recipient’s obligations under this Agreement shall continue indefinitely and shall
survive any termination hereof. Recipient acknowledges and agrees that the restrictions contained herein are reasonable and necessary to protect the confidentiality and value of the Confidential Material and that Recipient will receive a benefit by
having access thereto. 
 7. Miscellaneous. 
 a. This Agreement is for the benefit of the Company (and its subsidiaries and affiliates), and shall be governed by and construed in accordance with the laws of the state of New York applicable to
agreements made and to be performed entirely within the state of New York, without giving effect to New York principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of the laws of
another jurisdiction. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the courts of the state of New York for any actions, suits or proceedings arising out of or relating to this agreement and
the transactions contemplated hereby (and the parties agree not to commence any action, suit or proceeding relating thereto except in such courts, and further agree that service of any process, summons, notice or document by U.S. registered mail to
your address set forth above shall be effective service of process for any action, suit or proceeding brought against you in any such court). The parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any
action, suit or proceeding arising out of this agreement or the transactions contemplated hereby in the courts of the state of New York, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that
any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum. 
 b. This Agreement
contains the entire agreement between us and you regarding its subject matter and supersedes all prior agreements, understandings, arrangements and discussions between Recipient and the Company regarding such subject matter. 

c. No provision in this Agreement can be waived or amended except by written consent of the Company, which consent shall specifically
refer to this paragraph (or such provision) and explicitly make such waiver or amendment. 

 d. This Agreement may be signed by facsimile and in one or more counterparts, each of which
shall be deemed an original but all of which shall be deemed to constitute a single instrument. 
 [Signature page
follows] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by
their respective authorized officers as of the date first above written. 
  

							
	RECIPIENT	 		 	COMPANY
			
		 		 	Q-MED AB
				
	  
	 		 	By:	 	  

	[NAME OF RECIPIENT]	 		 	Name:	 	
		 		 	Title:	 	

 SCHEDULE 2.1(c) 

NASHA Trademark User Instructions 
 The Deflux® and SolestaTM products are manufactured using
Q-Med’s patented NASHATM technology for the production of the stabilized non-animal hyaluronic acid, also used in all other Q-Med products. The word mark “NASHA” and the design mark depicted at the bottom of this document are both
trademarks owned by Q-Med AB. 
 NASHA Word Mark 
 Instructions for Use 
 In all use of the trademark NASHA, QMS shall clearly indicate that
NASHA is a trademark owned by Q-Med and in using the trademark follow the below instructions. 
  

	 	•	 	 NASHA may only be used in direct conjunction with Deflux and Solesta. 

 

	 	•	 	 In the use of NASHA, in conjunction with Deflux and Solesta, NASHA shall always have a clear function as the trademark for the technology and/or the
gel that is manufactured using the technology, on which Deflux and Solesta are based. 

  

	 	•	 	 NASHA may not be used separately or out of context. 

  

	 	•	 	 Never indicate or imply that NASHA is an acronym or abbreviation of non-animal stabilized hyaluronic acid, or that it “means” stabilized
non-animal hyaluronic acid. If NASHA needs to be “explained”, write: “NASHATM is a patented technology for the production of stabilized non-animal hyaluronic acid” or equivalent. Always write: “stabilized non-animal
hyaluronic acid” and not “non-animal stabilized hyaluronic acid”, in order to avoid the use of NASHATM as an acronym/abbreviation. 

  

	 	•	 	 Always write NASHA in uppercase letters. 

  

	 	•	 	 NASHA with the affixed
® symbol may be used in countries where NASHA has been registered as a trademark. In all other countries, the
TM symbol shall be used, including countries where a trademark application is pending. Use TM also for material intended for international use, if such use includes both countries in which NASHA is registered and countries where it is not.
For status on trademark applications and registrations as of the [DATE], please see Exhibit [INSERT] to the [License Agreement]. 

  

	 	•	 	 The first time NASHA is used on every page of a document or website, use either TM or ® to alert the reader that NASHA is a trademark, like this: “NASHATM” or “NASHA®”. 

  

	 	•	 	 All use of the NASHA trademark shall be accompanied by the wording “NASHATM/®
, is a trademark licensed to QMS Therapeutics, Inc. by Q-Med AB (publ)”, somewhere in the same document. 

 Examples of Acceptable Use 
 NASHA may be used as an adjective, like this: “NASHATM
gel”, “NASHATM technology” or “patented NASHATM technology”. The following phrases are examples of acceptable use of the trademark and may provide guidance. 

 

	 	•	 	 “The
Deflux® product is based on NASHATM gel, consisting of stabilized hyaluronic acid and dextranomer
microspheres.” 

  

	 	•	 	 “The NASHATM gel in SolestaTM includes dextranomer.” 

 

	 	•	 	 “NASHATM gels are produced using a patented biotechnological method and hyaluronic acid of high purity from a non-animal (bacterial) source.
The unique stabilization process used to manufacture the NASHA gel prolongs its residence time (half-life) within the body. NASHA gel contain only the minimum number of cross-links needed to ensure that almost every hyaluronic acid molecule in the
network is connected to another molecule. The structure of the hyaluronic acid in NASHA gels is therefore almost identical to that found in the body, as only about 1% of the molecule is modified.” 

 

	 	•	 	 “NASHATM Gel Half-Life (head line) – The residence time of NASHA gels depends on the size of the gel beads, the degree of hyaluronic acid
cross-linkage, the concentration of stabilized hyaluronic acid in the gel and the presence of inflammatory reactions in the area where it is injected.” 

 

	 	•	 	 “The manufacturing of NASHATM gel is performed under controlled conditions at Q-Med AB, Uppsala, Sweden. The manufacturing includes the
stabilization of hyaluronic acid to form NASHA gel.” 

  

	 	•	 	 “The hyaluronic acid used in the manufacture of NASHATM is biosynthesized from a non-animal source.” 

 

	 	•	 	 “In NASHATM gel, a very low degree of stabilization (less than 1%) has proven sufficient to obtain a product with the desired
properties.” 

  

	 	•	 	 “Q-Med has created the NASHATM technology, a science-based technological platform that makes it possible to design products with special
properties to address different intended uses and patient needs. 

  

	 	•	 	 “The hospital healthcare segment includes products based on NASHATM gels containing dextranomer beads for use in the treatment of urinal and
fecal incontinence.” 

 NASHA Design Mark 
 QMS may only use the design mark (depicted below) on the Deflux and Solesta products labelling as provided by Q-Med under the Supply Agreement. For use in any other context QMS shall acquire Q-Med’s
prior approval in each case. 
  
 

 

  

 SCHEDULE 4.2(a)(ii) 

	1.	Solesta PMA Approval Clinical Trial 

 Title: “Randomized, Subject and Evaluator Blinded, Sham-Controlled, Multi-Center Study to Evaluate Efficacy and Safety of NASHA/Dx for the Treatment of Fecal Incontinence”. Study number
33DA0404. 
 Q-Med and QMS shall each pay one half of the clinical study cost for the PMA study up to the time point for the
primary objective of the study. The total costs are: 
 (i) 2008 – [*]. QMS will pay its portion of these costs ([*]) at
Closing (as defined in the SPA). 
 (ii) 2009 – [*]. QMS will pay one-half of its obligations ([*]) at Closing, and the
remaining one-half ([*]) on November 30, 2009. 
 Any additional study cost for 2008 and 2009 will be paid by Q-Med.

 The remaining study costs (considered to be a post market follow-up) shall be paid by QMS. 

(iii) 2010 – [*]. 
 (iv) 2011 – [*]. 
 (v) 2012 – [*]. 

QMS will pay one-half of its annual obligations under clauses (iii) – (v) on January 31 of the respective year, and
the other half on November 30 of such year. 
  

	2.	Solesta PMCS Trial 

Title: “Open Non-comparative Post-Marketing Multi-Center Study to Evaluate Safety and Efficacy of Solesta for the Treatment of Fecal
Incontinence”. Study number 33DA0605. 
 Q-Med and QMS shall each pay one half of the clinical study cost for the PMCS
study up to the time point for the primary objective of the study. The total costs are: 
 (i) 2008 – [*]. QMS will pay its
portion of these costs ([*]) at Closing. 
 (ii) 2009 – [*]. QMS will pay one-half of its obligations ([*]) at Closing, and
the remaining one-half ([*]) on November 30, 2009. 
  

 

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  

 (iii) 2010 – [*] 

(iv) 2011 – [*] 
 QMS will pay one-half of its annual obligations under clauses (iii) and (iv) on January 31 of the respective year, and the other half on November 30 of such year. 

Any additional study cost for the PMCS Study during 2008–2011 will be paid by Q-Med. 

 
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC. 

  

 SCHEDULE 8.1(c) 
 [*] 
  
  

	*	Confidential treatment requested; certain information omitted and filed separately with the SEC.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}]]